<SEC-DOCUMENT>0000320017-20-000085.txt : 20200813
<SEC-HEADER>0000320017-20-000085.hdr.sgml : 20200813
<ACCEPTANCE-DATETIME>20200813161054
ACCESSION NUMBER:		0000320017-20-000085
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20200630
FILED AS OF DATE:		20200813
DATE AS OF CHANGE:		20200813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALADRIUS BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0000320017
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				222343568
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33650
		FILM NUMBER:		201099417

	BUSINESS ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920
		BUSINESS PHONE:		908-842-0100

	MAIL ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Caladrius Biosciences, Inc.
		DATE OF NAME CHANGE:	20150608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NeoStem, Inc.
		DATE OF NAME CHANGE:	20060906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHASE III MEDICAL INC/DE
		DATE OF NAME CHANGE:	20030819
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>clbs-20200630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:b55a4230-0bd3-4ac9-874e-83b223cb82b0,g:af6da92c-f069-4627-844d-929d63342442,d:2cf061fb46114e1f91cf023e523adb4b--><html xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:clbs="http://www.caladrius.com/20200630" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>clbs-20200630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF80LTEtMS0xLTA_391ac748-be6f-461e-9535-d16560df6db9">0000320017</ix:nonNumeric><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF81LTEtMS0xLTA_9676a208-448f-45bd-a65d-142bc993954c">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF8xNC0xLTEtMS0w_89adf603-3b1d-4c7a-b7e5-7c1f8c0e0703">2020</ix:nonNumeric><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF8xNS0xLTEtMS0w_26041a37-1d92-49e7-9612-89dbd0e26a81">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF8xNi0xLTEtMS0w_137b0d9a-b56f-4575-aab1-a8ad11cbe98b">false</ix:nonNumeric><ix:nonNumeric contextRef="i848cc63cd4a84516a987b6158ef085e8_I20200430" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xMDY5L2ZyYWc6M2JhZTVhOTI3OTllNDg3MmJlYzI2YTM3NWIzY2QzM2IvdGV4dHJlZ2lvbjozYmFlNWE5Mjc5OWU0ODcyYmVjMjZhMzc1YjNjZDMzYl8zODQ4MjkwNjk3MzE4_d6e9a0a5-23aa-4533-8be1-123010056eea">P5Y6M</ix:nonNumeric><ix:nonNumeric contextRef="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xMDY5L2ZyYWc6M2JhZTVhOTI3OTllNDg3MmJlYzI2YTM3NWIzY2QzM2IvdGV4dHJlZ2lvbjozYmFlNWE5Mjc5OWU0ODcyYmVjMjZhMzc1YjNjZDMzYl8zODQ4MjkwNjk3MzI2_bae774c3-c2f4-4a14-b364-86f1bbc2d461">P5Y6M</ix:nonNumeric><ix:nonNumeric contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83OS9mcmFnOmFmOWEyZTQ2NjRmMDQ0ODE5ZWE2NzlhYTdmZDFhODViL3RleHRyZWdpb246YWY5YTJlNDY2NGYwNDQ4MTllYTY3OWFhN2ZkMWE4NWJfMjg_f5904ed7-46b6-40d4-9e58-b19509c7bfb4">P5Y6M</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="clbs-20200630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i993879b12e9c46ef87314fc725152301_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ifb6fff8afda14ce9bec5a2259842ba20_I20200813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i399de42232e340bdada57acc3912526b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6459a8b2bfa4e9082f15bfcaa393a83_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e533b0893054a86bfe347dbdf504805_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2ad58fffd254fa6a207551b32eb272c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i269772cc59a54b0c86ec5c667dd00789_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d672d653e4742d8a45260d9f07da1e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b482ff5b63841c3a4083518a2149ea8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8d9ecc646214e10a6fa5daea1b9058a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dd06004c95043da94c6cdc17a8cfaf3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a63a15d847c4890ab70d804d8c08b3d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i089823aad76040799b9222c0960ec021_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdb421367f6b418eb556790e87e553b9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideecb37c5c654bbdb1037b8614cfe6db_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if60108fc7b4e4965bb4dde5e421bbbe9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d5516dfdf124b3a8d81163650685d21_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7d90e607a71431f993c74e5ab4a5440_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie28f9e36c9ac490fbe91763704341b93_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81c0cb854ba944e884bf1b00aa79f1f3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6473bb916b34426eadad2eb4a6da4c45_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35b49c8bd3db41caab9d777b94e006fa_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4ddd050588b49a880ea307c34a8a2e7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd6315550f8948388dc33311dd0f3a47_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cceac2b4239467bbd9c4ba097a4cca3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia26c7702fea34fd481006912dd3c74c9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40ffe924ff214949875e811de6652307_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i029555c24dfb4f87ba3330c27022e676_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i689a47bf1d5b4d35ae49c687b8e5350e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ca7c31d550e476ca25f4b1ee88a810a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i853de77024f446ae9c1994c45de246d9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3e54a78a6c1475c81756074222ed700_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf7a5efcf6464b84b6908c5a79f851df_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12238a4194304af292dc658a465a9869_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i154ad1efb34e44c493e4cd358f0e3a5e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2f96be1df6e4c74b5d8378edbdd33e5_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaa90470a948448e99d1c0fd28e4ae2f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d54e245b2e5412195f8068f0ed21f5d_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92147aaa2f774770bf474845fc45022b_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2055b13cfd8546fe94673210f1f9a5a1_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaec8a33e801747fba17f3eb0f6415905_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ab690b1ab2746df8e3a13c32d2e3d2c_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0091c8c5e99c4b7285f64866343c8242_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf716bf4e64c42eb93f27e30efd66f84_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a228f73f8ea40d091b343b12607676d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia45d7e7fa98744c99e820d7277685eb7_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa36c77971f34e0e8b157159bb4fe935_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic17110eb863e4e77a7720e0ac50759c1_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85327901e88841e5a13ea69126435f01_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i075dc3333dea40c2b3dea37dbfd62c23_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3039884f741e48f9b0efd984a250fb4f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec42dab4bf014f308c2e8b7cb3366e6a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie90a881e895f4066aca8e8f3ef8d2873_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bdde77f835d486ca4fed2229c62a8a4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd6ef19f18054f819eeb15b3287fbe0a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id046043ef8e444678382caffe7cd0326_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f3e93561fbd44bca60dac0ff1dfeb64_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08e9560f917440508f3a6e5bb1608f07_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie704db0571b14cf290b0bd0ffc4cf0df_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5460b9db956c4914aca35e670e270e39_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f8b8e70272d4ce4a1797485ee724b54_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bf22901ac704008bb0379111f81d35d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad1bde95aa094ca19a60db89e9eea0f6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8f7c328741c458db2fcb7810eb691bd_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b5ff024d164f15800522b18c9be2f1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590dc48391b942189240efd0d0206942_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib05a707433594a25a0606a9575997357_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6668795c6a884dada418bd8caf1a7f54_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic320af918fb24539b5a45cf9f2d8e810_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc243f82141e47c286e480f5a84eb2eb_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ddf56079b524d5fbfac58c6fecb5f39_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id07a4c5e1fc340b1b770d4937c2a3c08_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aaeabe181a943b6a69e23bdc1cfd7d0_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6dbf5e9d75a470d9afc9bc9527aa4d6_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic32d3c882e084aa79bd397aa974b4613_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa079d11b5954062bd47deae009f8794_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia192e319dcd6445490a592f325146563_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b882abb91484bcfb43daf1e92edb3c7_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2baaf7ccbcd1454fb5493e534db9c3e5_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2010021fc3d045089492ab8ba091452b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8caa352b6c734881a00e24477692efc9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i435d817d085a4640b5a6c1464fc2d6c6_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">clbs:IschemicRepairCD34CellTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9cdd25bf88475f8e513d4db47ee846_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51276a8f169f436da9ec48301dcd051a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b8db529f1db479582f2818c75225c64_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i411233e5c6644b1299e6cd2602fff077_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie09e7b16df084c27894b034b50301fc2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52a8a4bbf7814421a7344fbca72e4db2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i380bbd1c1ef540988fa905c4d3a9bbd9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i038f7c88311e4f759817629c9442fb4e_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6840633376a8464bb5028c503efbd70d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id489cdfd5a324069840e47683d89ebd3_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aaa04fcbbd04e748061483302747deb_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7481b7eaae714c60a1ff50e6a622db4d_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60d3cfe6b6ff47e5a543fcfdc2245182_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e4029dd45d4a2e993c6cc753ebd83e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57debf008f6741c6a70e1068fc6fe3c0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d727b490abb4a08b6bc611450220f08_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie87a77d2f0f048cda7eb6a19d339ae3f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcebce19867e4bf9b34357c8eedd8e33_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcb791e9b72843fcb667122a6a337f82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i523ce19cd95244908556f420c606e80b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="office"><xbrli:measure>clbs:office</xbrli:measure></xbrli:unit><xbrli:context id="if91087121ec44256b8962731a81173e2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i899c54667f134030ae5390e6bdd1b0f3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f781bdb8e5f41e99cf7d9a445cea06c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20af34c4f7754a0cb76befe079bbf0c6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic00237ce125744ceb6a8b4882def3994_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabb27bf045414866879a04335d6c62eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i832251079f054ea08f5f541fc8a5f428_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27dbcb6ac24e46399fb67838c65e5bbe_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6ee95ae2dee4705b58d1a3b61eaf330_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc34b6e97fd4ee8b4dd911463597ac5_D20180201-20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6b5f2a163bb41f395f2f166843dc9c1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d2f30f90a5e4e7c836f63de04b42380_D20180201-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06ddd3f40ce1488cb4db1f51b16d53a5_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AprilPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i848cc63cd4a84516a987b6158ef085e8_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AprilPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfde3833e9e746b7bb672ba96a4b144d_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:MayPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:MayPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i798ecf9e15c5435a90a4a4a6b80c21e8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clbs:StockOptionsActivityAxis">clbs:UsEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idccb2e05fee74cb3b8743e49713e31b6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clbs:StockOptionsActivityAxis">clbs:UsEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0f802c6ed3941c18eac0365a12a53e3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clbs:StockOptionsActivityAxis">clbs:UsEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icde65320b8824859b7fc2395f13c2799_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="clbs:StockOptionsActivityAxis">clbs:UsEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f6a0bbceb0d475db409f328331721e3_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ff3343eb5e7446abb32c279fd9ef744_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26dc6f410bb34ef1b20a17e4d3226752_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i573aeb998eaf418389958e830a4fd5b6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fe2517ab39b4e1aa621db4c39dbf740_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibee88ce40a3a47fdab9f0302d0f48d88_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a63f2bc4e742469418ccdee39935e5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if73c2d1f89dc4b9eba1e9511f636f5fa_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f90fb65ff524ed98e292273fda18895_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a5da1d8176f41c3abcf0352434e0dff_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e40117026924a3da318f41263045d8c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieac73b68636a4e2d89630fe927e17eb8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9da5c1afc9a24304ab6103f6095e3e85_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36becd2504164b3aab52d7e8b2b6c31d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e481ed9443b4a88befbcf284f32660a_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id59dd6e8c9f64370960e3b4a0b377a6a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67413a83b057456c9a1af22965e51368_I20170228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5ddb34eb58439ca82e6cd0adcb36c0_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407cfd607b264cfb8ff9e7af6c462f5a_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fbf17ede593415fbc33607b4bbe3350_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb77f2e7779642d2a6eb659130a096f8_D20180301-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcdfcccad39e4c2fa35c49cd9d022159_D20190501-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i928a14f6fa8847b7afd1d223a9a29cc4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29dd98104b1c4e8e92246825600cce61_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7aa8c0b4d6d4e7395c1bdb89f3a9231_D20200421-20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-21</xbrli:startDate><xbrli:endDate>2020-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib917b042859f49cd9af5962cf0b25fe8_D20200710-20200710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-10</xbrli:startDate><xbrli:endDate>2020-07-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i669ac4164c3a4aca9afb03a13773ca45_I20200710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5da6f23879be4c3f9b9ff3c489d244ba_D20200701-20200806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-08-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2cf061fb46114e1f91cf023e523adb4b_1"></div><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UNITED STATES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Washington, D.C. 20549</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">FORM <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDE5_24d470b8-cdaa-4b66-8e4e-67dcf9a85b53">10-Q</ix:nonNumeric></span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:1.367%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:94.633%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ODBjM2JhN2EyMzQxNDM4OGJhNDcyZDdmZmI2ZjBmNjYvdGFibGVyYW5nZTo4MGMzYmE3YTIzNDE0Mzg4YmE0NzJkN2ZmYjZmMGY2Nl8wLTAtMS0xLTEzMzc_15f96836-a69c-4de8-805d-e7ede69f8cde">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">FOR THE QUARTERLY PERIOD ENDED <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDE3_755c2917-a6fe-4c66-9420-36f97b3dc8ac">June&#160;30, 2020</ix:nonNumeric> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">OR</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:0.1%;"></td><td style="width:2.728%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:95.072%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZGU5ZWNhM2ZlZGIxNDk5MThkMGU4NjZjOWQwNmQzMzIvdGFibGVyYW5nZTpkZTllY2EzZmVkYjE0OTkxOGQwZTg2NmM5ZDA2ZDMzMl8wLTAtMS0xLTEzMzk_653c65f3-732d-4da2-9bea-eb58428a6467">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the Transition Period from __________________&#160;&#160;&#160;to _________________________</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Commission File Number <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDIw_27b7917c-9268-40b9-8396-be9d2840a4c2">001-33650</ix:nonNumeric></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDIx_01510d3d-17ed-41da-bac9-16a22e17e3f8">CALADRIUS BIOSCIENCES, INC.</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:52.105%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:43.895%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8wLTAtMS0xLTEzNDM_b805ecd4-2dc1-4a92-8827-4fb558fcbf53">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8wLTEtMS0xLTEzNDU_9ab6ac47-0896-42db-ad9f-a7bd1524b054">22-2343568</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8zLTAtMS0xLTEyMzIvdGV4dHJlZ2lvbjo0M2VkNmNlYTQxY2Q0YmNhYmQ2ZjRmMGI1YTc1MjViNF8zODQ4MjkwNjk3Mjk3_850e8c29-b76e-4149-92a3-5734017f1607">110 Allen Road, 2nd Floor</ix:nonNumeric>, <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8zLTAtMS0xLTEyMzIvdGV4dHJlZ2lvbjo0M2VkNmNlYTQxY2Q0YmNhYmQ2ZjRmMGI1YTc1MjViNF8zODQ4MjkwNjk3MzEy_6359bf0b-c519-4825-886a-ee9a598e2d71">Basking Ridge</ix:nonNumeric>, <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8zLTAtMS0xLTEyMzIvdGV4dHJlZ2lvbjo0M2VkNmNlYTQxY2Q0YmNhYmQ2ZjRmMGI1YTc1MjViNF8zODQ4MjkwNjk3MzI0_4c137d16-a23f-4d14-a17b-4bc44f91dc5b">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8zLTEtMS0xLTEzNDc_224d53ff-1431-4a03-8b0d-4cab38e6e202">07920</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Address of principal executive offices)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(zip code)</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDIz_51da5961-00c8-4ba6-9595-f349811e70fc">908</ix:nonNumeric>-<ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDMy_684494c0-c87f-4c2d-a1c8-294c8219d99e">842-0100</ix:nonNumeric></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:31.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:31.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:31.334%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities registered pursuant to Section 12(b) of the Act:</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol(s)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6YzQxZTgyNDRlYWFkNDY1MjljOGFkMjVmYjhjMmYzMjkvdGFibGVyYW5nZTpjNDFlODI0NGVhYWQ0NjUyOWM4YWQyNWZiOGMyZjMyOV8yLTAtMS0xLTEzNTE_74ba6fa7-ef7f-4942-8bb1-792830f603b3">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6YzQxZTgyNDRlYWFkNDY1MjljOGFkMjVmYjhjMmYzMjkvdGFibGVyYW5nZTpjNDFlODI0NGVhYWQ0NjUyOWM4YWQyNWZiOGMyZjMyOV8yLTEtMS0xLTEzNTM_c207018d-650f-41df-8804-b3cf894c9b57">CLBS</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">The <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6YzQxZTgyNDRlYWFkNDY1MjljOGFkMjVmYjhjMmYzMjkvdGFibGVyYW5nZTpjNDFlODI0NGVhYWQ0NjUyOWM4YWQyNWZiOGMyZjMyOV8yLTItMS0xLTEzNTUvdGV4dHJlZ2lvbjoyN2UwYTYxZjZkZjg0MGRmOWI1NDQxMDg2MjM1NDRhNV8zODQ4MjkwNjk3MjUx_ccb77b7b-e6cb-4427-b9e1-d6674c261bab">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="padding-left:6.75pt;padding-right:2.25pt;text-align:center;margin-bottom:3.3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section 12(g) of the Act:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> None</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:13.5pt;padding-left:6.75pt;padding-right:2.25pt;text-align:justify;margin-bottom:3.3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y180Mzk4MDQ2NTEzMjI1_3d1f84f2-730f-4b4d-91af-6aeb934f769f">Yes</ix:nonNumeric> &#9746;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">No &#9744;</span></div><div style="text-indent:13.5pt;padding-left:6.75pt;padding-right:2.25pt;text-align:justify;margin-bottom:3.3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y180Mzk4MDQ2NTEzMjI2_7b951dd1-79fc-47b9-877b-0032afbd8153">Yes</ix:nonNumeric> &#9746;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">No &#9744;</span></div><div style="text-indent:13.5pt;padding-left:6.75pt;padding-right:2.25pt;text-align:justify;margin-bottom:3.3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:24.900%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.947%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.304%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:24.900%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.949%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Large accelerated filer</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accelerated filer</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6MzMxY2Y1OTg5NzliNGE4NjkzYzE3Y2Y0OTExMjk3ZmEvdGFibGVyYW5nZTozMzFjZjU5ODk3OWI0YTg2OTNjMTdjZjQ5MTEyOTdmYV8xLTAtMS0xLTEzNTk_bac01932-8932-49f1-b817-eb72ecd88836">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9746;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Smaller reporting company</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6MzMxY2Y1OTg5NzliNGE4NjkzYzE3Y2Y0OTExMjk3ZmEvdGFibGVyYW5nZTozMzFjZjU5ODk3OWI0YTg2OTNjMTdjZjQ5MTEyOTdmYV8xLTQtMS0xLTEzNjE_de53fc84-033d-4de1-9b01-5012dac9c420">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Emerging growth company</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6MzMxY2Y1OTg5NzliNGE4NjkzYzE3Y2Y0OTExMjk3ZmEvdGFibGVyYW5nZTozMzFjZjU5ODk3OWI0YTg2OTNjMTdjZjQ5MTEyOTdmYV8yLTQtMS0xLTEzNjM_5ce82093-dab0-4ef1-995f-866c9a38abe3">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#9744;</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Yes&#160;<ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MzA1_90239e67-4a8b-4248-9043-b8d6c117ba8b">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;No&#160;&#9746;</span></div><div style="padding-right:2.25pt;text-align:justify;margin-bottom:3.3pt;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt;"><tr><td style="width:1.0pt;"></td><td style="width:331.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:88.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:88.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Class</span></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding as of Aug 13th, 2020</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock, $0.001 par value per share</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ifb6fff8afda14ce9bec5a2259842ba20_I20200813" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6NWYwZDhjNGJlMzRjNGIwZmFiMzFiM2U0MzYyNThhZWQvdGFibGVyYW5nZTo1ZjBkOGM0YmUzNGM0YjBmYWIzMWIzZTQzNjI1OGFlZF8xLTEtMS0xLTA_a356a3f9-b2b8-4451-8627-bba2b248ac33">19,323,107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">shares</span></td></tr></table></div><div style="text-indent:18pt;padding-right:2.25pt;"><span><br/></span></div><div style="text-indent:18pt;padding-right:2.25pt;text-align:center;margin-bottom:3.3pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="padding-left:9pt;text-align:center;margin-bottom:3.3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This quarterly report (this "Quarterly Report") contains &#8220;forward-looking&#8221; statements within the meaning of the Private Securities Litigation Reform Act of 1995, as well as historical information. When used in this Quarterly Report, statements that are not statements of current or historical fact may be deemed to be forward-looking statements, including, without limitation, all statements&#160; related to any expectations of revenues, expenses, cash flows, earnings or losses from operations, cash required to maintain current and planned operations, capital or other financial items; any statements of the plans, strategies and objectives of management for future operations; any plans or expectations with respect to product research, development and commercialization, including regulatory approvals; any other statements of expectations, plans, intentions or beliefs; and any statements of assumptions underlying any of the foregoing. Without limiting the foregoing, the words &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;forecast,&#8221; &#8220;outlook,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;likely,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue&#8221; or similar expressions or other variations or comparable terminology are intended to identify such forward-looking statements, although some forward-looking statements are expressed differently. We remind readers that forward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown risks that could cause the actual results, performance, levels of activity or our achievements or industry results, to be materially different from any future results, performance, levels of activity or our achievements or industry results expressed or implied by such forward-looking statements. Factors that could cause our actual results to differ materially from anticipated results expressed or implied by forward-looking statements include, among others:</span></div><div style="padding-left:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to obtain sufficient capital or strategic business arrangements to fund our operations and expansion plans, including meeting our financial obligations under various licensing and other strategic arrangements, the funding of our clinical trials for product candidates, and the commercialization of the relevant technology;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to build and maintain the management and human resources infrastructure necessary to support the growth of our business;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">whether a market is established for our cell-based products and services and our ability to capture a meaningful share of this market;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">scientific, regulatory and medical developments beyond our control;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to obtain and maintain, as applicable, appropriate governmental licenses, accreditations or certifications or to comply with healthcare laws and regulations or any other adverse effect or limitations caused by government regulation of our business;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">whether any of our current or future patent applications result in issued patents, the scope of those patents and our ability to obtain and maintain other rights to technology required or desirable for the conduct of our business;&#160;and our ability to commercialize products without infringing upon the claims of third-party patents;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">whether any potential strategic or financial benefits of various licensing agreements will be realized;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">the results of our development activities; </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to complete our other planned clinical trials (or initiate other trials) in accordance with our estimated timelines due to delays associated with enrolling patients due to the novelty of the treatment, the size of the patient population and the need of patients to meet the inclusion criteria of the trial or otherwise; </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">the extent to which the COVID-19 coronavirus may impact our business, including our clinical trials and financial condition; and </span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">other factors discussed in "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 5, 2020 (our "2019 Form 10-K").</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The factors discussed herein, including those risks described in "Item 1A. Risk Factors" and elsewhere in our 2019 Form 10-K and in our other periodic filings with the SEC, which are available for review at </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">www.sec.gov,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> could cause actual results and developments to be materially different from those expressed or implied by such statements. All forward-looking statements attributable to us are expressly qualified in their entirety by these and other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they were made. Except as required by law, we undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div style="margin-bottom:3.3pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="padding-left:9pt;text-align:center;margin-bottom:3.3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">TABLE OF CONTENTS</span></div><div style="padding-left:9pt;text-align:center;margin-top:5pt;margin-bottom:8.3pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%;"><tr><td style="width:1.0%;"></td><td style="width:6.507%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:82.925%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:4.568%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">PART I- FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Page No.</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 1.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_10">Financial Statements:</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_16">Consolidated Balance Sheets at June 30, 2020 (unaudited) and December 31, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_16">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_22">Consolidated Statements of Operations for the three and six months ended June 30, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_25">Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_28">Consolidated Statements of Equity for the three and six months ended June 30, 2020 and 2019 (unaudited) </a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_31">Consolidated Statements of Cash Flows for the six months ended June 30, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_31">10</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Notes to Unaudited Consolidated Financial Statements</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_34">11</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 2.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_82">22</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 3.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Quantitative and Qualitative Disclosures About Market Risk</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_94">28</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 4.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Controls and Procedures</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_97">28</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">PART II- OTHER INFORMATION</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 1.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Legal Proceedings</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_103">30</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 1A.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Risk Factors</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_106">30</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 2.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Unregistered Sales of Equity Securities and Use of Proceeds</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_109">30</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 3.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Defaults Upon Senior Securities</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_112">30</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 4.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Mine Safety Disclosures</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_115">30</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 5.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Other Information</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_118">30</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Item 6.</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Exhibits</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_121">30</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">Signatures</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration: none;" href="#i2cf061fb46114e1f91cf023e523adb4b_124">31</a></span></div></td></tr></table></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PART I. FINANCIAL INFORMATION</span></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM I. FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_13"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 1. CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_16"></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(In thousands, except share data)</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:71.167%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.049%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.051%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ASSETS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMi0xLTEtMS0w_0becc7c9-be0f-4c0e-b134-ae24978da3b3">26,684</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMi0zLTEtMS0w_4ba314fb-b001-4d0c-ab00-93e339f017ff">14,032</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:20.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Marketable securities</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMy0xLTEtMS0w_21339e16-320e-429e-88ff-e0eea65fb643">8,207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMy0zLTEtMS0w_3833fc01-111c-4b6f-b741-fbf9c7189b28">11,125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid and other current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNC0xLTEtMS0w_e9f5657d-6849-48d3-8ddc-6c5f182d2e44">1,735</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNC0zLTEtMS0w_0b813a03-2be3-4887-8115-f3e36a01df42">815</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNS0xLTEtMS0w_cfcc6c11-d3a0-4d49-85d5-e47f7fa9aaf2">36,626</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNS0zLTEtMS0w_9f041065-dc50-41b3-8a02-e7412e2816c0">25,972</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNi0xLTEtMS0w_60c6d645-aee9-4f67-8a64-34f7efbea4c9">83</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNi0zLTEtMS0w_9a934a7d-10c4-40e9-8ae2-857c2c9d8e36">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNy0xLTEtMS0w_a3cadd03-83d1-4a93-96d7-bac910379a7b">772</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNy0zLTEtMS0w_61a71021-09c6-4908-a2ca-be670742eff7">1,081</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfOC0xLTEtMS0w_366cbcbb-9e85-416a-b636-766ae6ef409a">37,481</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfOC0zLTEtMS0w_4230033f-b0dd-445e-93b8-420cd1573841">27,153</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTItMS0xLTEtMA_62bd5ee0-5494-49c8-9996-482e77ce680e">592</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTItMy0xLTEtMA_d1910555-b03f-43b3-a50a-c990a33dd913">1,490</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTMtMS0xLTEtMA_7fa4b2f2-1f59-48b6-9fca-5afe533c7523">2,888</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTMtMy0xLTEtMA_2441ffe3-ee23-477a-9271-bb67fc5fee8a">4,486</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTQtMS0xLTEtMA_3ab4face-2050-4615-8476-53e0eb9cb0b3">3,480</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTQtMy0xLTEtMA_b41c2d73-3b91-4a09-9e0d-5cc6642c4210">5,976</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTUtMS0xLTEtMA_5d07da0c-53c7-42d4-bed6-ad8727fd357c">445</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTUtMy0xLTEtMA_988164a5-51b7-4c44-9cf9-b58e8b5ba954">624</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTYtMS0xLTEtMA_8b3870e0-74ac-4aae-accd-794b5efdace3">3,925</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTYtMy0xLTEtMA_db47e1b9-0fde-4b09-800b-1a44b7de0258">6,600</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitments and Contingencies</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTctMS0xLTEtMA_0ed32e74-bf4f-4201-8594-dd435209ea94"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTctMy0xLTEtMA_77877662-555a-4c1a-a52e-d3ff587b94f5"></ix:nonFraction></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-22.5pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Preferred stock, authorized, <ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc3OTU_1a42e781-41f7-4dc4-8527-d73346b1177d"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc3OTU_5fa9afd8-31f8-4f8b-85d6-0c70015b8936">20,000,000</ix:nonFraction></ix:nonFraction> shares</span></div><div style="padding-left:27pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Series B convertible redeemable preferred stock liquidation value, <ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" name="clbs:PreferredStockLiquidationPreferenceShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MDI_1c8334f4-d3da-4ed5-b018-64f7ccb5d187"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" name="clbs:PreferredStockLiquidationPreferenceShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MDI_89aded8a-5417-4fc3-81ae-7ac50f1fc382">0.001</ix:nonFraction></ix:nonFraction> share of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MDk_a7cf5cfa-4f20-4f0f-ba70-2c25f1342775"><ix:nonFraction unitRef="usdPerShare" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MDk_d3c85725-da9c-400b-b50a-a1f2fdeeeec4">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="clbs:PreferredStockSharesDesignated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MTg_45ae8aa2-e7c0-4a09-9e9d-9a392acc72c9"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="clbs:PreferredStockSharesDesignated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MTg_b8281de7-784d-4352-9f39-43f9d93c3771">825,000</ix:nonFraction></ix:nonFraction> shares designated; issued and outstanding, <ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MjY_0a01b82d-c6d6-4408-81b4-5482866759b7"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MjY_22081a36-6a94-42b3-b418-24e619da16cb"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MjY_62419ce7-40d2-42e2-ac1f-e8666457cd41"><ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MjY_8fcf8c00-3c16-4f32-b002-0411499d47da">10,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares at June 30, 2020 and December 31, 2019, respectively</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMS0xLTEtMA_1766a03f-9dfb-44de-b2e4-dfaaceedba00">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMy0xLTEtMA_df4ff24d-b6a4-45b6-b068-6e1df979e579">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:27pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc1ODc_3ffae40d-3483-45f8-9dfa-3a9042c8f4a7"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc1ODc_7c920fcb-47bc-4721-89b5-4f70760f40fc">0.001</ix:nonFraction></ix:nonFraction> par value, authorized <ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MDA_b10cfae4-7e91-4292-a597-604a064aaeb6"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MDA_f9a4ac45-88e1-4266-99be-2663eb8a2c91">500,000,000</ix:nonFraction></ix:nonFraction> shares; issued and outstanding, <ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MTI_2aff9e76-f0f1-43e1-b8f1-e7298aab2b21"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MTI_b44a5ce8-808e-4001-944e-4542b6a9d3b1">15,585,194</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MjQ_928a13c8-191c-4823-a1dc-a8c41ad7ff3a"><ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MjQ_dce73de5-016a-4f99-8a78-465932ea2991">10,528,689</ix:nonFraction></ix:nonFraction> shares at June 30, 2020 and December 31, 2019, respectively</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMS0xLTEtMA_dbad0c5e-5162-4f7f-8b8c-6e2e40a7e188">16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMy0xLTEtMA_01976da2-2bf7-4715-b6c4-1e4a252334ab">11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional paid-in capital</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjItMS0xLTEtMA_edaf474c-52cc-483e-9747-bc5e22146d9c">449,302</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjItMy0xLTEtMA_65aba412-e621-4f87-9ed7-c9cb4e96b7c1">438,911</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjNjNDQ4OWVlNmZiYjQ4ZDA5NWQ1YTIyYzlkYzA0MTIzXzM4NDgyOTA2OTczMDM_0bb3e62a-4111-4cf4-8860-6829beb613ea"><ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjNjNDQ4OWVlNmZiYjQ4ZDA5NWQ1YTIyYzlkYzA0MTIzXzM4NDgyOTA2OTczMDM_c563b4d0-c06e-44f2-b656-7c8938731b28">11,080</ix:nonFraction></ix:nonFraction> shares at June 30, 2020 and December 31, 2019</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjMtMS0xLTEtMA_7971e7f2-5844-4479-862e-4a5bbf62bcee">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjMtMy0xLTEtMA_20fb149c-21a5-40f6-8817-7459a90aa3a4">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated deficit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjQtMS0xLTEtMA_5f83de30-0e8e-426a-a6e8-e35c3ed6a1b4">414,792</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjQtMy0xLTEtMA_0cdbfd97-aea8-4095-a273-6b480a2558c3">417,400</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjUtMS0xLTEtMA_03e8bec9-02a6-41c3-b19f-4a05d8a9eab4">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjUtMy0xLTEtMA_aceba4f4-cf30-43de-890b-6a079ca6f575">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Caladrius Biosciences, Inc. stockholders' equity</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjYtMS0xLTEtMA_af008d1f-7a43-4b6f-af1a-04b36b5d1478">33,811</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjYtMy0xLTEtMA_d75631a1-04f5-468c-ada3-1e23920b27e5">20,816</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Noncontrolling interests</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" sign="-" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjctMS0xLTEtMA_be8c36b0-a596-4d2b-8592-97257cd6737d">255</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" sign="-" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjctMy0xLTEtMA_0019ae3c-9f08-40a4-954d-6782b994dac7">263</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total stockholders' equity</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjgtMS0xLTEtMA_71222753-5385-4811-88c9-e8c6711dca96">33,556</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjgtMy0xLTEtMA_38e22526-acc3-4f9c-bbbc-d3141a237dd3">20,553</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities and stockholders' equity</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjktMS0xLTEtMA_98572959-9c1f-4a3a-8346-0b02ee2f230a">37,481</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjktMy0xLTEtMA_c22e3fdd-567e-48cf-9697-e86e86aa6a2e">27,153</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See accompanying notes to consolidated financial statements.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;(Unaudited)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(In thousands, except per share data)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:60.134%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.918%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.918%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.918%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.922%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMy0xLTEtMS0w_ba9437d2-fef6-42fd-be6f-31f606109799">1,818</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMy0zLTEtMS0w_cf2b4fdd-6396-4d2b-9b22-695eb812ee02">2,988</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMy01LTEtMS0w_f5ec03a8-ea73-4ba7-96df-43ea8813169b">3,317</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMy03LTEtMS0w_d981b110-9719-47c5-9853-bc54e2012e10">5,026</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General and administrative</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNC0xLTEtMS0w_db94300e-1f7a-4934-9190-8cfed057a412">2,474</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNC0zLTEtMS0w_38b025b3-8c17-4af1-a9d0-9bca25e1e4ea">2,358</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNC01LTEtMS0w_b0fb7ba0-42b8-48b7-90e8-f8dc122bac52">5,032</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNC03LTEtMS0w_ab27d208-1236-4997-b4b9-fff9e585e97f">4,912</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNS0xLTEtMS0w_38f2b27d-43d6-4b58-8665-692f0d063ca6">4,292</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNS0zLTEtMS0w_ba1a37a0-e83d-4555-98f1-08d1efb9524c">5,346</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNS01LTEtMS0w_be656386-20bf-4301-992b-c76cab9a42d3">8,349</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNS03LTEtMS0w_ee99918e-b5bd-483a-96e3-d2ad6dde9c82">9,938</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNy0xLTEtMS0w_5513c670-7097-465e-9636-7eeb7f89af1b">4,292</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNy0zLTEtMS0w_1cd3a36f-29a7-4910-98a5-03f48897dc8c">5,346</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNy01LTEtMS0w_301f2f18-3b6a-4bf1-a2e1-7788f3c3b8e5">8,349</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNy03LTEtMS0w_b90c58c6-fed1-457a-85de-bfa3c1e1c164">9,938</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Investment income, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTAtMS0xLTEtMA_f51478df-1319-4df3-937a-7da8d0d6d626">22</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTAtMy0xLTEtMA_27455188-83f7-4a87-a620-cf7cfccee6e7">209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTAtNS0xLTEtMA_197444e1-a415-4562-97ca-563b9bd86886">93</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTAtNy0xLTEtMA_270881a0-b0d4-4213-b6b6-4cce84ac4d8a">436</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTItMS0xLTEtMA_4a00ae7a-bf85-446d-96f7-864d2cda585b">22</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTItMy0xLTEtMA_001f55ee-11c1-45a3-9c17-f560c2bc6bc9">209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTItNS0xLTEtMA_bd6dc24f-5710-4b3b-a0e7-0d378c4eaaaa">93</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTItNy0xLTEtMA_b8437579-a8d2-45c1-a0e3-2789dbe0e68b">436</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Loss before benefit from income taxes and noncontrolling interests</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTQtMS0xLTEtMA_6f4818c3-cac6-4825-8b4a-2ea7334138d9">4,270</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTQtMy0xLTEtMA_d0fabddf-e6ee-4e72-9f8b-535c42097c5c">5,137</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTQtNS0xLTEtMA_b6f5a846-ec7d-4681-8e40-98ac5be81a62">8,256</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTQtNy0xLTEtMA_bfc12965-baa0-4b25-8f1f-7ba6e968df8a">9,502</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit from income taxes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTUtMS0xLTEtMA_894c2ff2-2c1d-40f0-a612-158b48b4f1ff">10,872</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTUtMy0xLTEtMA_7df23ebd-c72b-4fb9-82c7-f8daf36e71f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTUtNS0xLTEtMA_8c08c5c0-7440-4cd9-9f5a-f655dba2688b">10,872</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTUtNy0xLTEtMA_f2ad9749-38ed-432c-aa9f-49f912bf05ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTYtMS0xLTEtMA_72dfce57-cc28-41d7-8b7f-aceb4aecdd69">6,602</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTYtMy0xLTEtMA_80a20563-44d6-4c11-bc25-bbe2f28a257a">5,137</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTYtNS0xLTEtMA_97345d97-2e6b-4188-abe5-ef0bac00768b">2,616</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTYtNy0xLTEtMA_fb7d2c9e-7b52-4449-bc12-4c7ca6163c53">9,502</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:25.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Less - net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTctMS0xLTEtMA_d402b1b6-49f2-4cdf-b07e-a6c9e2a70eb8">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTctMy0xLTEtMA_03344162-7be6-4788-a958-38db4b6d6595">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTctNS0xLTEtMA_f113cf18-513f-4920-a891-5bf247b50fd8">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTctNy0xLTEtMA_05fff9f8-f12b-447c-a0f8-fe9ec128ace7">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Net income (loss) attributable to Caladrius Biosciences, Inc. common stockholders</span></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTgtMS0xLTEtMA_d1340d3c-05a5-4f83-829a-4b7bb4b3e226">6,598</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTgtMy0xLTEtMA_6e67ebd8-e9fd-463b-9b7e-f644431951c0">5,140</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTgtNS0xLTEtMA_d6f03489-2361-4609-90ff-dc638d6bb0e4">2,608</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTgtNy0xLTEtMA_58d60254-3c3e-405c-82e1-7d61a8290a74">9,507</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Basic and diluted income (loss) per share</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Caladrius Biosciences, Inc. common stockholders</span></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjItMS0xLTEtMA_3f6d46c3-ceb9-460c-9c7b-f71b9bb4c451">0.50</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjItMy0xLTEtMA_6840b637-3bf2-4fbf-bbe5-cddf26d5455a">0.49</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjItNS0xLTEtMA_cb8a4d80-fb82-4021-9abc-7cfc33921901">0.22</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjItNy0xLTEtMA_63f5f6c8-e071-4e06-ba6b-8dcf08c56eae">0.93</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">Weighted average common shares outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Basic and diluted shares</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjUtMS0xLTEtMA_6ab28903-ff26-48b7-ba40-31f195fc7a62">13,151</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjUtMy0xLTEtMA_70e90ee9-7f8b-42fc-a97f-b1ce21f095b1">10,393</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjUtNS0xLTEtMA_79e166b3-c4e9-4b26-8f24-bf18b8721f21">11,880</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjUtNy0xLTEtMA_cb963ad6-ac89-440e-82bd-1c3902cc596f">10,211</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See accompanying notes to consolidated financial statements.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Unaudited)&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(In thousands)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:68.321%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:4.871%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.871%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.871%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.530%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.876%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMi0xLTEtMS0w_503c4380-7bf7-4c84-860a-beb379737645">6,602</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMi0zLTEtMS0w_2ac4de9a-653f-4afa-80d6-f6e3f5e2cdd5">5,137</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMi01LTEtMS0w_9f6a1f0c-5746-4b00-beb4-6c3fd593490f">2,616</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMi03LTEtMS0w_0e4cdf6d-be41-4509-b9d0-1d016c1f0a39">9,502</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Available for sale securities - net unrealized (loss) income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNS0xLTEtMS0w_79d710ad-6b09-44e3-b0ea-4f559dbeaa36">9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNS0zLTEtMS0w_d63554ea-5060-41f7-a902-ed1bef2b72f1">17</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNS01LTEtMS0w_cd628ef6-307f-45d7-946b-051e57a2eb63">9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNS03LTEtMS0w_edf92020-edda-4f89-b264-73168c778c53">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other comprehensive (loss) income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNi0xLTEtMS0w_90f84c22-6935-49dc-9e49-efb4d6f68f89">9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNi0zLTEtMS0w_06ca46bd-be01-46aa-9774-d7d5bf742527">17</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNi01LTEtMS0w_3889c787-1b94-457e-9724-d2d2bccb04ff">9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNi03LTEtMS0w_5331eea0-0ffb-4af7-9022-410d18f55a78">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfOC0xLTEtMS0w_189abc4f-f725-435a-8e90-37b7517bfbaf">6,593</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfOC0zLTEtMS0w_7270dff8-0e16-44cb-acf1-64963147a2d9">5,120</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfOC01LTEtMS0w_ec1743e1-f186-4413-8d3b-0109decfb1f3">2,607</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfOC03LTEtMS0w_93a30925-a193-4a12-9df3-f5b4ecd98394">9,471</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTAtMS0xLTEtMA_844f204b-d251-4deb-ac6d-606b7f477e10">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTAtMy0xLTEtMA_7792de84-d313-43b4-b539-2939cc618e8a">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTAtNS0xLTEtMA_1dc7eb04-5e8d-4daa-8d3e-d19610a86ae3">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTAtNy0xLTEtMA_484ca23c-048b-4133-a1f9-1582089127f9">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Comprehensive income (loss) attributable to Caladrius Biosciences, Inc. common stockholders</span></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTItMS0xLTEtMA_9a0c5a56-14c7-422f-84a8-8b41949695f0">6,589</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTItMy0xLTEtMA_452e1fc0-91f7-4400-b3a4-4e7263db3c13">5,123</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTItNS0xLTEtMA_067d5203-f544-4651-9e51-4dbc734ee9db">2,599</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTItNy0xLTEtMA_309e98a5-43f4-43c6-a7b4-876cfbe1a833">9,476</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See accompanying notes to consolidated financial statements.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">6</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Unaudited)&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(In thousands)</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.458%;"><tr><td style="width:1.0%;"></td><td style="width:21.503%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.461%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.896%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.528%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.896%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.508%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.161%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.943%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.984%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.290%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.420%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.970%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B Convertible<br/>Preferred Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional<br/>Paid in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Caladrius Biosciences,<br/>Inc.<br/>Stockholders'<br/>Equity</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-<br/>Controlling<br/>Interest in<br/>Subsidiary</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Equity</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia6459a8b2bfa4e9082f15bfcaa393a83_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMS0xLTEtMA_31ca26f0-9d6a-4799-b38f-83b3492f8e58">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia6459a8b2bfa4e9082f15bfcaa393a83_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMy0xLTEtMA_9cd14206-324c-4dd7-ba70-442165db835d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1e533b0893054a86bfe347dbdf504805_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtNS0xLTEtMA_d226de9b-ed9b-4a3c-9051-a787e98430fb">10,529</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1e533b0893054a86bfe347dbdf504805_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtNy0xLTEtMA_8cba4fd7-d416-4269-80ad-6a7d75f601c1">11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia2ad58fffd254fa6a207551b32eb272c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtOS0xLTEtMA_bc37389b-33e1-4109-8b7d-42b712d487a7">438,911</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i269772cc59a54b0c86ec5c667dd00789_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTEtMS0xLTA_e1d11f5b-2991-4f54-b28a-e1f02d81b716">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4d672d653e4742d8a45260d9f07da1e4_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTMtMS0xLTA_7ba5a0f1-30a2-4b70-98a5-bb8a0a186987">417,400</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9b482ff5b63841c3a4083518a2149ea8_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTUtMS0xLTA_35eddfe7-207e-4586-9ae8-09aca1cf05ea">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib8d9ecc646214e10a6fa5daea1b9058a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTctMS0xLTA_232ef221-4af9-4edb-9158-c7d9d0879b9f">20,816</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i8dd06004c95043da94c6cdc17a8cfaf3_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTktMS0xLTA_13d30e7e-9383-4fec-ad66-9c5901be4fb3">263</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMjEtMS0xLTA_9d73a5cc-3be0-4a10-ab9f-74c74ba735db">20,553</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a63a15d847c4890ab70d804d8c08b3d_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTUtMTMtMS0xLTA_560c01af-0c7c-4e4e-b750-3b7428008994">2,608</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i089823aad76040799b9222c0960ec021_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTUtMTctMS0xLTA_08737212-9892-47ee-ae88-554c7ae66a0f">2,608</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icdb421367f6b418eb556790e87e553b9_D20200101-20200630" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTUtMTktMS0xLTA_a44738ab-c277-417d-ae2f-e057a0d385b1">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTUtMjEtMS0xLTA_30a9dcee-e252-4804-97c4-bd93cb902fda">2,616</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gain on marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ideecb37c5c654bbdb1037b8614cfe6db_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTYtMTEtMS0xLTA_4e3ef893-ad6a-45b6-82ae-93ae17d80c2d">9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i089823aad76040799b9222c0960ec021_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTYtMTctMS0xLTA_badf5ed0-52de-4b6a-b97a-572d56156956">9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTYtMjEtMS0xLTA_802440cc-362d-4eaf-967c-83aa7fc6980c">9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if60108fc7b4e4965bb4dde5e421bbbe9_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTctNS0xLTEtMA_7610e972-fe5a-4b0c-834e-51991e1dc7ce">106</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d5516dfdf124b3a8d81163650685d21_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTctOS0xLTEtMA_c89cf32f-8c32-492a-bdcf-776e706cea8d">713</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i089823aad76040799b9222c0960ec021_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTctMTctMS0xLTA_51cb287d-4b69-4ee2-9eff-844ae3f457d1">713</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTctMjEtMS0xLTA_99944aa5-69ce-4d68-836b-56e07e822bc5">713</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net proceeds from issuance of common stock and warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if60108fc7b4e4965bb4dde5e421bbbe9_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtNS0xLTEtMA_d39215e2-687e-43b2-9e02-e5031f504dd1">4,950</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if60108fc7b4e4965bb4dde5e421bbbe9_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtNy0xLTEtMA_badaf7ed-9b75-478a-a4cf-65085a8f3abb">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d5516dfdf124b3a8d81163650685d21_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtOS0xLTEtMA_b4a7163c-fe3f-4362-a666-139ecd1f8201">9,678</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i089823aad76040799b9222c0960ec021_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtMTctMS0xLTA_836d486e-4fd3-4dde-a86a-6a5c9bebd737">9,683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtMjEtMS0xLTA_f6df84bb-2ce9-4ef2-a93f-a26d380a9a0a">9,683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if7d90e607a71431f993c74e5ab4a5440_I20200630" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMS0xLTEtMA_3e9f478d-9268-4785-ad71-b528630bb1e3">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7d90e607a71431f993c74e5ab4a5440_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMy0xLTEtMA_4eb6a1ce-7b30-41d0-b92e-96a9976b533b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie28f9e36c9ac490fbe91763704341b93_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtNS0xLTEtMA_dfb96164-c469-40a7-9aa3-efb55833680c">15,585</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie28f9e36c9ac490fbe91763704341b93_I20200630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtNy0xLTEtMA_d4d156d3-e249-4cd7-8ed2-a5822d35fcc4">16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81c0cb854ba944e884bf1b00aa79f1f3_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtOS0xLTEtMA_dfa3eb8d-f446-451c-8913-6d77af946e7b">449,302</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6473bb916b34426eadad2eb4a6da4c45_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTEtMS0xLTA_ba0a404f-27f5-4d0c-8a7a-721e7be9a3ba">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i35b49c8bd3db41caab9d777b94e006fa_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTMtMS0xLTA_da46828b-a07d-4818-92dc-8cb1c140638b">414,792</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id4ddd050588b49a880ea307c34a8a2e7_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTUtMS0xLTA_08d77b2b-9ec2-4504-93e0-63ceaaa09a99">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd6315550f8948388dc33311dd0f3a47_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTctMS0xLTA_3b653dfb-907f-43e9-838c-79d4157bdefb">33,811</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9cceac2b4239467bbd9c4ba097a4cca3_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTktMS0xLTA_9e9d5f6b-4aba-420c-9b76-7aab2b0ff913">255</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMjEtMS0xLTA_eba908db-2d01-4629-89ab-b1e4ca0f2f82">33,556</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.458%;"><tr><td style="width:1.0%;"></td><td style="width:21.503%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.461%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.896%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.528%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.896%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.508%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.161%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.943%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.984%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.290%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.420%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.970%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B Convertible<br/>Preferred Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional<br/>Paid in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Caladrius Biosciences,<br/>Inc.<br/>Stockholders'<br/>Equity</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-<br/>Controlling<br/>Interest in<br/>Subsidiary</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Equity</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia26c7702fea34fd481006912dd3c74c9_I20181231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMS0xLTEtMA_3d30f967-0fdf-4c61-a011-1961262fc83b">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia26c7702fea34fd481006912dd3c74c9_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMy0xLTEtMA_3a1d9abe-4d3c-426f-9a15-afa56f3970ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i40ffe924ff214949875e811de6652307_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtNS0xLTEtMA_2c0663e6-f948-4f5d-bc1d-28d183dc2d0a">9,866</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i40ffe924ff214949875e811de6652307_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtNy0xLTEtMA_905a3761-7f3f-4106-9ddf-4e983cee02a8">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i029555c24dfb4f87ba3330c27022e676_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtOS0xLTEtMA_a4a2363e-ab45-4003-af0c-5dd336ae4b2d">436,433</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i689a47bf1d5b4d35ae49c687b8e5350e_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTEtMS0xLTA_b1adb4ff-af7d-4ddd-8acb-0be4b554f8f8">32</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6ca7c31d550e476ca25f4b1ee88a810a_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTMtMS0xLTA_ad330e79-9280-4181-997e-7ef419b474c8">397,977</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i853de77024f446ae9c1994c45de246d9_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTUtMS0xLTA_c9dc0d7b-cace-4323-8b2f-79d2a57c6898">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if3e54a78a6c1475c81756074222ed700_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTctMS0xLTA_9f653f42-52e9-4166-b932-1881607d1a3a">37,726</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idf7a5efcf6464b84b6908c5a79f851df_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTktMS0xLTA_17e14844-64ad-4de2-9a2a-5844b78b8d5a">272</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12238a4194304af292dc658a465a9869_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMjEtMS0xLTA_2956d0c4-e6b4-4658-940b-11720134960c">37,454</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adoption of accounting standard</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i154ad1efb34e44c493e4cd358f0e3a5e_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTQtMTMtMS0xLTA_43dde4de-e502-4e2e-be65-fe9c11f27ba0">62</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic2f96be1df6e4c74b5d8378edbdd33e5_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTQtMTctMS0xLTA_d6442a6e-7ee1-4ad5-b596-ca80c7ddf0e3">62</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifaa90470a948448e99d1c0fd28e4ae2f_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTQtMjEtMS0xLTA_41eb4121-6760-4ab5-b5c0-92d0a20c0391">62</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2d54e245b2e5412195f8068f0ed21f5d_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTUtMTMtMS0xLTA_b33643dd-dccd-48a8-b18a-d4affac3b9f6">9,507</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i92147aaa2f774770bf474845fc45022b_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTUtMTctMS0xLTA_0439ae61-bc94-4d56-90c8-482b626fcd5b">9,507</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2055b13cfd8546fe94673210f1f9a5a1_D20190101-20190630" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTUtMTktMS0xLTA_5bb2800b-7b5f-4d66-b2ce-808171d5b65a">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTUtMjEtMS0xLTA_81387881-d2e5-4ec8-a5a3-0d57f52392ca">9,502</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gain on marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaec8a33e801747fba17f3eb0f6415905_D20190101-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTYtMTEtMS0xLTA_009671ae-9fc0-479f-9603-63d2e0556b28">32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i92147aaa2f774770bf474845fc45022b_D20190101-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTYtMTctMS0xLTA_58c23fc9-4cbf-4d0c-8f8c-96e0ddf43ae3">32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTYtMjEtMS0xLTA_8052e570-025c-411e-817f-91f450fabf0c">32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5ab690b1ab2746df8e3a13c32d2e3d2c_D20190101-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTctNS0xLTEtMA_bee8c361-300c-42a0-99a9-ca1d20558677">96</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0091c8c5e99c4b7285f64866343c8242_D20190101-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTctOS0xLTEtMA_7a126c7e-c572-45d3-aeee-9db97bc0dc3a">663</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i92147aaa2f774770bf474845fc45022b_D20190101-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTctMTctMS0xLTA_ff8de438-a84a-465f-8c0c-464f57593cf5">663</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTctMjEtMS0xLTA_2b4259f4-a8a9-4800-a124-229880dface3">663</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net proceeds from issuance of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5ab690b1ab2746df8e3a13c32d2e3d2c_D20190101-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTgtNS0xLTEtMA_12b92fb3-8e72-4db7-b315-05b47e4769b8">451</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0091c8c5e99c4b7285f64866343c8242_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTgtOS0xLTEtMA_5c890289-60e1-4e00-b8b1-f37ad755ad56">1,037</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i92147aaa2f774770bf474845fc45022b_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTgtMTctMS0xLTA_61325578-ed88-4dfb-8ec9-34efb334b973">1,037</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTgtMjEtMS0xLTA_fa873d66-6850-4f67-92fc-1587b2053a98">1,037</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idf716bf4e64c42eb93f27e30efd66f84_I20190630" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMS0xLTEtMA_55b7e3d1-c55e-4477-8681-da805a5d78eb">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idf716bf4e64c42eb93f27e30efd66f84_I20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMy0xLTEtMA_c70b398b-ca6a-4277-8411-788698aa3b2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4a228f73f8ea40d091b343b12607676d_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtNS0xLTEtMA_b810d1f8-f79d-423d-addc-3d64322bee67">10,413</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4a228f73f8ea40d091b343b12607676d_I20190630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtNy0xLTEtMA_5b2c1fb9-6e22-43dd-801a-7661f0e9fe82">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia45d7e7fa98744c99e820d7277685eb7_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtOS0xLTEtMA_d4e19ed0-0c9c-48a5-ad0e-95a4977ac4a5">438,133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaa36c77971f34e0e8b157159bb4fe935_I20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTEtMS0xLTA_7f202de9-8acb-441f-b82f-64aeba7ea788">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic17110eb863e4e77a7720e0ac50759c1_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTMtMS0xLTA_bdd18281-cf02-4810-947e-e05876e26cbc">407,546</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i85327901e88841e5a13ea69126435f01_I20190630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTUtMS0xLTA_9067bee2-5256-48c3-ad28-0bb28813c89b">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i075dc3333dea40c2b3dea37dbfd62c23_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTctMS0xLTA_53c5bfd8-704f-456d-b1ce-a9c6dc9ec051">29,889</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3039884f741e48f9b0efd984a250fb4f_I20190630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTktMS0xLTA_43a3ce51-c681-45fc-86b7-467ced0697f2">267</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iec42dab4bf014f308c2e8b7cb3366e6a_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMjEtMS0xLTA_29c2cb9a-ca68-482c-b058-4c2a4c1a9074">29,622</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.458%;"><tr><td style="width:1.0%;"></td><td style="width:21.503%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.461%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.896%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.528%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.896%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.508%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.161%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.943%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.984%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.290%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.420%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.970%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B Convertible<br/>Preferred Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional<br/>Paid in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Caladrius Biosciences,<br/>Inc.<br/>Stockholders'<br/>Equity</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-<br/>Controlling<br/>Interest in<br/>Subsidiary</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Equity</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at March 31, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie90a881e895f4066aca8e8f3ef8d2873_I20200331" decimals="INF" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMS0xLTEtMA_a4754b60-8dd8-4447-93b3-aca1135f0513">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie90a881e895f4066aca8e8f3ef8d2873_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMy0xLTEtMA_eb744426-c0e0-419d-bee3-07ef13ecf07b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0bdde77f835d486ca4fed2229c62a8a4_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtNS0xLTEtMA_c2dae4b6-feb0-4cd2-9440-3501780f1eb6">10,639</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0bdde77f835d486ca4fed2229c62a8a4_I20200331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtNy0xLTEtMA_b4b28567-dfb1-43c9-a9a7-473e3f9ab98f">11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd6ef19f18054f819eeb15b3287fbe0a_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtOS0xLTEtMA_3236e522-fe8d-42ea-beb0-9d60e29ebee5">439,330</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id046043ef8e444678382caffe7cd0326_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTEtMS0xLTA_699954bd-a691-489e-8515-7807275089ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2f3e93561fbd44bca60dac0ff1dfeb64_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTMtMS0xLTA_9f7b3bc3-f098-483f-ba81-095bf9150837">421,390</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i08e9560f917440508f3a6e5bb1608f07_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTUtMS0xLTA_ad8f0c20-6cd6-4bb8-871b-37b5f19d2782">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie704db0571b14cf290b0bd0ffc4cf0df_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTctMS0xLTA_0e49b18a-37b7-4bd1-871d-bc0c72e5649c">17,243</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5460b9db956c4914aca35e670e270e39_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTktMS0xLTA_d857906f-cdba-436d-8b2d-e6931eff9f68">259</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7f8b8e70272d4ce4a1797485ee724b54_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMjEtMS0xLTA_6bb9580f-1d36-46e8-8cdb-672db5257914">16,984</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0bf22901ac704008bb0379111f81d35d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTUtMTMtMS0xLTA_00280bfa-e4bb-4914-a79d-bf9118cd86cb">6,598</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTUtMTctMS0xLTA_e12c4a92-013e-4cc0-ac31-9dfa153f828b">6,598</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iad1bde95aa094ca19a60db89e9eea0f6_D20200401-20200630" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTUtMTktMS0xLTA_de2723ad-3c5b-4ed4-ab70-f9605b1717c7">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTUtMjEtMS0xLTA_d3248a06-190b-4938-b854-11db92bf8576">6,602</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gain on marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if8f7c328741c458db2fcb7810eb691bd_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTYtMTEtMS0xLTA_d5bda29b-eddd-48ff-a92c-6d090cbdaca5">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTYtMTctMS0xLTA_03058e71-2b78-4270-a00b-99282f47f5cc">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTYtMjEtMS0xLTA_ada83dc4-9351-420c-a14e-383125e6e080">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i52b5ff024d164f15800522b18c9be2f1_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTctNS0xLTEtMA_c3be2519-7c21-4f8c-81f4-4f7e5fb83bd4">4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i590dc48391b942189240efd0d0206942_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTctOS0xLTEtMA_625e22a1-f559-4da3-8b70-3e0e0b8764fe">294</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTctMTctMS0xLTA_1f3cab4e-ddc5-4d4b-8cb7-1c09ee93903f">294</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTctMjEtMS0xLTA_7414e066-b4ab-474f-97ce-efc0f0dc03d8">294</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net proceeds from issuance of common stock and warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i52b5ff024d164f15800522b18c9be2f1_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtNS0xLTEtMA_a827f166-89fa-44fd-a242-4503d745dd11">4,950</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52b5ff024d164f15800522b18c9be2f1_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtNy0xLTEtMA_f1d16fc4-e931-4244-8030-5e8dbec3bfa0">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i590dc48391b942189240efd0d0206942_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtOS0xLTEtMA_3c93fa77-f6e5-494c-8ad7-bb318838ac90">9,678</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtMTctMS0xLTA_68539e3e-14aa-462c-b3ad-2283cfaf3a3b">9,683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtMjEtMS0xLTA_ee111432-0d5a-45b0-bb74-16461bb8e96c">9,683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if7d90e607a71431f993c74e5ab4a5440_I20200630" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMS0xLTEtMA_941fd74b-d9a4-4fd3-971b-d4a270e14b55">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7d90e607a71431f993c74e5ab4a5440_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMy0xLTEtMA_2dc39c7a-fb01-4f0b-a556-65716355277c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie28f9e36c9ac490fbe91763704341b93_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtNS0xLTEtMA_69f05fad-6884-417d-8306-645d03650ad2">15,585</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie28f9e36c9ac490fbe91763704341b93_I20200630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtNy0xLTEtMA_89eb89d6-e14a-455d-ae12-6910fb177d3a">16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81c0cb854ba944e884bf1b00aa79f1f3_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtOS0xLTEtMA_7328abbb-bfba-4d5a-ad54-f7fff471d5ac">449,302</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6473bb916b34426eadad2eb4a6da4c45_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTEtMS0xLTA_0c6a0abe-9e0f-47c3-a67d-4a1405ccf28f">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i35b49c8bd3db41caab9d777b94e006fa_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTMtMS0xLTA_ed6ec286-28cc-4f80-889f-9c305399583b">414,792</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id4ddd050588b49a880ea307c34a8a2e7_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTUtMS0xLTA_36c8c32d-331a-481e-9b0a-806416a68d35">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd6315550f8948388dc33311dd0f3a47_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTctMS0xLTA_1ad890f7-72ff-4b71-a94e-177806273a41">33,811</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9cceac2b4239467bbd9c4ba097a4cca3_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTktMS0xLTA_72cfb328-c5b0-4b64-8ee1-f9e0f76c25b6">255</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMjEtMS0xLTA_fdc4fea7-419d-4fab-9fb8-7c06cf656323">33,556</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.458%;"><tr><td style="width:1.0%;"></td><td style="width:21.503%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.461%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.896%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.528%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.896%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.508%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.161%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.943%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.984%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.290%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.420%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.344%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.970%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B Convertible<br/>Preferred Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional<br/>Paid in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Caladrius Biosciences,<br/>Inc.<br/>Stockholders'<br/>Equity</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-<br/>Controlling<br/>Interest in<br/>Subsidiary</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" rowspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Equity</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at March 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib05a707433594a25a0606a9575997357_I20190331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMS0xLTEtMA_ec23a9ad-52ca-4685-bcf8-762841e8dfc8">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib05a707433594a25a0606a9575997357_I20190331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMy0xLTEtMA_7fdc6deb-40ee-46bc-bb95-9e8462412c6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i6668795c6a884dada418bd8caf1a7f54_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtNS0xLTEtMA_c545ae6c-13c7-47fd-93cf-2ee6a5b47282">10,393</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6668795c6a884dada418bd8caf1a7f54_I20190331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtNy0xLTEtMA_b6e9c6cb-df1e-425d-9da4-84c128d9a6f7">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic320af918fb24539b5a45cf9f2d8e810_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtOS0xLTEtMA_ea180e44-ca46-485a-ad41-3bbc6f2742f0">437,850</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ibc243f82141e47c286e480f5a84eb2eb_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTEtMS0xLTA_91dc31c2-5f32-4cef-9bcf-becf5f405051">18</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7ddf56079b524d5fbfac58c6fecb5f39_I20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTMtMS0xLTA_f2867dc3-6133-45af-a38a-f9cd9a4dd964">402,406</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id07a4c5e1fc340b1b770d4937c2a3c08_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTUtMS0xLTA_4d5897c0-88d9-40cf-9c4d-7e8db3d71cfb">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1aaeabe181a943b6a69e23bdc1cfd7d0_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTctMS0xLTA_0de8f567-d470-41d5-8809-f124845695b9">34,728</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf5e9d75a470d9afc9bc9527aa4d6_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTktMS0xLTA_16ed0387-8f6c-42e2-b116-4ba003f1c3a9">270</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic32d3c882e084aa79bd397aa974b4613_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMjEtMS0xLTA_065bdd41-4f7a-435e-bb0c-538f4459ff52">34,458</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1.5pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iaa079d11b5954062bd47deae009f8794_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTQtMTMtMS0xLTA_114fc2c0-7f05-453e-9bc2-ab05bca6feb0">5,140</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia192e319dcd6445490a592f325146563_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTQtMTctMS0xLTA_e4e89d19-a954-410d-b928-db8681eb7e3a">5,140</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b882abb91484bcfb43daf1e92edb3c7_D20190401-20190630" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTQtMTktMS0xLTA_a9867bbe-4c01-4f2f-8043-12c3d3b1ceb5">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTQtMjEtMS0xLTA_c0d35883-ca5d-4821-a2d8-85d23de9fd9b">5,137</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:2pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gain on marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2baaf7ccbcd1454fb5493e534db9c3e5_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTUtMTEtMS0xLTA_7bef9126-57d0-4cbf-8739-b07140cb72b4">18</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia192e319dcd6445490a592f325146563_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTUtMTctMS0xLTA_03c2e249-dead-45ee-9cdc-b6e05ca5bb2c">18</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTUtMjEtMS0xLTA_c4eb4cac-c47a-4f39-b10b-acd2586ee30f">18</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Share-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i2010021fc3d045089492ab8ba091452b_D20190401-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTYtNS0xLTEtMA_0fcec855-66a6-4824-ad9e-17b597950d58">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8caa352b6c734881a00e24477692efc9_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTYtOS0xLTEtMA_d658f8ee-7f93-4ba6-b219-0aeb30421b52">246</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia192e319dcd6445490a592f325146563_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTYtMTctMS0xLTA_8b410123-3c7a-4777-a16a-b3f8b53239e7">246</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTYtMjEtMS0xLTA_da657785-37c7-4319-b180-7da2d554246e">246</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net proceeds from issuance of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i2010021fc3d045089492ab8ba091452b_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTctNS0xLTEtMA_945f1d0a-a356-400e-89e8-a57e617142b7">20</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8caa352b6c734881a00e24477692efc9_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTctOS0xLTEtMA_c12eb8f8-1169-46b9-a817-9f2e9b8f1604">37</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia192e319dcd6445490a592f325146563_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTctMTctMS0xLTA_5290d44c-bdd2-4b35-abcf-122067405b8f">37</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTctMjEtMS0xLTA_6230c563-d9ff-48f0-8802-f83e5316027a">37</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idf716bf4e64c42eb93f27e30efd66f84_I20190630" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMS0xLTEtMA_17358e71-c37a-4c74-8470-1b7223c93ebe">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idf716bf4e64c42eb93f27e30efd66f84_I20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMy0xLTEtMA_6c35c977-965b-432d-98b5-09f933e1836a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4a228f73f8ea40d091b343b12607676d_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtNS0xLTEtMA_330de0bf-9999-41b9-ab0d-e180a1385ea9">10,413</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4a228f73f8ea40d091b343b12607676d_I20190630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtNy0xLTEtMA_36fec857-43c2-4b5a-9d5c-3dc0321018f9">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia45d7e7fa98744c99e820d7277685eb7_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtOS0xLTEtMA_21abdbd2-8b55-4ecf-bcea-e74dd1f69f03">438,133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaa36c77971f34e0e8b157159bb4fe935_I20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTEtMS0xLTA_7115d125-812f-483a-a5be-f5657f8ad2bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic17110eb863e4e77a7720e0ac50759c1_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTMtMS0xLTA_1dc826bd-ba8a-4c3c-96d1-3e9920a18832">407,546</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i85327901e88841e5a13ea69126435f01_I20190630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTUtMS0xLTA_4d2a754c-fdcd-4bda-82b3-132b3514f66c">708</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i075dc3333dea40c2b3dea37dbfd62c23_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTctMS0xLTA_42bc659b-0265-4610-9895-d505833e5af6">29,889</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3039884f741e48f9b0efd984a250fb4f_I20190630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTktMS0xLTA_e1937e97-a139-495a-957f-b86b2a49c428">267</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iec42dab4bf014f308c2e8b7cb3366e6a_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMjEtMS0xLTA_dd5206c3-29e5-490a-b682-a6f4383568cd">29,622</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See accompanying notes to consolidated financial statements.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">8</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(Unaudited)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(In thousands)</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:69.700%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.636%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.931%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from operating activities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income (loss)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMy0xLTEtMS0w_65062eff-e05e-4690-86f7-16ee1d92680b">2,616</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMy0zLTEtMS0w_fe317975-c91a-4c9f-ac27-673dc5b28a1d">9,502</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments to reconcile net income (loss) to net cash used in operating activities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-13.5pt;padding-left:38.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">Share-based compensation</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfNS0xLTEtMS0w_a3c447d6-3814-42d2-afed-d6d7f9e0fc4a">861</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfNS0zLTEtMS0w_99cbae1f-0d09-430d-bb6f-d0f634252021">793</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfNi0xLTEtMS0w_24591008-81bf-41c2-b717-f3c68d64a214">30</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfNi0zLTEtMS0w_c34518ba-cfc7-4215-b11f-40076e98a132">35</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accretion on marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfOS0xLTEtMS0w_5eb6ad85-e0fa-4973-9cdf-d91e501be93b">40</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfOS0zLTEtMS0w_e0ada0b6-463c-48a1-bbed-2719755f4a63">133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid and other current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTEtMS0xLTEtMA_7e314445-1f3e-4865-8546-0d55424cb8c2">920</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTEtMy0xLTEtMA_57bfc394-c239-49ae-ab42-439b11a6e913">110</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTItMS0xLTEtMA_974d7ebd-59dc-4c8e-8145-b1ab068083e9">308</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTItMy0xLTEtMA_fc848dd7-815a-4b74-89ba-fb07163d9568">181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:36pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable, accrued liabilities and other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTMtMS0xLTEtMA_38bd304a-c06c-41a6-8329-ef67c8314f64">2,673</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTMtMy0xLTEtMA_4605bbcb-dbc3-4338-8373-5f0a5b1005b0">1,735</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTQtMS0xLTEtMA_54c1bf76-5680-4183-80d3-35993788b118">262</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTQtMy0xLTEtMA_19d3a354-5cd4-4a1c-a528-0063d5f0968f">10,205</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from investing activities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase of marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTYtMS0xLTEtMA_f884f7c2-0f76-4f02-936a-81dc7e34cf30">8,235</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTYtMy0xLTEtMA_0a00c9c3-89c4-4c7e-83fa-8a5108bd11ae">25,969</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sale of marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTctMS0xLTEtMA_c715bb89-2230-4977-af09-be1b8aafd317">11,104</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTctMy0xLTEtMA_0b6d6154-fee0-4fde-8f42-bcf941d858d7">36,721</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase of property and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTgtMS0xLTEtMA_9d9c1148-5777-412b-942f-c258888bf40a">14</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTgtMy0xLTEtMA_10fc3f64-9b6e-4af1-961b-09f8a47e6043">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by investing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTktMS0xLTEtMA_0996f8d8-c026-4429-8401-309de5682b72">2,855</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTktMy0xLTEtMA_1351b05c-d820-448c-bf44-abcb70baff52">10,752</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from financing activities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax withholding payments on net share settlement equity awards</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjItMS0xLTEtMA_01898859-4806-47db-9817-1bfee0142943">148</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjItMy0xLTEtMA_7c1176b4-d993-4133-90a6-cdd4955a3505">130</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net proceeds from issuance of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjMtMS0xLTEtMA_370aaab1-740d-43bd-8aec-155db2ab4de4">9,683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjMtMy0xLTEtMA_78ae9a01-6719-4140-994b-86bc04e1a206">1,038</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by financing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjUtMS0xLTEtMA_cb2c4ba3-b579-4a18-96c6-bacbec484e3e">9,535</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjUtMy0xLTEtMA_0a7449b3-a43e-44f3-b464-c314c824b136">908</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net increase in cash and cash equivalents</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjYtMS0xLTEtMA_6225e180-45c1-4016-859f-34585233d85f">12,652</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjYtMy0xLTEtMA_ac891cc1-5f23-4f4f-9c5a-f6cadccb2163">1,455</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjctMS0xLTEtMA_d5308ba8-e311-463a-a69f-93be8800dc7d">14,032</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12238a4194304af292dc658a465a9869_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjctMy0xLTEtMA_729794b3-9e9b-428c-887c-bd20864cdbe6">10,299</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents at end of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjgtMS0xLTEtMA_a7ab5224-ecea-475d-b13e-23d23333096d">26,684</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iec42dab4bf014f308c2e8b7cb3366e6a_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjgtMy0xLTEtMA_96e33449-5fde-42a8-9723-55f3e9caf440">11,754</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See accompanying notes to consolidated financial statements.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">9</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_37"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 1&#160;&#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="clbs:BusinessTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zNy9mcmFnOmE2MmQ0NjAyMmVlOTQ2ZDVhZDE1MzNkMDI2NjUzYWY3L3RleHRyZWdpb246YTYyZDQ2MDIyZWU5NDZkNWFkMTUzM2QwMjY2NTNhZjdfMTE5MTM_9193c624-9e29-4d2f-8397-7d6789704624" continuedAt="i3399829f383d4501a5576570f99bfd0d" escape="true">The Business</ix:nonNumeric></span></div><ix:continuation id="i3399829f383d4501a5576570f99bfd0d" continuedAt="i94fca5ea867149d693ad315c2937e3ff"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; "our," &#8220;Caladrius&#8221; or the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of cellular therapies designed to reverse disease and/or promote the regeneration of damaged tissue. The Company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. The Company's technology leverages these cells to enable the body's natural repair mechanisms using formulations unique to each medical indication.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company's leadership team has decades of collective biopharmaceutical development experience and world-recognized scientific achievement in the field of cardiovascular disease, among other therapeutic areas. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The Company's current product candidates include CLBS119, an emergent CD34+ stem cell therapy responding to the COVID-19 pandemic and the potentially permanent damage the virus inflicts on the lungs of many patients, as well as three other developmental treatments for ischemic diseases based on its CD34+ cell therapy platform: CLBS12, recipient of SAKIGAKE designation and eligible for early conditional approval in Japan for the treatment of critical limb ischemia ("CLI") based on the results of an ongoing clinical trial; CLBS16, the subject of a recently completed positive Phase 2 clinical trial in the U.S. for the treatment of coronary microvascular dysfunction ("CMD"); and CLBS14, a Regenerative Medicine Advanced Therapy ("RMAT") designated therapy for which the Company has finalized with the U.S. Food and Drug Administration (the "FDA") a protocol for a Phase 3 confirmatory trial in subjects with no-option refractory disabling angina ("NORDA").</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Ischemic Repair (CD34 Cell Technology)</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The CD34+ cell was discovered as a result of the deliberate search for a stem cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels after injury. A CD34+ cell is a stem cell that has the ability to stimulate new blood vessel formation. No other native cell discovered to date has demonstrated this same capability.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s proprietary CD34+ cell technology has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is restricted. Through the administration of CD34+ cells, the Company seeks to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. Caladrius believes that a number of conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology, including but not limited to, CLI, CMD, NORDA and COVID-19 induced lung damage.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS119 for Treatment of COVID -19 Induced Lung Damage</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">COVID-19 appears to damage the vasculature of the lungs and Caladrius believes that repair of that vasculature will prove necessary for patients to achieve a full recovery. Survivors of COVID-19 often remain debilitated even after leaving the hospital due to the damage caused to their lungs, and while many developmental therapies responding to the COVID-19 pandemic are appropriately targeting the SARS-CoV-2 virus itself or the manifestations of the acute phase of the illness, Caladrius is aware of no therapy that has demonstrated the ability to repair COVID-19 induced lung damage. With consistent clinical and pre-clinical evidence that CD34+ cells can repair multiple organs, including models of severe lung inflammation, the Company sought and received FDA authorization for its investigational new drug (&#8220;IND&#8221;) application for the study of CLBS119, a CD34+ cell therapy for repair of COVID-19 induced lung damage. The planned study, with enrollment expected to commence in the second half of 2020, will target patients with severe SARS-CoV-2 infection who, after ventilatory support due to respiratory failure, had otherwise recovered but remained debilitated due to persistent pulmonary damage. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS12 for Treatment of Critical Limb Ischemia</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's open-label, registration-eligible study of CLBS12 in Japan for the treatment of critical limb ischemia ("CLI"), a disease with no currently available approved therapy and a higher combined incidence and mortality rate than all cancers but lung cancer, has shown strong results to date. The initial responses observed in the subjects who have reached an </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><ix:continuation id="i94fca5ea867149d693ad315c2937e3ff" continuedAt="i070d068df30843e48b30a8ec2e7a83da"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">endpoint in this open label study are consistent with a positive therapeutic effect and safety profile as reported by previously published clinical trials in Japan. Although the study's enrollment, which is targeted for completion this year, has been slowed by the pandemic's impact in Japan, the Company is encouraged by the patient pre-screening pipeline that has been identified and hopes to conclude trial enrollment rapidly once the coronavirus abates. While the final outcome of the trial will depend on all data from all subjects, data from the concluded Buerger's Disease cohort and the data to date in the no-option CLI cohort remain very encouraging.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS16 for Treatment of Coronary Microvascular Dysfunction</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2017, with the assistance of a $<ix:nonFraction unitRef="usd" contextRef="i435d817d085a4640b5a6c1464fc2d6c6_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrantsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zNy9mcmFnOmE2MmQ0NjAyMmVlOTQ2ZDVhZDE1MzNkMDI2NjUzYWY3L3RleHRyZWdpb246YTYyZDQ2MDIyZWU5NDZkNWFkMTUzM2QwMjY2NTNhZjdfNDM5ODA0NjUyMzQ2NA_0baf9d70-79d6-452b-9a49-74f04b1b6118">1.9</ix:nonFraction>&#160;million grant from the National Institutes of Health (Award Number R44HL135889), Caladrius initiated its program for CLBS16 for the treatment of coronary microvascular dysfunction ("CMD"), a disease that potentially afflicts millions of patients with no current targeted treatment options. That study, titled ESCaPE-CMD, was a Phase 2 proof-of-concept study that enrolled patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. In June 2019, the Company announced the completion of enrollment in this study. Results of the first 17 of 20 patients enrolled in this trial who reached 6-month follow-up were presented as a rapid fire oral presentation on November 16, 2019 at the annual meeting of the American Heart Association in Philadelphia, PA by one of the principal investigators, Dr. Noel Bairey Merz, FACC, FAHA, FESC, the director of the Barbra Streisand Women's Heart Center at Cedars-Sinai in Los Angeles, CA. That data set showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian Cardiovascular Society Angina Class and Seattle Questionnaire score, as well as an acceptable safety profile. The full data from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May 14, 2020 and we now expect to initiate the next CMD trial, a Phase 2b study, by the end of 2020.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS14 for Treatment of No Option Refractory Disabling Angina (NORDA)</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company acquired the rights to data and regulatory filings for a CD34+ cell therapy program for refractory angina that had been advanced to Phase 3 by a previous sponsor.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on the clinical evidence from the completed studies that a single administration of CLBS14 reduces mortality, improves angina and increases exercise capacity in patients with otherwise untreatable angina, this product received Regenerative Medicine Advanced Therapy (&#8220;RMAT&#8221;) designation from the FDA. The Company, working closely with the FDA, has finalized the design of a confirmatory Phase 3 trial which, in combination with previously filed Phase 1, 2 and 3 data, will be considered for the registration of CLBS14. Notably, this study design includes a 6-month primary endpoint and, with the benefit of the RMAT designation, the biologics license application ("BLA"), once submitted, is expected to receive a 6-month review. The Company has substantially completed the preparatory work for initiation of this trial. Caladrius will not, however, commence enrollment of patients until sufficient capital is acquired and dedicated to this program such that the Company has confidence that it can fund the trial uninterrupted through completion.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Additional Out-licensing Opportunities</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's broad intellectual property portfolio of cell therapy assets includes notable programs available for out-licensing in order to continue their clinical development. Its current long-term strategy focuses on advancing its therapies through development with the ultimate objective of obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to realize potentially meaningful value increases within its own proprietary pipeline if the Company is successful in advancing its product candidates to their next significant development milestones.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Coronavirus Considerations</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which causes COVID-19, was reported to have surfaced in China.  In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects.  While the disruption currently is expected to be temporary, there is uncertainty around the extent and duration of disruption, and any future related financial impact cannot be reasonably estimated at this time.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Basis of Presentation</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim financial information. Accordingly, they do </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><ix:continuation id="i070d068df30843e48b30a8ec2e7a83da"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of June&#160;30, 2020, and the results of its operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2019 and 2018 included in our 2019 Form 10-K. Operating results for the three and six months ended June&#160;30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amount of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly, actual results could differ from those estimates and assumptions.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Principles of Consolidation</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Consolidated Financial Statements include the accounts of Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</span></div></ix:continuation><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_40"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 2 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80MC9mcmFnOmYxNTBhYWRkNWMwZjQ0ZWY4ZDEyODg4NWY5NmRkNmM0L3RleHRyZWdpb246ZjE1MGFhZGQ1YzBmNDRlZjhkMTI4ODg1Zjk2ZGQ2YzRfNTU0NA_d474bdcc-60da-4d21-9751-95fa3a9b78f0" continuedAt="ie5202fa35c414869a61a89ed2d811662" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ie5202fa35c414869a61a89ed2d811662" continuedAt="i50e93eb1957f45c0a215e388bcc03ff6"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to the policies below, the Company's significant accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included in its 2019 Form 10-K. There were no changes to these policies during the three and six months ended June&#160;30, 2020.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80MC9mcmFnOmYxNTBhYWRkNWMwZjQ0ZWY4ZDEyODg4NWY5NmRkNmM0L3RleHRyZWdpb246ZjE1MGFhZGQ1YzBmNDRlZjhkMTI4ODg1Zjk2ZGQ2YzRfNTU0Ng_224b4cf3-26f4-44a1-909c-bbfd9f6e0be6" escape="true"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Concentration of Risks</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States.  Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</span></div></ix:nonNumeric><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80MC9mcmFnOmYxNTBhYWRkNWMwZjQ0ZWY4ZDEyODg4NWY5NmRkNmM0L3RleHRyZWdpb246ZjE1MGFhZGQ1YzBmNDRlZjhkMTI4ODg1Zjk2ZGQ2YzRfNTU0MQ_7879e279-c2b4-47c8-a51a-038575f49339" continuedAt="i3cfd7f4c578e46c68c66e4e7c562ee87" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Share-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;</span></ix:nonNumeric></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i3cfd7f4c578e46c68c66e4e7c562ee87">The Company expenses all share-based payment awards to employees, directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant.</ix:continuation> </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80MC9mcmFnOmYxNTBhYWRkNWMwZjQ0ZWY4ZDEyODg4NWY5NmRkNmM0L3RleHRyZWdpb246ZjE1MGFhZGQ1YzBmNDRlZjhkMTI4ODg1Zjk2ZGQ2YzRfNTUyNg_fcd36c92-3886-46e7-ae94-c073f00caf62" continuedAt="ic41d3bc85c41429094eb5aef996cfd08" escape="true"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">New Accounting Pronouncements</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires that a lessee recognize lease assets and lease liabilities for those leases classified as operating leases. The guidance was effective for interim and annual periods beginning after December 15, 2018 and was adopted as of January 1, 2019. The Company adopted the standard using the modified retrospective transition method, with an immaterial adjustment to accumulated deficit upon adoption. The comparative information has not been restated and continues to be reported under the accounting standards that were in effect </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><ix:continuation id="i50e93eb1957f45c0a215e388bcc03ff6"><ix:continuation id="ic41d3bc85c41429094eb5aef996cfd08"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">for those periods. The Company concluded that the adoption of ASU 2016-02 was non-cash in nature, did not affect the Company's cash position, and did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#8212;Credit Losses, which will require companies to present assets held at amortized cost and available for sale debt securities net of the amount expected to be collected. The guidance requires the measurement of expected credit losses to be based on relevant information from past events, including historical experiences, current conditions and reasonable and supportable forecasts that affect collectability. The guidance was effective for fiscal years and interim periods beginning after December 15, 2019 and early adoption was permitted. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, the FASB issued ASU 2018-07, "Improvements to Nonemployee Share-Based Payment Accounting," which supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payments arrangements related to the acquisition of goods and services from both employees and nonemployees. For public companies, the amendments are effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual periods. Early adoption was permitted, but no earlier than a company's adoption date of ASC 606. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, the FASB issued ASU 2019-07, "Codification Updates to SEC Sections", to codify the SEC releases that clarify and improve the disclosure and presentation requirements of a variety of codification topics, thereby eliminating certain disclosure requirements that were redundant, duplicative, overlapping, outdated, or superseded. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2019, the FASB issued ASU 2019-12, which affects general principles within Topic 740, Income Taxes. The amendments of&#160;ASU 2019-12&#160;are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company believes that the adoption of this new accounting guidance will not have a material impact on its financial statements and footnote disclosures.</span></div></ix:continuation></ix:continuation><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_43"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 3 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RleHRyZWdpb246MWI1ZjNiM2M1NDYzNDhkOGEyYTI5YmNjNTliNDcxNmJfNjM4_612a8fc9-622a-4db5-a3d6-5c3d8840c1f0" continuedAt="if68887d261894ca68d71ad1aa093998b" escape="true">Available-for-Sale-Securities</ix:nonNumeric></span></div><ix:continuation id="if68887d261894ca68d71ad1aa093998b" continuedAt="i0ca9461f89c94c36a7534e8d2f8d52ff"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RleHRyZWdpb246MWI1ZjNiM2M1NDYzNDhkOGEyYTI5YmNjNTliNDcxNmJfNjM0_3b1b5304-7998-4db4-9f66-5311b8732467" escape="true"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.00pt;"><tr><td style="width:1.0pt;"></td><td style="width:94.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gains</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Losses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gains</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Losses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc9cdd25bf88475f8e513d4db47ee846_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0xLTEtMS0w_5ec9da01-b44b-403b-abf5-781aff9a9841">6,430</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc9cdd25bf88475f8e513d4db47ee846_I20200630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0zLTEtMS0w_7e572201-57d8-4be8-a6f4-cfd4462a6191">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ibc9cdd25bf88475f8e513d4db47ee846_I20200630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy01LTEtMS0w_6f465176-484d-41dd-98c0-84cda9138b0d">6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc9cdd25bf88475f8e513d4db47ee846_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy03LTEtMS0w_a7bf0b95-c08d-4e7f-821e-5526db0a5db9">6,425</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51276a8f169f436da9ec48301dcd051a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy05LTEtMS0w_28f6c7b0-5698-4d39-9dd6-4e2be0d5d08f">11,673</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51276a8f169f436da9ec48301dcd051a_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0xMS0xLTEtMA_132e0417-9220-47fd-b1c1-842dda1b1978">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i51276a8f169f436da9ec48301dcd051a_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0xMy0xLTEtMA_11ea3b82-9306-4cbc-bd69-d783d7929c63">1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51276a8f169f436da9ec48301dcd051a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0xNS0xLTEtMA_ceb9bcb1-37c4-4bbd-8438-1f3e6745254f">11,675</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b8db529f1db479582f2818c75225c64_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0xLTEtMS0w_eb7c5ed2-cfbb-4bd8-9fa1-e213dd0ef994">5,019</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b8db529f1db479582f2818c75225c64_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0zLTEtMS0w_d13fa779-3605-45f2-9783-b97a5549dcbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b8db529f1db479582f2818c75225c64_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC01LTEtMS0w_a1a80cd4-849d-4f33-852f-045e067af3e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b8db529f1db479582f2818c75225c64_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC03LTEtMS0w_855184e7-98f9-4191-8f2e-b8c4751694d6">5,019</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC05LTEtMS0w_2531e988-736a-4ce1-8097-30d309418a4b">11,093</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0xMS0xLTEtMA_0729ba07-ab6c-4aa0-9fc3-00190cba4105">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0xMy0xLTEtMA_e2dc6084-15db-422d-be74-d16138792ed8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0xNS0xLTEtMA_a894b3a6-2f24-42ab-b19b-1d8789681533">11,093</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Municipal debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i411233e5c6644b1299e6cd2602fff077_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0xLTEtMS0w_8616ac2a-259e-4b43-8d39-3d60e6e05e25">20,975</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i411233e5c6644b1299e6cd2602fff077_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0zLTEtMS0w_c6cb6b61-3806-416f-85eb-5161678aeb1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i411233e5c6644b1299e6cd2602fff077_I20200630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS01LTEtMS00MTg_1e2a09a0-5bdb-4293-a0e2-37a514fe3ab4">2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i411233e5c6644b1299e6cd2602fff077_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS03LTEtMS0w_04b0f527-92d7-4ee6-9523-697aab3109bf">20,973</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie09e7b16df084c27894b034b50301fc2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS05LTEtMS0w_2f4c66b5-12cd-4fb2-a3b6-40eaaaabbd07">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie09e7b16df084c27894b034b50301fc2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0xMS0xLTEtMA_869aaf9c-33d2-483b-8e48-3cabbdc10e96">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie09e7b16df084c27894b034b50301fc2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0xMy0xLTEtMA_2c78e4fa-6ea0-4bf1-8d34-f8a301a40b62">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie09e7b16df084c27894b034b50301fc2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0xNS0xLTEtMA_2051f026-e55d-4ceb-99cc-f869c691c4ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sovereign government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52a8a4bbf7814421a7344fbca72e4db2_I20200630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0xLTEtMS0w_d166b5fa-02a9-4c19-9713-39c2c9e965cb">197</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52a8a4bbf7814421a7344fbca72e4db2_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0zLTEtMS0w_f94d10d6-ee10-49ac-90f0-49458214a19d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52a8a4bbf7814421a7344fbca72e4db2_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi01LTEtMS0w_38bcd6ce-35f5-4893-b0d6-339e1ee132a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52a8a4bbf7814421a7344fbca72e4db2_I20200630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi03LTEtMS0w_c032e921-b74a-406c-8c4f-e42d478655c3">197</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi05LTEtMS0w_f10298b6-fb52-40e0-b167-03b9cc9b7db3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0xMS0xLTEtMA_079789a2-d07b-4ee2-8e18-2264772a69cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0xMy0xLTEtMA_27619e23-fa49-4242-a411-c516a6febfb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0xNS0xLTEtMA_e53c4b94-c5bb-4aec-8bb4-0abc22e9f590">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0xLTEtMS0w_018c7607-ada7-47d4-8aad-205f9c65dbf3">32,621</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0zLTEtMS0w_9c6fdcb2-df0a-4748-b849-5fa4fc4afdd2">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy01LTEtMS0w_53bb8395-f761-4282-9414-f5cfb5997d5f">8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy03LTEtMS0w_752c50b1-73ef-4978-831c-8afdd376845f">32,614</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy05LTEtMS0w_2f65c715-7f0e-4499-88cb-f5736c724062">22,766</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0xMS0xLTEtMA_3e779d58-ccfa-4238-ac86-9b5822c950f0">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0xMy0xLTEtMA_8ce30841-38bc-47e6-9f66-74e5bb6f81f1">1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0xNS0xLTEtMA_3633b5f9-33c8-4a7d-a272-9f03c5cb3357">22,768</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;"><span><br/></span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RleHRyZWdpb246MWI1ZjNiM2M1NDYzNDhkOGEyYTI5YmNjNTliNDcxNmJfNjQ0_804bde8c-dd2a-4507-b234-0106ac3775d6" escape="true"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"></td><td style="width:360.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:70.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:70.75pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMS0xLTEtMS0w_0e187adc-1b91-4475-8bb6-1c89c8dc0b82">24,407</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMS0zLTEtMS0w_97b969e7-2287-4a0a-b6c4-d220c6ed3448">11,643</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMi0xLTEtMS0w_37eff920-fdd9-4470-b227-477ebf735bbc">8,207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMi0zLTEtMS0w_c4e81c16-0c98-4ef8-8119-bc1d512f3a7b">11,125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMy0xLTEtMS0w_7cce0f06-70bf-4ceb-9d34-99787b2f6665">32,614</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMy0zLTEtMS0w_6d8db7bf-c881-4a80-afcc-4cc65e92ce18">22,768</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RleHRyZWdpb246MWI1ZjNiM2M1NDYzNDhkOGEyYTI5YmNjNTliNDcxNmJfNjMw_20f1a1cc-102a-4398-a36b-1b33b8d42618" continuedAt="if8996daa667c4deaac36991006776324" escape="true"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i0ca9461f89c94c36a7534e8d2f8d52ff"><ix:continuation id="if8996daa667c4deaac36991006776324"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"></td><td style="width:361.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:70.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:70.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less than one year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfMi0xLTEtMS0w_382ad7c3-4e39-4a85-895a-fa4e639c89f6">32,621</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfMi0zLTEtMS0w_49d4695f-9256-4fca-98e5-f815e767fb16">32,614</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Greater than one year</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfMy0xLTEtMS0w_0281cc22-f963-4e57-b2bd-029857b39ccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfMy0zLTEtMS0w_d003f425-7e90-4720-b184-cc5bfb1a4db8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfNC0xLTEtMS0w_aef75846-205a-4738-9521-7cdcae8d2ca6">32,621</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfNC0zLTEtMS0w_34ced489-9ec4-4109-8122-badfa4f50891">32,614</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_49"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 4 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RleHRyZWdpb246OWVkYjA0YTZjNmVmNDFmNmFmNTI1YWQzZjE1YzhmZTRfMzg0ODI5MDY5Nzk5Mg_a2d607f9-6a1e-455e-a203-a7d3a71cf348" continuedAt="i1086bbc135744e70bf3e388da5456a89" escape="true">Income (Loss) Per Share</ix:nonNumeric></span></div><ix:continuation id="i1086bbc135744e70bf3e388da5456a89"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the three and six months ended June&#160;30, 2020, the Company reported net income in each period.  However, no common stock equivalents were utilized in the calculation of diluted income per share since any conversion as of June&#160;30, 2020 would have been anti-dilutive. For the three and six months ended June&#160;30, 2019, the Company incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive.  <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RleHRyZWdpb246OWVkYjA0YTZjNmVmNDFmNmFmNTI1YWQzZjE1YzhmZTRfMzI2_386c99b0-b931-4b22-85ca-64a577a96cdc" continuedAt="i18d26c179b0345828f19c51be8c04848" escape="true">At June&#160;30, 2020 and 2019, the Company excluded the following potentially dilutive securities (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i18d26c179b0345828f19c51be8c04848"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:65.789%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.666%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.813%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i380bbd1c1ef540988fa905c4d3a9bbd9_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfMi0xLTEtMS0w_373b96ae-691e-4691-af3e-47d8be92b282">1,161</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i038f7c88311e4f759817629c9442fb4e_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfMi0zLTEtMS0w_b50f32b5-708c-4dbc-9ca6-19013dec9777">1,101</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i6840633376a8464bb5028c503efbd70d_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfMy0xLTEtMS0w_73172ecc-5166-4262-89d5-dfd75ee0d223">2,154</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="id489cdfd5a324069840e47683d89ebd3_D20190101-20190630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfMy0zLTEtMS0w_c6b3cbea-733d-4863-aee8-fd2b567a6b05">30</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock Units</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i6aaa04fcbbd04e748061483302747deb_D20200101-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfNS0xLTEtMS0w_86832cf7-da69-4d37-8e9e-56f577006b6e">313</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7481b7eaae714c60a1ff50e6a622db4d_D20190101-20190630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfNS0zLTEtMS0w_d134cb9b-7be5-4591-96e7-b20f543dd94d">240</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></div></ix:continuation><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_52"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 5 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RleHRyZWdpb246YWYxMWJiMzViYmYyNGI4Y2JkMGI3NmU0OWZhMjkwMTVfMTQ3Mg_994d3f0b-7520-437d-9bba-a6ccfcf9e6c7" continuedAt="id02053be862a4fcab2037c898e63af7c" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="id02053be862a4fcab2037c898e63af7c"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of financial assets and liabilities that are being measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price). The Company is required to classify fair value measurements in one of the following categories:</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 1 inputs are defined as quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 2 inputs are defined as inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 3 inputs are defined as unobservable inputs for the assets or liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RleHRyZWdpb246YWYxMWJiMzViYmYyNGI4Y2JkMGI3NmU0OWZhMjkwMTVfMTQ3OQ_769eb8ee-c328-4304-b147-4312765edb65" escape="true"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth by level within the fair value hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of June&#160;30, 2020, and December&#160;31, 2019 (in thousands).</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"><tr><td style="width:1.0pt;"></td><td style="width:115.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:12.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketable securities - available for sale</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i60d3cfe6b6ff47e5a543fcfdc2245182_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0yLTEtMS0w_48dab390-37e2-4d30-9608-841cffb980bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e4029dd45d4a2e993c6cc753ebd83e_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy00LTEtMS0w_376dc702-ac44-4b3e-86dd-8c8ed69158b9">8,207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i57debf008f6741c6a70e1068fc6fe3c0_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy02LTEtMS0w_13b47d99-023d-455a-96bf-0ccf016f6dc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d727b490abb4a08b6bc611450220f08_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy04LTEtMS0w_f1d3d746-b190-4151-815e-1408c211f239">8,207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie87a77d2f0f048cda7eb6a19d339ae3f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0xMC0xLTEtMA_2158d5f9-1772-404d-bafb-1de40149966f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibcebce19867e4bf9b34357c8eedd8e33_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0xMi0xLTEtMA_5958ff54-f4df-4a52-88c4-4b93ab84cfaa">11,125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcb791e9b72843fcb667122a6a337f82_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0xNC0xLTEtMA_154730ab-2ed2-4b48-a204-fe846a23e755">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i523ce19cd95244908556f420c606e80b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0xNi0xLTEtMA_db039636-3203-4e2d-b1d6-1238a296200e">11,125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i60d3cfe6b6ff47e5a543fcfdc2245182_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0yLTEtMS0w_5e0dbfea-d5a2-4a8a-a445-8ebeb835bca5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e4029dd45d4a2e993c6cc753ebd83e_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC00LTEtMS0w_f6945713-6d94-48f7-86c6-8ff0056e4fcf">8,207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i57debf008f6741c6a70e1068fc6fe3c0_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC02LTEtMS0w_a849a8a3-a336-42c0-88da-4787471da98c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d727b490abb4a08b6bc611450220f08_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC04LTEtMS0w_a27e7976-7676-4663-8521-3f13ab2dcb7c">8,207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie87a77d2f0f048cda7eb6a19d339ae3f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0xMC0xLTEtMA_4908f4c4-82fe-44a1-aa76-cba9fad98615">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibcebce19867e4bf9b34357c8eedd8e33_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0xMi0xLTEtMA_73bf0ef5-f332-4a4a-bd17-21208cbafdbf">11,125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcb791e9b72843fcb667122a6a337f82_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0xNC0xLTEtMA_8f72d5d8-0905-433b-aa67-26f4ec208296">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i523ce19cd95244908556f420c606e80b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0xNi0xLTEtMA_6fbe1c32-8337-40e1-aa91-ba45eb69655a">11,125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">14</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 6&#160;&#8211;&#160;<ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RleHRyZWdpb246ZWIxNzhlMmUyMmQ2NDBhMThiYTQ0ZWIwYzNlZWEyZWNfMTEw_6bbdefcd-d59b-4253-b1cf-22facf4cad6e" continuedAt="id6a4ea7582094cb798c9def818339721" escape="true">Accrued Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id6a4ea7582094cb798c9def818339721"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RleHRyZWdpb246ZWIxNzhlMmUyMmQ2NDBhMThiYTQ0ZWIwYzNlZWEyZWNfMTA2_75fe1c29-f983-40be-8025-d303af793ee7" escape="true"><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accrued liabilities as of June&#160;30, 2020 and December&#160;31, 2019 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.75pt;"><tr><td style="width:1.0pt;"></td><td style="width:313.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:97.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:88.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Salaries, employee benefits and related taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMS0xLTEtMS0w_5ffdf98b-bae8-470f-a8b3-c7c59398cc7b">1,441</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMS0zLTEtMS0w_1e3f65ab-f78c-4adb-a4a1-f7518f60b53b">1,834</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities -- current</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMi0xLTEtMS0w_4944899b-6a5e-4574-b800-3f61e37265a6">349</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMi0zLTEtMS0w_bc69031b-0e7b-4b2f-942e-805f0c59a66c">354</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CIRM upfront funding -- current</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="clbs:AccruedGrantFunding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMy0xLTEtMS0w_c8076d04-9af0-4e24-8b55-26ce9267028e">229</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="clbs:AccruedGrantFunding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMy0zLTEtMS0w_c7df8f95-8ddb-4c2a-9490-434dc602f816">1,600</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfNC0xLTEtMS0w_d8b5183d-c4c5-44c1-8e11-0d982cb5df18">869</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfNC0zLTEtMS0w_ed884ba8-d1c2-444a-8fdb-55c1865df34c">698</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfNS0xLTEtMS0w_0964ec9e-0937-413a-90c7-948d8aa5b240">2,888</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfNS0zLTEtMS0w_208533d2-168f-4450-b586-9d2090d45f4c">4,486</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_58"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 7&#160;&#8211;&#160;<ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTM0OQ_15d589d3-9ba5-4876-a5bc-52ff6812cd85" continuedAt="i37677f49051c450c80c4816cc8a676af" escape="true">Operating Leases</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i37677f49051c450c80c4816cc8a676af"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has operating leases for <ix:nonFraction unitRef="office" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt-sec:numwordsen" name="clbs:NumberOfOfficesUnderOperatingLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfNzA_95a4c3ba-8926-49ac-84af-42e353eb0881">two</ix:nonFraction> offices with terms that expire in 2022 and 2023. The Company estimates its incremental borrowing rate, at lease commencement, to determine the present value of lease payments, since most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases include options for the Company to extend the lease term and/or sub-lease space in whole or in part.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTM0Nw_b1679151-5621-416e-adde-a6cab4915d13" continuedAt="id809cc6ced6b487ba5a3114e5db2293c" escape="true">Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet were as follows (in thousands):</ix:nonNumeric></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="id809cc6ced6b487ba5a3114e5db2293c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"></td><td style="width:325.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:88.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:88.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Right-of Use Assets:</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if91087121ec44256b8962731a81173e2_I20200630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfMi0xLTEtMS0w_4bcc1684-3437-493b-8dca-5831e075d1c9">731</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i899c54667f134030ae5390e6bdd1b0f3_I20191231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfMi0zLTEtMS0w_5339fdad-3709-43d2-83ee-d76cb8bb0961">906</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Right-of-Use Asset</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfMy0xLTEtMS0w_6906f8e0-3583-43b1-ab04-0508268f2314">731</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfMy0zLTEtMS0w_066eb194-171f-4faa-af1d-cfb2620d9bba">906</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Lease Liabilities:</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5f781bdb8e5f41e99cf7d9a445cea06c_I20200630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfNi0xLTEtMS0w_f67dc510-b580-46b8-a6e5-7d62041d7682">349</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i20af34c4f7754a0cb76befe079bbf0c6_I20191231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfNi0zLTEtMS0w_800ca813-34ff-4132-b25f-3adbcf077ab1">353</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic00237ce125744ceb6a8b4882def3994_I20200630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfNy0xLTEtMS0w_6441576f-b768-4151-a9a0-e62c644aac34">445</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iabb27bf045414866879a04335d6c62eb_I20191231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfNy0zLTEtMS0w_841496e1-ba55-4e13-8245-85ec05730e43">624</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Operating Lease Liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfOC0xLTEtMS0w_b78a173a-daa5-4774-8dcd-9829ceed70e8">794</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfOC0zLTEtMS0w_2547f61b-562f-4553-a3e3-a66a99672654">977</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of June&#160;30, 2020, the weighted average remaining lease term for our operating leases was <ix:nonNumeric contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTE2Mw_71b7bffb-3580-4653-a9fb-2a3e04786c4f">1.6</ix:nonNumeric> years, and the weighted average discount rate for our operating leases was <ix:nonFraction unitRef="number" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="5" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTIzNQ_65691802-055d-49e6-a3fd-b2e3e6a6d0aa">9.625</ix:nonFraction>%. <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTM0MQ_a90df96e-9bd2-4f99-8231-4557244552b2" continuedAt="i79d0da903d67420aabe04150b65c3963" escape="true">Future minimum lease payments under the lease agreements as of June&#160;30, 2020 were as follows (in thousands):</ix:nonNumeric></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i79d0da903d67420aabe04150b65c3963"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"><tr><td style="width:1.0pt;"></td><td style="width:448.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:60.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Years ended</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Leases</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfMi0xLTEtMS0w_1bfa45ae-4da4-4f39-b58e-d004f0832986">204</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfMy0xLTEtMS0w_21d046e4-3a11-4da2-8326-e92522c28e6e">414</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfNC0xLTEtMS0w_a81e9d9d-ae48-4c80-91dd-64047c075462">239</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfNS0xLTEtMS0w_cf7987b4-b8b7-4bb2-8e38-3af781fbbbf5">27</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfNi0xLTEtMS0w_d2e1d3ff-9d0e-4248-8ad6-095c1fca1a8e">884</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amounts representing interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfNy0xLTEtMS0w_f125d3b4-d2a2-4e86-9474-020144047b00">90</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of lease liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfOC0xLTEtMS0w_e73f519e-f434-4b80-b71b-962cc773be15">794</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_61"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 8 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjY0NA_0da353bb-a3ff-4718-a47c-c1b006d53ad6" continuedAt="i9b3cffb3b7d34cb1817b1ea1ab06256c" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><div style="text-align:justify;"><span><br/></span></div><ix:continuation id="i9b3cffb3b7d34cb1817b1ea1ab06256c" continuedAt="ic6e1b72349e8496bb35b3e7a3e504c34"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Equity Issuances</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Purchase Agreement</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In March&#160;2019, the Company and Lincoln Park Capital Fund, LLC (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><ix:continuation id="ic6e1b72349e8496bb35b3e7a3e504c34" continuedAt="i2b949fcfdbfc41d78a1d0abb3c94947c"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Company has the right to sell to Lincoln Park shares of the Company&#8217;s common stock having an aggregate value of up to $<ix:nonFraction unitRef="usd" contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331" decimals="-5" format="ixt:numdotdecimal" name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDMw_0b69ff9d-eb57-4cb0-8535-20501341b18b">26.0</ix:nonFraction> million, subject to certain limitations and conditions set forth in the Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional <ix:nonFraction unitRef="shares" contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331" decimals="INF" format="ixt:numdotdecimal" name="clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjQy_84907f69-1979-464c-9858-ef92c553691f">181,510</ix:nonFraction> shares of common stock as commitment shares.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pursuant to the Purchase Agreement, Lincoln Park purchased <ix:nonFraction unitRef="shares" contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNzUx_c3c26955-7ee7-4d67-a981-42cdf642fc56">250,000</ix:nonFraction> shares of common stock, at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNzky_f689d078-07a8-4d1f-93e5-e4989f679b6e">4.00</ix:nonFraction> per share, for a total gross purchase price of $<ix:nonFraction unitRef="usd" contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfODQy_7a30db6e-07ec-4833-a39f-4c0b4fe29ce2">1.0</ix:nonFraction> million (the &#8220;Initial Purchase&#8221;) upon commencement. Thereafter, as often as every business day from and after one business day following the date of the Initial Purchase and over the <ix:nonNumeric contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331" format="ixt-sec:durmonth" name="clbs:TermOfAgreement" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMTAyMA_3f76bc4b-3d87-4aa0-896e-55472b58727d">36</ix:nonNumeric>-month term of the Purchase Agreement the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to <ix:nonFraction unitRef="shares" contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331" decimals="INF" format="ixt:numdotdecimal" name="clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMTIwNQ_da974373-8a47-4a16-b2df-ddd1c00d1003">100,000</ix:nonFraction> shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln Park&#8217;s obligation under any single such purchase will not exceed $<ix:nonFraction unitRef="usd" contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331" decimals="-5" format="ixt:numdotdecimal" name="clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMTM5OQ_c8666206-a3dd-4b96-89ff-fc4d60be1bce">2.5</ix:nonFraction> million, unless the Company and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;).&#160;If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of (i)&#160;<ix:nonFraction unitRef="number" contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331" decimals="2" name="clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMTk0NA_16ab8680-f493-41e7-8634-980d5b5ab6e3">300</ix:nonFraction>% &#160;the number of shares purchased pursuant to the corresponding Regular Purchase or (ii)&#160;<ix:nonFraction unitRef="number" contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331" decimals="2" name="clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMjAzNA_2f705670-b51f-4414-b9cd-e28283041afb">30</ix:nonFraction>% of the total number of shares of the Company&#8217;s common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement. Under certain circumstances and in accordance with the Purchase Agreement, the Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company controls the timing and amount of any sales of its common stock to Lincoln Park.&#160;There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than <ix:nonFraction unitRef="number" contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331" decimals="4" name="clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMjkzNg_c798c149-b8f1-4379-86a9-cedcecdf6fcd">9.99</ix:nonFraction>% of its common stock.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Purchase Agreement does not limit the Company&#8217;s ability to raise capital from other sources at the Company&#8217;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating conversion rate or variable priced equity-like securities) during the <ix:nonNumeric contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331" format="ixt-sec:durmonth" name="clbs:TermOfAgreement" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMzM0NQ_3f76bc4b-3d87-4aa0-896e-55472b58727d">36</ix:nonNumeric> months after the date of the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of June&#160;30, 2020, the Company had not made any sales of common stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Common Stock Sales Agreement</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In February 2018, the Company entered into a common stock sales agreement with H.C. Wainwright&#160;&amp; Co., LLC ("HCW") as sales agent, which was subsequently amended in August 2018 (the "Sales Agreement"), in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock having an aggregate offering price of not more than $<ix:nonFraction unitRef="usd" contextRef="i27dbcb6ac24e46399fb67838c65e5bbe_I20180831" decimals="-5" format="ixt:numdotdecimal" name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDA3Mg_64e86d4b-01d2-48ad-aff7-1cbc225d9608">25.0</ix:nonFraction> million.&#160;In&#160;March&#160;2019, subsequent to the filing of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the "2018 Form 10-K"), the aggregate market value of our outstanding common stock held by non-affiliates was approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="ic32d3c882e084aa79bd397aa974b4613_I20190331" decimals="-5" format="ixt:numdotdecimal" name="clbs:AggregateMarketValueOfCommonStockNonAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDMxOA_0572c545-cc31-4456-829f-338fd3b06b8f">52.8</ix:nonFraction> million. Pursuant to General Instruction I.B.6 of Form S-3, since the aggregate market value of our outstanding common stock held by non-affiliates was below&#160;$75.0 million at the time of our 2018 Form 10-K filing, the aggregate amount of securities that we were permitted to offer and sell at such time was reduced to $<ix:nonFraction unitRef="usd" contextRef="if6ee95ae2dee4705b58d1a3b61eaf330_I20190331" decimals="-5" format="ixt:numdotdecimal" name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDYyMA_6a04ebed-64c4-419e-a7d7-d0bb7ab6cdd7">17.6</ix:nonFraction> million, which was equal to one-third of the aggregate market value of our common stock held by non-affiliates at such time.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the terms and conditions of the Sales Agreement, HCW will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell the shares from time to time, based upon the Company's instructions, including any price, time or size limits specified by the Company. The Company has provided HCW with customary indemnification rights, and HCW will be entitled to a commission at a fixed commission rate equal to <ix:nonFraction unitRef="number" contextRef="i0dc34b6e97fd4ee8b4dd911463597ac5_D20180201-20180228" decimals="INF" name="clbs:SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNTIyMw_b7de56cb-7bc9-4122-9d4d-f76ba456fc1d">3.0</ix:nonFraction>% of the gross proceeds per share sold. The Company has no obligation to sell any of the shares and may at any time suspend sales under the Sales Agreement or terminate the Sales Agreement. The Sales Agreement will terminate upon the sale of all of the shares under the Sales Agreement unless terminated earlier by either party as permitted under the Sales Agreement. </span></div></ix:continuation><div style="text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><ix:continuation id="i2b949fcfdbfc41d78a1d0abb3c94947c" continuedAt="i9e5ecd757e6a4f339ef62f062a81ccb9"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the six months ended June&#160;30, 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="id6b5f2a163bb41f395f2f166843dc9c1_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMTcyMw_8b91cdc4-76a4-46d8-88ca-d7a161c107b8">681,034</ix:nonFraction> shares of common stock under the Sales Agreement for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="id6b5f2a163bb41f395f2f166843dc9c1_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMTcxNA_0c2f4f53-1bb2-413d-8664-62cb085ded5e">1.3</ix:nonFraction>&#160;million. As of June&#160;30, 2020, the Company has issued <ix:nonFraction unitRef="shares" contextRef="i3d2f30f90a5e4e7c836f63de04b42380_D20180201-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNTcyMg_5d705aa0-cd11-481e-a9c0-eebc6614ed39">907,168</ix:nonFraction> shares of common stock under the Sales Agreement for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i3d2f30f90a5e4e7c836f63de04b42380_D20180201-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNTc5NA_6f6972ac-c223-4800-adf5-7c98aa094414">2.3</ix:nonFraction> million since inception. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Registered Direct Offerings</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In April 2020, the Company entered into a securities purchase agreement (the &#8220;April Purchase Agreement&#8221;) with certain investors (the &#8220;April Purchasers&#8221;). Pursuant to the terms of the April Purchase Agreement, the Company agreed to sell to the Purchasers an aggregate of <ix:nonFraction unitRef="shares" contextRef="i06ddd3f40ce1488cb4db1f51b16d53a5_D20200401-20200430" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYxNg_21092f4c-31a3-4823-83b2-ea96fb8a41a5">2,162,166</ix:nonFraction> shares of its common stock at a purchase price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i848cc63cd4a84516a987b6158ef085e8_I20200430" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYyMg_477a1758-920a-40d5-8d9f-64dcb6210acf">2.3125</ix:nonFraction> per share. In a concurrent private placement, the Company issued to the April Purchasers warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="i848cc63cd4a84516a987b6158ef085e8_I20200430" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYxOQ_4e354696-e036-4cb8-97a5-9a63fa453c89">1,081,083</ix:nonFraction> shares of its common stock. In connection with the registered direct offering and concurrent private placement, the Company received gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i06ddd3f40ce1488cb4db1f51b16d53a5_D20200401-20200430" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYyOA_2ca12bef-29c5-44aa-9179-fe9ee5fed23b">5,000,009</ix:nonFraction>. Each warrant is exercisable for one share of common stock and features an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i848cc63cd4a84516a987b6158ef085e8_I20200430" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYyNQ_76042a68-d762-43f6-8261-6748f39b29e1">2.2500</ix:nonFraction> per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In May 2020, the Company entered into a securities purchase agreement (the &#8220;May Purchase Agreement&#8221;) with certain investors (the &#8220;May Purchasers&#8221;). Pursuant to the terms of the May Purchase Agreement, the Company agreed to sell to the May Purchasers an aggregate of <ix:nonFraction unitRef="shares" contextRef="icfde3833e9e746b7bb672ba96a4b144d_D20200501-20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYzMQ_615a189d-5219-4849-ae0e-17e7e80165c6">2,084,850</ix:nonFraction> shares of its common stock at a purchase price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYzNw_023a3e20-8dff-4e5d-9b6f-29fc4052a6a9">2.0625</ix:nonFraction> per share. In a concurrent private placement, the Company issued to the Purchasers warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYzNA_89ab9c41-1da8-43e3-a225-3b5384a6d2a5">1,042,425</ix:nonFraction> shares of its common stock. In connection with the registered direct offering and concurrent private placement, the Company received gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="icfde3833e9e746b7bb672ba96a4b144d_D20200501-20200531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzY0Mw_d9967dcb-dd9b-4306-86f9-87c61b7926f1">4.3</ix:nonFraction> million. Each warrant is exercisable for one share of common stock and features an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzY0MA_8d74c731-e328-4c1f-a094-babf96181a79">2.0625</ix:nonFraction> per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Options and Warrants</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjYzNQ_5c89cb5f-3627-4429-95c4-b99c4dadac6e" continuedAt="i62411140df724d8286b1c4f45a9bb0f2" escape="true">The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2020:</ix:nonNumeric></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i62411140df724d8286b1c4f45a9bb0f2"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:21.865%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.224%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.638%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.638%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.224%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.052%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.638%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.638%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.227%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (In Thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (In Thousands)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i798ecf9e15c5435a90a4a4a6b80c21e8_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0yLTEtMS0w_e2e4d5b4-b9ab-46ec-99c4-02258b5bb7b6">1,044,417</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i798ecf9e15c5435a90a4a4a6b80c21e8_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi00LTEtMS0w_af5fcc6d-7f9b-4e04-8073-35246a23edab">18.31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="idccb2e05fee74cb3b8743e49713e31b6_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi02LTEtMS0w_aa1b3239-652d-4980-91ed-a487090c1bcb">6.06</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i798ecf9e15c5435a90a4a4a6b80c21e8_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi04LTEtMS0w_1dccd5b5-8f6e-415c-bf46-848384a7dd54">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="clbs:CommonStockWarrantsShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0xMC0xLTEtMA_1a3ba13e-fa98-4b9a-9855-b713f737d584">30,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0xMi0xLTEtMA_c8ae571a-cafd-4841-b4aa-8e21977849f5">5.89</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ic0f802c6ed3941c18eac0365a12a53e3_D20190101-20191231" format="ixt-sec:duryear" name="clbs:WeightedAverageRemainingContractualTermwarrantoutstanding" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0xNC0xLTEtMA_af706cec-da43-405e-9c28-cf569e00283c">3.19</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-3" format="ixt:zerodash" name="clbs:AggregateIntrinsicValueWarrantsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0xNi0xLTEtMA_0cf09da0-6524-4da0-8866-5853a3d0d704">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes during the period:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNS0yLTEtMS0w_a44d0392-30b0-4e7f-9490-345f12bfe9e4">245,776</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNS00LTEtMS0w_7336d552-fbff-4325-b466-bd529f0c6d5d">3.22</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="clbs:WarrantsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNS0xMC0xLTEtMA_c5a07fe3-95ca-4393-a74e-0bc8b386fe31">2,123,508</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNS0xMi0xLTEtMA_f13b54cd-5a7c-44c9-bd9d-5fca29b4d133">2.16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNi0yLTEtMS0w_c1a39001-9c53-4f8f-8a46-51e3bce38251">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNi00LTEtMS0w_4ff01433-1072-409f-9d82-0a7df447ff84">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="INF" format="ixt:zerodash" name="clbs:WarrantsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNi0xMC0xLTEtMA_ba55ed8c-6f6c-4247-8c4c-398a1cdd7a09">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="2" format="ixt:zerodash" name="clbs:WeightedAverageExercisePriceWarrantsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNi0xMi0xLTEtMA_1312f8f8-f43e-429b-8b5b-e8bb11f97241">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNy0yLTEtMS0w_c026c0f6-c733-4c48-ac2f-eb3154f64f9d">5,400</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNy00LTEtMS0w_8129c70d-f4d3-44db-afed-44de01faf019">3.28</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="INF" format="ixt:zerodash" name="clbs:WarrantsCanceled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNy0xMC0xLTEtMA_da4842ee-0111-48e9-994f-84d5fe5f73eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="2" format="ixt:zerodash" name="clbs:WeightedAverageExercisePriceWarrantsCanceled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNy0xMi0xLTEtMA_a14de76e-fdc6-4931-a299-e9790994ea2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOC0yLTEtMS0w_e31bad3f-b3e1-4624-a157-6c20ca9d6c94">123,584</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOC00LTEtMS0w_fa147b5a-2324-4792-a895-293b1a52ba04">21.48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="INF" format="ixt:zerodash" name="clbs:WarrantsExpired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOC0xMC0xLTEtMA_a7fe56e0-6377-4f45-b50e-52181bae5e3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="2" format="ixt:zerodash" name="clbs:WeightedAverageExercisePriceWarrantsExpired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOC0xMi0xLTEtMA_a94840f9-cc97-4b46-8e04-19f7aa8f1a98">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0yLTEtMS0w_c1b1b691-cc44-49df-a862-88bafa7b299d">1,161,209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS00LTEtMS0w_9dde6ad6-6a77-4fd9-aad6-00a99422f183">14.85</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS02LTEtMS0w_76cf6452-e4f7-49f5-b48e-a7750f1be183">6.98</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS04LTEtMS0w_2d710b97-4885-4a34-bfa9-55c7804b5246">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="clbs:CommonStockWarrantsShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0xMC0xLTEtMA_ffb6af30-2b17-4164-b915-41e7e2e2e469">2,153,508</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0xMi0xLTEtMA_db0b5ed1-daf1-43f7-9d1a-c95d027926f7">2.21</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:duryear" name="clbs:WeightedAverageRemainingContractualTermwarrantoutstanding" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0xNC0xLTEtMA_c9fd5601-a036-4449-b5c4-b8c518287250">5.33</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:zerodash" name="clbs:AggregateIntrinsicValueWarrantsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0xNi0xLTEtMA_ed490965-b74b-4ee8-bf47-ae2caf433db0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested at June 30, 2020<br/> or expected to vest in the future</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMi0xLTEtMA_8380f686-a2ae-473f-ac0e-b0cde8301d17">1,131,822</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtNC0xLTEtMA_7e39ce3e-ab90-4c16-b485-597d7cf98fb8">15.14</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtNi0xLTEtMA_98d5faa8-efba-4543-b12a-47ab7af65b80">6.92</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtOC0xLTEtMA_2e5c9899-3e79-4f31-90cb-edf24ceae00a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="clbs:Sharesvestedandexpectedtovest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMTAtMS0xLTA_d23a64ba-aebf-488c-9dec-140870ca22cc">2,153,508</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMTItMS0xLTA_44ba308c-f7c8-4672-8d0d-ee040ea02d76">2.21</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:duryear" name="clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMTQtMS0xLTA_2f00393f-858f-4348-9283-b0ba284b4b9e">5.33</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:zerodash" name="clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMTYtMS0xLTA_df3c6c1d-bf79-4a2f-95cf-39e185ca8ae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested at June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMi0xLTEtMA_705fe819-3d08-4da4-80fa-e26a158e09b7">829,034</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtNC0xLTEtMA_9fa130d4-b2af-43fe-a865-cd2376be7e73">19.25</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630" format="ixt-sec:duryear" name="clbs:OptionsVestedweightedAverageRemainingContractualTerm" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtNi0xLTEtMA_b89a810a-ea83-4b33-b914-8928a3b51fa9">6.17</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icde65320b8824859b7fc2395f13c2799_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtOC0xLTEtMA_b46b23fd-fc70-4534-aa7b-f59811626c0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="INF" format="ixt:numdotdecimal" name="clbs:WarrantsVested" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMTAtMS0xLTA_74381b17-0c4d-4c91-9ef7-9d4dc08b871a">2,153,508</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsExercisable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMTItMS0xLTA_557171cd-eb21-4eab-82ef-0a8d50614d1b">2.21</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" format="ixt-sec:duryear" name="clbs:WeightedAverageRemainingContractualTermwarrantsvested" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMTQtMS0xLTA_cbcf4242-facc-49c9-8afc-4084fab6af9c">5.33</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630" decimals="-3" format="ixt:zerodash" name="clbs:AggregateIntrinsicValueWarrantsvested" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMTYtMS0xLTA_bdd8c7b9-72b2-4b65-b0fe-78b1855e5aae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:2.25pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restricted Stock</span></div><div style="text-indent:2.25pt;text-align:justify;"><span><br/></span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjYyNA_8c48c8c2-73dc-4ba0-a23f-4faee8dd1cab" escape="true"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock for services as follows ($ in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:483.75pt;"><tr><td style="width:1.0pt;"></td><td style="width:322.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:72.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:4.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:73.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of restricted stock issued</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmUyZjQ5Njg4ZDgzNjQ4NTU4ZDY0OGQwNWU3ZTc4MjMyL3RhYmxlcmFuZ2U6ZTJmNDk2ODhkODM2NDg1NThkNjQ4ZDA1ZTdlNzgyMzJfMi0yLTEtMS0w_0725bf2c-5f1c-470c-9f85-8ed1981c2180">156,184</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3f6a0bbceb0d475db409f328331721e3_D20190101-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmUyZjQ5Njg4ZDgzNjQ4NTU4ZDY0OGQwNWU3ZTc4MjMyL3RhYmxlcmFuZ2U6ZTJmNDk2ODhkODM2NDg1NThkNjQ4ZDA1ZTdlNzgyMzJfMi00LTEtMS0w_17fa7b38-223b-49aa-9871-2e544de61761">123,564</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value of restricted stock issued</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmUyZjQ5Njg4ZDgzNjQ4NTU4ZDY0OGQwNWU3ZTc4MjMyL3RhYmxlcmFuZ2U6ZTJmNDk2ODhkODM2NDg1NThkNjQ4ZDA1ZTdlNzgyMzJfMy0yLTEtMS0w_8c0ae7b6-d453-4f9a-b291-bfafeb9dd0ed">512</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3f6a0bbceb0d475db409f328331721e3_D20190101-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmUyZjQ5Njg4ZDgzNjQ4NTU4ZDY0OGQwNWU3ZTc4MjMyL3RhYmxlcmFuZ2U6ZTJmNDk2ODhkODM2NDg1NThkNjQ4ZDA1ZTdlNzgyMzJfMy00LTEtMS0w_49f346ae-6655-49c7-a500-1c217ac97ae4">612</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:2.25pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restricted Stock Units</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-indent:2.25pt;text-align:justify;"><span><br/></span></div><ix:continuation id="i9e5ecd757e6a4f339ef62f062a81ccb9" continuedAt="ide3e35326d2740feaa1e4a462f87f247"><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjYzMA_7998bbba-d8bc-4ed1-a006-e67c433b8a21" escape="true"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock units for services as follows ($ in thousands, except share data):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:498.00pt;"><tr><td style="width:1.0pt;"></td><td style="width:343.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:72.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:73.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of restricted stock units issued</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmFmOWFmMTJmZGIxZDRkM2Y5NDBhMjFlMGQ2NDU1NWE4L3RhYmxlcmFuZ2U6YWY5YWYxMmZkYjFkNGQzZjk0MGEyMWUwZDY0NTU1YThfMi0xLTEtMS0w_ebb5bf24-f571-49a4-a457-bbc80b4e40e2">195,320</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9ff3343eb5e7446abb32c279fd9ef744_D20190101-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmFmOWFmMTJmZGIxZDRkM2Y5NDBhMjFlMGQ2NDU1NWE4L3RhYmxlcmFuZ2U6YWY5YWYxMmZkYjFkNGQzZjk0MGEyMWUwZDY0NTU1YThfMi0zLTEtMS0w_f5be701b-95a1-433f-aa01-799a1916d072">184,454</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value of restricted stock units issued </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmFmOWFmMTJmZGIxZDRkM2Y5NDBhMjFlMGQ2NDU1NWE4L3RhYmxlcmFuZ2U6YWY5YWYxMmZkYjFkNGQzZjk0MGEyMWUwZDY0NTU1YThfMy0xLTEtMS0w_9f10e18e-d140-41d9-9513-13525837d918">623</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ff3343eb5e7446abb32c279fd9ef744_D20190101-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmFmOWFmMTJmZGIxZDRkM2Y5NDBhMjFlMGQ2NDU1NWE4L3RhYmxlcmFuZ2U6YWY5YWYxMmZkYjFkNGQzZjk0MGEyMWUwZDY0NTU1YThfMy0zLTEtMS0w_b4d58f33-9b82-4ad1-b25d-011e94606c5e">909</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ide3e35326d2740feaa1e4a462f87f247">The weighted average estimated fair value of restricted stock issued for services in the six months ended June&#160;30, 2020 and 2019 was $<ix:nonFraction unitRef="usdPerShare" contextRef="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjMzMA_0488ce92-fe21-4dff-805b-004aacd75a9f">3.19</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i3f6a0bbceb0d475db409f328331721e3_D20190101-20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjMzNw_7f007936-d7f2-48ff-8a72-5886f5bd0a3d">4.93</ix:nonFraction> per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms of restricted stock unit issuances are generally <ix:nonNumeric contextRef="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDM5ODA0NjUxOTc3Nw_9ada1948-28f6-4b83-b39b-fa1327bbd928">one year</ix:nonNumeric>, or upon the achievement of performance-based milestones.</ix:continuation> </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_64"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 9 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RleHRyZWdpb246NzE0YTBmMDA0NzhiNDY3NDk2YmJkYTZhNDgwZDIyZmZfMTE1Mg_e13d80e7-e740-4356-8174-1a3b33f275d6" continuedAt="i4b03ebe3b3cc4b66a9931a06382b6770" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4b03ebe3b3cc4b66a9931a06382b6770"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Share-Based Compensation</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We utilize share-based compensation in the form of stock options, restricted stock, and restricted stock units.&#160; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RleHRyZWdpb246NzE0YTBmMDA0NzhiNDY3NDk2YmJkYTZhNDgwZDIyZmZfMTE0MQ_ce45ba2b-0ee4-4380-8c00-84977741dc9d" continuedAt="i99ada6a0338647578fddbe24cf29120d" escape="true">The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2020 and 2019 (in thousands):</ix:nonNumeric></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i99ada6a0338647578fddbe24cf29120d"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:45.067%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.463%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.826%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.463%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.826%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.463%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.826%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.466%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i26dc6f410bb34ef1b20a17e4d3226752_D20200401-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMi0xLTEtMS0w_73de261c-97c0-4447-9087-51fd43b80792">56</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i573aeb998eaf418389958e830a4fd5b6_D20190401-20190630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMi0zLTEtMS0w_32ea3d4b-f000-4bc7-8565-280a832b92ff">50</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6fe2517ab39b4e1aa621db4c39dbf740_D20200101-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMi01LTEtMS0w_1a1c737d-67ea-4871-b9a8-ab0b96e99ecb">181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibee88ce40a3a47fdab9f0302d0f48d88_D20190101-20190630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMi03LTEtMS0w_21d53b3b-4de4-4c2f-8dce-eaadf55ef8cf">174</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General and administrative</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia1a63f2bc4e742469418ccdee39935e5_D20200401-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMy0xLTEtMS0w_13b72a0c-b922-4ced-b5a1-873a07757837">239</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if73c2d1f89dc4b9eba1e9511f636f5fa_D20190401-20190630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMy0zLTEtMS0w_762ea57b-6fac-477e-b542-3d56e2900033">195</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8f90fb65ff524ed98e292273fda18895_D20200101-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMy01LTEtMS0w_45c4ea8b-5653-451c-a498-f6cdc661160b">680</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a5da1d8176f41c3abcf0352434e0dff_D20190101-20190630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMy03LTEtMS0w_dc85c5fa-f4fe-4f78-9949-984e98f347f8">619</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total share-based compensation expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfNC0xLTEtMS0w_34b83b17-65fb-43c6-8652-d77bf88350d0">295</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfNC0zLTEtMS0w_cdf7033d-8ed2-4444-98cf-22b92a0a4a1c">245</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfNC01LTEtMS0w_16a28d71-7146-4a8d-b70a-b57ff16dcb29">861</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfNC03LTEtMS0w_85d0d63b-c313-4b45-b62b-72be597e1d98">793</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></div><div style="text-align:center;"><span><br/></span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RleHRyZWdpb246NzE0YTBmMDA0NzhiNDY3NDk2YmJkYTZhNDgwZDIyZmZfMTE0Mw_921ca58d-adca-40cd-9e79-8adc70fc136d" escape="true"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total compensation cost related to non-vested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2020 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:66.081%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.956%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.824%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.956%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.824%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.959%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock Units</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized compensation cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e40117026924a3da318f41263045d8c_I20200630" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMS0xLTEtMS0w_c13aa52f-01e3-4783-88a9-2efa61489220">734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieac73b68636a4e2d89630fe927e17eb8_I20200630" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMS0zLTEtMS0w_f0185051-3dea-4966-b718-32bfd5a14619">188</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9da5c1afc9a24304ab6103f6095e3e85_I20200630" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMS01LTEtMS0w_6d6b90f8-55d8-4394-8bb9-9807fc4db321">172</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i36becd2504164b3aab52d7e8b2b6c31d_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMi0xLTEtMS0w_4d50063c-2fba-469a-b73a-e7d245e3bcfa">1.83</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMi0zLTEtMS0w_8ff0493d-e8b0-465f-8116-726629e663f8">0.66</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMi01LTEtMS0w_6fb4795e-73aa-4bf2-9a7c-22947ee0b9a0">0.50</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="text-align:center;"><span><br/></span></div><ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RleHRyZWdpb246NzE0YTBmMDA0NzhiNDY3NDk2YmJkYTZhNDgwZDIyZmZfMTEzMQ_347fa720-022f-4c86-b5a9-71dbeb772abb" escape="true"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2020 and 2019 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt;"><tr><td style="width:1.0pt;"></td><td style="width:378.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:61.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:3.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:61.75pt;"></td><td style="width:1.0pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total fair value of shares vested</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i36becd2504164b3aab52d7e8b2b6c31d_D20200101-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOjkxMzQ1NzdhNzQxNTRmYTNiZTVlNDhhOWJlNWNlY2VjL3RhYmxlcmFuZ2U6OTEzNDU3N2E3NDE1NGZhM2JlNWU0OGE5YmU1Y2VjZWNfMy0xLTEtMS0w_ad9cb5f1-c7da-4a22-89af-9455ff7dc1f7">515</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e481ed9443b4a88befbcf284f32660a_D20190101-20190630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOjkxMzQ1NzdhNzQxNTRmYTNiZTVlNDhhOWJlNWNlY2VjL3RhYmxlcmFuZ2U6OTEzNDU3N2E3NDE1NGZhM2JlNWU0OGE5YmU1Y2VjZWNfMy0zLTEtMS0w_1ffca62e-5f4a-42bf-9175-0969836d47bc">378</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average estimated fair value of shares granted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e40117026924a3da318f41263045d8c_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOjkxMzQ1NzdhNzQxNTRmYTNiZTVlNDhhOWJlNWNlY2VjL3RhYmxlcmFuZ2U6OTEzNDU3N2E3NDE1NGZhM2JlNWU0OGE5YmU1Y2VjZWNfNC0xLTEtMS0w_dcb23dff-d268-41dc-80a4-cf42f9753b51">2.12</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="id59dd6e8c9f64370960e3b4a0b377a6a_I20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOjkxMzQ1NzdhNzQxNTRmYTNiZTVlNDhhOWJlNWNlY2VjL3RhYmxlcmFuZ2U6OTEzNDU3N2E3NDE1NGZhM2JlNWU0OGE5YmU1Y2VjZWNfNC0zLTEtMS0w_f00d8893-a0ab-4552-994f-8990dc7bc2ba">3.18</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Valuation Assumptions</span></div><div><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of stock options and warrants at the date of grant was estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.</span></div></ix:continuation><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_67"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 10&#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfMTEzOQ_c2e0bd56-7794-4c3f-8561-1b11273366c2" continuedAt="i406bdb20acb5467b9b8b5a6f873e99ee" escape="true">Research Funding</ix:nonNumeric></span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"><ix:continuation id="i406bdb20acb5467b9b8b5a6f873e99ee" continuedAt="iaf892ce23007404db3e9abccaa1771b6">California Institute of Regenerative Medicine Grant Award</ix:continuation></span></div><div style="text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="iaf892ce23007404db3e9abccaa1771b6">In February 2017, the California Institute for Regenerative Medicine ("CIRM") awarded the Company funds of up to $<ix:nonFraction unitRef="usd" contextRef="i67413a83b057456c9a1af22965e51368_I20170228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrantsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfMjA0_d711f981-0b2c-4ad2-865a-3c721b2491de">12.2</ix:nonFraction> million to support the T-Rex Study. The funding is based upon the achievement of certain milestones related to the proportion of subjects enrolled in California, as well as manufacturing and development costs incurred in California. Based on the actual number of subjects enrolled in California, the total amount of funding was revised to $<ix:nonFraction unitRef="usd" contextRef="icd5ddb34eb58439ca82e6cd0adcb36c0_I20180331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrantsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjIwMA_a7e83f04-58cb-44b3-bab3-2ef1701ac307">8.1</ix:nonFraction> million. The Company received $<ix:nonFraction unitRef="usd" contextRef="i407cfd607b264cfb8ff9e7af6c462f5a_D20170501-20170531" decimals="-5" format="ixt:numdotdecimal" name="clbs:FundingOfGrantAwardCashReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNTk5_3041ef0d-2210-4215-be70-f0c4738d0a00">5.7</ix:nonFraction> million in initial funding in May 2017, a $<ix:nonFraction unitRef="usd" contextRef="i1fbf17ede593415fbc33607b4bbe3350_D20171201-20171231" decimals="-5" format="ixt:numdotdecimal" name="clbs:MilestonePaymentOnGrantAwardCashReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNjM2_2a11809f-bd74-448d-bfb5-bc669163764a">1.9</ix:nonFraction> million milestone payment in December 2017, a $<ix:nonFraction unitRef="usd" contextRef="ifb77f2e7779642d2a6eb659130a096f8_D20180301-20180331" decimals="-5" format="ixt:numdotdecimal" name="clbs:ProgressPaymentOnGrantAwardCashReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNjc3_bafd3660-f955-4272-b5c7-e87216ba727f">0.3</ix:nonFraction> million progress payment in March 2018, and a $<ix:nonFraction unitRef="usd" contextRef="ifcdfcccad39e4c2fa35c49cd9d022159_D20190501-20190531" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNzE4_940c8958-eb9c-46d3-a917-d02384759d7c">200,000</ix:nonFraction> progress payment in May 2019, of which the total will be amortized over the estimated award period through July 2020 as a reduction to the related research and development expenses. As of June&#160;30, 2020, $<ix:nonFraction unitRef="usd" contextRef="i928a14f6fa8847b7afd1d223a9a29cc4_I20200630" decimals="-5" format="ixt:numdotdecimal" name="clbs:AccruedGrantFunding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfOTEz_ca96c8d2-2853-49f1-8526-28a237743e6f">0.2</ix:nonFraction> million of the funding received was recorded in accrued liabilities.  During the three and six months ended June&#160;30, 2020, the Company amortized and recognized $<ix:nonFraction unitRef="usd" contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjYxNA_c8479528-af01-4b82-b899-92cafabd5d84">0.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjYxNw_b96a6363-9f17-4348-aa49-6c489bd32546">1.4</ix:nonFraction>&#160;million in credits, respectively, to research and development related to CIRM funds received. During the three and six months ended June&#160;30, 2019, the Company amortized and recognized $<ix:nonFraction unitRef="usd" contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjYyMA_cccccc19-25fd-46ff-83ae-190daa79896a">0.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630" decimals="-5" format="ixt:numdotdecimal" name="clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjYyMw_5c325bc2-6392-4933-b78e-5fe67b5889bd">1.3</ix:nonFraction>&#160;million in credits, respectively, to research and development related to CIRM funds received.</ix:continuation> </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_70"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 11 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfMzg0ODI5MDcwMDc4Mw_56bb9257-e011-43e4-b356-46acf296b775" continuedAt="i5ca4a1a4a26d41c4b013e35d46e7de5c" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i5ca4a1a4a26d41c4b013e35d46e7de5c" continuedAt="i7d887dc95d4d49c9b13e32bd2f0a24a2"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In assessing the realizability of deferred tax assets, including the net operating loss carryforwards ("NOLs"), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets.&#160; Based on its assessment, the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i29dd98104b1c4e8e92246825600cce61_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfNTM0_e0352524-c335-440f-84d0-553814162172">246</ix:nonFraction> million of federal NOLs available to offset future taxable income expiring from 2030 through 2036.&#160;In accordance with Section 382 of the Internal Revenue code, the usage of the Company&#8217;s NOLs could be limited in the event of a change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences become deductible.&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company performed an analysis and determined that it has had ownership changes of greater than 50% over a 3-year testing period.  The last ownership change was determined to be in 2015.  Based on a market capitalization of $<ix:nonFraction unitRef="usd" contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="clbs:MarketCapitalizationUsedInNetOperatingLossAnalysis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfMTE4MQ_a969213e-874e-4989-90d0-c75a174a7837">124.5</ix:nonFraction> million and using an applicable federal rate of 2.5%, the annual limitation would be approximately $<ix:nonFraction unitRef="usd" contextRef="ic0f802c6ed3941c18eac0365a12a53e3_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="clbs:NetOperatingLossAnalysisAnnualLimitation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfMTI3NQ_b8735654-9171-41b8-870d-d6fa4603f9f5">3.0</ix:nonFraction> million. Post change losses generated after June 2, 2015 would not be subject to 382 limitations. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company applies the FASB&#8217;s provisions for uncertain tax positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with certain tax positions as a component of income tax expense. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;30, 2020, management does not believe the Company has any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in future periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For years prior to 2016, the federal statute of limitations is closed for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from date of filing. </span></div></ix:continuation><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i7d887dc95d4d49c9b13e32bd2f0a24a2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In December 2019, the Company received preliminary approval from the New Jersey Economic Development Authority ("NJEDA") to participate in the Technology Business Tax Certificate Transfer Program (the "Program"). The Program permits qualified companies to sell a percentage of their New Jersey net operating losses ("NJ NOLs") to unrelated profitable corporations. On April 21, 2020, the Company received final approval from NJEDA to sell $<ix:nonFraction unitRef="usd" contextRef="ia7aa8c0b4d6d4e7395c1bdb89f3a9231_D20200421-20200421" decimals="-5" format="ixt:numdotdecimal" name="clbs:SaleOfNetOperatingLossesNJEDAProgramValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfNDk0NzgwMjMyODYzNQ_b2649af3-9d99-4989-b1a0-ec709e541b45">11.5</ix:nonFraction>&#160;million of its NJ NOLs, which was subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia7aa8c0b4d6d4e7395c1bdb89f3a9231_D20200421-20200421" decimals="-5" format="ixt:numdotdecimal" name="clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfNDk0NzgwMjMyODI0OA_e33f1309-7831-4da8-814c-1433040d0cd4">10.9</ix:nonFraction> million.  The net proceeds have been recorded as a benefit from income taxes in the consolidated financial statements.</ix:continuation> </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_73"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 12 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83My9mcmFnOmMzYzYxNDlkNmE4YTQwYjJiNWNlZWI2ZTJjMjQ4OWQyL3RleHRyZWdpb246YzNjNjE0OWQ2YThhNDBiMmI1Y2VlYjZlMmMyNDg5ZDJfNDM5_a726c07e-e98f-460e-8477-842dc8d9a342" continuedAt="iac4e0a3802b8419aab63f7d78e34c493" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="iac4e0a3802b8419aab63f7d78e34c493" continuedAt="if0b143c02a73447bb2752cdb08302e79"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Contingencies</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From time to time, the Company is subject to legal proceedings and claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="if0b143c02a73447bb2752cdb08302e79">believe that the outcome of any pending claims will have a material adverse effect on the Company's financial condition or operating results.</ix:continuation></span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_76"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Note 13 &#8211; <ix:nonNumeric contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMzg0ODI5MDcwNTU3OA_a574539a-3e18-41ae-8f4e-14ef18733d32" continuedAt="i21cac045371c451f9747ae34f72458be" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="text-align:justify;"><span><br/></span></div><ix:continuation id="i21cac045371c451f9747ae34f72458be" continuedAt="i6a09b5af0cb74ce396e4a559afe851e9"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Private Placement Offering</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On July 10, 2020, the Company entered into a securities purchase agreement (the &#8220;Private Placement&#8221;) with certain investors (the &#8220;Private Placement Purchasers&#8221;). Pursuant to the terms of the Private Placement, the Company agreed to sell to the Private Placement Purchasers an aggregate of <ix:nonFraction unitRef="shares" contextRef="ib917b042859f49cd9af5962cf0b25fe8_D20200710-20200710" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfOTM1_5b60df07-61f8-4a20-9743-9b7c0d391906">969,694</ix:nonFraction> shares of its common stock at a purchase price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfNDk0NzgwMjMyNzMwOQ_9e503136-5dd3-4289-a56c-2e76c73e4548">2.0625</ix:nonFraction> per share, along with warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMTExNw_24c98156-f81e-4d5e-a9f5-44906e9f21bf">484,847</ix:nonFraction> shares of its common stock. In connection with the Private Placement, the Company received gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib917b042859f49cd9af5962cf0b25fe8_D20200710-20200710" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMTI3MQ_dd2c0242-ec67-49fb-9828-fa915cc8c628">2.0</ix:nonFraction> million. Each warrant is exercisable for <ix:nonFraction unitRef="shares" contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMTMwNw_9d6355cf-1fc7-4d85-b215-83e48a451f0d">one</ix:nonFraction> share of common stock and features an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMTM3Mg_99356038-321a-46b0-b709-9170a2b1dd69">2.0625</ix:nonFraction> per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Common Stock Sales Agreement</span></div></ix:continuation><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i6a09b5af0cb74ce396e4a559afe851e9">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent to June&#160;30, 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="i5da6f23879be4c3f9b9ff3c489d244ba_D20200701-20200806" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfNDk0NzgwMjMzMjU2Ng_2959dfd2-d320-487b-9a76-6653a2ccc72d">2,779,299</ix:nonFraction> shares of common stock under the Sales Agreement with HCW for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i5da6f23879be4c3f9b9ff3c489d244ba_D20200701-20200806" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfNDk0NzgwMjMzMjU2Mw_bf0f1415-99ed-4fe2-8939-d7ecbb458e26">6.9</ix:nonFraction> million.</ix:continuation> </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">20</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 2.&#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; herein and under &#8220;Risk Factors&#8221; in our 2019 Form 10-K.  The following discussion should be read in conjunction with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report and in our 2019 Form 10-K.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Overview</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; "our," &#8220;Caladrius&#8221; or the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of cellular therapies designed to reverse disease and/or promote the regeneration of damaged tissue. We are developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Our technology leverages these cells to enable the body's natural repair mechanisms using formulations unique to each medical indication.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Our leadership team has decades of collective biopharmaceutical development experience and world-recognized scientific achievement in the field of cardiovascular disease, among other therapeutic areas. Our goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. Our current product candidates include CLBS119, an emergent CD34+ stem cell therapy responding to the COVID-19 pandemic and the potentially permanent damage the virus inflicts on the lungs of many patients, as well as three other developmental treatments for ischemic diseases based on its CD34+ cell therapy platform: CLBS12, recipient of SAKIGAKE designation and eligible for early conditional approval in Japan for the treatment of critical limb ischemia ("CLI") based on the results of an ongoing clinical trial; CLBS16, the subject of a recently completed positive Phase 2 clinical trial in the U.S. for the treatment of coronary microvascular dysfunction ("CMD"); and CLBS14, a Regenerative Medicine Advanced Therapy ("RMAT") designated therapy for which we have finalized with the U.S. Food and Drug Administration (the "FDA") a protocol for a Phase 3 confirmatory trial in subjects with no-option refractory disabling angina ("NORDA").</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Ischemic Repair (CD34 Cell Technology)</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The CD34+ cell was discovered as a result of the deliberate search for a stem cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels after injury. A CD34+ cell is a stem cell that has the ability to stimulate new blood vessel formation. No other native cell discovered to date has demonstrated this same capability.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our proprietary CD34+ cell technology has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is restricted. Through the administration of CD34+ cells, we seek to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. We believe that a number of conditions caused by underlying ischemic injury can be improved through our CD34+ cell technology, including but not limited to, CLI, CMD, NORDA and COVID-19 induced lung damage.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS119 for Treatment of COVID -19 Induced Lung Damage</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">COVID-19 appears to damage the vasculature of the lungs and Caladrius believes that repair of that vasculature will prove necessary for patients to achieve a full recovery. Survivors of COVID-19 often remain debilitated even after leaving the hospital due to the damage caused to their lungs, and while many developmental therapies responding to the COVID-19 pandemic are appropriately targeting the SARS-CoV-2 virus itself or the manifestations of the acute phase of the illness, we are aware of no therapy that has demonstrated the ability to repair COVID-19 induced lung damage. With consistent clinical and pre-clinical evidence that CD34+ cells can repair multiple organs, including models of severe lung inflammation, we sought and received FDA authorization for its investigational new drug (&#8220;IND&#8221;) application for the study of CLBS119, a CD34+ cell therapy for repair of COVID-19 induced lung damage. The planned study, with enrollment expected to commence in the second half of 2020, will target patients with severe SARS-CoV-2 infection who, after ventilatory support due to respiratory failure, had otherwise recovered but remained debilitated due to persistent pulmonary damage. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS12 for Treatment of Critical Limb Ischemia</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our open-label, registration-eligible study of CLBS12 in Japan for the treatment of critical limb ischemia ("CLI"), a disease with no currently available approved therapy and a higher combined incidence and mortality rate than all cancers but lung cancer, has shown strong results to date. The initial responses observed in the subjects who have reached an endpoint in this open label study are consistent with a positive therapeutic effect and safety profile as reported by previously published clinical trials in Japan. Although the study's enrollment, which is targeted for completion this year, has been slowed by the pandemic's impact in Japan, we are encouraged by the patient pre-screening pipeline that has been identified and hope to conclude trial enrollment rapidly once the coronavirus abates. While the final outcome of the trial will depend on all data from all subjects, data from the concluded Buerger's Disease cohort and the data to date in the no-option CLI cohort remain very encouraging.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS16 for Treatment of Coronary Microvascular Dysfunction</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2017, with the assistance of a $1.9 million grant from the National Institutes of Health (Award Number R44HL135889), we initiated our program for CLBS16 for the treatment of coronary microvascular dysfunction ("CMD"), a disease that potentially afflicts millions of patients with no current targeted treatment options. That study, titled ESCaPE-CMD, was a Phase 2 proof-of-concept study that enrolled patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. In June 2019, we announced the completion of enrollment in this study. Results of the first 17 of 20 patients enrolled in this trial who reached 6-month follow-up were presented as a rapid fire oral presentation on November 16, 2019 at the annual meeting of the American Heart Association in Philadelphia, PA by one of the principal investigators, Dr. Noel Bairey Merz, FACC, FAHA, FESC, the director of the Barbra Streisand Women's Heart Center at Cedars-Sinai in Los Angeles, CA. That data set showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian Cardiovascular Society Angina Class and Seattle Questionnaire score, as well as an acceptable safety profile. The full data from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May 14, 2020 and we now expect to initiate the next CMD trial, a Phase 2b study, by the end of 2020.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS14 for Treatment of No Option Refractory Disabling Angina (NORDA)</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We acquired the rights to data and regulatory filings for a CD34+ cell therapy program for refractory angina that had been advanced to Phase 3 by a previous sponsor.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on the clinical evidence from the completed studies that a single administration of CLBS14 reduces mortality, improves angina and increases exercise capacity in patients with otherwise untreatable angina, this product received Regenerative Medicine Advanced Therapy (&#8220;RMAT&#8221;) designation from the FDA. We, working closely with the FDA, have finalized the design of a confirmatory Phase 3 trial which, in combination with previously filed Phase 1, 2 and 3 data, will be considered for the registration of CLBS14. Notably, this study design includes a 6-month primary endpoint and, with the benefit of the RMAT designation, the biologics license application ("BLA"), once submitted, is expected to receive a 6-month review. We have substantially completed the preparatory work for initiation of this trial. We will not, however, commence enrollment of patients until sufficient capital is acquired and dedicated to this program such that we have confidence that we can fund the trial uninterrupted through completion.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Additional Out-licensing Opportunities</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our broad intellectual property portfolio of cell therapy assets includes notable programs available for out-licensing in order to continue their clinical development. Our current long-term strategy focuses on advancing our therapies through development with the ultimate objective of obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. We believe that we are well-positioned to realize potentially meaningful value increases within our own proprietary pipeline if we are successful in advancing our product candidates to their next significant development milestones. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Coronavirus Considerations</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which causes COVID-19, was reported to have surfaced in China.  In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects.  While the disruption currently is expected to be temporary, there is uncertainty around the extent and duration of disruption, and any future related financial impact cannot be reasonably estimated at this time.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_85"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Results of Operations</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Three Months Ended June&#160;30, 2020 Compared to Three Months Ended June&#160;30, 2019 </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Overall, net income was $6.6 million for the three months ended June&#160;30, 2020, which included a $10.9 million income tax benefit from the sale of New Jersey net operating losses, compared to net loss of $5.1 million for the three months ended June&#160;30, 2019. </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Operating Expenses</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the three months ended June&#160;30, 2020, operating expenses totaled $4.3 million compared to $5.3 million for the three months ended June&#160;30, 2019, representing a decrease of 20%.  Operating expenses comprised the following:</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Research and development expenses were approximately $1.8 million for the three months ended June&#160;30, 2020, compared to $3.0 million for the three months ended June&#160;30, 2019, representing a decrease of 39%.  Research and development in both periods focused on the advancement of our ischemic repair platform and related to:</span></div><div style="padding-left:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:72pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9702;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">expenses associated with investigational new drug application and planning for commencement in the second quarter of 2020 of a pilot study of CLBS119, a CD34+ cell therapy for repair of COVID-19 induced lung damage targeting patients with severe SARS-CoV-2 infection that required ventilatory support due to respiratory failure.;</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:72pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9702;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">ongoing registration-eligible study expenses for CLBS12 in critical limb ischemia in Japan, whereby we continue to focus spending on our patient enrollment and anticipate completing enrollment by the end of 2020;</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:72pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9702;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">expenses associated with the proof-of-concept study for CLBS16 in coronary microvascular dysfunction, whereby study enrollment was completed in the second quarter of 2019 and full results reported in May 2020. We initiated efforts to advance CLBS16 into a Phase 2b study in the second quarter of 2020; and</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:72pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9702;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">expenses associated with the preparation of our confirmatory Phase 3 study of CLBS14 in NORDA in the second quarter of 2019.  In late 2019, we projected that the Phase 3 study would cost approximately $70 million in external expenses over the next several years, and as a result, we elected to postpone the initiation of the study until we have confidence that we can access sufficient capital to allow us to complete the study uninterrupted.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">General and administrative expenses were approximately $2.5 million for the three months ended June&#160;30, 2020, compared to $2.4 million and the three months ended June&#160;30, 2019. Our general and administrative expenses focus on general corporate-related activities.  </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Historically, to minimize our use of cash, we have used a variety of equity and equity-linked instruments to compensate employees, consultants and other service providers. The use of these instruments has resulted in charges to the results of operations, which have been significant in the past.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other Income</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total other income is primarily comprised of investment income on cash, cash equivalents and marketable securities. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Tax Benefit</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, we received approval from the New Jersey Economic Development Authority ("NJEDA") to participate in the Technology Business Tax Certificate Transfer Program ("Program"), whereby we qualified to sell a percentage of our New Jersey net operating losses ("NJ NOLs"). We subsequently sold a portion of our NJ NOLs to a qualifying and approved buyer pursuant to the Program for net proceeds of $10.9 million.  </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Six Months Ended June&#160;30, 2020 Compared to Six Months Ended June&#160;30, 2019 </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Overall, net income was $2.6 million for the six months ended June&#160;30, 2020, which included a $10.9 million income tax benefit from the sale of New Jersey net operating losses, compared to net loss of $9.5 million for the six months ended June&#160;30, 2019. </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Operating Expenses</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the six months ended June&#160;30, 2020, operating expenses totaled $8.3 million compared to $9.9 million for the six months ended June&#160;30, 2019, representing a decrease 16%.  Operating expenses comprised the following:</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Research and development expenses were approximately $3.3 million for the six months ended June&#160;30, 2020, compared to $5.0 million for the six months ended June&#160;30, 2019, representing a decrease of 34%.  Research and development in both periods focused on the advancement of our ischemic repair platform and related to:</span></div><div style="padding-left:36pt;text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:72pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9702;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">expenses associated with investigational new drug application and planning for commencement in the second quarter of 2020 of a pilot study of CLBS119, a CD34+ cell therapy for repair of COVID-19 induced lung damage targeting patients with severe SARS-CoV-2 infection that required ventilatory support due to respiratory failure.;</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:72pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9702;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">ongoing registration-eligible study expenses for CLBS12 in critical limb ischemia in Japan, whereby we continue to focus spending on our patient enrollment and anticipate completing enrollment by the end of 2020;</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:72pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9702;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">expenses associated with the proof-of-concept study for CLBS16 in coronary microvascular dysfunction, whereby study enrollment was completed in the second quarter of 2019 and full results reported in May 2020. We initiated efforts to advance CLBS16 into a Phase 2b study in the second quarter of 2020; and</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:72pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9702;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">expenses associated with the preparation of our confirmatory Phase 3 study of CLBS14 in NORDA in the second quarter of 2019.  In late 2019, we projected that the Phase 3 study would cost approximately $70 million in external expenses over the next several years, and as a result, we elected to postpone the initiation of the study until we have confidence that we can access sufficient capital to allow us to complete the study uninterrupted.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">General and administrative expenses were approximately $5.0 million for the six months ended June&#160;30, 2020, compared to $4.9 million for the six months ended June&#160;30, 2019. Our general and administrative expenses focus on general corporate-related activities.  </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Historically, to minimize our use of cash, we have used a variety of equity and equity-linked instruments to compensate employees, consultants and other service providers. The use of these instruments has resulted in charges to the results of operations, which have been significant in the past.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other Income</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total other income is primarily comprised of investment income on cash, cash equivalents and marketable securities. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Tax Benefit</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, we received approval from the NJEDA to participate in the Program, whereby we qualified to sell a percentage of our NJ NOLs. We subsequently sold a portion of our NJ NOLs to a qualifying and approved buyer pursuant to the Program for net proceeds of $10.9 million.  </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">24</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Analysis of Liquidity and Capital Resources</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At June&#160;30, 2020, we had cash, cash equivalents and marketable securities of approximately $34.9 million, working capital of approximately $33.1 million, and stockholders&#8217; equity of approximately $33.8 million.</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June&#160;30, 2020, we met our immediate cash requirements through existing cash balances.  Additionally, we used equity and equity-linked instruments to pay for services and compensation. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash provided by or used in operating, investing and financing activities were as follows (in thousands):&#160;</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:65.595%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.835%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.837%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by (used in) operating activities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">262&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10,205)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by investing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,855&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,752&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by financing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,535&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">908&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration: underline;">Operating Activities</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our cash used in operating activities during the six months ended June&#160;30, 2020 was $0.3 million, which is comprised of (i) our net income of $2.6 million, adjusted for non-cash expenses totaling $0.9 million (which includes adjustments for equity-based compensation, depreciation and amortization, and amortization/accretion of marketable securities), and (ii) changes in operating assets and liabilities using approximately $3.3 million.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our cash used in operating activities during the six months ended June&#160;30, 2019 was $10.2 million, which is comprised of (i) our net loss of $9.5 million, adjusted for non-cash expenses totaling $1.0 million (which includes adjustments for equity-based compensation, depreciation and amortization, and amortization/accretion of marketable securities), and (ii) changes in operating assets and liabilities using approximately $1.7 million.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration: underline;">&#160;Investing Activities</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our cash provided by investing activities during the six months ended June&#160;30, 2020 totaled $2.9 million and was primarily due to net proceeds from the sale of marketable securities (net of purchases of marketable securities).</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our cash provided by investing activities during the six months ended June&#160;30, 2019 totaled $10.8 million and was primarily due to net proceeds from sales of marketable securities (net of purchases of marketable securities).</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration: underline;">Financing Activities</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our cash provided by in financing activities during the six months ended June&#160;30, 2020 primarily consisted of (i) net proceeds of $4.5 million through the issuance of common shares and warrants in our April 2020 registered direct offering, (ii) net proceeds of $3.8 million through the issuance of common shares and warrants in our May 2020 registered direct offering, and (iii) net proceeds of $1.3 million through the issuance of common shares under our common stock sales agreement with H.C. Wainwright. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our cash provided by financing activities during the six months ended June&#160;30, 2019 consisted of proceeds of $1.0 million through the issuance of 250,000 shares of our common stock under the provisions of our common stock purchase agreement with Lincoln Park Capital, which was partially offset by tax withholding-related payments on net share settlement equity awards to employees. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Liquidity and Capital Requirements Outlook</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To meet our short and long-term liquidity needs, we expect to use existing cash balances and a variety of other means. Other sources of liquidity could include additional potential issuances of debt or equity securities in public or private financings, partnerships and/or collaborations and/or sale of assets. Our history of operating losses and liquidity challenges may make it difficult for us to raise capital on acceptable terms or at all. The demand for the equity and debt of biopharmaceutical companies like ours is dependent upon many factors, including the general state of the financial markets. During times of extreme market volatility, capital may not be available on favorable terms, if at all. Our inability to obtain such additional capital could materially and adversely affect our business operations. We will also continue to seek, as appropriate, grants for </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">scientific and clinical studies from various governmental agencies and foundations, and other sources of non-dilutive funding. We believe that our cash on hand will enable us to fund operating expenses for at least the next 12 months following the issuance of our financial statements considering the assumption that any initiation of a CLBS14 Phase 3 study is contingent on our acquisition of additional capital to fund such a study. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In July 2020, the Company entered into a securities purchase agreement (the &#8220;Private Placement&#8221;) with certain investors (the &#8220;Private Placement Purchasers&#8221;). Pursuant to the terms of the Private Placement, the Company agreed to sell to the Private Placement Purchasers an aggregate of 969,694 shares of its common stock at a purchase price equal to $2.0625 per share, along with warrants to purchase an aggregate of 484,847 shares of its common stock. In connection with the Private Placement, the Company received gross proceeds of $2.0 million. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.0625 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In May 2020, the Company entered into a securities purchase agreement (the &#8220;May Purchase Agreement&#8221;) with certain investors (the &#8220;May Purchasers&#8221;). Pursuant to the terms of the May Purchase Agreement, the Company agreed to sell to the May Purchasers an aggregate of 2,084,850 shares of its common stock at a purchase price equal to $2.0625 per share. In a concurrent private placement, the Company issued to the Purchasers warrants to purchase an aggregate of 1,042,425 shares of its common stock. In connection with the registered direct offering and concurrent private placement, the Company received gross proceeds of $4.3 million. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.0625 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In April 2020, the Company entered into a securities purchase agreement (the &#8220;April Purchase Agreement&#8221;) with certain investors (the &#8220;April Purchasers&#8221;). Pursuant to the terms of the April Purchase Agreement, the Company agreed to sell to the Purchasers an aggregate of 2,162,166 shares of its common stock at a purchase price equal to $2.3125 per share. In a concurrent private placement, the Company issued to the April Purchasers warrants to purchase an aggregate of 1,081,083 shares of its common stock. In connection with the registered direct offering and concurrent private placement, the Company received gross proceeds of $5,000,009. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.2500 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In December 2019, we received preliminary approval from the New Jersey Economic Development Authority ("NJEDA") to participate in the Technology Business Tax Certificate Transfer Program (the "Program"). The Program permits qualified companies to sell a percentage of their New Jersey net operating losses ("NJ NOLs") to unrelated profitable corporations. On April 21, 2020, the Company received final approval from NJEDA, and it subsequently sold a portion of its NJ NOLs to a qualifying and approved buyer pursuant to the Program for net proceeds of $10.9 million. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March&#160;2019, we and Lincoln Park Capital Fund, LLC (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which we have the right to sell to Lincoln Park shares of our common stock having an aggregate value of up to $26 million, subject to certain limitations and conditions set forth in the Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, we issued to Lincoln Park an additional 181,510 shares of common stock as commitment shares. Pursuant to the Purchase Agreement, Lincoln Park purchased 250,000 shares of common stock, at a price of $4.00 per share, for a total gross purchase price of $1.0 million (the &#8220;Initial Purchase&#8221;) upon commencement. Thereafter, as often as every business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase Agreement, we have the right, from time to time, at our sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to 100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln Park&#8217;s obligation under any single such purchase will not exceed $2,500,000, unless we and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;). If we direct Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, we may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of (i)&#160;300% &#160;the number of shares purchased pursuant to the corresponding Regular Purchase or (ii)&#160;30% of the total number of shares of our common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement. Under certain circumstances and in accordance with the Purchase Agreement, we may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day. As of June 30, 2020, the Company had not made any sales of common stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In February 2018, we entered into a common stock sales agreement (the "Sales Agreement") with H.C. Wainwright &amp; Co., LLC ("HCW"), as sales agent, in connection with an &#8220;at the market offering&#8221; under which we from time to time may offer and sell shares of our common stock, which was further amended in August 2018, having an aggregate offering price of up to $25 million. In&#160;March&#160;2019, subsequent to the filing of our 2018 Form 10-K, the aggregate market value of our outstanding common stock held by non-affiliates was approximately&#160;$52.8 million. Pursuant to General Instruction I.B.6 of Form S-3, since the aggregate market value of our outstanding common stock held by non-affiliates was below&#160;$75.0 million at the time of our 2018 Form 10-K filing, the aggregate amount of securities that we were permitted to offer and sell at such time was reduced to $17.6 million (or a maximum of 4.8 million shares), which was equal to one-third of the aggregate market value of our common stock held by non-affiliates at such time. Subject to the terms and conditions of the Sales Agreement, HCW will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell the shares from time to time, based upon our instructions, including any price, time or size limits specified by us. We have provided HCW with customary indemnification rights, and HCW will be entitled to a commission at a fixed commission rate equal to 3.0% of the gross proceeds per share sold. We have no obligation to sell any of the shares and may at any time suspend sales under the Sales Agreement or terminate the Sales Agreement. The Sales Agreement will terminate upon the sale of all of the shares under the Sales Agreement unless terminated earlier by either party as permitted under the Sales Agreement.  As of June&#160;30, 2020, we issued 907,168 shares of common stock under the Sales Agreement for net proceeds of $2.3 million. Subsequent to June&#160;30, 2020, the Company issued an additional 2,779,299 shares of common stock under the Sales Agreement for net proceeds of $6.9 million. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;While we continue to seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and our negotiating position in capital generating efforts may worsen as existing resources are used. Additional equity financing may be dilutive to our stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict our ability to operate as a business; our stock price may not reach levels necessary to induce option or warrant exercises; and asset sales may not be possible on terms we consider acceptable. If we are unable to access capital necessary to meet our long-term liquidity needs, we may have to delay the expansion of our business or raise funds on terms that we currently consider unfavorable. </span></div><div style="text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_91"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Seasonality</span></div><div style="text-indent:13.5pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We do not believe that our operations are seasonal in nature.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Off-Balance Sheet Arrangements</span></div><div style="text-indent:13.5pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We do not have any off-balance sheet arrangements.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:2.25pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Critical Accounting Policies and Estimates</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There have been no material changes in our critical accounting policies and estimates during the three and six months ended June&#160;30, 2020, compared to those reported in our 2019 Form 10-K.</span></div><div style="text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_94"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 3.&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-indent:18pt;"><span><br/></span></div><div style="text-indent:22.5pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Not applicable.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_97"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 4.&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(a)&#160;&#160;Disclosure Controls and Procedures</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Disclosure controls and procedures are the controls and other procedures we have designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports that we file under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well-designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Due to the inherent limitations of control systems, not all misstatements may be detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">collusion of two or more people, or by management override of the control. Controls and procedures can only provide reasonable, not absolute, assurance that the above objectives have been met.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;30, 2020, we carried out an evaluation, with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(b)&#160;&#160;Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no changes in our internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15, that occurred during our last quarter to which this Quarterly Report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">28</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PART II</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">OTHER INFORMATION</span></div><div style="text-align:center;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_103"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 1. LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">       There are no material changes to the disclosures previously reported in our 2019 Form 10-K.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_106"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 1A. RISK FACTORS</span></div><div><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other than as set forth below, there have been no material changes to the risk factors previously reported in our 2019 Form 10-K. See the risk factors set forth in our 2019 Annual Report on Form 10-K under the caption "Item 1 A - Risk Factors."</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Pandemics such as the coronavirus (COVID-19) could have an adverse impact on our developmental programs and our financial condition.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:22.5pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, a novel strain of coronavirus (COVID-19) was first identified in Wuhan, Hubei Province, China, which virus has since spread throughout the world and has become a formal pandemic. Any outbreak of contagious diseases, including the coronavirus, or other adverse public health developments, has had, and could continue to have, a material and adverse effect on our business operations. These have caused, and could continue to cause, disruptions or restrictions on our ability to travel, pursue partnerships and other business transactions, conduct clinical trials, make shipments of biologic materials, as well as be impacted by the closure, temporary or otherwise, of the facilities of suppliers and clinical trial sites. Disruption of suppliers, clinical trial sites or access to patients would likely impact, and in&#160;some cases has impacted, our clinical trial enrollment progress and rates as well as our ability to access capital through the financial markets. The extent to which the COVID-19, or any other contagious disease, may impact our results will depend on future developments, which developments are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of COVID-19 and the actions to contain the&#160;coronavirus&#160;or treat its impact, among others.</span></div><div style="text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_109"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 2.&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_112"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 3.&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_115"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Not applicable.</span></div><div><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_118"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 5. OTHER INFORMATION</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div id="i2cf061fb46114e1f91cf023e523adb4b_121"></div><div style="padding-right:2.25pt;text-align:justify;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 6. EXHIBITS</span></div><div style="padding-right:2.25pt;text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Exhibit Index appearing immediately after the signature page to this Form 10-Q is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">29</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="padding-left:9pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SIGNATURES</span></div><div style="padding-left:9pt;text-align:center;"><span><br/></span></div><div style="padding-left:6.75pt;padding-right:2.25pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:47.853%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:47.414%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CALADRIUS BIOSCIENCES, INC.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">August 13, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">By:   </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"> /s/ David J. Mazzo, PhD      </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Name: David J. Mazzo, PhD      </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Title:   President and Chief Executive Officer</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">(Principal Executive Officer)</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">August 13, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">By: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;">/s/ Joseph Talamo                    </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Name: Joseph Talamo    </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Title: Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="text-indent:15.75pt;padding-left:6.75pt;padding-right:2.25pt;text-align:justify;margin-bottom:3.3pt;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">30</span></div></div></div><div id="i2cf061fb46114e1f91cf023e523adb4b_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#i2cf061fb46114e1f91cf023e523adb4b_7">Index</a></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CALADRIUS BIOSCIENCES, INC.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">FORM 10-Q</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit Index</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:522.00pt;"><tr><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:13.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:457.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="clbs-ex31120200630xq2.htm">31.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="clbs-ex31220200630xq2.htm">31.2</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="clbs-ex32120200630q2.htm">32.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">**</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="clbs-ex32220200630xq2.htm">32.2</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">**</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.INS</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.SCH</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.CAL</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.DEF</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.LAB</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.PRE</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">XBRL Taxonomy Extension Presentation Linkbase</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">_______________</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:522.00pt;"><tr><td style="width:1.0pt;"></td><td style="width:16.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:502.00pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Filed herewith.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">**</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furnished herewith.</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">             </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">31</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>clbs-ex31120200630xq2.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i9611749df7834dae83c45a0a91850740_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit 31.1</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATIONS UNDER SECTION 302</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">I, David J. Mazzo, PhD, certify that&#58;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1.&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Caladrius Biosciences, Inc.&#59;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2.&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3.&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4.&#160;&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a)&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by&#160;this report based on such evaluation&#59; and</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5.&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a)&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58; August&#160;13, 2020 </font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">&#47;s&#47; David J. Mazzo, PhD&#160;       </font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Name&#58; David J. Mazzo, PhD</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Title&#58; President and Chief Executive Officer (Principal Executive Officer) </font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>clbs-ex31220200630xq2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i0ed0f00ebe41426886621c9ee9caf818_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit 31.2</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATIONS UNDER SECTION 302</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">I, Joseph Talamo, certify that&#58;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1.&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Caladrius Biosciences, Inc.&#59;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2.&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3.&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4.&#160;&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a)&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by&#160;this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5.&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a)&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58; August&#160;13, 2020 </font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">&#47;s&#47; Joseph Talamo       </font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Name&#58; Joseph Talamo</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Title&#58; Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)</font></div><div style="text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>clbs-ex32120200630q2.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i8ff201d423014db2b0983618df4c001f_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit 32.1</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the Quarterly Report on Form 10-Q of Caladrius Biosciences, Inc. (the &#8220;Company&#8221;) for the quarter ended June&#160;30, 2020 filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, David J. Mazzo, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that&#58;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the results of operations of the Company for the periods presented.</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dated&#58;&#160;&#160;August&#160;13, 2020 </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:57.970%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:38.030%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">&#47;s&#47; David J. Mazzo, PhD     </font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">David J. Mazzo, PhD</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">President and Chief Executive Officer (Principal Executive Officer)</font></td></tr></table></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:center;"><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>clbs-ex32220200630xq2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i965b9b95b8ae46c481f69c33218ad9f9_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit 32.2</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the Quarterly Report on Form 10-Q of Caladrius Biosciences, Inc. (the &#8220;Company&#8221;) for the quarter ended June&#160;30, 2020 filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Joseph Talamo, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that&#58;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended&#59; and</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the results of operations of the Company for the periods presented.</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dated&#58;&#160;&#160;August&#160;13, 2020 </font></div><div style="text-align:justify;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:57.970%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:38.030%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">&#47;s&#47; Joseph Talamo     </font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Joseph Talamo</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>clbs-20200630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b55a4230-0bd3-4ac9-874e-83b223cb82b0,g:af6da92c-f069-4627-844d-929d63342442-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:clbs="http://www.caladrius.com/20200630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.caladrius.com/20200630">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clbs-20200630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clbs-20200630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clbs-20200630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clbs-20200630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.caladrius.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParentheticals" roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004005 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquity" roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheBusiness" roleURI="http://www.caladrius.com/role/TheBusiness">
        <link:definition>2101101 - Disclosure - The Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheBusinessNarrativeDetails" roleURI="http://www.caladrius.com/role/TheBusinessNarrativeDetails">
        <link:definition>2402401 - Disclosure - The Business - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecurities" roleURI="http://www.caladrius.com/role/AvailableforSaleSecurities">
        <link:definition>2105103 - Disclosure - Available-for-Sale-Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecuritiesTables" roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables">
        <link:definition>2306301 - Disclosure - Available-for-Sale-Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails">
        <link:definition>2407402 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails">
        <link:definition>2408403 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails">
        <link:definition>2409404 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeLossPerShare" roleURI="http://www.caladrius.com/role/IncomeLossPerShare">
        <link:definition>2110104 - Disclosure - Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeLossPerShareTables" roleURI="http://www.caladrius.com/role/IncomeLossPerShareTables">
        <link:definition>2311302 - Disclosure - Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeLossPerShareDetails" roleURI="http://www.caladrius.com/role/IncomeLossPerShareDetails">
        <link:definition>2412405 - Disclosure - Income (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.caladrius.com/role/FairValueMeasurements">
        <link:definition>2113105 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.caladrius.com/role/FairValueMeasurementsTables">
        <link:definition>2314303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2415406 - Disclosure - Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilities" roleURI="http://www.caladrius.com/role/AccruedLiabilities">
        <link:definition>2116106 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.caladrius.com/role/AccruedLiabilitiesTables">
        <link:definition>2317304 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.caladrius.com/role/AccruedLiabilitiesDetails">
        <link:definition>2418407 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.caladrius.com/role/OperatingLeases">
        <link:definition>2119107 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.caladrius.com/role/OperatingLeasesTables">
        <link:definition>2320305 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesNarrativeDetails" roleURI="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails">
        <link:definition>2421408 - Disclosure - Operating Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesBalanceSheetPresentationDetails" roleURI="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails">
        <link:definition>2422409 - Disclosure - Operating Leases - Balance Sheet Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesFutureMinimumLeasePaymentsDetails" roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails">
        <link:definition>2423410 - Disclosure - Operating Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesFutureMinimumLeasePaymentsDetails_1" roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>2423410 - Disclosure - Operating Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.caladrius.com/role/StockholdersEquity">
        <link:definition>2124108 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.caladrius.com/role/StockholdersEquityTables">
        <link:definition>2325306 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityEquityIssuancesDetails" roleURI="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails">
        <link:definition>2426411 - Disclosure - Stockholders' Equity - Equity Issuances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionsandWarrantsDetails" roleURI="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails">
        <link:definition>2427412 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" roleURI="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails">
        <link:definition>2428413 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.caladrius.com/role/ShareBasedCompensation">
        <link:definition>2129109 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.caladrius.com/role/ShareBasedCompensationTables">
        <link:definition>2330307 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationDetails" roleURI="http://www.caladrius.com/role/ShareBasedCompensationDetails">
        <link:definition>2431414 - Disclosure - Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchFunding" roleURI="http://www.caladrius.com/role/ResearchFunding">
        <link:definition>2132110 - Disclosure - Research Funding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchFundingDetails" roleURI="http://www.caladrius.com/role/ResearchFundingDetails">
        <link:definition>2433415 - Disclosure - Research Funding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.caladrius.com/role/IncomeTaxes">
        <link:definition>2134111 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNetOperatingLossCarryForwardDetails" roleURI="http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails">
        <link:definition>2435416 - Disclosure - Income Taxes - Net Operating Loss Carry Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.caladrius.com/role/Contingencies">
        <link:definition>2136112 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.caladrius.com/role/SubsequentEvents">
        <link:definition>2137113 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.caladrius.com/role/SubsequentEventsDetails">
        <link:definition>2438417 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="clbs_IschemicRepairCD34CellTechnologyMember" abstract="true" name="IschemicRepairCD34CellTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" abstract="false" name="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" abstract="false" name="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" abstract="false" name="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="clbs_PreferredStockLiquidationPreferenceShare" abstract="false" name="PreferredStockLiquidationPreferenceShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsExpired" abstract="false" name="WeightedAverageExercisePriceWarrantsExpired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="clbs_LincolnParkAgreementMember" abstract="true" name="LincolnParkAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clbs_TermOfAgreement" abstract="false" name="TermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsCanceled" abstract="false" name="WeightedAverageExercisePriceWarrantsCanceled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="clbs_AprilPurchaseAgreementMember" abstract="true" name="AprilPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" abstract="false" name="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsOutstanding" abstract="false" name="WeightedAverageExercisePriceWarrantsOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="clbs_OptionsVestedweightedAverageRemainingContractualTerm" abstract="false" name="OptionsVestedweightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsExercised" abstract="false" name="WeightedAverageExercisePriceWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="clbs_WarrantsVested" abstract="false" name="WarrantsVested" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" abstract="false" name="StockIssuedDuringPeriodSharesIssuedAsConsideration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_WarrantsCanceled" abstract="false" name="WarrantsCanceled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_MilestonePaymentOnGrantAwardCashReceived" abstract="false" name="MilestonePaymentOnGrantAwardCashReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_AggregateIntrinsicValueWarrantsOutstanding" abstract="false" name="AggregateIntrinsicValueWarrantsOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsExercisable" abstract="false" name="WeightedAverageExercisePriceWarrantsExercisable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="clbs_ProgressPaymentOnGrantAwardCashReceived" abstract="false" name="ProgressPaymentOnGrantAwardCashReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_NetOperatingLossAnalysisAnnualLimitation" abstract="false" name="NetOperatingLossAnalysisAnnualLimitation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" abstract="false" name="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="clbs_Sharesvestedandexpectedtovest" abstract="false" name="Sharesvestedandexpectedtovest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" abstract="false" name="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" abstract="false" name="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_MayPurchaseAgreementMember" abstract="true" name="MayPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" abstract="false" name="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WarrantsExercised" abstract="false" name="WarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_UsEquityPlanMember" abstract="true" name="UsEquityPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" abstract="false" name="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" abstract="false" name="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" abstract="false" name="WeightedAverageRemainingContractualTermwarrantoutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_FundingOfGrantAwardCashReceived" abstract="false" name="FundingOfGrantAwardCashReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" abstract="false" name="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" abstract="false" name="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_PreferredStockSharesDesignated" abstract="false" name="PreferredStockSharesDesignated" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_WarrantsWeightedAverageExercisePriceRollForward" abstract="true" name="WarrantsWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clbs_StockOptionsActivityDomain" abstract="true" name="StockOptionsActivityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clbs_WarrantsGranted" abstract="false" name="WarrantsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_SaleOfNetOperatingLossesNJEDAProgramValue" abstract="false" name="SaleOfNetOperatingLossesNJEDAProgramValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_StockOptionsActivityAxis" abstract="true" name="StockOptionsActivityAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="clbs_AccruedGrantFunding" abstract="false" name="AccruedGrantFunding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" abstract="false" name="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" abstract="false" name="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_H.C.WainwrightSalesAmendedAgreementMember" abstract="true" name="H.C.WainwrightSalesAmendedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="clbs_BusinessTextBlock" abstract="false" name="BusinessTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="clbs_WarrantsExpired" abstract="false" name="WarrantsExpired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_NumberOfOfficesUnderOperatingLeases" abstract="false" name="NumberOfOfficesUnderOperatingLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="clbs_AggregateIntrinsicValueWarrantsvested" abstract="false" name="AggregateIntrinsicValueWarrantsvested" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_AggregateMarketValueOfCommonStockNonAffiliates" abstract="false" name="AggregateMarketValueOfCommonStockNonAffiliates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis" abstract="false" name="MarketCapitalizationUsedInNetOperatingLossAnalysis" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsGranted" abstract="false" name="WeightedAverageExercisePriceWarrantsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="clbs_WeightedAverageRemainingContractualTermwarrantsvested" abstract="false" name="WeightedAverageRemainingContractualTermwarrantsvested" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_CommonStockWarrantsShares" abstract="false" name="CommonStockWarrantsShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>clbs-20200630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b55a4230-0bd3-4ac9-874e-83b223cb82b0,g:af6da92c-f069-4627-844d-929d63342442-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.caladrius.com/role/CoverPage" xlink:type="simple" xlink:href="clbs-20200630.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_54133e22-0249-4615-9683-dbf634bd4856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_647e7bfc-13cb-4b1c-a4aa-86fe0ff27629" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_54133e22-0249-4615-9683-dbf634bd4856" xlink:to="loc_us-gaap_LiabilitiesCurrent_647e7bfc-13cb-4b1c-a4aa-86fe0ff27629" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_46b691e0-6168-4b5a-9566-6477c122fa09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_54133e22-0249-4615-9683-dbf634bd4856" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_46b691e0-6168-4b5a-9566-6477c122fa09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6ab36c70-d420-49b2-a97b-8d4f8f344f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_589cc6af-b770-4edd-9842-835fbf66e76f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6ab36c70-d420-49b2-a97b-8d4f8f344f39" xlink:to="loc_us-gaap_AssetsCurrent_589cc6af-b770-4edd-9842-835fbf66e76f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_357f0e64-755b-428d-a61b-835d5717c569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6ab36c70-d420-49b2-a97b-8d4f8f344f39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_357f0e64-755b-428d-a61b-835d5717c569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8cf0d8bd-7163-48fa-95b5-9b947e18759d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6ab36c70-d420-49b2-a97b-8d4f8f344f39" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8cf0d8bd-7163-48fa-95b5-9b947e18759d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_db51e221-1cbe-4d3c-b786-dac227429898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d40e888-662b-4765-98d7-015c12894385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_db51e221-1cbe-4d3c-b786-dac227429898" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d40e888-662b-4765-98d7-015c12894385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_883b103f-7013-4407-8a74-e630d0236e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_db51e221-1cbe-4d3c-b786-dac227429898" xlink:to="loc_us-gaap_MarketableSecurities_883b103f-7013-4407-8a74-e630d0236e08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d8dc77f5-b6f0-4fb7-b93f-d8d639e680c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_db51e221-1cbe-4d3c-b786-dac227429898" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d8dc77f5-b6f0-4fb7-b93f-d8d639e680c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b6da89d5-092b-4f89-abe4-e5a6c5783cf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_399e212e-98d8-47c8-ac92-b377327f806c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b6da89d5-092b-4f89-abe4-e5a6c5783cf6" xlink:to="loc_us-gaap_StockholdersEquity_399e212e-98d8-47c8-ac92-b377327f806c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_fa699f99-eeda-4529-a80d-fcb32a6b0894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b6da89d5-092b-4f89-abe4-e5a6c5783cf6" xlink:to="loc_us-gaap_MinorityInterest_fa699f99-eeda-4529-a80d-fcb32a6b0894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_16d305b8-8f40-4534-83a3-7025a1df184e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6ac6fd8e-7839-45dd-8798-34edb5453146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_16d305b8-8f40-4534-83a3-7025a1df184e" xlink:to="loc_us-gaap_AccountsPayableCurrent_6ac6fd8e-7839-45dd-8798-34edb5453146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6f3ee652-2231-4d36-8a1f-08d8601e7a72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_16d305b8-8f40-4534-83a3-7025a1df184e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6f3ee652-2231-4d36-8a1f-08d8601e7a72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7c53be02-ac31-4f6b-833e-92be32093ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a9211f8c-079f-4495-99fb-2df4aea3fca3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7c53be02-ac31-4f6b-833e-92be32093ace" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a9211f8c-079f-4495-99fb-2df4aea3fca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ee4efc93-2a6d-4e9e-a192-e5215ea52623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7c53be02-ac31-4f6b-833e-92be32093ace" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ee4efc93-2a6d-4e9e-a192-e5215ea52623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c80aafd8-701d-41c8-9f35-e2eadd67410c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7c53be02-ac31-4f6b-833e-92be32093ace" xlink:to="loc_us-gaap_Liabilities_c80aafd8-701d-41c8-9f35-e2eadd67410c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e9b8f59d-f39c-430f-84eb-a6f7a3ccd9f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0f442e8d-f83f-4faf-b977-a8d7b266f2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e9b8f59d-f39c-430f-84eb-a6f7a3ccd9f0" xlink:to="loc_us-gaap_PreferredStockValue_0f442e8d-f83f-4faf-b977-a8d7b266f2c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_47a10338-3857-44cc-ab9b-9efcd6022f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e9b8f59d-f39c-430f-84eb-a6f7a3ccd9f0" xlink:to="loc_us-gaap_CommonStockValue_47a10338-3857-44cc-ab9b-9efcd6022f1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_aa53f113-44f5-4da4-ac77-7bc7de27919f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e9b8f59d-f39c-430f-84eb-a6f7a3ccd9f0" xlink:to="loc_us-gaap_AdditionalPaidInCapital_aa53f113-44f5-4da4-ac77-7bc7de27919f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_19c711f6-7529-4c44-abb2-e353929995ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e9b8f59d-f39c-430f-84eb-a6f7a3ccd9f0" xlink:to="loc_us-gaap_TreasuryStockValue_19c711f6-7529-4c44-abb2-e353929995ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e31c3411-4443-4a43-8a85-d0299a5a1991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e9b8f59d-f39c-430f-84eb-a6f7a3ccd9f0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e31c3411-4443-4a43-8a85-d0299a5a1991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4c66cf01-7754-4c14-9ab5-a7a937898c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e9b8f59d-f39c-430f-84eb-a6f7a3ccd9f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4c66cf01-7754-4c14-9ab5-a7a937898c78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedBalanceSheetsParentheticals"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a880df7b-548c-4db0-9742-3294f5386d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e0ef3fd1-5692-4364-8f66-cf604848e132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a880df7b-548c-4db0-9742-3294f5386d51" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e0ef3fd1-5692-4364-8f66-cf604848e132" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_96a0b505-46ac-4388-9115-e5522bd9d5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a880df7b-548c-4db0-9742-3294f5386d51" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_96a0b505-46ac-4388-9115-e5522bd9d5e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5695f328-67ea-4ec3-bc54-3eb8c79d99a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4d67aec4-d2dd-424d-8d5a-5dba3ae5339a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5695f328-67ea-4ec3-bc54-3eb8c79d99a1" xlink:to="loc_us-gaap_ProfitLoss_4d67aec4-d2dd-424d-8d5a-5dba3ae5339a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_3e2d0cde-15f7-4022-b331-6706bfb559ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5695f328-67ea-4ec3-bc54-3eb8c79d99a1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_3e2d0cde-15f7-4022-b331-6706bfb559ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_63673b1b-e182-4212-978b-054209f9a3d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_22d1a84c-d888-4fa9-99ac-77ad53c1a905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63673b1b-e182-4212-978b-054209f9a3d4" xlink:to="loc_us-gaap_OperatingExpenses_22d1a84c-d888-4fa9-99ac-77ad53c1a905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a2ccf2b9-29fe-4074-bce7-c57d21de8362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ded81782-6ef6-4d4b-8264-4ae85c3a7a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a2ccf2b9-29fe-4074-bce7-c57d21de8362" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ded81782-6ef6-4d4b-8264-4ae85c3a7a18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6e8ab391-84ae-4f55-92e5-2ff6751a9543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3d8b2c31-1e8e-4a12-af7b-4b143b914300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6e8ab391-84ae-4f55-92e5-2ff6751a9543" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3d8b2c31-1e8e-4a12-af7b-4b143b914300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0b6c986e-76e5-4150-9255-62afe81e62fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6e8ab391-84ae-4f55-92e5-2ff6751a9543" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0b6c986e-76e5-4150-9255-62afe81e62fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64ffee50-4831-415a-9aa9-af14532a65c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b846ada0-0a5a-4a38-8e2e-773ed3e88dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64ffee50-4831-415a-9aa9-af14532a65c6" xlink:to="loc_us-gaap_ProfitLoss_b846ada0-0a5a-4a38-8e2e-773ed3e88dc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_965b549a-5f2c-45e2-8b05-8f3da6cffef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64ffee50-4831-415a-9aa9-af14532a65c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_965b549a-5f2c-45e2-8b05-8f3da6cffef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9136e3d9-0963-4b62-bc82-62f7e719687c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ef130c20-1b13-4e2c-bfaf-ed33f81f3795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9136e3d9-0963-4b62-bc82-62f7e719687c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ef130c20-1b13-4e2c-bfaf-ed33f81f3795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7b90f2e2-18c3-41cb-8fe8-f235182009ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9136e3d9-0963-4b62-bc82-62f7e719687c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7b90f2e2-18c3-41cb-8fe8-f235182009ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d74453a7-ef82-452e-b591-f8c0a77b8b01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_56adeda2-95fa-42d6-8322-e18397628031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d74453a7-ef82-452e-b591-f8c0a77b8b01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_56adeda2-95fa-42d6-8322-e18397628031" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofEquity"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75185798-ac3d-4ae3-96e5-20ab1c634ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ee9b730f-c583-472a-9558-7b9ab098e5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75185798-ac3d-4ae3-96e5-20ab1c634ef8" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ee9b730f-c583-472a-9558-7b9ab098e5e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_2b522d92-bcc4-44f5-9963-91245f11346f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75185798-ac3d-4ae3-96e5-20ab1c634ef8" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_2b522d92-bcc4-44f5-9963-91245f11346f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5888748f-4c4b-4edf-a848-51627050bcf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75185798-ac3d-4ae3-96e5-20ab1c634ef8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5888748f-4c4b-4edf-a848-51627050bcf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dced4d18-b737-4ab9-9bf2-c092fb10666c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83bfad36-de72-4813-9499-cfe109173d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dced4d18-b737-4ab9-9bf2-c092fb10666c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83bfad36-de72-4813-9499-cfe109173d16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_913901bb-a4fc-4fc6-8ca3-3bbb24c87afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dced4d18-b737-4ab9-9bf2-c092fb10666c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_913901bb-a4fc-4fc6-8ca3-3bbb24c87afa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_774a1bbb-617e-439e-b845-ded9304d650a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dced4d18-b737-4ab9-9bf2-c092fb10666c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_774a1bbb-617e-439e-b845-ded9304d650a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2b0bb8ac-06eb-424d-b55a-a5fbb0e35034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_14cf86e3-33ca-450c-9dbb-55cd1856e3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2b0bb8ac-06eb-424d-b55a-a5fbb0e35034" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_14cf86e3-33ca-450c-9dbb-55cd1856e3e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_ff6c26d5-78c4-42ed-8989-dd34997faec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2b0bb8ac-06eb-424d-b55a-a5fbb0e35034" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_ff6c26d5-78c4-42ed-8989-dd34997faec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93c69d8-cfea-4c19-8658-86e3d6ca9e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9f523245-369e-4fc5-99f0-b1a939aa4f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93c69d8-cfea-4c19-8658-86e3d6ca9e8e" xlink:to="loc_us-gaap_ProfitLoss_9f523245-369e-4fc5-99f0-b1a939aa4f4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_4cebe699-6e4f-417c-bb23-17a64ae1b8b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93c69d8-cfea-4c19-8658-86e3d6ca9e8e" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_4cebe699-6e4f-417c-bb23-17a64ae1b8b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_6065e764-7278-4f52-a677-c7e78b0f45ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93c69d8-cfea-4c19-8658-86e3d6ca9e8e" xlink:to="loc_us-gaap_DepreciationAndAmortization_6065e764-7278-4f52-a677-c7e78b0f45ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_5c350233-a260-4c27-8de3-7bc7230dab0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93c69d8-cfea-4c19-8658-86e3d6ca9e8e" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_5c350233-a260-4c27-8de3-7bc7230dab0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d20af443-c6e0-4b42-b869-2e71d66e5ffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93c69d8-cfea-4c19-8658-86e3d6ca9e8e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d20af443-c6e0-4b42-b869-2e71d66e5ffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_decc499b-7940-40ba-864b-19431377afa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93c69d8-cfea-4c19-8658-86e3d6ca9e8e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_decc499b-7940-40ba-864b-19431377afa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_f361e0ac-ce87-4a13-98f5-32992343b30c" xlink:href="clbs-20200630.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93c69d8-cfea-4c19-8658-86e3d6ca9e8e" xlink:to="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_f361e0ac-ce87-4a13-98f5-32992343b30c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusiness" xlink:type="simple" xlink:href="clbs-20200630.xsd#TheBusiness"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/TheBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusinessNarrativeDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#TheBusinessNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/TheBusinessNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="clbs-20200630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="clbs-20200630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecurities" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecurities"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecurities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesTables"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2cb5b038-b34e-459b-802b-810ec7478e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_16a4228d-0075-4200-b97a-0d5521afa48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2cb5b038-b34e-459b-802b-810ec7478e21" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_16a4228d-0075-4200-b97a-0d5521afa48e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ab994ae8-00d4-4eeb-8e81-bce565f8ae95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2cb5b038-b34e-459b-802b-810ec7478e21" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ab994ae8-00d4-4eeb-8e81-bce565f8ae95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2cb0e335-f6c3-463d-8168-2ab30c45a8b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2cb5b038-b34e-459b-802b-810ec7478e21" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2cb0e335-f6c3-463d-8168-2ab30c45a8b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_471938a6-6afc-4f22-9f50-e4b70b389711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_6c4030c1-bafc-402c-9822-6170fa048ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_471938a6-6afc-4f22-9f50-e4b70b389711" xlink:to="loc_us-gaap_Cash_6c4030c1-bafc-402c-9822-6170fa048ee3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_44c22e83-6366-4033-b183-bd57a51099f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_471938a6-6afc-4f22-9f50-e4b70b389711" xlink:to="loc_us-gaap_MarketableSecurities_44c22e83-6366-4033-b183-bd57a51099f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9af63190-a58b-4dc9-8883-76fc3ad425f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_c8644b00-9d83-4db8-8da8-48b1a92fe31a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9af63190-a58b-4dc9-8883-76fc3ad425f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_c8644b00-9d83-4db8-8da8-48b1a92fe31a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_cd26cf23-4034-463d-be30-5c6f17f57ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9af63190-a58b-4dc9-8883-76fc3ad425f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_cd26cf23-4034-463d-be30-5c6f17f57ceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b8ac5f1a-bbb1-4b22-a4dc-c443d014752a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_703f4013-3b09-4b14-a89d-0b1e5cd56e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b8ac5f1a-bbb1-4b22-a4dc-c443d014752a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_703f4013-3b09-4b14-a89d-0b1e5cd56e00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_33dc6dad-4d1b-4d7d-a74d-3fed47d96c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b8ac5f1a-bbb1-4b22-a4dc-c443d014752a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_33dc6dad-4d1b-4d7d-a74d-3fed47d96c57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShare" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShare"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShareTables"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_16eb3d76-ccf9-4679-8828-b4e7882aac7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_d999ace8-219b-4fb7-b772-f239136c6326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_16eb3d76-ccf9-4679-8828-b4e7882aac7e" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_d999ace8-219b-4fb7-b772-f239136c6326" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilities"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8cb7bb29-6323-4624-b058-66b22ddd323e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c37899a4-d4e2-41d7-a045-6216d1456547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8cb7bb29-6323-4624-b058-66b22ddd323e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c37899a4-d4e2-41d7-a045-6216d1456547" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_00a58b7d-745f-4561-9e44-b7562d769ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8cb7bb29-6323-4624-b058-66b22ddd323e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_00a58b7d-745f-4561-9e44-b7562d769ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AccruedGrantFunding_947f63ff-80ba-434e-ad71-9c6e54bc9622" xlink:href="clbs-20200630.xsd#clbs_AccruedGrantFunding"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8cb7bb29-6323-4624-b058-66b22ddd323e" xlink:to="loc_clbs_AccruedGrantFunding_947f63ff-80ba-434e-ad71-9c6e54bc9622" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5c340a35-124b-4b26-bd41-00ad517fedf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8cb7bb29-6323-4624-b058-66b22ddd323e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5c340a35-124b-4b26-bd41-00ad517fedf1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeases" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeases"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesTables"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesBalanceSheetPresentationDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ab0420f0-d091-4625-aa3b-1046c1fa4e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9c2742af-6f04-4424-bbc7-6c8a108ad236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ab0420f0-d091-4625-aa3b-1046c1fa4e7c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9c2742af-6f04-4424-bbc7-6c8a108ad236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_da582eb5-84ee-4290-82ee-9c541c4091bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ab0420f0-d091-4625-aa3b-1046c1fa4e7c" xlink:to="loc_us-gaap_OperatingLeaseLiability_da582eb5-84ee-4290-82ee-9c541c4091bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6825950-6f3a-4111-8c5d-f8ebc3c7afde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a82ba322-9d47-4876-a83e-ec15fbd435a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6825950-6f3a-4111-8c5d-f8ebc3c7afde" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a82ba322-9d47-4876-a83e-ec15fbd435a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_823014a7-4fe7-4e0f-bf89-669daee03d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6825950-6f3a-4111-8c5d-f8ebc3c7afde" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_823014a7-4fe7-4e0f-bf89-669daee03d52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_79213b22-9245-427a-bec3-6433bc34b673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6825950-6f3a-4111-8c5d-f8ebc3c7afde" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_79213b22-9245-427a-bec3-6433bc34b673" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5d4e5f83-6e15-44e9-ad9c-f1d963b8fe80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6825950-6f3a-4111-8c5d-f8ebc3c7afde" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5d4e5f83-6e15-44e9-ad9c-f1d963b8fe80" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquity" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityEquityIssuancesDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityStockOptionsandWarrantsDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchFunding" xlink:type="simple" xlink:href="clbs-20200630.xsd#ResearchFunding"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ResearchFunding" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchFundingDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#ResearchFundingDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ResearchFundingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxes" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeTaxesNetOperatingLossCarryForwardDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/Contingencies" xlink:type="simple" xlink:href="clbs-20200630.xsd#Contingencies"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/Contingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEvents" xlink:type="simple" xlink:href="clbs-20200630.xsd#SubsequentEvents"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/SubsequentEvents" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#SubsequentEventsDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>clbs-20200630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b55a4230-0bd3-4ac9-874e-83b223cb82b0,g:af6da92c-f069-4627-844d-929d63342442-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/CoverPage" xlink:type="simple" xlink:href="clbs-20200630.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/CoverPage" xlink:type="extended" id="id2d80efc3fd24a5d9baa20ae5b3a6b6e_CoverPage"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="ie726ffdb3fb24a59b62e9b4ee481ec5d_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedBalanceSheetsParentheticals"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="extended" id="i0126b1dde4ec4101a10a19953ab79517_ConsolidatedBalanceSheetsParentheticals"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i5614df9fc0114c0fb59c5cd20519763c_ConsolidatedStatementsofOperations"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended" id="i445e82cecc1c433a8f87562a96937ff1_ConsolidatedStatementsofComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="extended" id="i2813391e851c48c2a259ef93254757ef_ConsolidatedStatementsofEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c99c9575-9be0-4001-a3f8-c0e311e0761e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c99c9575-9be0-4001-a3f8-c0e311e0761e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e26cd07c-9dab-4573-be95-7f7cb45c3c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_SharesOutstanding_e26cd07c-9dab-4573-be95-7f7cb45c3c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ca50525-1873-4e59-a62e-22abc89ec8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ca50525-1873-4e59-a62e-22abc89ec8ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_356e2897-40e5-415f-a0bb-d2de0b3100b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_ProfitLoss_356e2897-40e5-415f-a0bb-d2de0b3100b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2a4ebcb1-2023-477e-ae41-6296540c1f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2a4ebcb1-2023-477e-ae41-6296540c1f2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_caf0ee41-5f4d-45d6-b7c4-763e3cf53908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_caf0ee41-5f4d-45d6-b7c4-763e3cf53908" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ca8e2ffd-58af-4849-bd1d-1a68c0db36bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ca8e2ffd-58af-4849-bd1d-1a68c0db36bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_57a0d982-a72a-496d-ba50-c60f5cc08e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_57a0d982-a72a-496d-ba50-c60f5cc08e10" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7a5d89f5-1baa-43e8-9506-90e2f7067cd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7a5d89f5-1baa-43e8-9506-90e2f7067cd9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5a92d032-6424-45cf-9d71-25b924a2fa36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3fae4ee6-3bb9-4d90-9073-8a9c1f5ba466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c99c9575-9be0-4001-a3f8-c0e311e0761e" xlink:to="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_eefeff04-e3cb-423a-9fc0-d71a65d86754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_eefeff04-e3cb-423a-9fc0-d71a65d86754" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eefeff04-e3cb-423a-9fc0-d71a65d86754_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eefeff04-e3cb-423a-9fc0-d71a65d86754" xlink:to="loc_us-gaap_EquityComponentDomain_eefeff04-e3cb-423a-9fc0-d71a65d86754_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2696a798-9b48-4d67-b8fe-5969ac6a9c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eefeff04-e3cb-423a-9fc0-d71a65d86754" xlink:to="loc_us-gaap_EquityComponentDomain_2696a798-9b48-4d67-b8fe-5969ac6a9c0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2696a798-9b48-4d67-b8fe-5969ac6a9c0e" xlink:to="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_b2a243c4-234d-4137-88a9-bb9903e6b141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_PreferredStockMember_b2a243c4-234d-4137-88a9-bb9903e6b141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c9c73234-d042-4192-8b7c-2e1fb7b5346d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_CommonStockMember_c9c73234-d042-4192-8b7c-2e1fb7b5346d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_99058e16-3ad8-4694-bfa7-2c87e3fb9be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_99058e16-3ad8-4694-bfa7-2c87e3fb9be2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7bf5451b-4d52-4612-a50f-2ee68450a92a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7bf5451b-4d52-4612-a50f-2ee68450a92a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_54bc6e61-c610-4d66-9421-e58b5351b834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_RetainedEarningsMember_54bc6e61-c610-4d66-9421-e58b5351b834" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_5718a218-2081-4bd9-8eee-fae34a787ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_TreasuryStockMember_5718a218-2081-4bd9-8eee-fae34a787ea3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_7890250d-a5ff-4e78-9f70-e2f3b2ace5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2696a798-9b48-4d67-b8fe-5969ac6a9c0e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_7890250d-a5ff-4e78-9f70-e2f3b2ace5a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_81b4ce54-e240-4326-84cd-efb35085a032" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_81b4ce54-e240-4326-84cd-efb35085a032" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_81b4ce54-e240-4326-84cd-efb35085a032_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_81b4ce54-e240-4326-84cd-efb35085a032" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_81b4ce54-e240-4326-84cd-efb35085a032_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41476512-e08a-43c7-b050-db17c1a3e0b9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_81b4ce54-e240-4326-84cd-efb35085a032" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41476512-e08a-43c7-b050-db17c1a3e0b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1cd6aeea-ed60-44e8-9fc2-c1bb4fec11e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41476512-e08a-43c7-b050-db17c1a3e0b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1cd6aeea-ed60-44e8-9fc2-c1bb4fec11e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="icf05ed59a272442fa0edb3371c615a02_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusiness" xlink:type="simple" xlink:href="clbs-20200630.xsd#TheBusiness"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/TheBusiness" xlink:type="extended" id="i66992df367084dd9857ce239834d3c1b_TheBusiness"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusinessNarrativeDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#TheBusinessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/TheBusinessNarrativeDetails" xlink:type="extended" id="i77d19b2f30e84d44a27ff266924d2e4a_TheBusinessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_3a211426-5f71-45d4-af68-783573bac0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantsReceivable_fc158be5-ccf1-484b-b733-92635d2541ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_3a211426-5f71-45d4-af68-783573bac0b2" xlink:to="loc_us-gaap_GrantsReceivable_fc158be5-ccf1-484b-b733-92635d2541ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_91b44fb1-9c43-4187-a032-b449de11aad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_3a211426-5f71-45d4-af68-783573bac0b2" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_91b44fb1-9c43-4187-a032-b449de11aad6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_91b44fb1-9c43-4187-a032-b449de11aad6" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b" xlink:to="loc_us-gaap_ProjectMember_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_9f8fc7c4-9ba7-4fde-ba86-ec329637ce5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b" xlink:to="loc_us-gaap_ProjectMember_9f8fc7c4-9ba7-4fde-ba86-ec329637ce5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IschemicRepairCD34CellTechnologyMember_9f703958-a83a-48b0-8c3a-7b70be16e379" xlink:href="clbs-20200630.xsd#clbs_IschemicRepairCD34CellTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_9f8fc7c4-9ba7-4fde-ba86-ec329637ce5d" xlink:to="loc_clbs_IschemicRepairCD34CellTechnologyMember_9f703958-a83a-48b0-8c3a-7b70be16e379" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="clbs-20200630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="ia75a8a60c32f4b2bb55a96067ed50fb6_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="clbs-20200630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="ia7a5de8dfb6646e9ba7e18009eda8ead_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecurities" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecurities"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecurities" xlink:type="extended" id="iacf6c0e45b3845e3a8e9ef87db9a85cb_AvailableforSaleSecurities"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesTables"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables" xlink:type="extended" id="iaec9477463e44f2a8d0217b7fb6bc9cc_AvailableforSaleSecuritiesTables"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="extended" id="i5a18675ba27e4054a91e87729afe29b8_AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_90e76bb0-3d91-4e85-9c89-addc4fa341ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_90e76bb0-3d91-4e85-9c89-addc4fa341ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9416399e-cd2f-438b-a914-6ec42d02e9d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9416399e-cd2f-438b-a914-6ec42d02e9d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d7282e71-747e-4984-a356-c50dc889277f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d7282e71-747e-4984-a356-c50dc889277f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a425f2f6-c9af-4448-8ffb-7831801055ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a425f2f6-c9af-4448-8ffb-7831801055ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_23df8472-f40f-4d4a-8524-3cadc66d392f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_23df8472-f40f-4d4a-8524-3cadc66d392f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_265c1ec5-23da-4cf5-a4d9-201006ab6618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_23df8472-f40f-4d4a-8524-3cadc66d392f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_265c1ec5-23da-4cf5-a4d9-201006ab6618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_265c1ec5-23da-4cf5-a4d9-201006ab6618_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_265c1ec5-23da-4cf5-a4d9-201006ab6618" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_265c1ec5-23da-4cf5-a4d9-201006ab6618_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_265c1ec5-23da-4cf5-a4d9-201006ab6618" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8209397e-1fcc-4f31-a441-dd28c07c49c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8209397e-1fcc-4f31-a441-dd28c07c49c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_240afd0f-c7a2-4464-a56e-d04a7916fd1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_240afd0f-c7a2-4464-a56e-d04a7916fd1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_de07797e-3316-405b-8234-ff081a328dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_de07797e-3316-405b-8234-ff081a328dae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtMember_449037cf-5973-43af-b91f-93d1ab6ce043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SovereignDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:to="loc_us-gaap_SovereignDebtMember_449037cf-5973-43af-b91f-93d1ab6ce043" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="extended" id="i21a5effa89d9410e9b0c7ab36136c6e1_AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="extended" id="i98201f4e992d42428f94e68a212c3d66_AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShare" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShare"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShare" xlink:type="extended" id="ic51113a4cf7441a79005a385bcadf655_IncomeLossPerShare"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShareTables"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareTables" xlink:type="extended" id="i65894f168b9f4e8881465ac5c4111a0d_IncomeLossPerShareTables"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="extended" id="i60f1bcc6f0634490b633a14c637d0825_IncomeLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be67fdbb-42cb-4173-bd45-ea3541e17b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f93374ac-7b6b-4b02-93a4-0331650ecb0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be67fdbb-42cb-4173-bd45-ea3541e17b87" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f93374ac-7b6b-4b02-93a4-0331650ecb0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d63f586c-a02c-4d3a-bc59-1d860a1dd038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be67fdbb-42cb-4173-bd45-ea3541e17b87" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d63f586c-a02c-4d3a-bc59-1d860a1dd038" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4f626b26-e7a6-41d2-b54b-b1df6cee96c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d63f586c-a02c-4d3a-bc59-1d860a1dd038" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4f626b26-e7a6-41d2-b54b-b1df6cee96c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4f626b26-e7a6-41d2-b54b-b1df6cee96c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4f626b26-e7a6-41d2-b54b-b1df6cee96c7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4f626b26-e7a6-41d2-b54b-b1df6cee96c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4f626b26-e7a6-41d2-b54b-b1df6cee96c7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_834ec3d8-7c10-4b58-873d-59843eb82da6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_834ec3d8-7c10-4b58-873d-59843eb82da6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_fd9037fa-c9fc-42aa-a886-0f6aedcd48c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:to="loc_us-gaap_WarrantMember_fd9037fa-c9fc-42aa-a886-0f6aedcd48c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_049f3fcb-0678-4bba-adf0-39165ee17c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_049f3fcb-0678-4bba-adf0-39165ee17c15" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/FairValueMeasurements" xlink:type="extended" id="i0f1ab26a2a02443d904d9e323a601136_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i7fa1bd7b0d5342fb937a5c4e8dc8a490_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="i39ae357c90a240e8aaf0abbbe7e4a267_FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_186c7341-daa5-439c-b297-8ff3a75bee60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_7b9102f2-de46-4cc2-bdfa-4a3c1f0d5f8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_186c7341-daa5-439c-b297-8ff3a75bee60" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_7b9102f2-de46-4cc2-bdfa-4a3c1f0d5f8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d8758fac-44ff-41c1-b242-77aa501051ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_186c7341-daa5-439c-b297-8ff3a75bee60" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d8758fac-44ff-41c1-b242-77aa501051ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_186c7341-daa5-439c-b297-8ff3a75bee60" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9057c5cf-4926-4a05-a81c-00839f644de3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9057c5cf-4926-4a05-a81c-00839f644de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9057c5cf-4926-4a05-a81c-00839f644de3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9057c5cf-4926-4a05-a81c-00839f644de3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9057c5cf-4926-4a05-a81c-00839f644de3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9057c5cf-4926-4a05-a81c-00839f644de3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6361e667-7161-4d10-9469-7103d0e9b85f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6361e667-7161-4d10-9469-7103d0e9b85f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3103af5a-9d51-49e1-85a3-40e05ad652c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3103af5a-9d51-49e1-85a3-40e05ad652c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_37f61090-0447-4c2c-9c80-ddaa105cf61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_37f61090-0447-4c2c-9c80-ddaa105cf61e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f779189-2db2-4dce-82d5-386c9b860e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f779189-2db2-4dce-82d5-386c9b860e93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4ed5033f-f3bd-48a3-8273-4656fac47d31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f779189-2db2-4dce-82d5-386c9b860e93" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4ed5033f-f3bd-48a3-8273-4656fac47d31" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilities"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AccruedLiabilities" xlink:type="extended" id="i749d7e0727c34369939f96b99ae48f84_AccruedLiabilities"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesTables" xlink:type="extended" id="i28d0c792b5fa43f3b2800a4f61c6c273_AccruedLiabilitiesTables"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="extended" id="i3832db847af5437e929be47afea254c5_AccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeases" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeases"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/OperatingLeases" xlink:type="extended" id="i500e591e807f4ad9b424973b0c648b5d_OperatingLeases"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesTables"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/OperatingLeasesTables" xlink:type="extended" id="i1d0a2660caf248eab0d134a29a0cfc49_OperatingLeasesTables"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails" xlink:type="extended" id="i433091f99a2d4e818cd08f5164491234_OperatingLeasesNarrativeDetails"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesBalanceSheetPresentationDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="extended" id="ie899f4543f08421483a525f8eab61a6e_OperatingLeasesBalanceSheetPresentationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_41a876a9-7585-4e49-a940-0cc7cf113745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_41a876a9-7585-4e49-a940-0cc7cf113745" xlink:to="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5ea727bd-9feb-42a4-bbe7-f0853f6b2a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5ea727bd-9feb-42a4-bbe7-f0853f6b2a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3a07cdb3-07cc-4972-b02c-9d19728974b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3a07cdb3-07cc-4972-b02c-9d19728974b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bf58fdd7-bc1b-49cf-bca0-3ae448120de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bf58fdd7-bc1b-49cf-bca0-3ae448120de0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8277c18e-31fe-4822-a35f-19a0b9d3e7fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:to="loc_us-gaap_OperatingLeaseLiability_8277c18e-31fe-4822-a35f-19a0b9d3e7fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_50fe2d76-81ad-4440-a3cc-84d29ed8f5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_41a876a9-7585-4e49-a940-0cc7cf113745" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_50fe2d76-81ad-4440-a3cc-84d29ed8f5b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9c98445e-7d46-42da-a4f4-ca89d2238385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_50fe2d76-81ad-4440-a3cc-84d29ed8f5b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9c98445e-7d46-42da-a4f4-ca89d2238385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9c98445e-7d46-42da-a4f4-ca89d2238385_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9c98445e-7d46-42da-a4f4-ca89d2238385" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9c98445e-7d46-42da-a4f4-ca89d2238385_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9c98445e-7d46-42da-a4f4-ca89d2238385" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_c7bc1f3d-8309-44a8-b047-d45ead15e32c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:to="loc_us-gaap_OtherAssetsMember_c7bc1f3d-8309-44a8-b047-d45ead15e32c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_8854b81b-2d9d-4627-aa9c-c71249d37418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_8854b81b-2d9d-4627-aa9c-c71249d37418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ded4f9fa-f0cd-489b-a7f2-0db01f17b192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ded4f9fa-f0cd-489b-a7f2-0db01f17b192" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended" id="i7ea14d20e84b4baf954ccd46d94f5207_OperatingLeasesFutureMinimumLeasePaymentsDetails"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquity" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/StockholdersEquity" xlink:type="extended" id="i2e35c9ae74e64c01adba56d2cf727f42_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/StockholdersEquityTables" xlink:type="extended" id="ic8b35cc10bb547c088701a0e4523e6e7_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityEquityIssuancesDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="extended" id="i8d32ece9fea249dcb9228e933de8fa99_StockholdersEquityEquityIssuancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_408411fa-59fa-4a01-8a56-fd36589a4bd3" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_408411fa-59fa-4a01-8a56-fd36589a4bd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_264d399b-f0a1-44aa-97d8-9ce2e5ed5b97" xlink:href="clbs-20200630.xsd#clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_264d399b-f0a1-44aa-97d8-9ce2e5ed5b97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f512c54d-8e9b-4a72-800b-02edc9f6c615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f512c54d-8e9b-4a72-800b-02edc9f6c615" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_751d2fb4-dcce-4361-b2c6-6461f95d7e92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_751d2fb4-dcce-4361-b2c6-6461f95d7e92" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a186b6e2-9e83-4adf-bde6-a9fe71630bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a186b6e2-9e83-4adf-bde6-a9fe71630bfb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_TermOfAgreement_27295271-c683-43ba-8a51-0642ab1f6303" xlink:href="clbs-20200630.xsd#clbs_TermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_TermOfAgreement_27295271-c683-43ba-8a51-0642ab1f6303" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_1c4fb11c-5c23-4dc3-88d8-81d05dce8468" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_1c4fb11c-5c23-4dc3-88d8-81d05dce8468" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_0a212a2f-f516-4a86-b300-e02042b81005" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_0a212a2f-f516-4a86-b300-e02042b81005" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_a271bfc7-0672-41df-a2a1-b38f439ef76b" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_a271bfc7-0672-41df-a2a1-b38f439ef76b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_b9e80c31-fbf8-44d8-ac88-ebcef68595b1" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_b9e80c31-fbf8-44d8-ac88-ebcef68595b1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_cf43602d-f92f-4a55-82d3-c1acec2021c0" xlink:href="clbs-20200630.xsd#clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_cf43602d-f92f-4a55-82d3-c1acec2021c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_42f87e0c-0c2b-4efa-b8f1-47b0dae7a202" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_42f87e0c-0c2b-4efa-b8f1-47b0dae7a202" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateMarketValueOfCommonStockNonAffiliates_7d426d95-35c1-4076-8855-7899ac0f8edd" xlink:href="clbs-20200630.xsd#clbs_AggregateMarketValueOfCommonStockNonAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_AggregateMarketValueOfCommonStockNonAffiliates_7d426d95-35c1-4076-8855-7899ac0f8edd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2814f01a-20c1-40dc-aee7-89d933f31711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2814f01a-20c1-40dc-aee7-89d933f31711" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_74e36537-4443-47b0-8f7c-2291333920cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_74e36537-4443-47b0-8f7c-2291333920cc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5aa345a3-2e13-4576-8c52-4f761795e7cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5aa345a3-2e13-4576-8c52-4f761795e7cd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cdf6e25c-ab04-46b2-a8f4-4a669dc405f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cdf6e25c-ab04-46b2-a8f4-4a669dc405f7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_7b15cc39-6e92-4098-9975-eeb72111ff33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_7b15cc39-6e92-4098-9975-eeb72111ff33" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b46db483-e14a-4567-a7f2-8d3a054dc6f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b46db483-e14a-4567-a7f2-8d3a054dc6f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_20936397-37a0-4656-acf2-b78e5c6cae92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b46db483-e14a-4567-a7f2-8d3a054dc6f1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_20936397-37a0-4656-acf2-b78e5c6cae92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20936397-37a0-4656-acf2-b78e5c6cae92_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_20936397-37a0-4656-acf2-b78e5c6cae92" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20936397-37a0-4656-acf2-b78e5c6cae92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_20936397-37a0-4656-acf2-b78e5c6cae92" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LincolnParkAgreementMember_9d7de11a-83a6-4dd2-b870-dd5d820d16e1" xlink:href="clbs-20200630.xsd#clbs_LincolnParkAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:to="loc_clbs_LincolnParkAgreementMember_9d7de11a-83a6-4dd2-b870-dd5d820d16e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember_78f03784-e381-4c9d-880f-1b4ebbff65d3" xlink:href="clbs-20200630.xsd#clbs_H.C.WainwrightSalesAmendedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:to="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember_78f03784-e381-4c9d-880f-1b4ebbff65d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AprilPurchaseAgreementMember_70a98327-c08c-4dc3-8ba4-3da85999a0b9" xlink:href="clbs-20200630.xsd#clbs_AprilPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:to="loc_clbs_AprilPurchaseAgreementMember_70a98327-c08c-4dc3-8ba4-3da85999a0b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MayPurchaseAgreementMember_d761e583-a45f-4485-a3a3-e25bf9864db5" xlink:href="clbs-20200630.xsd#clbs_MayPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:to="loc_clbs_MayPurchaseAgreementMember_d761e583-a45f-4485-a3a3-e25bf9864db5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityStockOptionsandWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails" xlink:type="extended" id="if7f3afa6691e433795003ca572b2a875_StockholdersEquityStockOptionsandWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_95e12222-42ff-4102-b78a-922154e54018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_95e12222-42ff-4102-b78a-922154e54018" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e5f3d0bd-d049-4e3a-95b5-338621057547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e5f3d0bd-d049-4e3a-95b5-338621057547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_08629510-d21e-4751-aebf-6a70566d31a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_08629510-d21e-4751-aebf-6a70566d31a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cac30cf5-ed84-471c-885c-99867166007a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cac30cf5-ed84-471c-885c-99867166007a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d2eb31b7-7bfa-4c08-a989-6acd6fb5ddd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d2eb31b7-7bfa-4c08-a989-6acd6fb5ddd5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_92b5fe06-50f8-4f4c-b9b9-45510fd5b065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_92b5fe06-50f8-4f4c-b9b9-45510fd5b065" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_671b1a09-a4d3-489a-b152-2515f3217617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_77dec3fc-8269-4400-bc06-3b074abddafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_77dec3fc-8269-4400-bc06-3b074abddafd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bf7910ec-8ff5-4221-ac65-fd1a57d6fa43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bf7910ec-8ff5-4221-ac65-fd1a57d6fa43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_eb24e272-6f75-4ea1-ac42-16caa5082d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_eb24e272-6f75-4ea1-ac42-16caa5082d6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_dcc6534f-7e0e-4773-8bfe-5ff2f039ed4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_dcc6534f-7e0e-4773-8bfe-5ff2f039ed4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3cc1630e-dcb3-4613-a3c6-5423259cd273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3cc1630e-dcb3-4613-a3c6-5423259cd273" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_66a0c445-ed09-4d08-8958-0c944b35f435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f60d75a1-eb92-4568-bf9c-50a91de8eb8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f60d75a1-eb92-4568-bf9c-50a91de8eb8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90d159ca-a15a-4064-993b-920012414966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90d159ca-a15a-4064-993b-920012414966" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e6761698-5683-45f1-bd8a-9a00b37ef518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e6761698-5683-45f1-bd8a-9a00b37ef518" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_f155de1c-f860-4b0b-8d48-5025cb543867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_f155de1c-f860-4b0b-8d48-5025cb543867" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_fe653e92-a2e1-4c0d-bf5d-8d2ef15c5293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_fe653e92-a2e1-4c0d-bf5d-8d2ef15c5293" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_afce10e6-7356-4d66-9cd9-dbbaeb7ca880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_afce10e6-7356-4d66-9cd9-dbbaeb7ca880" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_f76e14e5-2525-4c54-9856-29f00c1a3a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_f76e14e5-2525-4c54-9856-29f00c1a3a1c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_38975891-887f-4295-bdac-d8d565bf9cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_38975891-887f-4295-bdac-d8d565bf9cc2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm_816913b3-a047-4eb7-8d3f-d9c8242c3853" xlink:href="clbs-20200630.xsd#clbs_OptionsVestedweightedAverageRemainingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm_816913b3-a047-4eb7-8d3f-d9c8242c3853" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_e7601c2e-2a65-4939-8b93-3ec2e4b10aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_e7601c2e-2a65-4939-8b93-3ec2e4b10aa7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_95e12222-42ff-4102-b78a-922154e54018" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CommonStockWarrantsShares_fcd95550-b77a-4972-a726-4f7eeb0b9d6c" xlink:href="clbs-20200630.xsd#clbs_CommonStockWarrantsShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_CommonStockWarrantsShares_fcd95550-b77a-4972-a726-4f7eeb0b9d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsGranted_a2a63ff8-e38f-4778-9e1d-46f94aa95490" xlink:href="clbs-20200630.xsd#clbs_WarrantsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_WarrantsGranted_a2a63ff8-e38f-4778-9e1d-46f94aa95490" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExercised_c2f77cc7-c469-48f6-88ae-d3a1eca65a4e" xlink:href="clbs-20200630.xsd#clbs_WarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_WarrantsExercised_c2f77cc7-c469-48f6-88ae-d3a1eca65a4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsCanceled_60fd3fbf-39cf-40e1-a899-4a64fcb27585" xlink:href="clbs-20200630.xsd#clbs_WarrantsCanceled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_WarrantsCanceled_60fd3fbf-39cf-40e1-a899-4a64fcb27585" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExpired_ced21459-d883-4b29-8dc3-5093f13895a2" xlink:href="clbs-20200630.xsd#clbs_WarrantsExpired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_WarrantsExpired_ced21459-d883-4b29-8dc3-5093f13895a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CommonStockWarrantsShares_1fc1ae27-8400-4b9b-b2b2-5d3459c2568c" xlink:href="clbs-20200630.xsd#clbs_CommonStockWarrantsShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:href="clbs-20200630.xsd#clbs_WarrantsWeightedAverageExercisePriceRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsGranted_a1f84274-57d8-43d8-a59a-9de70d25176b" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsGranted_a1f84274-57d8-43d8-a59a-9de70d25176b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercised_c8ec822b-a3c7-4e4f-a24f-6f3d6545deca" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExercised_c8ec822b-a3c7-4e4f-a24f-6f3d6545deca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled_e038e880-e1a3-4351-96ad-e8cc3dfbfd61" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsCanceled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled_e038e880-e1a3-4351-96ad-e8cc3dfbfd61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExpired_9c39490b-2d94-47db-b8af-768b795ec751" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExpired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExpired_9c39490b-2d94-47db-b8af-768b795ec751" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding_e782067a-c914-4293-ba1b-6650daef95ef" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding_e782067a-c914-4293-ba1b-6650daef95ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_710a1ec8-0748-44bd-94c0-5ff37d167767" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantoutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_710a1ec8-0748-44bd-94c0-5ff37d167767" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding_1743fd57-4b6f-4564-b8ac-21d57ed5b99a" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding_1743fd57-4b6f-4564-b8ac-21d57ed5b99a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_Sharesvestedandexpectedtovest_6953483f-ef25-496b-9b8b-3a8d6998df32" xlink:href="clbs-20200630.xsd#clbs_Sharesvestedandexpectedtovest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_Sharesvestedandexpectedtovest_6953483f-ef25-496b-9b8b-3a8d6998df32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_f33efcdc-c0d7-4f60-8faf-5de051f66cbe" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_f33efcdc-c0d7-4f60-8faf-5de051f66cbe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_dfb6ae74-9d1a-421d-b68d-eac2355a7555" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_dfb6ae74-9d1a-421d-b68d-eac2355a7555" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_bd8c5998-4c19-4ace-8aec-01592ad7f40d" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_bd8c5998-4c19-4ace-8aec-01592ad7f40d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsVested_d38262ca-2fc1-4d2b-bc6f-2759e89ea74e" xlink:href="clbs-20200630.xsd#clbs_WarrantsVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WarrantsVested_d38262ca-2fc1-4d2b-bc6f-2759e89ea74e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable_01c812bb-69f9-4911-8463-43b0ef7b567c" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercisable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable_01c812bb-69f9-4911-8463-43b0ef7b567c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested_7bf7f7c3-9a83-497d-a8cb-b57d8a3d266c" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantsvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested_7bf7f7c3-9a83-497d-a8cb-b57d8a3d266c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvested_922ce0ed-3c3b-47ca-bde7-224d19608b7e" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsvested_922ce0ed-3c3b-47ca-bde7-224d19608b7e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_a36c7e95-74a8-4963-b293-2814eb6b29fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_95e12222-42ff-4102-b78a-922154e54018" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_a36c7e95-74a8-4963-b293-2814eb6b29fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockOptionsActivityAxis_080de5eb-d00b-4816-bc1b-76af829473ac" xlink:href="clbs-20200630.xsd#clbs_StockOptionsActivityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_a36c7e95-74a8-4963-b293-2814eb6b29fa" xlink:to="loc_clbs_StockOptionsActivityAxis_080de5eb-d00b-4816-bc1b-76af829473ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockOptionsActivityDomain_080de5eb-d00b-4816-bc1b-76af829473ac_default" xlink:href="clbs-20200630.xsd#clbs_StockOptionsActivityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_clbs_StockOptionsActivityAxis_080de5eb-d00b-4816-bc1b-76af829473ac" xlink:to="loc_clbs_StockOptionsActivityDomain_080de5eb-d00b-4816-bc1b-76af829473ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockOptionsActivityDomain_84418414-9304-4c29-9f54-66b9a59938f6" xlink:href="clbs-20200630.xsd#clbs_StockOptionsActivityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_clbs_StockOptionsActivityAxis_080de5eb-d00b-4816-bc1b-76af829473ac" xlink:to="loc_clbs_StockOptionsActivityDomain_84418414-9304-4c29-9f54-66b9a59938f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_UsEquityPlanMember_15f44bbc-abe1-4884-8138-827d3c2bcade" xlink:href="clbs-20200630.xsd#clbs_UsEquityPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clbs_StockOptionsActivityDomain_84418414-9304-4c29-9f54-66b9a59938f6" xlink:to="loc_clbs_UsEquityPlanMember_15f44bbc-abe1-4884-8138-827d3c2bcade" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="extended" id="i7885c434bc6145fcbc859d7e126733c4_StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_d4c5c1bb-7baf-4a07-9b3b-c54b723b27fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_d4c5c1bb-7baf-4a07-9b3b-c54b723b27fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_084d32c2-f87b-409a-8971-1623bb9803b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_084d32c2-f87b-409a-8971-1623bb9803b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ccb65ed7-eb30-4688-9cbc-32e7b391703d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ccb65ed7-eb30-4688-9cbc-32e7b391703d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e895d9b0-964a-4676-83e5-15707704b2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e895d9b0-964a-4676-83e5-15707704b2fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f9d0b11-23f2-4649-856c-c77c4dc844e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f9d0b11-23f2-4649-856c-c77c4dc844e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2476dee1-7777-4be2-9b7a-4476095130fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f9d0b11-23f2-4649-856c-c77c4dc844e3" xlink:to="loc_us-gaap_AwardTypeAxis_2476dee1-7777-4be2-9b7a-4476095130fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2476dee1-7777-4be2-9b7a-4476095130fe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2476dee1-7777-4be2-9b7a-4476095130fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2476dee1-7777-4be2-9b7a-4476095130fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1151b34c-9c4e-42e0-978c-83a4e8260f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2476dee1-7777-4be2-9b7a-4476095130fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1151b34c-9c4e-42e0-978c-83a4e8260f22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_c413731c-7cc5-411c-93fe-3aefa28c4cd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1151b34c-9c4e-42e0-978c-83a4e8260f22" xlink:to="loc_us-gaap_RestrictedStockMember_c413731c-7cc5-411c-93fe-3aefa28c4cd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9b26cfc7-c7ff-4c4c-943a-68c842e9584d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1151b34c-9c4e-42e0-978c-83a4e8260f22" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9b26cfc7-c7ff-4c4c-943a-68c842e9584d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensation" xlink:type="extended" id="if6c12e6822d54dfdaf9988352ec6e46c_ShareBasedCompensation"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationTables" xlink:type="extended" id="i18413361dc624a148048ba97c606392f_ShareBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationDetails" xlink:type="extended" id="i20c60139f62d47fea608afcb34619d6f_ShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3ca37a53-7fa1-4a35-bf44-5c43da76f78e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3ca37a53-7fa1-4a35-bf44-5c43da76f78e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_650d268a-a805-41b8-bcf1-81dfe4940672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_650d268a-a805-41b8-bcf1-81dfe4940672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f6c5267-a6c4-480c-9ed9-8d596cce8057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f6c5267-a6c4-480c-9ed9-8d596cce8057" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ae93ee65-2ea9-4334-8587-fb01470016d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ae93ee65-2ea9-4334-8587-fb01470016d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4f0d1e20-992f-477f-a590-8aad57f930f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4f0d1e20-992f-477f-a590-8aad57f930f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7d13473a-81c6-4c7d-9e4b-75ad9eb99530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7d13473a-81c6-4c7d-9e4b-75ad9eb99530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7d13473a-81c6-4c7d-9e4b-75ad9eb99530_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d13473a-81c6-4c7d-9e4b-75ad9eb99530" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7d13473a-81c6-4c7d-9e4b-75ad9eb99530_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ce6734c2-9cd4-4403-9737-423977906e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d13473a-81c6-4c7d-9e4b-75ad9eb99530" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ce6734c2-9cd4-4403-9737-423977906e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2118dc3e-4ab8-4323-a88e-0d8c03daaaaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ce6734c2-9cd4-4403-9737-423977906e21" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2118dc3e-4ab8-4323-a88e-0d8c03daaaaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6366abbc-7edf-4926-b25e-309cd9389afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ce6734c2-9cd4-4403-9737-423977906e21" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6366abbc-7edf-4926-b25e-309cd9389afc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:to="loc_us-gaap_AwardTypeAxis_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e74640e0-443f-4d65-a259-197cff73c254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e74640e0-443f-4d65-a259-197cff73c254" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_37b0e8cb-bbbc-48da-a590-4d9e1ae3660b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_37b0e8cb-bbbc-48da-a590-4d9e1ae3660b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_1bbd1094-e35c-4b85-995a-8720733ae7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:to="loc_us-gaap_RestrictedStockMember_1bbd1094-e35c-4b85-995a-8720733ae7de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_214cdf01-c536-45e5-ba66-f71dd0ec8d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:to="loc_us-gaap_WarrantMember_214cdf01-c536-45e5-ba66-f71dd0ec8d94" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchFunding" xlink:type="simple" xlink:href="clbs-20200630.xsd#ResearchFunding"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ResearchFunding" xlink:type="extended" id="i0d7ba8cad82d46bdaab591c4a0e22d54_ResearchFunding"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchFundingDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#ResearchFundingDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ResearchFundingDetails" xlink:type="extended" id="i3ef6cec95c3543499509217a6330b8cb_ResearchFundingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantsReceivable_395f7fab-8456-420d-90d8-8dc657da42bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_us-gaap_GrantsReceivable_395f7fab-8456-420d-90d8-8dc657da42bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_FundingOfGrantAwardCashReceived_ce18afce-ff43-4c04-81fc-0d9e9a8bfb53" xlink:href="clbs-20200630.xsd#clbs_FundingOfGrantAwardCashReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_FundingOfGrantAwardCashReceived_ce18afce-ff43-4c04-81fc-0d9e9a8bfb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MilestonePaymentOnGrantAwardCashReceived_50ab5269-5396-4c4e-8447-ef2d5c23fedc" xlink:href="clbs-20200630.xsd#clbs_MilestonePaymentOnGrantAwardCashReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_MilestonePaymentOnGrantAwardCashReceived_50ab5269-5396-4c4e-8447-ef2d5c23fedc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProgressPaymentOnGrantAwardCashReceived_67973d27-c108-40b8-8dc4-a4f7f0a3c0de" xlink:href="clbs-20200630.xsd#clbs_ProgressPaymentOnGrantAwardCashReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_ProgressPaymentOnGrantAwardCashReceived_67973d27-c108-40b8-8dc4-a4f7f0a3c0de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_bb8d9d58-fb5f-46e8-bfd9-51a0b111b22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_bb8d9d58-fb5f-46e8-bfd9-51a0b111b22d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AccruedGrantFunding_0d2ba94e-60fe-4840-aeae-054a0398d196" xlink:href="clbs-20200630.xsd#clbs_AccruedGrantFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_AccruedGrantFunding_0d2ba94e-60fe-4840-aeae-054a0398d196" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_cf7c77e8-dd3e-4bc6-90b0-819b410193e6" xlink:href="clbs-20200630.xsd#clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_cf7c77e8-dd3e-4bc6-90b0-819b410193e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_fa3d27d3-3184-402d-8f5b-32942343223c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_fa3d27d3-3184-402d-8f5b-32942343223c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_fa3d27d3-3184-402d-8f5b-32942343223c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5d0fb7b4-dfb2-403b-963e-ac4304094ae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5d0fb7b4-dfb2-403b-963e-ac4304094ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_5d05c8f9-d3b9-4dc5-a28b-029ba6f61a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5d0fb7b4-dfb2-403b-963e-ac4304094ae9" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_5d05c8f9-d3b9-4dc5-a28b-029ba6f61a62" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxes" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/IncomeTaxes" xlink:type="extended" id="id3c5cad0580b4e3fb1b5dbe25e1a045f_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeTaxesNetOperatingLossCarryForwardDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails" xlink:type="extended" id="ieb362c0b0f73480daf8e34259b3b1c16_IncomeTaxesNetOperatingLossCarryForwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_230fca1c-c09b-4be7-900e-8e7b2ad12318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_us-gaap_OperatingLossCarryforwards_230fca1c-c09b-4be7-900e-8e7b2ad12318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis_5a603bdf-78a5-4922-9c09-0933b30b02e1" xlink:href="clbs-20200630.xsd#clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis_5a603bdf-78a5-4922-9c09-0933b30b02e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_NetOperatingLossAnalysisAnnualLimitation_47a02f0a-669b-4e1d-b7e7-54c47039f984" xlink:href="clbs-20200630.xsd#clbs_NetOperatingLossAnalysisAnnualLimitation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_clbs_NetOperatingLossAnalysisAnnualLimitation_47a02f0a-669b-4e1d-b7e7-54c47039f984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfNetOperatingLossesNJEDAProgramValue_cf303364-aa17-4693-92c5-67359865b8a0" xlink:href="clbs-20200630.xsd#clbs_SaleOfNetOperatingLossesNJEDAProgramValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_clbs_SaleOfNetOperatingLossesNJEDAProgramValue_cf303364-aa17-4693-92c5-67359865b8a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_789a14d4-de8a-4709-905e-49c379519df4" xlink:href="clbs-20200630.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_789a14d4-de8a-4709-905e-49c379519df4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_8b88ba9e-02cd-4265-aaec-d84ac46264b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_8b88ba9e-02cd-4265-aaec-d84ac46264b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_8b88ba9e-02cd-4265-aaec-d84ac46264b3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0b56d638-d554-4c0d-a6cc-d8fad79530e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0b56d638-d554-4c0d-a6cc-d8fad79530e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_45178f20-0f26-4cb9-aa60-eb394a30661c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0b56d638-d554-4c0d-a6cc-d8fad79530e9" xlink:to="loc_us-gaap_DomesticCountryMember_45178f20-0f26-4cb9-aa60-eb394a30661c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/Contingencies" xlink:type="simple" xlink:href="clbs-20200630.xsd#Contingencies"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/Contingencies" xlink:type="extended" id="i9caef5da4d1b403ca686a598fb9d2e13_Contingencies"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEvents" xlink:type="simple" xlink:href="clbs-20200630.xsd#SubsequentEvents"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/SubsequentEvents" xlink:type="extended" id="ief77878b4f6849eab3b38cbf4ce89450_SubsequentEvents"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="extended" id="i92d52e09483c4d04923d9e0327c9f908_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_91f8b364-0030-481d-886c-aa8354fc99a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_91f8b364-0030-481d-886c-aa8354fc99a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_36529a83-282b-4940-a911-636a934c7519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_36529a83-282b-4940-a911-636a934c7519" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f7f896b8-a1fd-4fd2-8733-6bd3347d5ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f7f896b8-a1fd-4fd2-8733-6bd3347d5ad6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_382dc70a-7675-4e91-826b-ca5b249c4092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_382dc70a-7675-4e91-826b-ca5b249c4092" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_8729b616-8250-43f7-badd-f9826e4e131d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_8729b616-8250-43f7-badd-f9826e4e131d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1219ae22-a218-4af9-aac7-e2e6751321c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1219ae22-a218-4af9-aac7-e2e6751321c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_51829b08-90f6-47d5-a29c-cdad8a89ca18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_51829b08-90f6-47d5-a29c-cdad8a89ca18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1e7880e5-2308-4671-a007-f63f719f6c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1e7880e5-2308-4671-a007-f63f719f6c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1e7880e5-2308-4671-a007-f63f719f6c5f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1e7880e5-2308-4671-a007-f63f719f6c5f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1e7880e5-2308-4671-a007-f63f719f6c5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_09c8b326-273a-4201-b218-ddc3def2c1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1e7880e5-2308-4671-a007-f63f719f6c5f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_09c8b326-273a-4201-b218-ddc3def2c1b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2226c54e-472a-4d4d-a749-33b20cf83bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_09c8b326-273a-4201-b218-ddc3def2c1b3" xlink:to="loc_us-gaap_SubsequentEventMember_2226c54e-472a-4d4d-a749-33b20cf83bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ceed5210-90f9-4bb9-813d-02170a540ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ceed5210-90f9-4bb9-813d-02170a540ed2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ceed5210-90f9-4bb9-813d-02170a540ed2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ceed5210-90f9-4bb9-813d-02170a540ed2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ceed5210-90f9-4bb9-813d-02170a540ed2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84cf6707-aee1-46d4-8789-9b374433ffdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ceed5210-90f9-4bb9-813d-02170a540ed2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84cf6707-aee1-46d4-8789-9b374433ffdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_1f2a6861-d900-4a58-89dc-bc5afd7cd259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84cf6707-aee1-46d4-8789-9b374433ffdf" xlink:to="loc_us-gaap_PrivatePlacementMember_1f2a6861-d900-4a58-89dc-bc5afd7cd259" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember_7552bc56-0866-4d3b-8c39-ff0ee11ae29e" xlink:href="clbs-20200630.xsd#clbs_H.C.WainwrightSalesAmendedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84cf6707-aee1-46d4-8789-9b374433ffdf" xlink:to="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember_7552bc56-0866-4d3b-8c39-ff0ee11ae29e" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>clbs-20200630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b55a4230-0bd3-4ac9-874e-83b223cb82b0,g:af6da92c-f069-4627-844d-929d63342442-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_b7dba47c-1c97-434c-a2bd-8f897b87d8b9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_de691974-f815-4d9e-82a2-0cce69f08d25_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ad38c5d7-1c80-4129-9952-29a73322ddb0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b7c7bb41-3a8f-4b6e-9cc4-3b62418340d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_c749296b-b799-4ec7-830d-41cdaa13596a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_f80652e8-b5fc-42e1-b89a-d376afb53cf0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_c3452e23-1eec-4516-8b46-f637f5dd66b1_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal debt securities</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1f06864f-8446-45b7-b529-52939c86a3b3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_511f8390-145e-47ea-a7b0-4242e5623cff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_c799c8fc-adf9-4a4f-824c-6c4158459978_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_294d48dd-b411-4af3-9870-8132ba206f5c_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9393eea8-76d1-4c11-a5d4-85ccafc27bc3_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_32bac91a-a63a-4c5e-b895-22b0f99d7981_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_8fb11939-d14b-47eb-9d93-5a351ca65dad_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_9379512e-d6c9-44f3-b379-75f97689573d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_5fb40d67-4dee-406e-9681-01edc6498fb9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_38adec52-5af5-4197-ba75-6f2ca60f3594_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_Sharesvestedandexpectedtovest_7be5666b-c580-4456-b2b7-394c67a1dd1b_terseLabel_en-US" xlink:label="lab_clbs_Sharesvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_clbs_Sharesvestedandexpectedtovest_label_en-US" xlink:label="lab_clbs_Sharesvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares, vested and expected to vest</link:label>
    <link:label id="lab_clbs_Sharesvestedandexpectedtovest_documentation_en-US" xlink:label="lab_clbs_Sharesvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares, vested and expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_Sharesvestedandexpectedtovest" xlink:href="clbs-20200630.xsd#clbs_Sharesvestedandexpectedtovest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_Sharesvestedandexpectedtovest" xlink:to="lab_clbs_Sharesvestedandexpectedtovest" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_b1821d3c-29f5-4d4d-b438-182855f2f786_terseLabel_en-US" xlink:label="lab_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of NOLs</link:label>
    <link:label id="lab_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_label_en-US" xlink:label="lab_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Net Operating Losses, NJEDA Program</link:label>
    <link:label id="lab_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_documentation_en-US" xlink:label="lab_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Net Operating Losses, NJEDA Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:href="clbs-20200630.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:to="lab_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_2b5f6484-3bac-4117-a0c4-b2f457dc5745_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_9d4bc766-d6f8-407e-a4ca-3a2c7cc22cda_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercised_30c96378-ab1b-4926-8828-f0cd336e1823_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Exercised (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercised_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Exercised</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercised_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_61b64fd8-84ff-4bf4-849f-1478b3499515_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6ac75eb9-a8ba-4cb5-a171-1db05904c48a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ab59b85b-60fc-4720-9e1d-8cb32f41fa13_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities -- current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_cc2810ec-8279-4490-b05b-6591063bee59_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_685d4b4b-da62-4dad-a1a7-7de42beb3116_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5e1aa72-df70-42cb-85bd-b77900bc7c8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm_5cf560fc-e798-443f-9404-0beb070aaf9f_terseLabel_en-US" xlink:label="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:href="clbs-20200630.xsd#clbs_OptionsVestedweightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:to="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_StockOptionsActivityDomain_4d6d95e2-c982-4ea0-a7c3-4711d80ed004_terseLabel_en-US" xlink:label="lab_clbs_StockOptionsActivityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Domain]</link:label>
    <link:label id="lab_clbs_StockOptionsActivityDomain_label_en-US" xlink:label="lab_clbs_StockOptionsActivityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Domain]</link:label>
    <link:label id="lab_clbs_StockOptionsActivityDomain_documentation_en-US" xlink:label="lab_clbs_StockOptionsActivityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockOptionsActivityDomain" xlink:href="clbs-20200630.xsd#clbs_StockOptionsActivityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_StockOptionsActivityDomain" xlink:to="lab_clbs_StockOptionsActivityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_406325ba-b947-4134-ac96-edefe6490afc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Share-based Compensation Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a74e64bd-45a5-494f-bf27-f914e3712d2b_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsExpired_ae74e663-4bcc-4a9e-93a0-0f40cb3abc30_negatedTerseLabel_en-US" xlink:label="lab_clbs_WarrantsExpired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Expired (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsExpired_label_en-US" xlink:label="lab_clbs_WarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Expired</link:label>
    <link:label id="lab_clbs_WarrantsExpired_documentation_en-US" xlink:label="lab_clbs_WarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Expired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExpired" xlink:href="clbs-20200630.xsd#clbs_WarrantsExpired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsExpired" xlink:to="lab_clbs_WarrantsExpired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_10b87a53-01b4-45f0-a98f-9dc35a98d839_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ac958035-c2a2-472b-b433-e6f64396789c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2d326d99-7255-4738-839c-febcd153da32_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_a65c5673-d87f-4e61-a576-3849538d43cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f49cba83-9343-4ab9-a3f4-0b8d146c6f32_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5b53aa6c-ec54-4a85-8f98-f43df8f94907_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsExercised_33bafa8f-dcd2-48e7-a3a1-890f72f5b7ba_negatedTerseLabel_en-US" xlink:label="lab_clbs_WarrantsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Exercised (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsExercised_label_en-US" xlink:label="lab_clbs_WarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Exercised</link:label>
    <link:label id="lab_clbs_WarrantsExercised_documentation_en-US" xlink:label="lab_clbs_WarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExercised" xlink:href="clbs-20200630.xsd#clbs_WarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsExercised" xlink:to="lab_clbs_WarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_901ba7e0-1a4e-466d-8199-d06b9e387a6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4dc1adc5-b5b3-4985-9773-3843220fe9b5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6bce32bd-d2bd-4657-85b6-98ff9dd07c22_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_6330b1e9-55ae-4d9f-844b-ae58526b6672_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b3af658f-86a5-4730-9eca-c44bb579786e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting standard</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_7c0f04d1-74d1-45ab-b385-a1cacf1085d2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2a372224-979a-472a-8728-c3d5c4a21281_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a2cb9c2d-b0df-4627-aaf0-f32b57363ffa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_eed26e9a-0362-49c4-9d3f-d58c04f1073a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8a7d07e6-c163-4360-90ef-623f0593afdf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate for operating leases (percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ecaf76f4-ca8e-475c-b876-f1f62c437d9e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_ae4c46a6-c018-4567-9b07-02b6ecb7ac62_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ab74dbb1-8552-4bda-ad18-f4c9708ebbb7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable_c542c7d8-b5c5-40e9-a65f-6b9ca45b67df_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Exercisable</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercisable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8fa38300-55dc-4ba3-8d0d-e2ebbd9a887d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_df66cea5-2b82-46a5-8726-bb7b4e80d610_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting terms (years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_8937a7d6-627a-4aa7-bf02-26f45f132a2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9edebdf3-2385-4b86-aab3-512bb4d75f20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_92689ca0-615a-4900-908b-5525db086455_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0a4cf840-bae6-4513-9043-7f6bb0b0daf8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_0b40c9a3-10d4-423e-89ba-f36eae78d738_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Warrants [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2a395dba-dc3c-416a-a63d-feb4964b48e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amounts representing interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_9331474b-4f12-4786-93af-07d29efef283_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_d2f63768-e99b-44bb-b473-d2c70f1b4efa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_a58f956a-f3b8-48a3-aef9-f4a36929ac2b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_f05b8da8-b369-49c7-9f14-febaca92c7ae_terseLabel_en-US" xlink:label="lab_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares allowable to direct for Regular Purchase (in shares)</link:label>
    <link:label id="lab_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_label_en-US" xlink:label="lab_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase</link:label>
    <link:label id="lab_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_documentation_en-US" xlink:label="lab_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:to="lab_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsVested_90cefba1-882a-414a-acce-58060105803b_terseLabel_en-US" xlink:label="lab_clbs_WarrantsVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsVested_label_en-US" xlink:label="lab_clbs_WarrantsVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested</link:label>
    <link:label id="lab_clbs_WarrantsVested_documentation_en-US" xlink:label="lab_clbs_WarrantsVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsVested" xlink:href="clbs-20200630.xsd#clbs_WarrantsVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsVested" xlink:to="lab_clbs_WarrantsVested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1cae5c6e-5b44-4128-96ae-4ef0c1b85d44_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_490fbb54-b976-4098-9008-fa35108191d0_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_32344a21-cee3-427e-a447-32d139528f19_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5f078d58-24ac-4abe-a490-907e5ab68e8f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0faec0d4-21c1-463d-972c-4ad2f7a28f3a_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_ab449a94-74e0-4e50-ad0d-39befaf01407_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueArrangementByTypeTable_3fd26b08-5219-4878-bdf0-a7e965cf1d55_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Arrangement, by Type [Table]</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueArrangementByTypeTable_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Arrangement, by Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:to="lab_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_28420c16-360e-4df3-84e6-9fab01046278_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0aa3e244-b524-4e22-b58a-9c62e57b91e7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SovereignDebtMember_28634aac-1274-42ad-83e9-596e98315a60_terseLabel_en-US" xlink:label="lab_us-gaap_SovereignDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sovereign government securities</link:label>
    <link:label id="lab_us-gaap_SovereignDebtMember_label_en-US" xlink:label="lab_us-gaap_SovereignDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sovereign Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SovereignDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SovereignDebtMember" xlink:to="lab_us-gaap_SovereignDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cc84875f-afe2-4184-ba81-fd5848067d32_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Beginning of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_42fdc311-eb5b-41ed-bd89-327ad6b58e25_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, End of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_BusinessTextBlock_7dee5719-751e-4ba6-855d-8e45cec40e71_terseLabel_en-US" xlink:label="lab_clbs_BusinessTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Business</link:label>
    <link:label id="lab_clbs_BusinessTextBlock_label_en-US" xlink:label="lab_clbs_BusinessTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Business [Text Block]</link:label>
    <link:label id="lab_clbs_BusinessTextBlock_documentation_en-US" xlink:label="lab_clbs_BusinessTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Business [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_BusinessTextBlock" xlink:href="clbs-20200630.xsd#clbs_BusinessTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_BusinessTextBlock" xlink:to="lab_clbs_BusinessTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_282d7860-e200-428d-9f25-e3ac571c9257_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_f6339d8c-62d0-4cc3-8822-cc6b0044c8e1_terseLabel_en-US" xlink:label="lab_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum beneficial ownership allowable per agreement (percent)</link:label>
    <link:label id="lab_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_label_en-US" xlink:label="lab_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty</link:label>
    <link:label id="lab_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_documentation_en-US" xlink:label="lab_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:href="clbs-20200630.xsd#clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:to="lab_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_93059e0b-2728-4376-abcd-2a9961bbeff5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_368fde31-c762-4dd8-b685-924a62eb0099_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_17ebd4e1-9618-492a-b5de-d2068f347daf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_adcece0b-9dd6-430b-8c31-f88c11b47191_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_84bae3a5-84e9-4381-b6f9-86e439117741_terseLabel_en-US" xlink:label="lab_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum obligation per directed purchase transaction for Regular Purchase</link:label>
    <link:label id="lab_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_label_en-US" xlink:label="lab_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase</link:label>
    <link:label id="lab_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_documentation_en-US" xlink:label="lab_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:to="lab_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_d076eb63-676b-4b2b-9a7b-ea8948ffe436_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_c5e87956-d964-4c65-8af8-1d28f8c163f2_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_01f5c971-22fa-451a-9301-41ac583da7a3_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested_7ebfe116-cc6c-4683-ac14-9483a358e134_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested_label_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted Average Remaining Contractual Term, warrants vested</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested_documentation_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted Average Remaining Contractual Term, warrants vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantsvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:to="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_31854510-0911-432e-a739-c8ee8a38dabd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at June 30, 2020 and December 31, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_d26aebd1-6314-4824-ac26-cefa1895f6f2_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f31eceed-d96a-4e0f-9c82-5e35d001bc28_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_9d2f7fc6-ad3e-426a-8ab9-51881e9592da_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_902447c1-b206-4d8e-80c1-7f2aaaec611a_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f8a4891c-33be-4860-96a3-706f7f0914f7_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8566dc8e-dbf8-4c02-9d2d-99c2e49fa472_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_61b017f4-bb32-46b7-bcab-51b1f821ef4e_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ce705b6d-3d90-405f-bafd-b90c32c79099_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_6a358ecb-f0f9-4358-b55e-faa9f1c65e67_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_label_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term warrant outstanding</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_documentation_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term warrant outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantoutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:to="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_33603004-a1b5-43b8-b4ec-2bb519c71ff8_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_1d31ecf8-efec-46d5-ba92-fc56a968aa35_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Stock Options and warrants [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_af8ef3b2-42ac-4165-8212-093bf23dd9ca_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_fba1706c-e010-4d36-81e6-3b5cb18d32b7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_780ce5f6-95f2-453c-90d7-9ac96adfe708_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ead78ce4-976b-47cb-8224-a06c372849ae_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2203f21b-12a5-48ff-bf92-74f197a7e3f6_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_afd4e806-4b0a-478c-8a08-50ef8278a52e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_2a374bb6-443f-4793-9391-e326726a0f70_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_2b259888-f756-498f-b628-f6fb695190aa_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, fair value disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_def64d1c-3db0-4665-b8be-f0bd7a4f7ae8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_2c9f6320-3cf0-4f34-ae9e-d59ee9099e28_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a6271544-e3cb-490d-9f38-6f0eaa7c7c67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_a2887604-17e8-4a86-ac78-67117191a0e4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2911fa31-b274-44db-b8fa-7dd51196c297_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_499aaa31-8333-4b17-8ee4-12cca3d13fef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_ea3e7193-82b8-4378-a26d-e423c6e0f466_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d84a4290-b51f-4c74-8969-4708f6c205cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_40f374c7-c7b7-4934-943f-e6521affff90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f249b59b-1548-4780-94fa-a1559be1bb6a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_eb145a02-096a-4bc8-bd83-8516100239ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_105faf91-0df7-401f-a179-2d448cab12f7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term for operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a537aafd-379c-4e0b-b6f4-4f1cc8b29911_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_dd9d8637-dd9e-45da-86bd-6a6ae9f8593f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_48269dec-85dd-432f-a001-19f2a22718df_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_482d51c0-6fec-4599-8928-60dc995432df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d8e9ed7b-464c-4734-86e6-06da07dc0031_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_844c46fa-5252-42dc-b57f-442f86ac3e05_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExpired_7effecf2-6d29-4b54-bd0a-c68ce1e278a0_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Expired (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExpired_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Expired</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExpired_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Expired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExpired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2f501503-d472-4a96-a594-3e86acb48eb0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_add23d8f-8868-4250-98b1-63ab740dad55_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1880df8b-50d5-422a-ba69-3508479d3fb9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value, authorized 500,000,000 shares; issued and outstanding, 15,585,194 and 10,528,689 shares at June 30, 2020 and December 31, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_22bd5d3a-0c11-4c08-b044-fbfda91c0752_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caladrius Biosciences, Inc. common stockholders (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_TermOfAgreement_56f75b3d-89b8-426d-aeaf-32a1044f109f_terseLabel_en-US" xlink:label="lab_clbs_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of agreement (in months)</link:label>
    <link:label id="lab_clbs_TermOfAgreement_label_en-US" xlink:label="lab_clbs_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Of Agreement</link:label>
    <link:label id="lab_clbs_TermOfAgreement_documentation_en-US" xlink:label="lab_clbs_TermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_TermOfAgreement" xlink:href="clbs-20200630.xsd#clbs_TermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_TermOfAgreement" xlink:to="lab_clbs_TermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_a90313cc-a350-402f-ad13-0e3ba6cf8f13_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less - net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_05782a0c-9902-40b2-81d7-c6f43aecc53b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b2ac2011-8c25-4922-bfa6-e21de92f2447_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_8225deee-48ee-4cc3-9c39-bcb260e06dd8_terseLabel_en-US" xlink:label="lab_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of accrued grant funding to offset expense</link:label>
    <link:label id="lab_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_label_en-US" xlink:label="lab_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Accrued Grant Funding Liability To Offset Expense</link:label>
    <link:label id="lab_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_documentation_en-US" xlink:label="lab_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Accrued Grant Funding Liability To Offset Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:href="clbs-20200630.xsd#clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:to="lab_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7fd05723-8fd6-4b92-8e7d-ba8f341f57e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_FundingOfGrantAwardCashReceived_a7fccc48-d08c-4d53-bd9a-a860ef8ba3b4_terseLabel_en-US" xlink:label="lab_clbs_FundingOfGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding of grant award</link:label>
    <link:label id="lab_clbs_FundingOfGrantAwardCashReceived_label_en-US" xlink:label="lab_clbs_FundingOfGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding Of Grant Award, Cash Received</link:label>
    <link:label id="lab_clbs_FundingOfGrantAwardCashReceived_documentation_en-US" xlink:label="lab_clbs_FundingOfGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding Of Grant Award, Cash Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_FundingOfGrantAwardCashReceived" xlink:href="clbs-20200630.xsd#clbs_FundingOfGrantAwardCashReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_FundingOfGrantAwardCashReceived" xlink:to="lab_clbs_FundingOfGrantAwardCashReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsCanceled_3856f4b5-282e-4b06-a4ce-868941680773_negatedLabel_en-US" xlink:label="lab_clbs_WarrantsCanceled" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Forfeited (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsCanceled_label_en-US" xlink:label="lab_clbs_WarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Canceled</link:label>
    <link:label id="lab_clbs_WarrantsCanceled_documentation_en-US" xlink:label="lab_clbs_WarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Canceled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsCanceled" xlink:href="clbs-20200630.xsd#clbs_WarrantsCanceled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsCanceled" xlink:to="lab_clbs_WarrantsCanceled" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_H.C.WainwrightSalesAmendedAgreementMember_36eb543d-b0f0-4181-9fdd-5b8806a9b47c_terseLabel_en-US" xlink:label="lab_clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">H.C. Wainwright Sales Amended Agreement</link:label>
    <link:label id="lab_clbs_H.C.WainwrightSalesAmendedAgreementMember_label_en-US" xlink:label="lab_clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">H.C. Wainwright Sales Amended Agreement [Member]</link:label>
    <link:label id="lab_clbs_H.C.WainwrightSalesAmendedAgreementMember_documentation_en-US" xlink:label="lab_clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">H.C. Wainwright Sales Amended Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:href="clbs-20200630.xsd#clbs_H.C.WainwrightSalesAmendedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:to="lab_clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_c26ed996-fb43-43cf-84fb-5f13ccdbb356_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ce18d16a-da98-477c-9c20-d008a6477ffe_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_e4327d29-dc6a-4928-92bc-4850992c1502_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price of shares sold (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AggregateMarketValueOfCommonStockNonAffiliates_cec84358-e40c-40c5-b537-726e7e73aea1_terseLabel_en-US" xlink:label="lab_clbs_AggregateMarketValueOfCommonStockNonAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate market of common stock held by non-affiliates</link:label>
    <link:label id="lab_clbs_AggregateMarketValueOfCommonStockNonAffiliates_label_en-US" xlink:label="lab_clbs_AggregateMarketValueOfCommonStockNonAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Market Value Of Common Stock, Non-Affiliates</link:label>
    <link:label id="lab_clbs_AggregateMarketValueOfCommonStockNonAffiliates_documentation_en-US" xlink:label="lab_clbs_AggregateMarketValueOfCommonStockNonAffiliates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Market Value Of Common Stock, Non-Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateMarketValueOfCommonStockNonAffiliates" xlink:href="clbs-20200630.xsd#clbs_AggregateMarketValueOfCommonStockNonAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AggregateMarketValueOfCommonStockNonAffiliates" xlink:to="lab_clbs_AggregateMarketValueOfCommonStockNonAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ade13c4-bae3-4354-bebb-cf75a4b1326a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_UsEquityPlanMember_0ba16618-67e2-4f40-9238-9c82581939f7_terseLabel_en-US" xlink:label="lab_clbs_UsEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Equity Plan [Member]</link:label>
    <link:label id="lab_clbs_UsEquityPlanMember_label_en-US" xlink:label="lab_clbs_UsEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Equity Plan [Member]</link:label>
    <link:label id="lab_clbs_UsEquityPlanMember_documentation_en-US" xlink:label="lab_clbs_UsEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Equity Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_UsEquityPlanMember" xlink:href="clbs-20200630.xsd#clbs_UsEquityPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_UsEquityPlanMember" xlink:to="lab_clbs_UsEquityPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_84f95e68-c9ab-474a-bd38-da23f331d34e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f87be316-8c56-4802-a417-6b0cca678305_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c49b15b0-d79c-47d8-b259-93ac93bca58b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_1b569324-d0c3-4d3d-8c0c-bff3bdf58a8d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a7f21c87-ee9c-40d0-a184-80b68de63cdb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8bfdebf1-4cd0-45f5-a487-0b93d611a777_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7e59b007-fd73-43e7-9d99-8cbea911e914_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_86c7b306-4e24-4a3b-adac-2807fd3d4c11_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Compensation Cost Related to Nonvested Awards</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b725cbe2-4c55-4bc1-b18b-660d68bd9ded_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_67909c75-fe14-4884-9a2c-52149bb8e4fe_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bb3dd541-3f72-4256-b1b7-b0c70854d3bb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average estimated fair value of restricted stock issued</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_59b86c78-1b36-45fc-9c9f-debc8aab3499_terseLabel_en-US" xlink:label="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum shares allowed in Accelerated Purchase as percent of shares In Regular Purchase (percent)</link:label>
    <link:label id="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_label_en-US" xlink:label="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase</link:label>
    <link:label id="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_documentation_en-US" xlink:label="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:to="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_c18f05aa-8a75-4280-9783-4ba9a7941d55_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_32e2e00f-70e9-44b6-8864-5b883be8c2ba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c998ec6e-0fba-471c-bfaa-b445466345f9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a71d5c5f-284f-4e12-be04-66868509c6ed_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_770ba275-a0f5-48b4-b96c-6ad18d5448d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_24dfee6c-38ef-4b5b-b9c5-5de4fb4dba35_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_78c2a8ec-d311-4fc0-b18d-3b8875fdb143_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_bac76500-e664-4b2b-a78a-37bf6f38a327_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_00a477f7-f49a-48bf-aaf4-200874f716cd_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale-Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1b699de2-e6a3-4bd6-adb1-9b934bc1c75f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f837c3ba-868c-44a8-9104-4cec8a1b1d3a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_f6d0c453-30bc-4a87-af98-d09082cd9cf0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProjectMember_41eae4a6-b64f-4dbe-afca-76f9a59252d5_terseLabel_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Domain]</link:label>
    <link:label id="lab_us-gaap_ProjectMember_label_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProjectMember" xlink:to="lab_us-gaap_ProjectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aee46485-3bb3-4c53-bf9f-fe1850630bfe_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bcc5d579-b3ee-494f-8d55-968f92c0ea54_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_4886e504-63d0-4b05-aa9f-fba16bc9ec67_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Caladrius Biosciences, Inc. stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_7ac92d4d-d0d6-4b04-95a8-a8a875d04371_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_ProgressPaymentOnGrantAwardCashReceived_078660cd-f2ad-4946-9da7-5211890a7dd7_terseLabel_en-US" xlink:label="lab_clbs_ProgressPaymentOnGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Progress payment received on grant award</link:label>
    <link:label id="lab_clbs_ProgressPaymentOnGrantAwardCashReceived_label_en-US" xlink:label="lab_clbs_ProgressPaymentOnGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Progress Payment On Grant Award, Cash Received</link:label>
    <link:label id="lab_clbs_ProgressPaymentOnGrantAwardCashReceived_documentation_en-US" xlink:label="lab_clbs_ProgressPaymentOnGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Progress Payment On Grant Award, Cash Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProgressPaymentOnGrantAwardCashReceived" xlink:href="clbs-20200630.xsd#clbs_ProgressPaymentOnGrantAwardCashReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_ProgressPaymentOnGrantAwardCashReceived" xlink:to="lab_clbs_ProgressPaymentOnGrantAwardCashReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2e33050e-97dc-478a-8fbb-cd8c418c1892_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity, Total</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_NetOperatingLossAnalysisAnnualLimitation_130239ab-0273-4a16-8e3d-26c34b9c1131_terseLabel_en-US" xlink:label="lab_clbs_NetOperatingLossAnalysisAnnualLimitation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual limitation on usage of net operating losses</link:label>
    <link:label id="lab_clbs_NetOperatingLossAnalysisAnnualLimitation_label_en-US" xlink:label="lab_clbs_NetOperatingLossAnalysisAnnualLimitation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Analysis, Annual Limitation</link:label>
    <link:label id="lab_clbs_NetOperatingLossAnalysisAnnualLimitation_documentation_en-US" xlink:label="lab_clbs_NetOperatingLossAnalysisAnnualLimitation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Analysis, Annual Limitation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_NetOperatingLossAnalysisAnnualLimitation" xlink:href="clbs-20200630.xsd#clbs_NetOperatingLossAnalysisAnnualLimitation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_NetOperatingLossAnalysisAnnualLimitation" xlink:to="lab_clbs_NetOperatingLossAnalysisAnnualLimitation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_821d728d-67cb-4869-9e29-29f4d57e534a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_603215df-e1ae-4744-ad9a-e313fb083f7a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_068efea9-3d18-4d89-8529-7265c1b34d05_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_66796ef6-b07b-463a-a253-f329f2496fd2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries, employee benefits and related taxes</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_296b172e-6917-4e87-bc78-9588f990123e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_273c46e5-4463-45e3-b2eb-02725b285eb4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_93f6b194-1193-448f-a27e-7fd90a89d0a0_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrantsReceivable_86e7c2e0-eadb-40ea-bc46-c25cc4e29979_terseLabel_en-US" xlink:label="lab_us-gaap_GrantsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants awarded</link:label>
    <link:label id="lab_us-gaap_GrantsReceivable_label_en-US" xlink:label="lab_us-gaap_GrantsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantsReceivable" xlink:to="lab_us-gaap_GrantsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_3773747a-8bff-4171-a16c-98c046c0fdb9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_706c2f33-b078-4359-a4d7-094b06aae97f_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Caladrius Biosciences, Inc. Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract_0a31970d-6b06-4b76-8d02-31d38b342f51_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Captions</link:label>
    <link:label id="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_4e81d524-cbfa-480c-adc8-ac6f159547e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_bcc65bac-8d16-4be3-95de-d6071d735bf8_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_f3004447-e19d-4a38-94d9-a6d4032dfbd4_terseLabel_en-US" xlink:label="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate offering amount authorized per agreement</link:label>
    <link:label id="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_label_en-US" xlink:label="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</link:label>
    <link:label id="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_documentation_en-US" xlink:label="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:to="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d9646c8d-53a8-4659-9549-4e9f2621ca67_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueArrangementLineItems_1b87b888-3932-4c70-b9f4-2c2a004825b1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Arrangement [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueArrangementLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Arrangement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems" xlink:to="lab_us-gaap_DeferredRevenueArrangementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a4b600a3-810f-44da-99e5-0df6fcf15407_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4a6759e1-e27a-4e36-b40e-e03dc6627afd_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a97193d4-2d9e-4706-b1d2-ac2a76bb38d7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_35811c31-1175-4470-8490-4b4f2125ab41_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsGranted_24bbe7d5-074b-4612-85af-ea95acf244c0_terseLabel_en-US" xlink:label="lab_clbs_WarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Granted (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsGranted_label_en-US" xlink:label="lab_clbs_WarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Granted</link:label>
    <link:label id="lab_clbs_WarrantsGranted_documentation_en-US" xlink:label="lab_clbs_WarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsGranted" xlink:href="clbs-20200630.xsd#clbs_WarrantsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsGranted" xlink:to="lab_clbs_WarrantsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_9860ff53-f534-4701-8001-799fff13f225_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_d6813510-c97f-4716-81eb-265b5c823be8_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_081c7ea7-19a3-41d4-9f66-a340b3d3aaa2_terseLabel_en-US" xlink:label="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities and other liabilities</link:label>
    <link:label id="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_label_en-US" xlink:label="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</link:label>
    <link:label id="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_documentation_en-US" xlink:label="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:href="clbs-20200630.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_c6d7f2ae-53bb-4eef-8ab7-274b65246580_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_748e11e7-72e5-41b9-9a9d-f3b58ac750cb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b374ea8e-c72c-4427-bdc6-159075f6ed8a_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_9ded0080-53cd-459b-b8b8-f6906dfa3c29_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3dcfe3bc-3ea3-4ef9-a959-69e624b76605_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_95eb947e-7c1e-4be9-92d4-0be05c538589_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_047e7603-2eb2-4425-933d-1bf66669f950_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_d57b717d-7279-4492-914b-8edb2af664cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding_058d0a14-4db7-42f2-82ae-f5761a1a02dc_periodEndLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Outstanding, End of Period (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Outstanding</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7befcc75-7bae-4ca9-acfd-25536f289f27_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_62330b0a-a8c0-498b-ba0d-3269d6cad28d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_c5c1cfc5-4319-4b6a-b79c-8384d65bdfda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_d4770219-d85a-4472-844c-99f674dfc19d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_82638696-fd77-4233-b16a-61e3ec67a77e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward_773691a2-57b4-41d5-96aa-07904e9f3528_terseLabel_en-US" xlink:label="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:href="clbs-20200630.xsd#clbs_WarrantsWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:to="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_cec051a8-48bf-46c3-812b-370c1a2a4c4f_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants expiration term</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_cbb94561-aa6c-49b9-9b52-52bc2fca791a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_840b89a5-effc-4a76-b67a-542f9635acb4_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_3e12242b-9c07-48cd-abe2-7edf451efd08_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income attributable to Caladrius Biosciences, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d038ced7-a785-4c44-9d27-813049ecefec_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0d509614-4a6d-4aa7-9100-3e21d97b2b8e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_e7925235-19c9-4182-947a-cce87a63bdb2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_8078d326-0fef-4bbf-80a3-a2159cc06d72_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5c12c7d8-b063-4eb8-ae3a-2a8f4e060001_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_de11bf72-2c1c-489f-9818-c4f021953260_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_1890b36e-2033-429e-bfac-49849ece1e46_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_857b559f-8b37-40aa-9e84-e1eaeb60453d_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_7a65a0c9-85fc-4252-a5bf-ec8bea84e23e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_58824eb1-3246-4301-b3c1-01689cff7c72_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_2c03442f-80bb-4a51-9d5d-2d13c45945a3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_275fd104-24bd-476e-bc5e-451d6be22397_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_IschemicRepairCD34CellTechnologyMember_26177c72-55e0-4efa-9411-00cd50db7b25_terseLabel_en-US" xlink:label="lab_clbs_IschemicRepairCD34CellTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CD34 cell technology</link:label>
    <link:label id="lab_clbs_IschemicRepairCD34CellTechnologyMember_label_en-US" xlink:label="lab_clbs_IschemicRepairCD34CellTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ischemic Repair CD34 Cell Technology [Member]</link:label>
    <link:label id="lab_clbs_IschemicRepairCD34CellTechnologyMember_documentation_en-US" xlink:label="lab_clbs_IschemicRepairCD34CellTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ischemic Repair CD34 Cell Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IschemicRepairCD34CellTechnologyMember" xlink:href="clbs-20200630.xsd#clbs_IschemicRepairCD34CellTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_IschemicRepairCD34CellTechnologyMember" xlink:to="lab_clbs_IschemicRepairCD34CellTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c14910d2-4b22-42c4-adc3-9ba62ec7f871_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_20df3a38-10b8-4e9b-9993-7083142c5bce_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_49a07715-af47-4973-a695-e5a97084d8e1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9ede6685-ef52-48f2-b7d7-084f0b5e037f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_211529aa-f7fe-4441-952b-7ec3b5f9462a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_65148d45-f6ad-4d07-9cff-f9640849d9ab_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0b350855-b06e-428f-8ef3-bb6ea37e9a0e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AccruedGrantFunding_2de3a759-8733-4583-89ef-66b75fc941e4_terseLabel_en-US" xlink:label="lab_clbs_AccruedGrantFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CIRM upfront funding -- current</link:label>
    <link:label id="lab_clbs_AccruedGrantFunding_6a95d516-5e44-4a27-9e65-738ff84d6651_verboseLabel_en-US" xlink:label="lab_clbs_AccruedGrantFunding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued grant funding</link:label>
    <link:label id="lab_clbs_AccruedGrantFunding_label_en-US" xlink:label="lab_clbs_AccruedGrantFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Grant Funding</link:label>
    <link:label id="lab_clbs_AccruedGrantFunding_documentation_en-US" xlink:label="lab_clbs_AccruedGrantFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Grant Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AccruedGrantFunding" xlink:href="clbs-20200630.xsd#clbs_AccruedGrantFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AccruedGrantFunding" xlink:to="lab_clbs_AccruedGrantFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_c1da41a1-0c99-4692-a4f8-da002724c767_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_352ccca4-b8bd-4a41-b622-a7acdcc10107_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities - net unrealized (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_918a4771-7b1b-4029-917d-d13305024374_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b8e65365-eaf0-46ff-a99e-954c1773e8a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1921cb37-819d-45d6-8949-478325a34b7c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares called by warrants issued</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_ba78b175-f871-4c56-904d-249a5aa9e6d3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_284668ab-e43d-4bae-8c02-8cb1b71b205d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_9d0fb0b5-a7cb-4708-b8c8-e80d0d8fc9a7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_5ac22ba4-efd5-4b47-97a9-4f2c05f4c48a_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_label_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_documentation_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:to="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_16817bcd-8f2c-43fd-b180-5d671c127171_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of restricted stock issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_edace9e7-1f25-4d1c-8629-2cabf8653957_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross price for stock transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4f8b2e55-f78a-4576-813f-93c66034880f_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_LincolnParkAgreementMember_d7552c4f-6959-4c82-8dce-e515ca00e9da_terseLabel_en-US" xlink:label="lab_clbs_LincolnParkAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Park Agreement</link:label>
    <link:label id="lab_clbs_LincolnParkAgreementMember_label_en-US" xlink:label="lab_clbs_LincolnParkAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Park Agreement [Member]</link:label>
    <link:label id="lab_clbs_LincolnParkAgreementMember_documentation_en-US" xlink:label="lab_clbs_LincolnParkAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Park Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LincolnParkAgreementMember" xlink:href="clbs-20200630.xsd#clbs_LincolnParkAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_LincolnParkAgreementMember" xlink:to="lab_clbs_LincolnParkAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_65f120bc-3e99-4630-8790-c01ea4628e2d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_70ed2639-000d-4eab-8bbf-0cd15811bc49_terseLabel_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested and expected to vest, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_label_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants vested and expected to vest</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_documentation_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants vested and expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:to="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c0ee30d4-97d8-4c9d-a1b7-2e0e23e7340c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled_5cebd845-0d0a-4d54-bb30-f94f5b7504bc_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Forfeited (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Canceled</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Canceled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsCanceled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsGranted_83d7b85f-0010-4ce6-bf4f-27267cdb70f0_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Granted (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsGranted_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Granted</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsGranted_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_31d46a17-b45d-4740-8f5b-968b31c8e0a9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected weighted-average period in years of compensation cost to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_68c14bfb-57c7-4dcd-8d3d-a34ceba4702a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and expected to vest, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b150d1ff-1d32-43ed-b6f4-4caa9350daff_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4cf7bc18-8d80-4c07-942c-90c86e61eb1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Share-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_fc60b4e7-8de6-421a-9954-1fd10cff726a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfNetOperatingLossesNJEDAProgramValue_07fa2e0b-730e-4fb5-bf5b-dc7378483a86_terseLabel_en-US" xlink:label="lab_clbs_SaleOfNetOperatingLossesNJEDAProgramValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of NOLs, value</link:label>
    <link:label id="lab_clbs_SaleOfNetOperatingLossesNJEDAProgramValue_label_en-US" xlink:label="lab_clbs_SaleOfNetOperatingLossesNJEDAProgramValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Net Operating Losses, NJEDA Program, Value</link:label>
    <link:label id="lab_clbs_SaleOfNetOperatingLossesNJEDAProgramValue_documentation_en-US" xlink:label="lab_clbs_SaleOfNetOperatingLossesNJEDAProgramValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Net Operating Losses, NJEDA Program, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfNetOperatingLossesNJEDAProgramValue" xlink:href="clbs-20200630.xsd#clbs_SaleOfNetOperatingLossesNJEDAProgramValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfNetOperatingLossesNJEDAProgramValue" xlink:to="lab_clbs_SaleOfNetOperatingLossesNJEDAProgramValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_97bd392c-ff08-4275-9b42-ee20df0c98b4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis_a778f12d-f6de-4f0e-b4a7-a12fa372c646_terseLabel_en-US" xlink:label="lab_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market capitalization used in net operating loss analysis</link:label>
    <link:label id="lab_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis_label_en-US" xlink:label="lab_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Capitalization Used In Net Operating Loss Analysis</link:label>
    <link:label id="lab_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis_documentation_en-US" xlink:label="lab_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Capitalization Used In Net Operating Loss Analysis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis" xlink:href="clbs-20200630.xsd#clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis" xlink:to="lab_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b9125159-53c0-4689-9c59-68863e5f1a78_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding_d7375e7b-31d3-47ae-9fc7-9383908629ad_terseLabel_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding_label_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants Outstanding</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding_documentation_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:to="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvested_7447a301-b65b-48d2-992b-1b87329cce46_terseLabel_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvested_label_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants vested</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvested_documentation_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvested" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AggregateIntrinsicValueWarrantsvested" xlink:to="lab_clbs_AggregateIntrinsicValueWarrantsvested" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_29277a06-c906-428c-badc-7a36e28c28c2_terseLabel_en-US" xlink:label="lab_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment shares issued as consideration per agreement (in shares)</link:label>
    <link:label id="lab_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_label_en-US" xlink:label="lab_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued As Consideration</link:label>
    <link:label id="lab_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_documentation_en-US" xlink:label="lab_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued As Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:href="clbs-20200630.xsd#clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:to="lab_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_d20d04c1-6262-4960-9b94-55da6e1ffe84_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Funding</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b47d6c8c-650b-49aa-9b30-9eeb1789f78e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_92119cb8-7e82-4f3f-b11d-0b58325fe195_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c8a9b2c3-dd3f-4382-87fb-d91a519ab9c6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_77f253c4-e529-42d0-a80d-c6a264f437fc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_0690a847-66bc-4fa1-a1b8-fbd631f3cdb7_terseLabel_en-US" xlink:label="lab_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission on gross proceeds due to third party (percent)</link:label>
    <link:label id="lab_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_label_en-US" xlink:label="lab_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent</link:label>
    <link:label id="lab_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_documentation_en-US" xlink:label="lab_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:to="lab_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_b1c0d1f2-2f6c-4067-b102-94f92812b4b8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_01899324-1fd9-4e52-b710-197b0eb8956a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_3d7067df-ef9f-4734-afe6-3bfadc034273_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_ce5c89e5-d2c1-4cc7-aa36-21581014a30c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_09e529ff-9823-4765-b79f-4556a11113f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and expected to vest, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_92be4da1-54ad-4057-ba6d-efa816095b95_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2dc17b1b-1164-48e1-8a59-5ab98f2af498_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_73303f77-3409-4d59-9bcd-0bbbaa59b798_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d33fd1e4-f842-4436-a096-8aede4f02414_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_9e2c5b12-040f-4ff1-bcd9-ba1820a88904_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6b5b7b99-20f6-4b1b-8e20-9b3112c5c73a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_1d7870b4-3a20-47fe-ad90-68a6ad4ed3d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c09fcdd1-1154-4bc9-b8ab-ebd28b6d8528_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments Under Lease Agreements</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_58889aa9-3d7f-4404-8a98-679c40698004_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CommonStockWarrantsShares_35d58a85-7e11-4f21-9acf-721a2ad46596_periodStartLabel_en-US" xlink:label="lab_clbs_CommonStockWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Outstanding, Beginning of Period (in shares)</link:label>
    <link:label id="lab_clbs_CommonStockWarrantsShares_8f86c500-aa10-462b-a2cc-55ed2f476aa9_periodEndLabel_en-US" xlink:label="lab_clbs_CommonStockWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Outstanding, End of Period (in shares)</link:label>
    <link:label id="lab_clbs_CommonStockWarrantsShares_label_en-US" xlink:label="lab_clbs_CommonStockWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Shares</link:label>
    <link:label id="lab_clbs_CommonStockWarrantsShares_documentation_en-US" xlink:label="lab_clbs_CommonStockWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CommonStockWarrantsShares" xlink:href="clbs-20200630.xsd#clbs_CommonStockWarrantsShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CommonStockWarrantsShares" xlink:to="lab_clbs_CommonStockWarrantsShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_30e68c7b-5983-4fe8-aee7-153aea4be48d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4c48029a-7658-4d39-afde-b949a4c8510d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2040554e-388b-4920-bcd0-03f798c4436b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average estimated fair value of shares granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_StockOptionsActivityAxis_0bb82504-394c-44cd-b172-9dbbf305c2bf_terseLabel_en-US" xlink:label="lab_clbs_StockOptionsActivityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Axis]</link:label>
    <link:label id="lab_clbs_StockOptionsActivityAxis_label_en-US" xlink:label="lab_clbs_StockOptionsActivityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Axis]</link:label>
    <link:label id="lab_clbs_StockOptionsActivityAxis_documentation_en-US" xlink:label="lab_clbs_StockOptionsActivityAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockOptionsActivityAxis" xlink:href="clbs-20200630.xsd#clbs_StockOptionsActivityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_StockOptionsActivityAxis" xlink:to="lab_clbs_StockOptionsActivityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_5ec4f2cb-5033-4da0-b5c7-5e07eb222c7d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_4da22c42-389e-440b-b713-804db914edc1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_17dc9f2e-1460-494d-95cc-d95366bcd474_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_e96eaf87-c082-4de6-b343-1e16576e6f5c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_bc5e51db-5180-4bb2-b4c5-544916ae3db9_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_d79ddf65-35c7-451c-9a7f-425418d3911c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e343bdcd-153c-451f-943a-161ef37ddae8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding. Beginning of Period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_77ba81a0-6a81-4a10-97a5-9f9ac9604a88_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, End of Period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_8e380c6e-9971-4079-a8b9-f7354b5d910a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Name of Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_a17c1d67-0b11-4643-838f-5d3775e5b3c8_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_671f3bc1-e818-43e5-af80-52a151c9ab9d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_72c723da-594e-40bc-87bb-ac441bf62fa7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares called by each warrant</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_MayPurchaseAgreementMember_6bc00bc2-c30e-4978-b2f0-aaf6200457e7_terseLabel_en-US" xlink:label="lab_clbs_MayPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May Purchase Agreement</link:label>
    <link:label id="lab_clbs_MayPurchaseAgreementMember_label_en-US" xlink:label="lab_clbs_MayPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May Purchase Agreement [Member]</link:label>
    <link:label id="lab_clbs_MayPurchaseAgreementMember_documentation_en-US" xlink:label="lab_clbs_MayPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MayPurchaseAgreementMember" xlink:href="clbs-20200630.xsd#clbs_MayPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_MayPurchaseAgreementMember" xlink:to="lab_clbs_MayPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e61542b3-f7ce-4fa5-8caa-302e9c41bb00_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7879dfba-eed4-4c22-becd-784461c20e86_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a7583552-9c62-4622-bcfe-caca118a600d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f7621a99-8ad1-4f27-9910-0259e5077ee8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d905b9cb-ed76-4c6f-9587-36efd554d450_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_d0072b68-14c0-438e-97f4-fed587209a28_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_35671705-d63e-4f8e-b270-e6f38d4d532a_terseLabel_en-US" xlink:label="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum shares allowed in Accelerated Purchase as percent of shares traded during specified period (percent)</link:label>
    <link:label id="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_label_en-US" xlink:label="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period</link:label>
    <link:label id="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_documentation_en-US" xlink:label="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:to="lab_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_351cfc2b-d55d-417f-b6af-d2411754f5d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b5f65011-051d-4e4c-a6a0-85f3f340f0d6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bb5ad2ab-75db-457c-beeb-6dab804a82ad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_676c074b-4ad5-4fd9-b2fc-d9edb52a007c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_2cca162d-d6f3-4e8b-8fa0-7feba4b7cc00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_3c227ffd-a2b8-4e0f-a2b8-b3b5f08f0316_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_851c8233-d25d-4afd-a822-89c27e2e60ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_349aa9bd-61a2-4663-b63b-ef8285057f17_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d7e95a82-fe32-48b4-9614-71db2557f65b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_PreferredStockLiquidationPreferenceShare_cf32e45d-39ce-4004-961d-b797b5a1663a_terseLabel_en-US" xlink:label="lab_clbs_PreferredStockLiquidationPreferenceShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, liquidation value</link:label>
    <link:label id="lab_clbs_PreferredStockLiquidationPreferenceShare_label_en-US" xlink:label="lab_clbs_PreferredStockLiquidationPreferenceShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Share</link:label>
    <link:label id="lab_clbs_PreferredStockLiquidationPreferenceShare_documentation_en-US" xlink:label="lab_clbs_PreferredStockLiquidationPreferenceShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_PreferredStockLiquidationPreferenceShare" xlink:href="clbs-20200630.xsd#clbs_PreferredStockLiquidationPreferenceShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_PreferredStockLiquidationPreferenceShare" xlink:to="lab_clbs_PreferredStockLiquidationPreferenceShare" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_MilestonePaymentOnGrantAwardCashReceived_dc8c1ef4-0689-4979-a4aa-262dde92e3bb_terseLabel_en-US" xlink:label="lab_clbs_MilestonePaymentOnGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payment received on grant award</link:label>
    <link:label id="lab_clbs_MilestonePaymentOnGrantAwardCashReceived_label_en-US" xlink:label="lab_clbs_MilestonePaymentOnGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment On Grant Award, Cash Received</link:label>
    <link:label id="lab_clbs_MilestonePaymentOnGrantAwardCashReceived_documentation_en-US" xlink:label="lab_clbs_MilestonePaymentOnGrantAwardCashReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment On Grant Award, Cash Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MilestonePaymentOnGrantAwardCashReceived" xlink:href="clbs-20200630.xsd#clbs_MilestonePaymentOnGrantAwardCashReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_MilestonePaymentOnGrantAwardCashReceived" xlink:to="lab_clbs_MilestonePaymentOnGrantAwardCashReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_82a25476-6f0c-4ed5-8e7c-d69a4ab1cb89_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_951a541a-1f0f-4aa0-a0af-4003c139b5ec_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_3b510a2f-d71c-42c2-944c-5580792c56d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AprilPurchaseAgreementMember_d5dfdd4d-c2f5-43ef-8683-b29fcd8ca837_terseLabel_en-US" xlink:label="lab_clbs_AprilPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April Purchase Agreement</link:label>
    <link:label id="lab_clbs_AprilPurchaseAgreementMember_label_en-US" xlink:label="lab_clbs_AprilPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April Purchase Agreement [Member]</link:label>
    <link:label id="lab_clbs_AprilPurchaseAgreementMember_documentation_en-US" xlink:label="lab_clbs_AprilPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AprilPurchaseAgreementMember" xlink:href="clbs-20200630.xsd#clbs_AprilPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AprilPurchaseAgreementMember" xlink:to="lab_clbs_AprilPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_b88b6ee6-1b78-483e-ac8d-9cb143fd1cbf_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_3ed7d279-6934-42cf-8714-21c2afed11cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_e55183e3-ec38-41b1-98a3-e0698f959168_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_44618045-a422-40eb-acac-9f5e34cf75d9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_69fb9c7a-a267-4c62-bae7-82d1d0006398_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities - available for sale</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_2ce29944-ef64-4c68-b40d-d533673ab3e7_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_990ed5da-b956-4ec9-a60a-1b32e6fa4de0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f17d7193-9297-47b0-9c04-395b870e143a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_503b81b9-5c50-44ab-96bd-66643296897c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to Caladrius Biosciences, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_86bfe60b-6877-4dbb-95c1-0376e3a9ca20_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_NumberOfOfficesUnderOperatingLeases_a8e0e13b-bcf1-4a24-997b-305b31dcf192_terseLabel_en-US" xlink:label="lab_clbs_NumberOfOfficesUnderOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of offices under operating leases</link:label>
    <link:label id="lab_clbs_NumberOfOfficesUnderOperatingLeases_label_en-US" xlink:label="lab_clbs_NumberOfOfficesUnderOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Offices Under Operating Leases</link:label>
    <link:label id="lab_clbs_NumberOfOfficesUnderOperatingLeases_documentation_en-US" xlink:label="lab_clbs_NumberOfOfficesUnderOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Offices Under Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_NumberOfOfficesUnderOperatingLeases" xlink:href="clbs-20200630.xsd#clbs_NumberOfOfficesUnderOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_NumberOfOfficesUnderOperatingLeases" xlink:to="lab_clbs_NumberOfOfficesUnderOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f01cfb8d-2bea-4ba6-8cfc-c70a6e303ebe_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_228bee70-7afd-4a03-bfb6-8c5bb96fcb9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_feedb42d-0978-47e2-8e74-15222c4120fd_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7694b6e6-cedf-47c1-b428-d6da385553b7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_76467cd9-e382-4254-8bbf-5d4c0c6eac2c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- Controlling Interest in Subsidiary</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_7fa6c4a5-411c-401d-b857-a50cfde73ce0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_db67658a-0eba-4031-928b-3ecf8dc06f13_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_9b8b5e25-6e01-4498-9571-31f2a039586d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_ef52f6aa-4550-4169-8f33-629784b5f493_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_PreferredStockSharesDesignated_e29b83ed-a68d-4085-b408-65f4705d7d6d_terseLabel_en-US" xlink:label="lab_clbs_PreferredStockSharesDesignated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares designated</link:label>
    <link:label id="lab_clbs_PreferredStockSharesDesignated_label_en-US" xlink:label="lab_clbs_PreferredStockSharesDesignated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares designated</link:label>
    <link:label id="lab_clbs_PreferredStockSharesDesignated_documentation_en-US" xlink:label="lab_clbs_PreferredStockSharesDesignated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares designated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_PreferredStockSharesDesignated" xlink:href="clbs-20200630.xsd#clbs_PreferredStockSharesDesignated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_PreferredStockSharesDesignated" xlink:to="lab_clbs_PreferredStockSharesDesignated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9908bab2-4c44-41c8-aa16-9c7f38198038_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_50346418-b517-4a11-a875-eb942f3ec233_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_fbb869c9-8760-4c2c-b378-9d99031a0f20_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_593f80c0-3421-4610-a150-20d1cc37a56a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_63f68e47-6119-4a71-934c-b42b07f78f63_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_11b21a4c-60ab-41b6-ab52-4ab8f4c7fd83_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_914617df-dcef-4d19-94bc-7ec9b885137f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5e0a9952-7d10-438f-8ea3-585e5e4977f8_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d97d3e8-34e2-4a95-a93f-70e86662e72c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7a153a21-ec58-474b-9029-d11eda4f1081_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before benefit from income taxes and noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_6ce4b948-5060-4c1a-a156-891f40ce0671_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c693ad63-a095-47fe-88f7-fc0daf34789a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_bdc59e6f-ee5a-437e-b545-c2ba39ea1fde_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_df84d786-de50-4f68-8535-331a424a2d27_terseLabel_en-US" xlink:label="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet</link:label>
    <link:label id="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_label_en-US" xlink:label="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</link:label>
    <link:label id="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_documentation_en-US" xlink:label="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:href="clbs-20200630.xsd#clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:to="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_dc9f0814-d754-4f7c-b907-e7c44cf25b4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 11,080 shares at June 30, 2020 and December 31, 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_13ff5d91-5dc2-4b12-8bba-231656a17760_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_067c2a7a-8745-47f2-ac77-74eafe9ec528_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax withholding payments on net share settlement equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_e0edd53e-5966-477e-963e-3a51c83f459a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted stock issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_6c9b9dd1-7ca8-4c35-8e8d-0a74edfb3df7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_bf34af04-7cf8-491f-9994-6cfe2b66ba6c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_15c84ad6-dc03-4008-9191-4e0bfdf9e0f1_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd99bc0b-bcca-4d22-81ad-a008351bbe11_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e20dee08-7853-4523-96f7-3b66566fdaae_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_1d5d7c72-8e37-4f70-a428-73f36aa08786_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1aece5e9-5efc-412d-a137-b5df8fba6aa4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and expected to vest, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e319b909-8871-4691-84c3-0a972ca49f07_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fd6362bc-a440-4d9f-9eb6-689e94509e66_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d7bf54d3-a6d6-4dc9-8b63-d2f1fab88cff_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>clbs-20200630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b55a4230-0bd3-4ac9-874e-83b223cb82b0,g:af6da92c-f069-4627-844d-929d63342442-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.caladrius.com/role/CoverPage" xlink:type="simple" xlink:href="clbs-20200630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ed622815-54d5-4d11-9c09-616fe7eb50a8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_DocumentType_ed622815-54d5-4d11-9c09-616fe7eb50a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_b9857220-53bd-49c7-b19d-2ab28b787806" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_DocumentQuarterlyReport_b9857220-53bd-49c7-b19d-2ab28b787806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e80cbd5e-70f0-4128-84c2-42eb9357abcb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_DocumentPeriodEndDate_e80cbd5e-70f0-4128-84c2-42eb9357abcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a24bc5a6-8665-40d7-a5fd-594d01434ab8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_DocumentTransitionReport_a24bc5a6-8665-40d7-a5fd-594d01434ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3d9f1970-1c30-48fd-b8b2-0f56296c5ae8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityFileNumber_3d9f1970-1c30-48fd-b8b2-0f56296c5ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_77f7e2f3-6b71-43fd-8e94-f10c153b5a84" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityRegistrantName_77f7e2f3-6b71-43fd-8e94-f10c153b5a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c084e176-9481-4650-a73b-d790586f1929" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c084e176-9481-4650-a73b-d790586f1929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_149861a0-e816-4106-a77f-811a0b8f3f77" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityTaxIdentificationNumber_149861a0-e816-4106-a77f-811a0b8f3f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ab17e9cd-f8d6-4b54-bf15-b1a778e024f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityAddressAddressLine1_ab17e9cd-f8d6-4b54-bf15-b1a778e024f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fac5e32b-df50-41ff-b11b-3719c0a92dcc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityAddressCityOrTown_fac5e32b-df50-41ff-b11b-3719c0a92dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_28685575-2c3f-45e4-9608-5ab64f1a72da" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityAddressStateOrProvince_28685575-2c3f-45e4-9608-5ab64f1a72da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_79cc909a-6f4c-47b7-ae63-8b34ec44627b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityAddressPostalZipCode_79cc909a-6f4c-47b7-ae63-8b34ec44627b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d52cde6a-b71c-41db-a81a-57169665e15f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_CityAreaCode_d52cde6a-b71c-41db-a81a-57169665e15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1fb7684c-1e6f-4ebb-8cd9-08f2f29dc614" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_LocalPhoneNumber_1fb7684c-1e6f-4ebb-8cd9-08f2f29dc614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_89c3d663-979e-43a3-a7a0-739104677c8b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_Security12bTitle_89c3d663-979e-43a3-a7a0-739104677c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4a7164c3-52f9-48cf-a669-38262d3fbe71" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_TradingSymbol_4a7164c3-52f9-48cf-a669-38262d3fbe71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4a5433b6-e06b-4efe-bada-a242d8f3bf3a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_SecurityExchangeName_4a5433b6-e06b-4efe-bada-a242d8f3bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_160a7c05-f6a0-4167-ae17-bbd6e0d6dc81" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityCurrentReportingStatus_160a7c05-f6a0-4167-ae17-bbd6e0d6dc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9bab1fcd-573d-4819-94c1-4d62be2433b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityInteractiveDataCurrent_9bab1fcd-573d-4819-94c1-4d62be2433b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e84f9fb7-0732-4c3e-a7a2-5b1e7e383fae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityFilerCategory_e84f9fb7-0732-4c3e-a7a2-5b1e7e383fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2b6baac4-c8bd-4803-a503-65fa33649aa0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntitySmallBusiness_2b6baac4-c8bd-4803-a503-65fa33649aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c4c9fb8e-2415-4dd1-9c36-364688b21daf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityEmergingGrowthCompany_c4c9fb8e-2415-4dd1-9c36-364688b21daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b9f3923a-f144-4c9f-a80b-b65cd53a7462" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityShellCompany_b9f3923a-f144-4c9f-a80b-b65cd53a7462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8b1ddb60-043f-405c-b200-e54ddd600d39" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityCentralIndexKey_8b1ddb60-043f-405c-b200-e54ddd600d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d4189814-da5b-47cc-98a3-25e456c67261" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_CurrentFiscalYearEndDate_d4189814-da5b-47cc-98a3-25e456c67261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_c8c065f3-2e49-4ee1-8342-35e8e5a1be82" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_DocumentFiscalYearFocus_c8c065f3-2e49-4ee1-8342-35e8e5a1be82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_96310c7b-b3cc-45d4-9b7d-21554f131782" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_96310c7b-b3cc-45d4-9b7d-21554f131782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_38fac593-58f2-4e2e-ad51-b51565bdf8ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_AmendmentFlag_38fac593-58f2-4e2e-ad51-b51565bdf8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d69c3281-d146-4499-a814-f57f9af88ae6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8845724e-19ac-41f3-a612-3c5a600642e0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d69c3281-d146-4499-a814-f57f9af88ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_84af197a-20b4-49a9-82d6-a9b0f36c19b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_84af197a-20b4-49a9-82d6-a9b0f36c19b3" xlink:to="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2cd07778-5ae6-4edf-8291-dec5709493f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2cd07778-5ae6-4edf-8291-dec5709493f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_50a2a34b-0e85-4c4d-bab8-b1a669f04740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:to="loc_us-gaap_MarketableSecurities_50a2a34b-0e85-4c4d-bab8-b1a669f04740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f00498f5-e7f5-4ee6-8935-2c4dc27cf3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f00498f5-e7f5-4ee6-8935-2c4dc27cf3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_125982a9-4f58-4a0c-854b-3f21919d25b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:to="loc_us-gaap_AssetsCurrent_125982a9-4f58-4a0c-854b-3f21919d25b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c90c8122-4023-4d4d-b629-6b377506164b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c90c8122-4023-4d4d-b629-6b377506164b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_263eddab-4e74-4ae0-9f70-0bdedb0d3b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_263eddab-4e74-4ae0-9f70-0bdedb0d3b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_86e9282a-a9f3-4ec3-9a76-6e3968c6f2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_60a85759-b810-40df-94f4-6cc19da0e1a6" xlink:to="loc_us-gaap_Assets_86e9282a-a9f3-4ec3-9a76-6e3968c6f2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_324f957b-3f13-4714-a6e4-23105e3026fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_84af197a-20b4-49a9-82d6-a9b0f36c19b3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_324f957b-3f13-4714-a6e4-23105e3026fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_6144a00a-e5ca-459e-8d47-7fabf7f71009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_324f957b-3f13-4714-a6e4-23105e3026fb" xlink:to="loc_us-gaap_LiabilitiesAbstract_6144a00a-e5ca-459e-8d47-7fabf7f71009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_07388b2a-6a24-44e3-b8aa-0d6a73b6162b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6144a00a-e5ca-459e-8d47-7fabf7f71009" xlink:to="loc_us-gaap_AccountsPayableCurrent_07388b2a-6a24-44e3-b8aa-0d6a73b6162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3b158b2e-2c8b-4e57-8add-79572bfa268b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6144a00a-e5ca-459e-8d47-7fabf7f71009" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3b158b2e-2c8b-4e57-8add-79572bfa268b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_52b2b5a6-4437-448a-b09e-2fe454056ebd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6144a00a-e5ca-459e-8d47-7fabf7f71009" xlink:to="loc_us-gaap_LiabilitiesCurrent_52b2b5a6-4437-448a-b09e-2fe454056ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_045e3d98-e162-4e6f-8203-9a2fbadcf056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6144a00a-e5ca-459e-8d47-7fabf7f71009" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_045e3d98-e162-4e6f-8203-9a2fbadcf056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_28270786-0918-45e0-a7e3-06f3a1be03e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6144a00a-e5ca-459e-8d47-7fabf7f71009" xlink:to="loc_us-gaap_Liabilities_28270786-0918-45e0-a7e3-06f3a1be03e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3b95a702-b642-49ec-a661-12b7ba1204a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_324f957b-3f13-4714-a6e4-23105e3026fb" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3b95a702-b642-49ec-a661-12b7ba1204a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_324f957b-3f13-4714-a6e4-23105e3026fb" xlink:to="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c80e0483-35a0-468f-8fcf-c1064e2003ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_PreferredStockValue_c80e0483-35a0-468f-8fcf-c1064e2003ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_19ac77fc-ca17-4818-bff0-dee8ab7f3d71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_CommonStockValue_19ac77fc-ca17-4818-bff0-dee8ab7f3d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_fca71e02-1b20-4c3e-9f6d-8841520b0166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_AdditionalPaidInCapital_fca71e02-1b20-4c3e-9f6d-8841520b0166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3f35b4d8-9abc-4289-9f36-3a4950d9d541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_TreasuryStockValue_3f35b4d8-9abc-4289-9f36-3a4950d9d541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aa952407-af15-477f-a13c-6702074ab1a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aa952407-af15-477f-a13c-6702074ab1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a1c2497d-c9d0-47c7-925f-61bf472d8804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a1c2497d-c9d0-47c7-925f-61bf472d8804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4225bb96-dbc1-4573-a607-ab43c5eee864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_StockholdersEquity_4225bb96-dbc1-4573-a607-ab43c5eee864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7144646a-8bec-4824-8e12-7c105d4758f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_MinorityInterest_7144646a-8bec-4824-8e12-7c105d4758f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04f86424-38c0-4225-9d58-15bcab784646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_795697a8-b7ca-4021-9749-8c30d8494477" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04f86424-38c0-4225-9d58-15bcab784646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5e4a473a-1b4a-4322-a5c9-9799f06256c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_324f957b-3f13-4714-a6e4-23105e3026fb" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5e4a473a-1b4a-4322-a5c9-9799f06256c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedBalanceSheetsParentheticals"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_8c13e01f-6444-4039-9487-9b7da0e46fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_8c13e01f-6444-4039-9487-9b7da0e46fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_PreferredStockLiquidationPreferenceShare_221ad029-ec26-43e6-884f-df72ac9bbc2f" xlink:href="clbs-20200630.xsd#clbs_PreferredStockLiquidationPreferenceShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_clbs_PreferredStockLiquidationPreferenceShare_221ad029-ec26-43e6-884f-df72ac9bbc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8759ed40-9c86-4c66-a17c-4e0231a70727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8759ed40-9c86-4c66-a17c-4e0231a70727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_PreferredStockSharesDesignated_93375801-c6f9-4e25-81e4-c52ba5481624" xlink:href="clbs-20200630.xsd#clbs_PreferredStockSharesDesignated"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_clbs_PreferredStockSharesDesignated_93375801-c6f9-4e25-81e4-c52ba5481624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_cb7676b0-b8fd-4417-a2d6-f6d736294e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_PreferredStockSharesIssued_cb7676b0-b8fd-4417-a2d6-f6d736294e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0eb74131-6864-4837-9b2f-34ef86ab1475" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0eb74131-6864-4837-9b2f-34ef86ab1475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_de673304-14df-4f86-8dae-5b095020ac5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_de673304-14df-4f86-8dae-5b095020ac5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e2317338-477a-4236-b694-f230162c0e6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e2317338-477a-4236-b694-f230162c0e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_dfb35aee-9651-4639-a1b4-b73ae8e39e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_CommonStockSharesIssued_dfb35aee-9651-4639-a1b4-b73ae8e39e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a27f55e1-9e13-4382-bc3a-3ca17df7b932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a27f55e1-9e13-4382-bc3a-3ca17df7b932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d0bfb96f-29a1-4d1b-bbed-3d9244b29dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_765cce48-c296-43b0-af5f-fdb51c1b997d" xlink:to="loc_us-gaap_TreasuryStockShares_d0bfb96f-29a1-4d1b-bbed-3d9244b29dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e3d0272b-19e3-4a69-b6e1-2a3d5c92d2a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e3d0272b-19e3-4a69-b6e1-2a3d5c92d2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ed255e01-ab4c-499a-9a5a-26143c5d0a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e3d0272b-19e3-4a69-b6e1-2a3d5c92d2a9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ed255e01-ab4c-499a-9a5a-26143c5d0a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_742421c5-7729-4106-80be-bf330f4897b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e3d0272b-19e3-4a69-b6e1-2a3d5c92d2a9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_742421c5-7729-4106-80be-bf330f4897b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d813526b-5bdd-4819-86b8-885c70d0fdfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e3d0272b-19e3-4a69-b6e1-2a3d5c92d2a9" xlink:to="loc_us-gaap_OperatingExpenses_d813526b-5bdd-4819-86b8-885c70d0fdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bd264441-ad8b-4a25-af81-ef0738e1d17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_OperatingIncomeLoss_bd264441-ad8b-4a25-af81-ef0738e1d17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_975ef45e-4602-4004-bbc5-b1b2f38688ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_975ef45e-4602-4004-bbc5-b1b2f38688ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9c39de2a-c3e7-4fec-9a4c-51efbdde9c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_975ef45e-4602-4004-bbc5-b1b2f38688ab" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9c39de2a-c3e7-4fec-9a4c-51efbdde9c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_12aada65-5ce9-4021-a364-2451b63c6adf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_975ef45e-4602-4004-bbc5-b1b2f38688ab" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_12aada65-5ce9-4021-a364-2451b63c6adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_273cc0a3-1df9-4f91-bdb0-30fb8383c263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_273cc0a3-1df9-4f91-bdb0-30fb8383c263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e66b4cfa-6917-4636-9bd3-a91433fdfe1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e66b4cfa-6917-4636-9bd3-a91433fdfe1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5dc7934a-d657-492d-94d4-16553314ead6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_ProfitLoss_5dc7934a-d657-492d-94d4-16553314ead6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_2e30d1f1-5677-4c56-b688-e47a65a42a95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_2e30d1f1-5677-4c56-b688-e47a65a42a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f45a9128-13fc-462c-8c3e-a208d4d1b3f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_NetIncomeLoss_f45a9128-13fc-462c-8c3e-a208d4d1b3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_41731853-c647-4507-92b1-625a931fba9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_41731853-c647-4507-92b1-625a931fba9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_ebee9482-59cb-45d1-9fb2-8754cb92851d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_41731853-c647-4507-92b1-625a931fba9f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_ebee9482-59cb-45d1-9fb2-8754cb92851d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_edfd3ff1-6b28-426a-85bf-928843d3c9e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ead831c0-3829-4545-9be8-0a91d6ab40ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_edfd3ff1-6b28-426a-85bf-928843d3c9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c46bd157-40b8-4d94-aaa7-1dbe46fa6584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_edfd3ff1-6b28-426a-85bf-928843d3c9e7" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_c46bd157-40b8-4d94-aaa7-1dbe46fa6584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_78b686b0-8225-459e-a931-e47bd44494bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b74912cc-eabd-4278-9f35-b7df0a7140b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_78b686b0-8225-459e-a931-e47bd44494bc" xlink:to="loc_us-gaap_ProfitLoss_b74912cc-eabd-4278-9f35-b7df0a7140b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7c80a933-cf8b-48b1-b2e5-5eb6b7f51431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_78b686b0-8225-459e-a931-e47bd44494bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7c80a933-cf8b-48b1-b2e5-5eb6b7f51431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9faa9d57-fd6f-42b5-bb51-3eac915f54fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_78b686b0-8225-459e-a931-e47bd44494bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9faa9d57-fd6f-42b5-bb51-3eac915f54fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_006cd121-6585-4c7d-abb4-1ca1079a25c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_78b686b0-8225-459e-a931-e47bd44494bc" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_006cd121-6585-4c7d-abb4-1ca1079a25c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_949045e7-68c0-41e5-a9f7-dd686138440b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_78b686b0-8225-459e-a931-e47bd44494bc" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_949045e7-68c0-41e5-a9f7-dd686138440b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9b7a9282-387b-4e7f-9d1e-5094d001dd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_78b686b0-8225-459e-a931-e47bd44494bc" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_9b7a9282-387b-4e7f-9d1e-5094d001dd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_054017c1-fcec-4248-9c1b-5b062bdf85d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_054017c1-fcec-4248-9c1b-5b062bdf85d0" xlink:to="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_eefeff04-e3cb-423a-9fc0-d71a65d86754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_eefeff04-e3cb-423a-9fc0-d71a65d86754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2696a798-9b48-4d67-b8fe-5969ac6a9c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eefeff04-e3cb-423a-9fc0-d71a65d86754" xlink:to="loc_us-gaap_EquityComponentDomain_2696a798-9b48-4d67-b8fe-5969ac6a9c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2696a798-9b48-4d67-b8fe-5969ac6a9c0e" xlink:to="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_b2a243c4-234d-4137-88a9-bb9903e6b141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_PreferredStockMember_b2a243c4-234d-4137-88a9-bb9903e6b141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c9c73234-d042-4192-8b7c-2e1fb7b5346d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_CommonStockMember_c9c73234-d042-4192-8b7c-2e1fb7b5346d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_99058e16-3ad8-4694-bfa7-2c87e3fb9be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_99058e16-3ad8-4694-bfa7-2c87e3fb9be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7bf5451b-4d52-4612-a50f-2ee68450a92a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7bf5451b-4d52-4612-a50f-2ee68450a92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_54bc6e61-c610-4d66-9421-e58b5351b834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_RetainedEarningsMember_54bc6e61-c610-4d66-9421-e58b5351b834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_5718a218-2081-4bd9-8eee-fae34a787ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_4128a906-46bf-42c7-82d3-03e46ef2a7c2" xlink:to="loc_us-gaap_TreasuryStockMember_5718a218-2081-4bd9-8eee-fae34a787ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_7890250d-a5ff-4e78-9f70-e2f3b2ace5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2696a798-9b48-4d67-b8fe-5969ac6a9c0e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_7890250d-a5ff-4e78-9f70-e2f3b2ace5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_81b4ce54-e240-4326-84cd-efb35085a032" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_81b4ce54-e240-4326-84cd-efb35085a032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41476512-e08a-43c7-b050-db17c1a3e0b9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_81b4ce54-e240-4326-84cd-efb35085a032" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41476512-e08a-43c7-b050-db17c1a3e0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1cd6aeea-ed60-44e8-9fc2-c1bb4fec11e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_41476512-e08a-43c7-b050-db17c1a3e0b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1cd6aeea-ed60-44e8-9fc2-c1bb4fec11e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c99c9575-9be0-4001-a3f8-c0e311e0761e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dc090faa-cbfa-409f-8c7f-381a91770be3" xlink:to="loc_us-gaap_StatementLineItems_c99c9575-9be0-4001-a3f8-c0e311e0761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c99c9575-9be0-4001-a3f8-c0e311e0761e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e26cd07c-9dab-4573-be95-7f7cb45c3c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_SharesOutstanding_e26cd07c-9dab-4573-be95-7f7cb45c3c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ca50525-1873-4e59-a62e-22abc89ec8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ca50525-1873-4e59-a62e-22abc89ec8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_356e2897-40e5-415f-a0bb-d2de0b3100b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_ProfitLoss_356e2897-40e5-415f-a0bb-d2de0b3100b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2a4ebcb1-2023-477e-ae41-6296540c1f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2a4ebcb1-2023-477e-ae41-6296540c1f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_caf0ee41-5f4d-45d6-b7c4-763e3cf53908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_caf0ee41-5f4d-45d6-b7c4-763e3cf53908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ca8e2ffd-58af-4849-bd1d-1a68c0db36bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ca8e2ffd-58af-4849-bd1d-1a68c0db36bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_57a0d982-a72a-496d-ba50-c60f5cc08e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_57a0d982-a72a-496d-ba50-c60f5cc08e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7a5d89f5-1baa-43e8-9506-90e2f7067cd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7a5d89f5-1baa-43e8-9506-90e2f7067cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5a92d032-6424-45cf-9d71-25b924a2fa36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_SharesOutstanding_5a92d032-6424-45cf-9d71-25b924a2fa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3fae4ee6-3bb9-4d90-9073-8a9c1f5ba466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e0681f3-7352-491a-a947-a57db93786ea" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3fae4ee6-3bb9-4d90-9073-8a9c1f5ba466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="clbs-20200630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b25848f0-8c64-4e9d-a819-45a7dbdfddf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b25848f0-8c64-4e9d-a819-45a7dbdfddf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f7a5ff3e-6099-49f3-affb-61d22dbff121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b25848f0-8c64-4e9d-a819-45a7dbdfddf8" xlink:to="loc_us-gaap_ProfitLoss_f7a5ff3e-6099-49f3-affb-61d22dbff121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f25eec19-67ca-42a3-8ba1-c1d4f30f9936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b25848f0-8c64-4e9d-a819-45a7dbdfddf8" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f25eec19-67ca-42a3-8ba1-c1d4f30f9936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_bfb3bd49-227a-4f51-89a3-f1c89a027de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f25eec19-67ca-42a3-8ba1-c1d4f30f9936" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_bfb3bd49-227a-4f51-89a3-f1c89a027de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_277538df-62ed-4ffe-a773-2321bf54320d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f25eec19-67ca-42a3-8ba1-c1d4f30f9936" xlink:to="loc_us-gaap_DepreciationAndAmortization_277538df-62ed-4ffe-a773-2321bf54320d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cb90dc57-1ca4-4ac4-8900-761d87887a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f25eec19-67ca-42a3-8ba1-c1d4f30f9936" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cb90dc57-1ca4-4ac4-8900-761d87887a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f2e9b26b-ad22-4f56-b609-059b7bfcb663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b25848f0-8c64-4e9d-a819-45a7dbdfddf8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f2e9b26b-ad22-4f56-b609-059b7bfcb663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7f92bc51-b04f-4d64-a316-d8ce5b2bd5c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f2e9b26b-ad22-4f56-b609-059b7bfcb663" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7f92bc51-b04f-4d64-a316-d8ce5b2bd5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_17e1d295-2dc7-4e1e-8f92-8d00321454d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f2e9b26b-ad22-4f56-b609-059b7bfcb663" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_17e1d295-2dc7-4e1e-8f92-8d00321454d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_c1468357-cf50-4ade-8aba-f69c16311d2d" xlink:href="clbs-20200630.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f2e9b26b-ad22-4f56-b609-059b7bfcb663" xlink:to="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_c1468357-cf50-4ade-8aba-f69c16311d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc7c8881-1cd8-4260-960e-853329265187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc7c8881-1cd8-4260-960e-853329265187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d4ead127-2326-4d8b-ba66-2a5efff9d05c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d4ead127-2326-4d8b-ba66-2a5efff9d05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_548efb75-c9d5-409d-87c3-0d8f8460908c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d4ead127-2326-4d8b-ba66-2a5efff9d05c" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_548efb75-c9d5-409d-87c3-0d8f8460908c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_c68578ae-5097-4983-b501-5b70748c045f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d4ead127-2326-4d8b-ba66-2a5efff9d05c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_c68578ae-5097-4983-b501-5b70748c045f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e436bb96-571f-4414-8ec9-888c0283cf76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d4ead127-2326-4d8b-ba66-2a5efff9d05c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e436bb96-571f-4414-8ec9-888c0283cf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dea01a0b-0880-4c8c-8aa4-ae2a92d6c030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dea01a0b-0880-4c8c-8aa4-ae2a92d6c030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83260b6d-c46b-4ab9-bcfe-ce8a82f024b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83260b6d-c46b-4ab9-bcfe-ce8a82f024b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_323f2185-eafd-46e3-8dba-0a556af68273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83260b6d-c46b-4ab9-bcfe-ce8a82f024b5" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_323f2185-eafd-46e3-8dba-0a556af68273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_89d13e4d-ec08-419b-b82f-992fe11091f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_83260b6d-c46b-4ab9-bcfe-ce8a82f024b5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_89d13e4d-ec08-419b-b82f-992fe11091f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69b9af4d-5b73-44f2-ba49-d59fcd73a8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69b9af4d-5b73-44f2-ba49-d59fcd73a8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_afe22f1e-2806-473d-ac7d-ebeb1c9154a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_afe22f1e-2806-473d-ac7d-ebeb1c9154a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87ad3ede-246f-4ad4-8748-1f406a2e822f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87ad3ede-246f-4ad4-8748-1f406a2e822f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2b595910-c61a-4f43-a874-9c4ed1952e07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_541bdecf-871f-4229-8dd7-530d505ca426" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2b595910-c61a-4f43-a874-9c4ed1952e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusiness" xlink:type="simple" xlink:href="clbs-20200630.xsd#TheBusiness"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/TheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c705ed62-a933-451d-9b18-fa569db9fa15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_BusinessTextBlock_a470bff8-48cc-4a9d-b72d-67b85a8de215" xlink:href="clbs-20200630.xsd#clbs_BusinessTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c705ed62-a933-451d-9b18-fa569db9fa15" xlink:to="loc_clbs_BusinessTextBlock_a470bff8-48cc-4a9d-b72d-67b85a8de215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusinessNarrativeDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#TheBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/TheBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4842e458-80c4-4f02-baf0-0ecf0c6bb67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_91b44fb1-9c43-4187-a032-b449de11aad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4842e458-80c4-4f02-baf0-0ecf0c6bb67a" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_91b44fb1-9c43-4187-a032-b449de11aad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_91b44fb1-9c43-4187-a032-b449de11aad6" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_9f8fc7c4-9ba7-4fde-ba86-ec329637ce5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_bb2a3eb5-82c2-41cd-8eea-6bd7b5d5204b" xlink:to="loc_us-gaap_ProjectMember_9f8fc7c4-9ba7-4fde-ba86-ec329637ce5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IschemicRepairCD34CellTechnologyMember_9f703958-a83a-48b0-8c3a-7b70be16e379" xlink:href="clbs-20200630.xsd#clbs_IschemicRepairCD34CellTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_9f8fc7c4-9ba7-4fde-ba86-ec329637ce5d" xlink:to="loc_clbs_IschemicRepairCD34CellTechnologyMember_9f703958-a83a-48b0-8c3a-7b70be16e379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_3a211426-5f71-45d4-af68-783573bac0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_91b44fb1-9c43-4187-a032-b449de11aad6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_3a211426-5f71-45d4-af68-783573bac0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantsReceivable_fc158be5-ccf1-484b-b733-92635d2541ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_3a211426-5f71-45d4-af68-783573bac0b2" xlink:to="loc_us-gaap_GrantsReceivable_fc158be5-ccf1-484b-b733-92635d2541ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="clbs-20200630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c9ba3063-c279-43c6-bd4b-16ec9ab1b873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_2280f8d1-9c6e-4a9b-b8fb-a3c37d40fb31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c9ba3063-c279-43c6-bd4b-16ec9ab1b873" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_2280f8d1-9c6e-4a9b-b8fb-a3c37d40fb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="clbs-20200630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0007e589-20be-40a7-818d-c994965e3e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_362d7796-72f1-414a-a987-d8144cc02136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0007e589-20be-40a7-818d-c994965e3e75" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_362d7796-72f1-414a-a987-d8144cc02136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7f99cfc5-f13c-4416-b64e-0f6f02ce9dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0007e589-20be-40a7-818d-c994965e3e75" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7f99cfc5-f13c-4416-b64e-0f6f02ce9dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ea9a2b41-ce60-4970-874e-0a0bd52164b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0007e589-20be-40a7-818d-c994965e3e75" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ea9a2b41-ce60-4970-874e-0a0bd52164b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecurities" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecurities"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2c70acaf-af26-4bcf-ae52-0e3896e78f5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_f3a734ef-da79-4f09-b10b-276c8402f6b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2c70acaf-af26-4bcf-ae52-0e3896e78f5a" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_f3a734ef-da79-4f09-b10b-276c8402f6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_6623ca3e-33a0-44b2-a93c-7f4a43b02aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_ad4c9418-83aa-491e-97a0-9a69c13950b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_6623ca3e-33a0-44b2-a93c-7f4a43b02aa5" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_ad4c9418-83aa-491e-97a0-9a69c13950b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_c8e56d83-53db-412c-90db-d499c72278d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_6623ca3e-33a0-44b2-a93c-7f4a43b02aa5" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_c8e56d83-53db-412c-90db-d499c72278d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_55b9a45b-c183-46bf-a814-d0cf1129a633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_6623ca3e-33a0-44b2-a93c-7f4a43b02aa5" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_55b9a45b-c183-46bf-a814-d0cf1129a633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_854f2951-a9b4-4848-98f2-e07e813575b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_23df8472-f40f-4d4a-8524-3cadc66d392f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_854f2951-a9b4-4848-98f2-e07e813575b1" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_23df8472-f40f-4d4a-8524-3cadc66d392f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_265c1ec5-23da-4cf5-a4d9-201006ab6618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_23df8472-f40f-4d4a-8524-3cadc66d392f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_265c1ec5-23da-4cf5-a4d9-201006ab6618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_265c1ec5-23da-4cf5-a4d9-201006ab6618" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8209397e-1fcc-4f31-a441-dd28c07c49c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8209397e-1fcc-4f31-a441-dd28c07c49c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_240afd0f-c7a2-4464-a56e-d04a7916fd1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_240afd0f-c7a2-4464-a56e-d04a7916fd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_de07797e-3316-405b-8234-ff081a328dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_de07797e-3316-405b-8234-ff081a328dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtMember_449037cf-5973-43af-b91f-93d1ab6ce043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SovereignDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1f685b7b-f487-41fa-9f3e-ad151128591f" xlink:to="loc_us-gaap_SovereignDebtMember_449037cf-5973-43af-b91f-93d1ab6ce043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_23df8472-f40f-4d4a-8524-3cadc66d392f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_90e76bb0-3d91-4e85-9c89-addc4fa341ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_90e76bb0-3d91-4e85-9c89-addc4fa341ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9416399e-cd2f-438b-a914-6ec42d02e9d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9416399e-cd2f-438b-a914-6ec42d02e9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d7282e71-747e-4984-a356-c50dc889277f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d7282e71-747e-4984-a356-c50dc889277f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a425f2f6-c9af-4448-8ffb-7831801055ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5554f441-4c16-4b89-9d65-f8447b6cac76" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a425f2f6-c9af-4448-8ffb-7831801055ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_cf42cafa-3ac8-48df-88ea-a86186f7cf86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_4ba3627b-d5c5-4e3c-880a-98295d970cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_cf42cafa-3ac8-48df-88ea-a86186f7cf86" xlink:to="loc_us-gaap_Cash_4ba3627b-d5c5-4e3c-880a-98295d970cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_f92bd248-fcb3-4817-a8d7-f27f13c6d947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_cf42cafa-3ac8-48df-88ea-a86186f7cf86" xlink:to="loc_us-gaap_MarketableSecurities_f92bd248-fcb3-4817-a8d7-f27f13c6d947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_bb79bfca-af5d-4b95-89db-524185636724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_cf42cafa-3ac8-48df-88ea-a86186f7cf86" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_bb79bfca-af5d-4b95-89db-524185636724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_54d6b0d2-5f6f-456c-98d1-369536bf7e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_0278b77f-00d4-4382-a3aa-af6e6843d243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_54d6b0d2-5f6f-456c-98d1-369536bf7e81" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_0278b77f-00d4-4382-a3aa-af6e6843d243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_096d8e3d-8866-4ec0-b722-74cde576d6eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_0278b77f-00d4-4382-a3aa-af6e6843d243" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_096d8e3d-8866-4ec0-b722-74cde576d6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_e991b86c-d1de-4695-bf5b-95498bc86b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_0278b77f-00d4-4382-a3aa-af6e6843d243" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_e991b86c-d1de-4695-bf5b-95498bc86b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_00930f2a-e450-46c2-acc0-c7aa9b89cb02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_0278b77f-00d4-4382-a3aa-af6e6843d243" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_00930f2a-e450-46c2-acc0-c7aa9b89cb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_abf81dbf-ed98-4408-8399-53236cf64c2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_54d6b0d2-5f6f-456c-98d1-369536bf7e81" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_abf81dbf-ed98-4408-8399-53236cf64c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_a11146d3-3b9d-4137-8785-846e338a584f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_abf81dbf-ed98-4408-8399-53236cf64c2b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_a11146d3-3b9d-4137-8785-846e338a584f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_5884ffb9-b3b9-4d5b-8dc3-467e55cbd465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_abf81dbf-ed98-4408-8399-53236cf64c2b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_5884ffb9-b3b9-4d5b-8dc3-467e55cbd465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_92cc4646-0169-4975-b42f-f4bfccf972e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_abf81dbf-ed98-4408-8399-53236cf64c2b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_92cc4646-0169-4975-b42f-f4bfccf972e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShare" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_baf30867-bd87-4b08-9779-0f631a4625a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_93ddae48-ec75-4306-9d00-839a8f2a7835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_baf30867-bd87-4b08-9779-0f631a4625a0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_93ddae48-ec75-4306-9d00-839a8f2a7835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_47b8cefa-6ec6-4f9f-9802-50cfd9207150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ed0f851c-87a1-4657-8d66-0e9e6c5ff6bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_47b8cefa-6ec6-4f9f-9802-50cfd9207150" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ed0f851c-87a1-4657-8d66-0e9e6c5ff6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f0cf8f96-4607-48ca-8310-6377e2c5b1d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d63f586c-a02c-4d3a-bc59-1d860a1dd038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f0cf8f96-4607-48ca-8310-6377e2c5b1d2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d63f586c-a02c-4d3a-bc59-1d860a1dd038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4f626b26-e7a6-41d2-b54b-b1df6cee96c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d63f586c-a02c-4d3a-bc59-1d860a1dd038" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4f626b26-e7a6-41d2-b54b-b1df6cee96c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4f626b26-e7a6-41d2-b54b-b1df6cee96c7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_834ec3d8-7c10-4b58-873d-59843eb82da6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_834ec3d8-7c10-4b58-873d-59843eb82da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_fd9037fa-c9fc-42aa-a886-0f6aedcd48c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:to="loc_us-gaap_WarrantMember_fd9037fa-c9fc-42aa-a886-0f6aedcd48c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_049f3fcb-0678-4bba-adf0-39165ee17c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3fa2da24-26a7-495c-8b03-8f90d4d174a8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_049f3fcb-0678-4bba-adf0-39165ee17c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be67fdbb-42cb-4173-bd45-ea3541e17b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d63f586c-a02c-4d3a-bc59-1d860a1dd038" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be67fdbb-42cb-4173-bd45-ea3541e17b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f93374ac-7b6b-4b02-93a4-0331650ecb0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_be67fdbb-42cb-4173-bd45-ea3541e17b87" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f93374ac-7b6b-4b02-93a4-0331650ecb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6ff06b6d-97f2-4827-91c3-09fbc565e2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_0ead302e-dce3-4838-9a3f-77406a1ffcc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6ff06b6d-97f2-4827-91c3-09fbc565e2a4" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_0ead302e-dce3-4838-9a3f-77406a1ffcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5eb88e2e-6655-43ac-96ac-5f8c443d5236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_dd734375-a74c-45e5-b861-6f74b673065e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5eb88e2e-6655-43ac-96ac-5f8c443d5236" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_dd734375-a74c-45e5-b861-6f74b673065e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0ead9391-5010-4b8d-a9f3-c7f926f34fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0ead9391-5010-4b8d-a9f3-c7f926f34fe8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9057c5cf-4926-4a05-a81c-00839f644de3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9057c5cf-4926-4a05-a81c-00839f644de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9057c5cf-4926-4a05-a81c-00839f644de3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6361e667-7161-4d10-9469-7103d0e9b85f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6361e667-7161-4d10-9469-7103d0e9b85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3103af5a-9d51-49e1-85a3-40e05ad652c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3103af5a-9d51-49e1-85a3-40e05ad652c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_37f61090-0447-4c2c-9c80-ddaa105cf61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_880a9181-a1d5-4d13-8bba-c46dcde0d679" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_37f61090-0447-4c2c-9c80-ddaa105cf61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f779189-2db2-4dce-82d5-386c9b860e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1a7e139e-e4fc-4f30-b13a-9154dbb4f26a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f779189-2db2-4dce-82d5-386c9b860e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4ed5033f-f3bd-48a3-8273-4656fac47d31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3f779189-2db2-4dce-82d5-386c9b860e93" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4ed5033f-f3bd-48a3-8273-4656fac47d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_186c7341-daa5-439c-b297-8ff3a75bee60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_086d6131-6d43-453a-9406-3f31f364837d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_186c7341-daa5-439c-b297-8ff3a75bee60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_7b9102f2-de46-4cc2-bdfa-4a3c1f0d5f8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_186c7341-daa5-439c-b297-8ff3a75bee60" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_7b9102f2-de46-4cc2-bdfa-4a3c1f0d5f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d8758fac-44ff-41c1-b242-77aa501051ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_186c7341-daa5-439c-b297-8ff3a75bee60" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d8758fac-44ff-41c1-b242-77aa501051ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_35d1f12f-c083-43f9-8d12-5d7b04670849" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_922c299c-628e-4bc6-907f-8ccaba2e756d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_35d1f12f-c083-43f9-8d12-5d7b04670849" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_922c299c-628e-4bc6-907f-8ccaba2e756d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d8efc006-bf2f-4a24-8e7b-15b43774c224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_e7be61ac-da9b-4f89-8067-1decaeea80d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d8efc006-bf2f-4a24-8e7b-15b43774c224" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_e7be61ac-da9b-4f89-8067-1decaeea80d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_cfc9f46b-9783-4cae-95eb-a29ab77375b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b6140e8f-4916-4995-ba7c-7cb29c7f8738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_cfc9f46b-9783-4cae-95eb-a29ab77375b8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b6140e8f-4916-4995-ba7c-7cb29c7f8738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_36e4bdaf-efc5-41f5-9168-70944e6fcdae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_cfc9f46b-9783-4cae-95eb-a29ab77375b8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_36e4bdaf-efc5-41f5-9168-70944e6fcdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AccruedGrantFunding_cb1032cb-d54f-45e3-8877-abe4fb940661" xlink:href="clbs-20200630.xsd#clbs_AccruedGrantFunding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_cfc9f46b-9783-4cae-95eb-a29ab77375b8" xlink:to="loc_clbs_AccruedGrantFunding_cb1032cb-d54f-45e3-8877-abe4fb940661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7d62d459-4a94-4ac9-8b64-6b37db42dcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_cfc9f46b-9783-4cae-95eb-a29ab77375b8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7d62d459-4a94-4ac9-8b64-6b37db42dcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_43af2da4-a94f-406f-b945-56934ea35dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_cfc9f46b-9783-4cae-95eb-a29ab77375b8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_43af2da4-a94f-406f-b945-56934ea35dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeases" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bd980f87-fa93-4395-9454-97a774a0b244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_21743682-3afd-46a8-b7e6-5ef13f8ce020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bd980f87-fa93-4395-9454-97a774a0b244" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_21743682-3afd-46a8-b7e6-5ef13f8ce020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_854c1919-8875-4ca8-8851-e623955d1aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_243d3054-0878-4649-85b7-9b6242379d4d" xlink:href="clbs-20200630.xsd#clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_854c1919-8875-4ca8-8851-e623955d1aa4" xlink:to="loc_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_243d3054-0878-4649-85b7-9b6242379d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_49f5fdf5-5b12-4f93-83e9-20a12f59228d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_854c1919-8875-4ca8-8851-e623955d1aa4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_49f5fdf5-5b12-4f93-83e9-20a12f59228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_79e49bdf-3c10-4002-b787-9c13a92679e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_NumberOfOfficesUnderOperatingLeases_8a7fc7d6-eec4-4ffb-a963-b1d948fd6304" xlink:href="clbs-20200630.xsd#clbs_NumberOfOfficesUnderOperatingLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79e49bdf-3c10-4002-b787-9c13a92679e6" xlink:to="loc_clbs_NumberOfOfficesUnderOperatingLeases_8a7fc7d6-eec4-4ffb-a963-b1d948fd6304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_88ccb1ff-d6d3-4ea0-9e0b-1a37983c5b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79e49bdf-3c10-4002-b787-9c13a92679e6" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_88ccb1ff-d6d3-4ea0-9e0b-1a37983c5b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e439cca6-b5bc-46e9-adf8-94e4a99c497a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79e49bdf-3c10-4002-b787-9c13a92679e6" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e439cca6-b5bc-46e9-adf8-94e4a99c497a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesBalanceSheetPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e5cd2a23-453a-4b7b-a3f2-dfa8a7681537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_50fe2d76-81ad-4440-a3cc-84d29ed8f5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e5cd2a23-453a-4b7b-a3f2-dfa8a7681537" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_50fe2d76-81ad-4440-a3cc-84d29ed8f5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9c98445e-7d46-42da-a4f4-ca89d2238385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_50fe2d76-81ad-4440-a3cc-84d29ed8f5b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9c98445e-7d46-42da-a4f4-ca89d2238385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9c98445e-7d46-42da-a4f4-ca89d2238385" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_c7bc1f3d-8309-44a8-b047-d45ead15e32c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:to="loc_us-gaap_OtherAssetsMember_c7bc1f3d-8309-44a8-b047-d45ead15e32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_8854b81b-2d9d-4627-aa9c-c71249d37418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_8854b81b-2d9d-4627-aa9c-c71249d37418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ded4f9fa-f0cd-489b-a7f2-0db01f17b192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ef2929d-19ae-41cd-9cae-f34c6fc51fa9" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_ded4f9fa-f0cd-489b-a7f2-0db01f17b192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_41a876a9-7585-4e49-a940-0cc7cf113745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_50fe2d76-81ad-4440-a3cc-84d29ed8f5b6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_41a876a9-7585-4e49-a940-0cc7cf113745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_41a876a9-7585-4e49-a940-0cc7cf113745" xlink:to="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5ea727bd-9feb-42a4-bbe7-f0853f6b2a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5ea727bd-9feb-42a4-bbe7-f0853f6b2a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3a07cdb3-07cc-4972-b02c-9d19728974b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3a07cdb3-07cc-4972-b02c-9d19728974b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bf58fdd7-bc1b-49cf-bca0-3ae448120de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bf58fdd7-bc1b-49cf-bca0-3ae448120de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8277c18e-31fe-4822-a35f-19a0b9d3e7fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_19099cfe-fe45-470d-b49a-624d8fb97591" xlink:to="loc_us-gaap_OperatingLeaseLiability_8277c18e-31fe-4822-a35f-19a0b9d3e7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0401c9a6-0f4c-418d-90bf-ad0d1228dbb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0401c9a6-0f4c-418d-90bf-ad0d1228dbb8" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2bf3ebfc-0ccf-4477-804d-2663b3ae7123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2bf3ebfc-0ccf-4477-804d-2663b3ae7123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5a5b77c5-b338-4664-a0f0-b27c9a2e2b41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5a5b77c5-b338-4664-a0f0-b27c9a2e2b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4750b5a3-93a5-406b-a972-59e39016ca77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4750b5a3-93a5-406b-a972-59e39016ca77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7fe307ad-7f51-4116-803a-cc7a97bc5b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7fe307ad-7f51-4116-803a-cc7a97bc5b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_123286a0-dc04-4863-8c62-472dce8f14ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_123286a0-dc04-4863-8c62-472dce8f14ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f4a6432e-07c7-45aa-9a1a-3dd676684b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f4a6432e-07c7-45aa-9a1a-3dd676684b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_90335088-2246-4796-ab0b-b4112c5e66f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0e0ad843-baaa-4e3a-be59-aab8cc92401f" xlink:to="loc_us-gaap_OperatingLeaseLiability_90335088-2246-4796-ab0b-b4112c5e66f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="clbs-20200630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquity" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e6640e81-ee23-4a02-8bfe-25ad272d4acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_54fe5b8f-5933-470b-9bd3-0bba91d50c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e6640e81-ee23-4a02-8bfe-25ad272d4acc" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_54fe5b8f-5933-470b-9bd3-0bba91d50c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4d794aa4-33d8-4390-9707-93fc033c76b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_33cb68c1-9f7b-46cd-a955-aea37f7ea187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4d794aa4-33d8-4390-9707-93fc033c76b3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_33cb68c1-9f7b-46cd-a955-aea37f7ea187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_a2f2a185-aff4-41b2-a7f2-cedcd911784e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4d794aa4-33d8-4390-9707-93fc033c76b3" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_a2f2a185-aff4-41b2-a7f2-cedcd911784e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_023177b8-64e9-4a82-b57a-338a396c5e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4d794aa4-33d8-4390-9707-93fc033c76b3" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_023177b8-64e9-4a82-b57a-338a396c5e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityEquityIssuancesDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6d1d8b36-b6a9-49aa-bf57-b16e9a5d906f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b46db483-e14a-4567-a7f2-8d3a054dc6f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6d1d8b36-b6a9-49aa-bf57-b16e9a5d906f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b46db483-e14a-4567-a7f2-8d3a054dc6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_20936397-37a0-4656-acf2-b78e5c6cae92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b46db483-e14a-4567-a7f2-8d3a054dc6f1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_20936397-37a0-4656-acf2-b78e5c6cae92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_20936397-37a0-4656-acf2-b78e5c6cae92" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LincolnParkAgreementMember_9d7de11a-83a6-4dd2-b870-dd5d820d16e1" xlink:href="clbs-20200630.xsd#clbs_LincolnParkAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:to="loc_clbs_LincolnParkAgreementMember_9d7de11a-83a6-4dd2-b870-dd5d820d16e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember_78f03784-e381-4c9d-880f-1b4ebbff65d3" xlink:href="clbs-20200630.xsd#clbs_H.C.WainwrightSalesAmendedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:to="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember_78f03784-e381-4c9d-880f-1b4ebbff65d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AprilPurchaseAgreementMember_70a98327-c08c-4dc3-8ba4-3da85999a0b9" xlink:href="clbs-20200630.xsd#clbs_AprilPurchaseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:to="loc_clbs_AprilPurchaseAgreementMember_70a98327-c08c-4dc3-8ba4-3da85999a0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MayPurchaseAgreementMember_d761e583-a45f-4485-a3a3-e25bf9864db5" xlink:href="clbs-20200630.xsd#clbs_MayPurchaseAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3d54ce12-af4a-44d5-b20b-694b036bb1b6" xlink:to="loc_clbs_MayPurchaseAgreementMember_d761e583-a45f-4485-a3a3-e25bf9864db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b46db483-e14a-4567-a7f2-8d3a054dc6f1" xlink:to="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_408411fa-59fa-4a01-8a56-fd36589a4bd3" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_408411fa-59fa-4a01-8a56-fd36589a4bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_264d399b-f0a1-44aa-97d8-9ce2e5ed5b97" xlink:href="clbs-20200630.xsd#clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_264d399b-f0a1-44aa-97d8-9ce2e5ed5b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f512c54d-8e9b-4a72-800b-02edc9f6c615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f512c54d-8e9b-4a72-800b-02edc9f6c615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_751d2fb4-dcce-4361-b2c6-6461f95d7e92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_751d2fb4-dcce-4361-b2c6-6461f95d7e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a186b6e2-9e83-4adf-bde6-a9fe71630bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_a186b6e2-9e83-4adf-bde6-a9fe71630bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_TermOfAgreement_27295271-c683-43ba-8a51-0642ab1f6303" xlink:href="clbs-20200630.xsd#clbs_TermOfAgreement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_TermOfAgreement_27295271-c683-43ba-8a51-0642ab1f6303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_1c4fb11c-5c23-4dc3-88d8-81d05dce8468" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_1c4fb11c-5c23-4dc3-88d8-81d05dce8468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_0a212a2f-f516-4a86-b300-e02042b81005" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_0a212a2f-f516-4a86-b300-e02042b81005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_a271bfc7-0672-41df-a2a1-b38f439ef76b" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_a271bfc7-0672-41df-a2a1-b38f439ef76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_b9e80c31-fbf8-44d8-ac88-ebcef68595b1" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_b9e80c31-fbf8-44d8-ac88-ebcef68595b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_cf43602d-f92f-4a55-82d3-c1acec2021c0" xlink:href="clbs-20200630.xsd#clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_cf43602d-f92f-4a55-82d3-c1acec2021c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_42f87e0c-0c2b-4efa-b8f1-47b0dae7a202" xlink:href="clbs-20200630.xsd#clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_42f87e0c-0c2b-4efa-b8f1-47b0dae7a202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateMarketValueOfCommonStockNonAffiliates_7d426d95-35c1-4076-8855-7899ac0f8edd" xlink:href="clbs-20200630.xsd#clbs_AggregateMarketValueOfCommonStockNonAffiliates"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_clbs_AggregateMarketValueOfCommonStockNonAffiliates_7d426d95-35c1-4076-8855-7899ac0f8edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2814f01a-20c1-40dc-aee7-89d933f31711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2814f01a-20c1-40dc-aee7-89d933f31711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_74e36537-4443-47b0-8f7c-2291333920cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_74e36537-4443-47b0-8f7c-2291333920cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5aa345a3-2e13-4576-8c52-4f761795e7cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_5aa345a3-2e13-4576-8c52-4f761795e7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cdf6e25c-ab04-46b2-a8f4-4a669dc405f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cdf6e25c-ab04-46b2-a8f4-4a669dc405f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_7b15cc39-6e92-4098-9975-eeb72111ff33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_532fc63a-abe6-4796-87f6-93e549c1accc" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_7b15cc39-6e92-4098-9975-eeb72111ff33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityStockOptionsandWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_510573df-c9da-4ec3-8215-8d7b18946709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_a36c7e95-74a8-4963-b293-2814eb6b29fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_510573df-c9da-4ec3-8215-8d7b18946709" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_a36c7e95-74a8-4963-b293-2814eb6b29fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockOptionsActivityAxis_080de5eb-d00b-4816-bc1b-76af829473ac" xlink:href="clbs-20200630.xsd#clbs_StockOptionsActivityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_a36c7e95-74a8-4963-b293-2814eb6b29fa" xlink:to="loc_clbs_StockOptionsActivityAxis_080de5eb-d00b-4816-bc1b-76af829473ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_StockOptionsActivityDomain_84418414-9304-4c29-9f54-66b9a59938f6" xlink:href="clbs-20200630.xsd#clbs_StockOptionsActivityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_StockOptionsActivityAxis_080de5eb-d00b-4816-bc1b-76af829473ac" xlink:to="loc_clbs_StockOptionsActivityDomain_84418414-9304-4c29-9f54-66b9a59938f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_UsEquityPlanMember_15f44bbc-abe1-4884-8138-827d3c2bcade" xlink:href="clbs-20200630.xsd#clbs_UsEquityPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_StockOptionsActivityDomain_84418414-9304-4c29-9f54-66b9a59938f6" xlink:to="loc_clbs_UsEquityPlanMember_15f44bbc-abe1-4884-8138-827d3c2bcade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_95e12222-42ff-4102-b78a-922154e54018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_a36c7e95-74a8-4963-b293-2814eb6b29fa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_95e12222-42ff-4102-b78a-922154e54018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_95e12222-42ff-4102-b78a-922154e54018" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e5f3d0bd-d049-4e3a-95b5-338621057547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e5f3d0bd-d049-4e3a-95b5-338621057547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_08629510-d21e-4751-aebf-6a70566d31a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_08629510-d21e-4751-aebf-6a70566d31a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cac30cf5-ed84-471c-885c-99867166007a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cac30cf5-ed84-471c-885c-99867166007a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d2eb31b7-7bfa-4c08-a989-6acd6fb5ddd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d2eb31b7-7bfa-4c08-a989-6acd6fb5ddd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_92b5fe06-50f8-4f4c-b9b9-45510fd5b065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_92b5fe06-50f8-4f4c-b9b9-45510fd5b065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_671b1a09-a4d3-489a-b152-2515f3217617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9884d2-f1e4-4005-a339-dffe0e97a6a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_671b1a09-a4d3-489a-b152-2515f3217617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_77dec3fc-8269-4400-bc06-3b074abddafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_77dec3fc-8269-4400-bc06-3b074abddafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bf7910ec-8ff5-4221-ac65-fd1a57d6fa43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bf7910ec-8ff5-4221-ac65-fd1a57d6fa43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_eb24e272-6f75-4ea1-ac42-16caa5082d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_eb24e272-6f75-4ea1-ac42-16caa5082d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_dcc6534f-7e0e-4773-8bfe-5ff2f039ed4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_dcc6534f-7e0e-4773-8bfe-5ff2f039ed4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3cc1630e-dcb3-4613-a3c6-5423259cd273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3cc1630e-dcb3-4613-a3c6-5423259cd273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_66a0c445-ed09-4d08-8958-0c944b35f435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9fe2404b-5f4b-440a-8d53-d97c89d5fd01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_66a0c445-ed09-4d08-8958-0c944b35f435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f60d75a1-eb92-4568-bf9c-50a91de8eb8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f60d75a1-eb92-4568-bf9c-50a91de8eb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90d159ca-a15a-4064-993b-920012414966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90d159ca-a15a-4064-993b-920012414966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e6761698-5683-45f1-bd8a-9a00b37ef518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e6761698-5683-45f1-bd8a-9a00b37ef518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_f155de1c-f860-4b0b-8d48-5025cb543867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_f155de1c-f860-4b0b-8d48-5025cb543867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_fe653e92-a2e1-4c0d-bf5d-8d2ef15c5293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_fe653e92-a2e1-4c0d-bf5d-8d2ef15c5293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_afce10e6-7356-4d66-9cd9-dbbaeb7ca880" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_afce10e6-7356-4d66-9cd9-dbbaeb7ca880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_f76e14e5-2525-4c54-9856-29f00c1a3a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_f76e14e5-2525-4c54-9856-29f00c1a3a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_38975891-887f-4295-bdac-d8d565bf9cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_38975891-887f-4295-bdac-d8d565bf9cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm_816913b3-a047-4eb7-8d3f-d9c8242c3853" xlink:href="clbs-20200630.xsd#clbs_OptionsVestedweightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm_816913b3-a047-4eb7-8d3f-d9c8242c3853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_e7601c2e-2a65-4939-8b93-3ec2e4b10aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_a6c65479-3d2e-49cf-aa57-d6e4c9d1e2cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_e7601c2e-2a65-4939-8b93-3ec2e4b10aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_95e12222-42ff-4102-b78a-922154e54018" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CommonStockWarrantsShares_fcd95550-b77a-4972-a726-4f7eeb0b9d6c" xlink:href="clbs-20200630.xsd#clbs_CommonStockWarrantsShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_CommonStockWarrantsShares_fcd95550-b77a-4972-a726-4f7eeb0b9d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsGranted_a2a63ff8-e38f-4778-9e1d-46f94aa95490" xlink:href="clbs-20200630.xsd#clbs_WarrantsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_WarrantsGranted_a2a63ff8-e38f-4778-9e1d-46f94aa95490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExercised_c2f77cc7-c469-48f6-88ae-d3a1eca65a4e" xlink:href="clbs-20200630.xsd#clbs_WarrantsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_WarrantsExercised_c2f77cc7-c469-48f6-88ae-d3a1eca65a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsCanceled_60fd3fbf-39cf-40e1-a899-4a64fcb27585" xlink:href="clbs-20200630.xsd#clbs_WarrantsCanceled"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_WarrantsCanceled_60fd3fbf-39cf-40e1-a899-4a64fcb27585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExpired_ced21459-d883-4b29-8dc3-5093f13895a2" xlink:href="clbs-20200630.xsd#clbs_WarrantsExpired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_WarrantsExpired_ced21459-d883-4b29-8dc3-5093f13895a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CommonStockWarrantsShares_1fc1ae27-8400-4b9b-b2b2-5d3459c2568c" xlink:href="clbs-20200630.xsd#clbs_CommonStockWarrantsShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b16dc270-7a7d-450a-b07b-5e61fd81665b" xlink:to="loc_clbs_CommonStockWarrantsShares_1fc1ae27-8400-4b9b-b2b2-5d3459c2568c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:href="clbs-20200630.xsd#clbs_WarrantsWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsGranted_a1f84274-57d8-43d8-a59a-9de70d25176b" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsGranted_a1f84274-57d8-43d8-a59a-9de70d25176b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercised_c8ec822b-a3c7-4e4f-a24f-6f3d6545deca" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExercised_c8ec822b-a3c7-4e4f-a24f-6f3d6545deca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled_e038e880-e1a3-4351-96ad-e8cc3dfbfd61" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsCanceled"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled_e038e880-e1a3-4351-96ad-e8cc3dfbfd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExpired_9c39490b-2d94-47db-b8af-768b795ec751" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExpired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExpired_9c39490b-2d94-47db-b8af-768b795ec751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding_e782067a-c914-4293-ba1b-6650daef95ef" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_84c6a231-6952-4c43-b074-4a5c3d74d7a3" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding_e782067a-c914-4293-ba1b-6650daef95ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_710a1ec8-0748-44bd-94c0-5ff37d167767" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantoutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_710a1ec8-0748-44bd-94c0-5ff37d167767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding_1743fd57-4b6f-4564-b8ac-21d57ed5b99a" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding_1743fd57-4b6f-4564-b8ac-21d57ed5b99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_Sharesvestedandexpectedtovest_6953483f-ef25-496b-9b8b-3a8d6998df32" xlink:href="clbs-20200630.xsd#clbs_Sharesvestedandexpectedtovest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_Sharesvestedandexpectedtovest_6953483f-ef25-496b-9b8b-3a8d6998df32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_f33efcdc-c0d7-4f60-8faf-5de051f66cbe" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_f33efcdc-c0d7-4f60-8faf-5de051f66cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_dfb6ae74-9d1a-421d-b68d-eac2355a7555" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_dfb6ae74-9d1a-421d-b68d-eac2355a7555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_bd8c5998-4c19-4ace-8aec-01592ad7f40d" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_bd8c5998-4c19-4ace-8aec-01592ad7f40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsVested_d38262ca-2fc1-4d2b-bc6f-2759e89ea74e" xlink:href="clbs-20200630.xsd#clbs_WarrantsVested"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WarrantsVested_d38262ca-2fc1-4d2b-bc6f-2759e89ea74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable_01c812bb-69f9-4911-8463-43b0ef7b567c" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercisable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable_01c812bb-69f9-4911-8463-43b0ef7b567c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested_7bf7f7c3-9a83-497d-a8cb-b57d8a3d266c" xlink:href="clbs-20200630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantsvested"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested_7bf7f7c3-9a83-497d-a8cb-b57d8a3d266c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvested_922ce0ed-3c3b-47ca-bde7-224d19608b7e" xlink:href="clbs-20200630.xsd#clbs_AggregateIntrinsicValueWarrantsvested"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_55947eda-4b35-41c7-9d49-315051f4a9cc" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsvested_922ce0ed-3c3b-47ca-bde7-224d19608b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6ac50c77-df96-4a2c-b221-47b8e24152ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f9d0b11-23f2-4649-856c-c77c4dc844e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ac50c77-df96-4a2c-b221-47b8e24152ce" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f9d0b11-23f2-4649-856c-c77c4dc844e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2476dee1-7777-4be2-9b7a-4476095130fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f9d0b11-23f2-4649-856c-c77c4dc844e3" xlink:to="loc_us-gaap_AwardTypeAxis_2476dee1-7777-4be2-9b7a-4476095130fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1151b34c-9c4e-42e0-978c-83a4e8260f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2476dee1-7777-4be2-9b7a-4476095130fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1151b34c-9c4e-42e0-978c-83a4e8260f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_c413731c-7cc5-411c-93fe-3aefa28c4cd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1151b34c-9c4e-42e0-978c-83a4e8260f22" xlink:to="loc_us-gaap_RestrictedStockMember_c413731c-7cc5-411c-93fe-3aefa28c4cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9b26cfc7-c7ff-4c4c-943a-68c842e9584d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1151b34c-9c4e-42e0-978c-83a4e8260f22" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9b26cfc7-c7ff-4c4c-943a-68c842e9584d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5f9d0b11-23f2-4649-856c-c77c4dc844e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_d4c5c1bb-7baf-4a07-9b3b-c54b723b27fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_d4c5c1bb-7baf-4a07-9b3b-c54b723b27fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_084d32c2-f87b-409a-8971-1623bb9803b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_084d32c2-f87b-409a-8971-1623bb9803b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ccb65ed7-eb30-4688-9cbc-32e7b391703d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ccb65ed7-eb30-4688-9cbc-32e7b391703d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e895d9b0-964a-4676-83e5-15707704b2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b76d191f-0085-4bb1-abd6-1e0f149b7bf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e895d9b0-964a-4676-83e5-15707704b2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_e653aa99-126d-46f4-b1d7-a168e9e0d357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e37c982a-560b-4655-8c9c-1a21739ac7be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_e653aa99-126d-46f4-b1d7-a168e9e0d357" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e37c982a-560b-4655-8c9c-1a21739ac7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_0b702f5a-af6a-4819-9244-8d489cbdee09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7361870d-6631-40b7-a02c-666081c69982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_0b702f5a-af6a-4819-9244-8d489cbdee09" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7361870d-6631-40b7-a02c-666081c69982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_e5b0c4a3-e21e-456c-b6fb-07a23196d888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_0b702f5a-af6a-4819-9244-8d489cbdee09" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_e5b0c4a3-e21e-456c-b6fb-07a23196d888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_99b9803f-214a-4ac6-8750-16dbf9bdba93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_0b702f5a-af6a-4819-9244-8d489cbdee09" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_99b9803f-214a-4ac6-8750-16dbf9bdba93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#ShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_3ef20100-bd49-4a13-a2f3-1731434079a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_3ef20100-bd49-4a13-a2f3-1731434079a2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7d13473a-81c6-4c7d-9e4b-75ad9eb99530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7d13473a-81c6-4c7d-9e4b-75ad9eb99530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ce6734c2-9cd4-4403-9737-423977906e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7d13473a-81c6-4c7d-9e4b-75ad9eb99530" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ce6734c2-9cd4-4403-9737-423977906e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2118dc3e-4ab8-4323-a88e-0d8c03daaaaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ce6734c2-9cd4-4403-9737-423977906e21" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2118dc3e-4ab8-4323-a88e-0d8c03daaaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6366abbc-7edf-4926-b25e-309cd9389afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ce6734c2-9cd4-4403-9737-423977906e21" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6366abbc-7edf-4926-b25e-309cd9389afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:to="loc_us-gaap_AwardTypeAxis_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5c59ebeb-508e-4bdc-9f5d-fc2665ab9f31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e74640e0-443f-4d65-a259-197cff73c254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e74640e0-443f-4d65-a259-197cff73c254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_37b0e8cb-bbbc-48da-a590-4d9e1ae3660b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_37b0e8cb-bbbc-48da-a590-4d9e1ae3660b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_1bbd1094-e35c-4b85-995a-8720733ae7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:to="loc_us-gaap_RestrictedStockMember_1bbd1094-e35c-4b85-995a-8720733ae7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_214cdf01-c536-45e5-ba66-f71dd0ec8d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2528c853-989b-43bd-9ef3-9e302530471a" xlink:to="loc_us-gaap_WarrantMember_214cdf01-c536-45e5-ba66-f71dd0ec8d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c1a0307-be32-4edc-a237-5beb219cfa71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3ca37a53-7fa1-4a35-bf44-5c43da76f78e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3ca37a53-7fa1-4a35-bf44-5c43da76f78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_650d268a-a805-41b8-bcf1-81dfe4940672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_650d268a-a805-41b8-bcf1-81dfe4940672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f6c5267-a6c4-480c-9ed9-8d596cce8057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f6c5267-a6c4-480c-9ed9-8d596cce8057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ae93ee65-2ea9-4334-8587-fb01470016d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ae93ee65-2ea9-4334-8587-fb01470016d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4f0d1e20-992f-477f-a590-8aad57f930f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e24d07a7-f21f-4a57-9e43-d6aa09741584" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4f0d1e20-992f-477f-a590-8aad57f930f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchFunding" xlink:type="simple" xlink:href="clbs-20200630.xsd#ResearchFunding"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ResearchFunding" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_90f0edf8-b15a-43a7-9a5d-0e84daa79b72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_07246c29-5246-45b1-b886-822d1c45963a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_90f0edf8-b15a-43a7-9a5d-0e84daa79b72" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_07246c29-5246-45b1-b886-822d1c45963a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchFundingDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#ResearchFundingDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ResearchFundingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_d285c821-c47b-40bf-88c7-594a7414c417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_fa3d27d3-3184-402d-8f5b-32942343223c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_d285c821-c47b-40bf-88c7-594a7414c417" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_fa3d27d3-3184-402d-8f5b-32942343223c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_fa3d27d3-3184-402d-8f5b-32942343223c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5d0fb7b4-dfb2-403b-963e-ac4304094ae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_577113fd-7a5a-46ba-81c3-c9f35d1ceaaf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5d0fb7b4-dfb2-403b-963e-ac4304094ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_5d05c8f9-d3b9-4dc5-a28b-029ba6f61a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5d0fb7b4-dfb2-403b-963e-ac4304094ae9" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_5d05c8f9-d3b9-4dc5-a28b-029ba6f61a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_fa3d27d3-3184-402d-8f5b-32942343223c" xlink:to="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantsReceivable_395f7fab-8456-420d-90d8-8dc657da42bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_us-gaap_GrantsReceivable_395f7fab-8456-420d-90d8-8dc657da42bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_FundingOfGrantAwardCashReceived_ce18afce-ff43-4c04-81fc-0d9e9a8bfb53" xlink:href="clbs-20200630.xsd#clbs_FundingOfGrantAwardCashReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_FundingOfGrantAwardCashReceived_ce18afce-ff43-4c04-81fc-0d9e9a8bfb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MilestonePaymentOnGrantAwardCashReceived_50ab5269-5396-4c4e-8447-ef2d5c23fedc" xlink:href="clbs-20200630.xsd#clbs_MilestonePaymentOnGrantAwardCashReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_MilestonePaymentOnGrantAwardCashReceived_50ab5269-5396-4c4e-8447-ef2d5c23fedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProgressPaymentOnGrantAwardCashReceived_67973d27-c108-40b8-8dc4-a4f7f0a3c0de" xlink:href="clbs-20200630.xsd#clbs_ProgressPaymentOnGrantAwardCashReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_ProgressPaymentOnGrantAwardCashReceived_67973d27-c108-40b8-8dc4-a4f7f0a3c0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_bb8d9d58-fb5f-46e8-bfd9-51a0b111b22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_bb8d9d58-fb5f-46e8-bfd9-51a0b111b22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AccruedGrantFunding_0d2ba94e-60fe-4840-aeae-054a0398d196" xlink:href="clbs-20200630.xsd#clbs_AccruedGrantFunding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_AccruedGrantFunding_0d2ba94e-60fe-4840-aeae-054a0398d196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_cf7c77e8-dd3e-4bc6-90b0-819b410193e6" xlink:href="clbs-20200630.xsd#clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_2018cd5d-c0a5-421b-9d2d-6fe0d9cb52bc" xlink:to="loc_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_cf7c77e8-dd3e-4bc6-90b0-819b410193e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxes" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2a4140d7-665c-42a8-a4ab-2e00256b1e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_33ffa301-e1cb-44a5-ba02-cadbdbd62329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2a4140d7-665c-42a8-a4ab-2e00256b1e4c" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_33ffa301-e1cb-44a5-ba02-cadbdbd62329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#IncomeTaxesNetOperatingLossCarryForwardDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_351543e3-5142-4eb0-ab94-df7c6e1bb95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_8b88ba9e-02cd-4265-aaec-d84ac46264b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_351543e3-5142-4eb0-ab94-df7c6e1bb95f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_8b88ba9e-02cd-4265-aaec-d84ac46264b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_8b88ba9e-02cd-4265-aaec-d84ac46264b3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0b56d638-d554-4c0d-a6cc-d8fad79530e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_acf4bf8c-7692-42a9-aa1d-b6e6a78ee164" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0b56d638-d554-4c0d-a6cc-d8fad79530e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_45178f20-0f26-4cb9-aa60-eb394a30661c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0b56d638-d554-4c0d-a6cc-d8fad79530e9" xlink:to="loc_us-gaap_DomesticCountryMember_45178f20-0f26-4cb9-aa60-eb394a30661c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_8b88ba9e-02cd-4265-aaec-d84ac46264b3" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_230fca1c-c09b-4be7-900e-8e7b2ad12318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_us-gaap_OperatingLossCarryforwards_230fca1c-c09b-4be7-900e-8e7b2ad12318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis_5a603bdf-78a5-4922-9c09-0933b30b02e1" xlink:href="clbs-20200630.xsd#clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis_5a603bdf-78a5-4922-9c09-0933b30b02e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_NetOperatingLossAnalysisAnnualLimitation_47a02f0a-669b-4e1d-b7e7-54c47039f984" xlink:href="clbs-20200630.xsd#clbs_NetOperatingLossAnalysisAnnualLimitation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_clbs_NetOperatingLossAnalysisAnnualLimitation_47a02f0a-669b-4e1d-b7e7-54c47039f984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfNetOperatingLossesNJEDAProgramValue_cf303364-aa17-4693-92c5-67359865b8a0" xlink:href="clbs-20200630.xsd#clbs_SaleOfNetOperatingLossesNJEDAProgramValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_clbs_SaleOfNetOperatingLossesNJEDAProgramValue_cf303364-aa17-4693-92c5-67359865b8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_789a14d4-de8a-4709-905e-49c379519df4" xlink:href="clbs-20200630.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fc8b188d-449b-4839-b54a-f1ae9f18ec91" xlink:to="loc_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_789a14d4-de8a-4709-905e-49c379519df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/Contingencies" xlink:type="simple" xlink:href="clbs-20200630.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a4dab69c-9b0c-4553-9da0-94857e1e136d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_da370979-f81d-4f42-919c-a3b734ec3601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a4dab69c-9b0c-4553-9da0-94857e1e136d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_da370979-f81d-4f42-919c-a3b734ec3601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEvents" xlink:type="simple" xlink:href="clbs-20200630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_5a0f4c57-7b93-4fb4-8045-d7f3932c4759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_53456e57-24bb-41db-a9e1-11e3b40f3e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_5a0f4c57-7b93-4fb4-8045-d7f3932c4759" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_53456e57-24bb-41db-a9e1-11e3b40f3e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="clbs-20200630.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_87f6fa2f-ae8d-4b64-a2e4-45450e7de115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_87f6fa2f-ae8d-4b64-a2e4-45450e7de115" xlink:to="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1e7880e5-2308-4671-a007-f63f719f6c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1e7880e5-2308-4671-a007-f63f719f6c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_09c8b326-273a-4201-b218-ddc3def2c1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1e7880e5-2308-4671-a007-f63f719f6c5f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_09c8b326-273a-4201-b218-ddc3def2c1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2226c54e-472a-4d4d-a749-33b20cf83bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_09c8b326-273a-4201-b218-ddc3def2c1b3" xlink:to="loc_us-gaap_SubsequentEventMember_2226c54e-472a-4d4d-a749-33b20cf83bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ceed5210-90f9-4bb9-813d-02170a540ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ceed5210-90f9-4bb9-813d-02170a540ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84cf6707-aee1-46d4-8789-9b374433ffdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ceed5210-90f9-4bb9-813d-02170a540ed2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84cf6707-aee1-46d4-8789-9b374433ffdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_1f2a6861-d900-4a58-89dc-bc5afd7cd259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84cf6707-aee1-46d4-8789-9b374433ffdf" xlink:to="loc_us-gaap_PrivatePlacementMember_1f2a6861-d900-4a58-89dc-bc5afd7cd259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember_7552bc56-0866-4d3b-8c39-ff0ee11ae29e" xlink:href="clbs-20200630.xsd#clbs_H.C.WainwrightSalesAmendedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84cf6707-aee1-46d4-8789-9b374433ffdf" xlink:to="loc_clbs_H.C.WainwrightSalesAmendedAgreementMember_7552bc56-0866-4d3b-8c39-ff0ee11ae29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d1f43259-1f46-46bc-9490-90f967988309" xlink:to="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_91f8b364-0030-481d-886c-aa8354fc99a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_91f8b364-0030-481d-886c-aa8354fc99a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_36529a83-282b-4940-a911-636a934c7519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_36529a83-282b-4940-a911-636a934c7519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f7f896b8-a1fd-4fd2-8733-6bd3347d5ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f7f896b8-a1fd-4fd2-8733-6bd3347d5ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_382dc70a-7675-4e91-826b-ca5b249c4092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_382dc70a-7675-4e91-826b-ca5b249c4092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_8729b616-8250-43f7-badd-f9826e4e131d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_8729b616-8250-43f7-badd-f9826e4e131d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1219ae22-a218-4af9-aac7-e2e6751321c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1219ae22-a218-4af9-aac7-e2e6751321c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_51829b08-90f6-47d5-a29c-cdad8a89ca18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9120d687-866d-4a49-a49f-196e0797684b" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_51829b08-90f6-47d5-a29c-cdad8a89ca18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>clbs-20200630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:clbs="http://www.caladrius.com/20200630"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="clbs-20200630.xsd" xlink:type="simple"/>
    <context id="i993879b12e9c46ef87314fc725152301_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifb6fff8afda14ce9bec5a2259842ba20_I20200813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2020-08-13</instant>
        </period>
    </context>
    <context id="i6d039286e7ad457e9448ba787ec1cf9d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5714f756c7ef49ebbeb8c792722bd60f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i399de42232e340bdada57acc3912526b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia6459a8b2bfa4e9082f15bfcaa393a83_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1e533b0893054a86bfe347dbdf504805_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia2ad58fffd254fa6a207551b32eb272c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i269772cc59a54b0c86ec5c667dd00789_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4d672d653e4742d8a45260d9f07da1e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9b482ff5b63841c3a4083518a2149ea8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib8d9ecc646214e10a6fa5daea1b9058a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8dd06004c95043da94c6cdc17a8cfaf3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2a63a15d847c4890ab70d804d8c08b3d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i089823aad76040799b9222c0960ec021_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icdb421367f6b418eb556790e87e553b9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ideecb37c5c654bbdb1037b8614cfe6db_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if60108fc7b4e4965bb4dde5e421bbbe9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5d5516dfdf124b3a8d81163650685d21_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if7d90e607a71431f993c74e5ab4a5440_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie28f9e36c9ac490fbe91763704341b93_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i81c0cb854ba944e884bf1b00aa79f1f3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6473bb916b34426eadad2eb4a6da4c45_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i35b49c8bd3db41caab9d777b94e006fa_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id4ddd050588b49a880ea307c34a8a2e7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icd6315550f8948388dc33311dd0f3a47_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9cceac2b4239467bbd9c4ba097a4cca3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia26c7702fea34fd481006912dd3c74c9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i40ffe924ff214949875e811de6652307_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i029555c24dfb4f87ba3330c27022e676_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i689a47bf1d5b4d35ae49c687b8e5350e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6ca7c31d550e476ca25f4b1ee88a810a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i853de77024f446ae9c1994c45de246d9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if3e54a78a6c1475c81756074222ed700_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="idf7a5efcf6464b84b6908c5a79f851df_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i12238a4194304af292dc658a465a9869_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i154ad1efb34e44c493e4cd358f0e3a5e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic2f96be1df6e4c74b5d8378edbdd33e5_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifaa90470a948448e99d1c0fd28e4ae2f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2d54e245b2e5412195f8068f0ed21f5d_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i92147aaa2f774770bf474845fc45022b_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2055b13cfd8546fe94673210f1f9a5a1_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iaec8a33e801747fba17f3eb0f6415905_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5ab690b1ab2746df8e3a13c32d2e3d2c_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0091c8c5e99c4b7285f64866343c8242_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idf716bf4e64c42eb93f27e30efd66f84_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i4a228f73f8ea40d091b343b12607676d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ia45d7e7fa98744c99e820d7277685eb7_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iaa36c77971f34e0e8b157159bb4fe935_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ic17110eb863e4e77a7720e0ac50759c1_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i85327901e88841e5a13ea69126435f01_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i075dc3333dea40c2b3dea37dbfd62c23_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3039884f741e48f9b0efd984a250fb4f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iec42dab4bf014f308c2e8b7cb3366e6a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie90a881e895f4066aca8e8f3ef8d2873_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0bdde77f835d486ca4fed2229c62a8a4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icd6ef19f18054f819eeb15b3287fbe0a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id046043ef8e444678382caffe7cd0326_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2f3e93561fbd44bca60dac0ff1dfeb64_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i08e9560f917440508f3a6e5bb1608f07_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie704db0571b14cf290b0bd0ffc4cf0df_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5460b9db956c4914aca35e670e270e39_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7f8b8e70272d4ce4a1797485ee724b54_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0bf22901ac704008bb0379111f81d35d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iad1bde95aa094ca19a60db89e9eea0f6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if8f7c328741c458db2fcb7810eb691bd_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i52b5ff024d164f15800522b18c9be2f1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i590dc48391b942189240efd0d0206942_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib05a707433594a25a0606a9575997357_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i6668795c6a884dada418bd8caf1a7f54_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic320af918fb24539b5a45cf9f2d8e810_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ibc243f82141e47c286e480f5a84eb2eb_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7ddf56079b524d5fbfac58c6fecb5f39_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id07a4c5e1fc340b1b770d4937c2a3c08_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1aaeabe181a943b6a69e23bdc1cfd7d0_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib6dbf5e9d75a470d9afc9bc9527aa4d6_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic32d3c882e084aa79bd397aa974b4613_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="iaa079d11b5954062bd47deae009f8794_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia192e319dcd6445490a592f325146563_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5b882abb91484bcfb43daf1e92edb3c7_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2baaf7ccbcd1454fb5493e534db9c3e5_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2010021fc3d045089492ab8ba091452b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8caa352b6c734881a00e24477692efc9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i435d817d085a4640b5a6c1464fc2d6c6_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">clbs:IschemicRepairCD34CellTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ibc9cdd25bf88475f8e513d4db47ee846_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i51276a8f169f436da9ec48301dcd051a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b8db529f1db479582f2818c75225c64_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i411233e5c6644b1299e6cd2602fff077_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie09e7b16df084c27894b034b50301fc2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i52a8a4bbf7814421a7344fbca72e4db2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i380bbd1c1ef540988fa905c4d3a9bbd9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i038f7c88311e4f759817629c9442fb4e_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6840633376a8464bb5028c503efbd70d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id489cdfd5a324069840e47683d89ebd3_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6aaa04fcbbd04e748061483302747deb_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7481b7eaae714c60a1ff50e6a622db4d_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i60d3cfe6b6ff47e5a543fcfdc2245182_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i19e4029dd45d4a2e993c6cc753ebd83e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i57debf008f6741c6a70e1068fc6fe3c0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9d727b490abb4a08b6bc611450220f08_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie87a77d2f0f048cda7eb6a19d339ae3f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibcebce19867e4bf9b34357c8eedd8e33_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idcb791e9b72843fcb667122a6a337f82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i523ce19cd95244908556f420c606e80b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if91087121ec44256b8962731a81173e2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i899c54667f134030ae5390e6bdd1b0f3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5f781bdb8e5f41e99cf7d9a445cea06c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i20af34c4f7754a0cb76befe079bbf0c6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic00237ce125744ceb6a8b4882def3994_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iabb27bf045414866879a04335d6c62eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i832251079f054ea08f5f541fc8a5f428_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i27dbcb6ac24e46399fb67838c65e5bbe_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="if6ee95ae2dee4705b58d1a3b61eaf330_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i0dc34b6e97fd4ee8b4dd911463597ac5_D20180201-20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-28</endDate>
        </period>
    </context>
    <context id="id6b5f2a163bb41f395f2f166843dc9c1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3d2f30f90a5e4e7c836f63de04b42380_D20180201-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i06ddd3f40ce1488cb4db1f51b16d53a5_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AprilPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i848cc63cd4a84516a987b6158ef085e8_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AprilPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="icfde3833e9e746b7bb672ba96a4b144d_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:MayPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:MayPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i798ecf9e15c5435a90a4a4a6b80c21e8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clbs:StockOptionsActivityAxis">clbs:UsEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idccb2e05fee74cb3b8743e49713e31b6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clbs:StockOptionsActivityAxis">clbs:UsEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic0f802c6ed3941c18eac0365a12a53e3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clbs:StockOptionsActivityAxis">clbs:UsEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icde65320b8824859b7fc2395f13c2799_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="clbs:StockOptionsActivityAxis">clbs:UsEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3f6a0bbceb0d475db409f328331721e3_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9ff3343eb5e7446abb32c279fd9ef744_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i26dc6f410bb34ef1b20a17e4d3226752_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i573aeb998eaf418389958e830a4fd5b6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6fe2517ab39b4e1aa621db4c39dbf740_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibee88ce40a3a47fdab9f0302d0f48d88_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia1a63f2bc4e742469418ccdee39935e5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if73c2d1f89dc4b9eba1e9511f636f5fa_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8f90fb65ff524ed98e292273fda18895_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2a5da1d8176f41c3abcf0352434e0dff_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3e40117026924a3da318f41263045d8c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ieac73b68636a4e2d89630fe927e17eb8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9da5c1afc9a24304ab6103f6095e3e85_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i36becd2504164b3aab52d7e8b2b6c31d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2e481ed9443b4a88befbcf284f32660a_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id59dd6e8c9f64370960e3b4a0b377a6a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i67413a83b057456c9a1af22965e51368_I20170228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2017-02-28</instant>
        </period>
    </context>
    <context id="icd5ddb34eb58439ca82e6cd0adcb36c0_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="i407cfd607b264cfb8ff9e7af6c462f5a_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="i1fbf17ede593415fbc33607b4bbe3350_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ifb77f2e7779642d2a6eb659130a096f8_D20180301-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="ifcdfcccad39e4c2fa35c49cd9d022159_D20190501-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="i928a14f6fa8847b7afd1d223a9a29cc4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i29dd98104b1c4e8e92246825600cce61_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia7aa8c0b4d6d4e7395c1bdb89f3a9231_D20200421-20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-21</endDate>
        </period>
    </context>
    <context id="ib917b042859f49cd9af5962cf0b25fe8_D20200710-20200710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-10</startDate>
            <endDate>2020-07-10</endDate>
        </period>
    </context>
    <context id="i669ac4164c3a4aca9afb03a13773ca45_I20200710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-10</instant>
        </period>
    </context>
    <context id="i5da6f23879be4c3f9b9ff3c489d244ba_D20200701-20200806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-08-06</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="office">
        <measure>clbs:office</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF80LTEtMS0xLTA_391ac748-be6f-461e-9535-d16560df6db9">0000320017</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF81LTEtMS0xLTA_9676a208-448f-45bd-a65d-142bc993954c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF8xNC0xLTEtMS0w_89adf603-3b1d-4c7a-b7e5-7c1f8c0e0703">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF8xNS0xLTEtMS0w_26041a37-1d92-49e7-9612-89dbd0e26a81">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80L2ZyYWc6YmM0MmUxMTFkOWE4NDlkNmFkMjliZWUyNDU4NTU4NDEvdGFibGU6NzU4OWExNzc3NzdlNGY5NGFiZTdlYWY0YjU2OGY4N2QvdGFibGVyYW5nZTo3NTg5YTE3Nzc3N2U0Zjk0YWJlN2VhZjRiNTY4Zjg3ZF8xNi0xLTEtMS0w_137b0d9a-b56f-4575-aab1-a8ad11cbe98b">false</dei:AmendmentFlag>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i848cc63cd4a84516a987b6158ef085e8_I20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xMDY5L2ZyYWc6M2JhZTVhOTI3OTllNDg3MmJlYzI2YTM3NWIzY2QzM2IvdGV4dHJlZ2lvbjozYmFlNWE5Mjc5OWU0ODcyYmVjMjZhMzc1YjNjZDMzYl8zODQ4MjkwNjk3MzE4_d6e9a0a5-23aa-4533-8be1-123010056eea">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xMDY5L2ZyYWc6M2JhZTVhOTI3OTllNDg3MmJlYzI2YTM3NWIzY2QzM2IvdGV4dHJlZ2lvbjozYmFlNWE5Mjc5OWU0ODcyYmVjMjZhMzc1YjNjZDMzYl8zODQ4MjkwNjk3MzI2_bae774c3-c2f4-4a14-b364-86f1bbc2d461">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83OS9mcmFnOmFmOWEyZTQ2NjRmMDQ0ODE5ZWE2NzlhYTdmZDFhODViL3RleHRyZWdpb246YWY5YTJlNDY2NGYwNDQ4MTllYTY3OWFhN2ZkMWE4NWJfMjg_f5904ed7-46b6-40d4-9e58-b19509c7bfb4">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <dei:DocumentType
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDE5_24d470b8-cdaa-4b66-8e4e-67dcf9a85b53">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ODBjM2JhN2EyMzQxNDM4OGJhNDcyZDdmZmI2ZjBmNjYvdGFibGVyYW5nZTo4MGMzYmE3YTIzNDE0Mzg4YmE0NzJkN2ZmYjZmMGY2Nl8wLTAtMS0xLTEzMzc_15f96836-a69c-4de8-805d-e7ede69f8cde">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDE3_755c2917-a6fe-4c66-9420-36f97b3dc8ac">2020-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZGU5ZWNhM2ZlZGIxNDk5MThkMGU4NjZjOWQwNmQzMzIvdGFibGVyYW5nZTpkZTllY2EzZmVkYjE0OTkxOGQwZTg2NmM5ZDA2ZDMzMl8wLTAtMS0xLTEzMzk_653c65f3-732d-4da2-9bea-eb58428a6467">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDIw_27b7917c-9268-40b9-8396-be9d2840a4c2">001-33650</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDIx_01510d3d-17ed-41da-bac9-16a22e17e3f8">CALADRIUS BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8wLTAtMS0xLTEzNDM_b805ecd4-2dc1-4a92-8827-4fb558fcbf53">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8wLTEtMS0xLTEzNDU_9ab6ac47-0896-42db-ad9f-a7bd1524b054">22-2343568</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8zLTAtMS0xLTEyMzIvdGV4dHJlZ2lvbjo0M2VkNmNlYTQxY2Q0YmNhYmQ2ZjRmMGI1YTc1MjViNF8zODQ4MjkwNjk3Mjk3_850e8c29-b76e-4149-92a3-5734017f1607">110 Allen Road, 2nd Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8zLTAtMS0xLTEyMzIvdGV4dHJlZ2lvbjo0M2VkNmNlYTQxY2Q0YmNhYmQ2ZjRmMGI1YTc1MjViNF8zODQ4MjkwNjk3MzEy_6359bf0b-c519-4825-886a-ee9a598e2d71">Basking Ridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8zLTAtMS0xLTEyMzIvdGV4dHJlZ2lvbjo0M2VkNmNlYTQxY2Q0YmNhYmQ2ZjRmMGI1YTc1MjViNF8zODQ4MjkwNjk3MzI0_4c137d16-a23f-4d14-a17b-4bc44f91dc5b">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6ZDc5MzE1MGVhOGRiNDhlNjgwYTE0YTFmMzNjODE4NGYvdGFibGVyYW5nZTpkNzkzMTUwZWE4ZGI0OGU2ODBhMTRhMWYzM2M4MTg0Zl8zLTEtMS0xLTEzNDc_224d53ff-1431-4a03-8b0d-4cab38e6e202">07920</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDIz_51da5961-00c8-4ba6-9595-f349811e70fc">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MDMy_684494c0-c87f-4c2d-a1c8-294c8219d99e">842-0100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6YzQxZTgyNDRlYWFkNDY1MjljOGFkMjVmYjhjMmYzMjkvdGFibGVyYW5nZTpjNDFlODI0NGVhYWQ0NjUyOWM4YWQyNWZiOGMyZjMyOV8yLTAtMS0xLTEzNTE_74ba6fa7-ef7f-4942-8bb1-792830f603b3">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6YzQxZTgyNDRlYWFkNDY1MjljOGFkMjVmYjhjMmYzMjkvdGFibGVyYW5nZTpjNDFlODI0NGVhYWQ0NjUyOWM4YWQyNWZiOGMyZjMyOV8yLTEtMS0xLTEzNTM_c207018d-650f-41df-8804-b3cf894c9b57">CLBS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6YzQxZTgyNDRlYWFkNDY1MjljOGFkMjVmYjhjMmYzMjkvdGFibGVyYW5nZTpjNDFlODI0NGVhYWQ0NjUyOWM4YWQyNWZiOGMyZjMyOV8yLTItMS0xLTEzNTUvdGV4dHJlZ2lvbjoyN2UwYTYxZjZkZjg0MGRmOWI1NDQxMDg2MjM1NDRhNV8zODQ4MjkwNjk3MjUx_ccb77b7b-e6cb-4427-b9e1-d6674c261bab">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y180Mzk4MDQ2NTEzMjI1_3d1f84f2-730f-4b4d-91af-6aeb934f769f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y180Mzk4MDQ2NTEzMjI2_7b951dd1-79fc-47b9-877b-0032afbd8153">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6MzMxY2Y1OTg5NzliNGE4NjkzYzE3Y2Y0OTExMjk3ZmEvdGFibGVyYW5nZTozMzFjZjU5ODk3OWI0YTg2OTNjMTdjZjQ5MTEyOTdmYV8xLTAtMS0xLTEzNTk_bac01932-8932-49f1-b817-eb72ecd88836">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6MzMxY2Y1OTg5NzliNGE4NjkzYzE3Y2Y0OTExMjk3ZmEvdGFibGVyYW5nZTozMzFjZjU5ODk3OWI0YTg2OTNjMTdjZjQ5MTEyOTdmYV8xLTQtMS0xLTEzNjE_de53fc84-033d-4de1-9b01-5012dac9c420">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6MzMxY2Y1OTg5NzliNGE4NjkzYzE3Y2Y0OTExMjk3ZmEvdGFibGVyYW5nZTozMzFjZjU5ODk3OWI0YTg2OTNjMTdjZjQ5MTEyOTdmYV8yLTQtMS0xLTEzNjM_5ce82093-dab0-4ef1-995f-866c9a38abe3">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGV4dHJlZ2lvbjozMGUzNzY2MWE4NWQ0MTY2OTYxMmE3ZjJjOTQ3Y2Y3Y18zODQ4MjkwNjk5MzA1_90239e67-4a8b-4248-9043-b8d6c117ba8b">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ifb6fff8afda14ce9bec5a2259842ba20_I20200813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xL2ZyYWc6MzBlMzc2NjFhODVkNDE2Njk2MTJhN2YyYzk0N2NmN2MvdGFibGU6NWYwZDhjNGJlMzRjNGIwZmFiMzFiM2U0MzYyNThhZWQvdGFibGVyYW5nZTo1ZjBkOGM0YmUzNGM0YjBmYWIzMWIzZTQzNjI1OGFlZF8xLTEtMS0xLTA_a356a3f9-b2b8-4451-8627-bba2b248ac33"
      unitRef="shares">19323107</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMi0xLTEtMS0w_0becc7c9-be0f-4c0e-b134-ae24978da3b3"
      unitRef="usd">26684000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMi0zLTEtMS0w_4ba314fb-b001-4d0c-ab00-93e339f017ff"
      unitRef="usd">14032000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMy0xLTEtMS0w_21339e16-320e-429e-88ff-e0eea65fb643"
      unitRef="usd">8207000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMy0zLTEtMS0w_3833fc01-111c-4b6f-b741-fbf9c7189b28"
      unitRef="usd">11125000</us-gaap:MarketableSecurities>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNC0xLTEtMS0w_e9f5657d-6849-48d3-8ddc-6c5f182d2e44"
      unitRef="usd">1735000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNC0zLTEtMS0w_0b813a03-2be3-4887-8115-f3e36a01df42"
      unitRef="usd">815000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNS0xLTEtMS0w_cfcc6c11-d3a0-4d49-85d5-e47f7fa9aaf2"
      unitRef="usd">36626000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNS0zLTEtMS0w_9f041065-dc50-41b3-8a02-e7412e2816c0"
      unitRef="usd">25972000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNi0xLTEtMS0w_60c6d645-aee9-4f67-8a64-34f7efbea4c9"
      unitRef="usd">83000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNi0zLTEtMS0w_9a934a7d-10c4-40e9-8ae2-857c2c9d8e36"
      unitRef="usd">100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNy0xLTEtMS0w_a3cadd03-83d1-4a93-96d7-bac910379a7b"
      unitRef="usd">772000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfNy0zLTEtMS0w_61a71021-09c6-4908-a2ca-be670742eff7"
      unitRef="usd">1081000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfOC0xLTEtMS0w_366cbcbb-9e85-416a-b636-766ae6ef409a"
      unitRef="usd">37481000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfOC0zLTEtMS0w_4230033f-b0dd-445e-93b8-420cd1573841"
      unitRef="usd">27153000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTItMS0xLTEtMA_62bd5ee0-5494-49c8-9996-482e77ce680e"
      unitRef="usd">592000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTItMy0xLTEtMA_d1910555-b03f-43b3-a50a-c990a33dd913"
      unitRef="usd">1490000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTMtMS0xLTEtMA_7fa4b2f2-1f59-48b6-9fca-5afe533c7523"
      unitRef="usd">2888000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTMtMy0xLTEtMA_2441ffe3-ee23-477a-9271-bb67fc5fee8a"
      unitRef="usd">4486000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTQtMS0xLTEtMA_3ab4face-2050-4615-8476-53e0eb9cb0b3"
      unitRef="usd">3480000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTQtMy0xLTEtMA_b41c2d73-3b91-4a09-9e0d-5cc6642c4210"
      unitRef="usd">5976000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTUtMS0xLTEtMA_5d07da0c-53c7-42d4-bed6-ad8727fd357c"
      unitRef="usd">445000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTUtMy0xLTEtMA_988164a5-51b7-4c44-9cf9-b58e8b5ba954"
      unitRef="usd">624000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTYtMS0xLTEtMA_8b3870e0-74ac-4aae-accd-794b5efdace3"
      unitRef="usd">3925000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTYtMy0xLTEtMA_db47e1b9-0fde-4b09-800b-1a44b7de0258"
      unitRef="usd">6600000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTctMS0xLTEtMA_0ed32e74-bf4f-4201-8594-dd435209ea94"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMTctMy0xLTEtMA_77877662-555a-4c1a-a52e-d3ff587b94f5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc3OTU_1a42e781-41f7-4dc4-8527-d73346b1177d"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc3OTU_5fa9afd8-31f8-4f8b-85d6-0c70015b8936"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <clbs:PreferredStockLiquidationPreferenceShare
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MDI_1c8334f4-d3da-4ed5-b018-64f7ccb5d187"
      unitRef="shares">0.001</clbs:PreferredStockLiquidationPreferenceShare>
    <clbs:PreferredStockLiquidationPreferenceShare
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MDI_89aded8a-5417-4fc3-81ae-7ac50f1fc382"
      unitRef="shares">0.001</clbs:PreferredStockLiquidationPreferenceShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MDk_a7cf5cfa-4f20-4f0f-ba70-2c25f1342775"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MDk_d3c85725-da9c-400b-b50a-a1f2fdeeeec4"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <clbs:PreferredStockSharesDesignated
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MTg_45ae8aa2-e7c0-4a09-9e9d-9a392acc72c9"
      unitRef="shares">825000</clbs:PreferredStockSharesDesignated>
    <clbs:PreferredStockSharesDesignated
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MTg_b8281de7-784d-4352-9f39-43f9d93c3771"
      unitRef="shares">825000</clbs:PreferredStockSharesDesignated>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MjY_0a01b82d-c6d6-4408-81b4-5482866759b7"
      unitRef="shares">10000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MjY_22081a36-6a94-42b3-b418-24e619da16cb"
      unitRef="shares">10000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MjY_62419ce7-40d2-42e2-ac1f-e8666457cd41"
      unitRef="shares">10000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjE1ODIwMzE5MWU3ZTRjMjBhM2RiNTVkYTQ5YjdjMzU0XzM4NDgyOTA2OTc4MjY_8fcf8c00-3c16-4f32-b002-0411499d47da"
      unitRef="shares">10000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMS0xLTEtMA_1766a03f-9dfb-44de-b2e4-dfaaceedba00"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjAtMy0xLTEtMA_df4ff24d-b6a4-45b6-b068-6e1df979e579"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc1ODc_3ffae40d-3483-45f8-9dfa-3a9042c8f4a7"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc1ODc_7c920fcb-47bc-4721-89b5-4f70760f40fc"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MDA_b10cfae4-7e91-4292-a597-604a064aaeb6"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MDA_f9a4ac45-88e1-4266-99be-2663eb8a2c91"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MTI_2aff9e76-f0f1-43e1-b8f1-e7298aab2b21"
      unitRef="shares">15585194</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MTI_b44a5ce8-808e-4001-944e-4542b6a9d3b1"
      unitRef="shares">15585194</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MjQ_928a13c8-191c-4823-a1dc-a8c41ad7ff3a"
      unitRef="shares">10528689</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNjhiMDQyOWQ4OTQ3ZDU5ZjFkNzRiZThiZjFmY2MwXzM4NDgyOTA2OTc2MjQ_dce73de5-016a-4f99-8a78-465932ea2991"
      unitRef="shares">10528689</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMS0xLTEtMA_dbad0c5e-5162-4f7f-8b8c-6e2e40a7e188"
      unitRef="usd">16000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjEtMy0xLTEtMA_01976da2-2bf7-4715-b6c4-1e4a252334ab"
      unitRef="usd">11000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjItMS0xLTEtMA_edaf474c-52cc-483e-9747-bc5e22146d9c"
      unitRef="usd">449302000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjItMy0xLTEtMA_65aba412-e621-4f87-9ed7-c9cb4e96b7c1"
      unitRef="usd">438911000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjNjNDQ4OWVlNmZiYjQ4ZDA5NWQ1YTIyYzlkYzA0MTIzXzM4NDgyOTA2OTczMDM_0bb3e62a-4111-4cf4-8860-6829beb613ea"
      unitRef="shares">11080</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjNjNDQ4OWVlNmZiYjQ4ZDA5NWQ1YTIyYzlkYzA0MTIzXzM4NDgyOTA2OTczMDM_c563b4d0-c06e-44f2-b656-7c8938731b28"
      unitRef="shares">11080</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjMtMS0xLTEtMA_7971e7f2-5844-4479-862e-4a5bbf62bcee"
      unitRef="usd">708000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjMtMy0xLTEtMA_20fb149c-21a5-40f6-8817-7459a90aa3a4"
      unitRef="usd">708000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjQtMS0xLTEtMA_5f83de30-0e8e-426a-a6e8-e35c3ed6a1b4"
      unitRef="usd">-414792000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjQtMy0xLTEtMA_0cdbfd97-aea8-4095-a273-6b480a2558c3"
      unitRef="usd">-417400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjUtMS0xLTEtMA_03e8bec9-02a6-41c3-b19f-4a05d8a9eab4"
      unitRef="usd">-7000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjUtMy0xLTEtMA_aceba4f4-cf30-43de-890b-6a079ca6f575"
      unitRef="usd">2000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjYtMS0xLTEtMA_af008d1f-7a43-4b6f-af1a-04b36b5d1478"
      unitRef="usd">33811000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjYtMy0xLTEtMA_d75631a1-04f5-468c-ada3-1e23920b27e5"
      unitRef="usd">20816000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjctMS0xLTEtMA_be8c36b0-a596-4d2b-8592-97257cd6737d"
      unitRef="usd">-255000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjctMy0xLTEtMA_0019ae3c-9f08-40a4-954d-6782b994dac7"
      unitRef="usd">-263000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjgtMS0xLTEtMA_71222753-5385-4811-88c9-e8c6711dca96"
      unitRef="usd">33556000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjgtMy0xLTEtMA_38e22526-acc3-4f9c-bbbc-d3141a237dd3"
      unitRef="usd">20553000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjktMS0xLTEtMA_98572959-9c1f-4a3a-8346-0b02ee2f230a"
      unitRef="usd">37481000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8xNi9mcmFnOmY2NmE1ZWViNjc3MTRlMGJhNjQ5MzQ5MTQwYzJhNDA2L3RhYmxlOjlkMzk1YmJjOWZhOTQ1NzNiY2Q1NGIyMWE5ZWNhMmViL3RhYmxlcmFuZ2U6OWQzOTViYmM5ZmE5NDU3M2JjZDU0YjIxYTllY2EyZWJfMjktMy0xLTEtMA_c22e3fdd-567e-48cf-9697-e86e86aa6a2e"
      unitRef="usd">27153000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMy0xLTEtMS0w_ba9437d2-fef6-42fd-be6f-31f606109799"
      unitRef="usd">1818000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMy0zLTEtMS0w_cf2b4fdd-6396-4d2b-9b22-695eb812ee02"
      unitRef="usd">2988000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMy01LTEtMS0w_f5ec03a8-ea73-4ba7-96df-43ea8813169b"
      unitRef="usd">3317000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMy03LTEtMS0w_d981b110-9719-47c5-9853-bc54e2012e10"
      unitRef="usd">5026000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNC0xLTEtMS0w_db94300e-1f7a-4934-9190-8cfed057a412"
      unitRef="usd">2474000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNC0zLTEtMS0w_38b025b3-8c17-4af1-a9d0-9bca25e1e4ea"
      unitRef="usd">2358000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNC01LTEtMS0w_b0fb7ba0-42b8-48b7-90e8-f8dc122bac52"
      unitRef="usd">5032000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNC03LTEtMS0w_ab27d208-1236-4997-b4b9-fff9e585e97f"
      unitRef="usd">4912000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNS0xLTEtMS0w_38f2b27d-43d6-4b58-8665-692f0d063ca6"
      unitRef="usd">4292000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNS0zLTEtMS0w_ba1a37a0-e83d-4555-98f1-08d1efb9524c"
      unitRef="usd">5346000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNS01LTEtMS0w_be656386-20bf-4301-992b-c76cab9a42d3"
      unitRef="usd">8349000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNS03LTEtMS0w_ee99918e-b5bd-483a-96e3-d2ad6dde9c82"
      unitRef="usd">9938000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNy0xLTEtMS0w_5513c670-7097-465e-9636-7eeb7f89af1b"
      unitRef="usd">-4292000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNy0zLTEtMS0w_1cd3a36f-29a7-4910-98a5-03f48897dc8c"
      unitRef="usd">-5346000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNy01LTEtMS0w_301f2f18-3b6a-4bf1-a2e1-7788f3c3b8e5"
      unitRef="usd">-8349000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfNy03LTEtMS0w_b90c58c6-fed1-457a-85de-bfa3c1e1c164"
      unitRef="usd">-9938000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTAtMS0xLTEtMA_f51478df-1319-4df3-937a-7da8d0d6d626"
      unitRef="usd">22000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTAtMy0xLTEtMA_27455188-83f7-4a87-a620-cf7cfccee6e7"
      unitRef="usd">209000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTAtNS0xLTEtMA_197444e1-a415-4562-97ca-563b9bd86886"
      unitRef="usd">93000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTAtNy0xLTEtMA_270881a0-b0d4-4213-b6b6-4cce84ac4d8a"
      unitRef="usd">436000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTItMS0xLTEtMA_4a00ae7a-bf85-446d-96f7-864d2cda585b"
      unitRef="usd">22000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTItMy0xLTEtMA_001f55ee-11c1-45a3-9c17-f560c2bc6bc9"
      unitRef="usd">209000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTItNS0xLTEtMA_bd6dc24f-5710-4b3b-a0e7-0d378c4eaaaa"
      unitRef="usd">93000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTItNy0xLTEtMA_b8437579-a8d2-45c1-a0e3-2789dbe0e68b"
      unitRef="usd">436000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTQtMS0xLTEtMA_6f4818c3-cac6-4825-8b4a-2ea7334138d9"
      unitRef="usd">-4270000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTQtMy0xLTEtMA_d0fabddf-e6ee-4e72-9f8b-535c42097c5c"
      unitRef="usd">-5137000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTQtNS0xLTEtMA_b6f5a846-ec7d-4681-8e40-98ac5be81a62"
      unitRef="usd">-8256000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTQtNy0xLTEtMA_bfc12965-baa0-4b25-8f1f-7ba6e968df8a"
      unitRef="usd">-9502000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTUtMS0xLTEtMA_894c2ff2-2c1d-40f0-a612-158b48b4f1ff"
      unitRef="usd">-10872000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTUtMy0xLTEtMA_7df23ebd-c72b-4fb9-82c7-f8daf36e71f9"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTUtNS0xLTEtMA_8c08c5c0-7440-4cd9-9f5a-f655dba2688b"
      unitRef="usd">-10872000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTUtNy0xLTEtMA_f2ad9749-38ed-432c-aa9f-49f912bf05ea"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTYtMS0xLTEtMA_72dfce57-cc28-41d7-8b7f-aceb4aecdd69"
      unitRef="usd">6602000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTYtMy0xLTEtMA_80a20563-44d6-4c11-bc25-bbe2f28a257a"
      unitRef="usd">-5137000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTYtNS0xLTEtMA_97345d97-2e6b-4188-abe5-ef0bac00768b"
      unitRef="usd">2616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTYtNy0xLTEtMA_fb7d2c9e-7b52-4449-bc12-4c7ca6163c53"
      unitRef="usd">-9502000</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTctMS0xLTEtMA_d402b1b6-49f2-4cdf-b07e-a6c9e2a70eb8"
      unitRef="usd">4000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTctMy0xLTEtMA_03344162-7be6-4788-a958-38db4b6d6595"
      unitRef="usd">3000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTctNS0xLTEtMA_f113cf18-513f-4920-a891-5bf247b50fd8"
      unitRef="usd">8000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTctNy0xLTEtMA_05fff9f8-f12b-447c-a0f8-fe9ec128ace7"
      unitRef="usd">5000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTgtMS0xLTEtMA_d1340d3c-05a5-4f83-829a-4b7bb4b3e226"
      unitRef="usd">6598000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTgtMy0xLTEtMA_6e67ebd8-e9fd-463b-9b7e-f644431951c0"
      unitRef="usd">-5140000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTgtNS0xLTEtMA_d6f03489-2361-4609-90ff-dc638d6bb0e4"
      unitRef="usd">2608000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMTgtNy0xLTEtMA_58d60254-3c3e-405c-82e1-7d61a8290a74"
      unitRef="usd">-9507000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjItMS0xLTEtMA_3f6d46c3-ceb9-460c-9c7b-f71b9bb4c451"
      unitRef="usdPerShare">0.50</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjItMy0xLTEtMA_6840b637-3bf2-4fbf-bbe5-cddf26d5455a"
      unitRef="usdPerShare">-0.49</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjItNS0xLTEtMA_cb8a4d80-fb82-4021-9abc-7cfc33921901"
      unitRef="usdPerShare">0.22</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjItNy0xLTEtMA_63f5f6c8-e071-4e06-ba6b-8dcf08c56eae"
      unitRef="usdPerShare">-0.93</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjUtMS0xLTEtMA_6ab28903-ff26-48b7-ba40-31f195fc7a62"
      unitRef="shares">13151000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjUtMy0xLTEtMA_70e90ee9-7f8b-42fc-a97f-b1ce21f095b1"
      unitRef="shares">10393000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjUtNS0xLTEtMA_79e166b3-c4e9-4b26-8f24-bf18b8721f21"
      unitRef="shares">11880000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yMi9mcmFnOjhlZGZkMjUxMmJlMDQ3NThhZTQ4NGUyNDA5MWNkYzVlL3RhYmxlOjUzMmJkN2E4MTg3ZjQ4MDY4NDVjNjQxOGNiOTlmNTUzL3RhYmxlcmFuZ2U6NTMyYmQ3YTgxODdmNDgwNjg0NWM2NDE4Y2I5OWY1NTNfMjUtNy0xLTEtMA_cb963ad6-ac89-440e-82bd-1c3902cc596f"
      unitRef="shares">10211000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:ProfitLoss
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMi0xLTEtMS0w_503c4380-7bf7-4c84-860a-beb379737645"
      unitRef="usd">6602000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMi0zLTEtMS0w_2ac4de9a-653f-4afa-80d6-f6e3f5e2cdd5"
      unitRef="usd">-5137000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMi01LTEtMS0w_9f6a1f0c-5746-4b00-beb4-6c3fd593490f"
      unitRef="usd">2616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMi03LTEtMS0w_0e4cdf6d-be41-4509-b9d0-1d016c1f0a39"
      unitRef="usd">-9502000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNS0xLTEtMS0w_79d710ad-6b09-44e3-b0ea-4f559dbeaa36"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNS0zLTEtMS0w_d63554ea-5060-41f7-a902-ed1bef2b72f1"
      unitRef="usd">17000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNS01LTEtMS0w_cd628ef6-307f-45d7-946b-051e57a2eb63"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNS03LTEtMS0w_edf92020-edda-4f89-b264-73168c778c53"
      unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNi0xLTEtMS0w_90f84c22-6935-49dc-9e49-efb4d6f68f89"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNi0zLTEtMS0w_06ca46bd-be01-46aa-9774-d7d5bf742527"
      unitRef="usd">17000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNi01LTEtMS0w_3889c787-1b94-457e-9724-d2d2bccb04ff"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfNi03LTEtMS0w_5331eea0-0ffb-4af7-9022-410d18f55a78"
      unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfOC0xLTEtMS0w_189abc4f-f725-435a-8e90-37b7517bfbaf"
      unitRef="usd">6593000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfOC0zLTEtMS0w_7270dff8-0e16-44cb-acf1-64963147a2d9"
      unitRef="usd">-5120000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfOC01LTEtMS0w_ec1743e1-f186-4413-8d3b-0109decfb1f3"
      unitRef="usd">2607000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfOC03LTEtMS0w_93a30925-a193-4a12-9df3-f5b4ecd98394"
      unitRef="usd">-9471000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTAtMS0xLTEtMA_844f204b-d251-4deb-ac6d-606b7f477e10"
      unitRef="usd">4000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTAtMy0xLTEtMA_7792de84-d313-43b4-b539-2939cc618e8a"
      unitRef="usd">3000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTAtNS0xLTEtMA_1dc7eb04-5e8d-4daa-8d3e-d19610a86ae3"
      unitRef="usd">8000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTAtNy0xLTEtMA_484ca23c-048b-4133-a1f9-1582089127f9"
      unitRef="usd">5000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTItMS0xLTEtMA_9a0c5a56-14c7-422f-84a8-8b41949695f0"
      unitRef="usd">6589000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTItMy0xLTEtMA_452e1fc0-91f7-4400-b3a4-4e7263db3c13"
      unitRef="usd">-5123000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTItNS0xLTEtMA_067d5203-f544-4651-9e51-4dbc734ee9db"
      unitRef="usd">2599000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yNS9mcmFnOjA3ODVkZTdmOWFlYTQwMTU4YzRiMDYyMjZkMmQwYmY3L3RhYmxlOjc0YjEyOTEyNzJhZDRiODFiZDk0MjFlNWVmMzExMDhmL3RhYmxlcmFuZ2U6NzRiMTI5MTI3MmFkNGI4MWJkOTQyMWU1ZWYzMTEwOGZfMTItNy0xLTEtMA_309e98a5-43f4-43c6-a7b4-876cfbe1a833"
      unitRef="usd">-9476000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="ia6459a8b2bfa4e9082f15bfcaa393a83_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMS0xLTEtMA_31ca26f0-9d6a-4799-b38f-83b3492f8e58"
      unitRef="shares">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6459a8b2bfa4e9082f15bfcaa393a83_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMy0xLTEtMA_9cd14206-324c-4dd7-ba70-442165db835d"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i1e533b0893054a86bfe347dbdf504805_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtNS0xLTEtMA_d226de9b-ed9b-4a3c-9051-a787e98430fb"
      unitRef="shares">10529000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1e533b0893054a86bfe347dbdf504805_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtNy0xLTEtMA_8cba4fd7-d416-4269-80ad-6a7d75f601c1"
      unitRef="usd">11000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2ad58fffd254fa6a207551b32eb272c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtOS0xLTEtMA_bc37389b-33e1-4109-8b7d-42b712d487a7"
      unitRef="usd">438911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i269772cc59a54b0c86ec5c667dd00789_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTEtMS0xLTA_e1d11f5b-2991-4f54-b28a-e1f02d81b716"
      unitRef="usd">2000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d672d653e4742d8a45260d9f07da1e4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTMtMS0xLTA_7ba5a0f1-30a2-4b70-98a5-bb8a0a186987"
      unitRef="usd">-417400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b482ff5b63841c3a4083518a2149ea8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTUtMS0xLTA_35eddfe7-207e-4586-9ae8-09aca1cf05ea"
      unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8d9ecc646214e10a6fa5daea1b9058a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTctMS0xLTA_232ef221-4af9-4edb-9158-c7d9d0879b9f"
      unitRef="usd">20816000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8dd06004c95043da94c6cdc17a8cfaf3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMTktMS0xLTA_13d30e7e-9383-4fec-ad66-9c5901be4fb3"
      unitRef="usd">-263000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTMtMjEtMS0xLTA_9d73a5cc-3be0-4a10-ab9f-74c74ba735db"
      unitRef="usd">20553000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i2a63a15d847c4890ab70d804d8c08b3d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTUtMTMtMS0xLTA_560c01af-0c7c-4e4e-b750-3b7428008994"
      unitRef="usd">2608000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i089823aad76040799b9222c0960ec021_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTUtMTctMS0xLTA_08737212-9892-47ee-ae88-554c7ae66a0f"
      unitRef="usd">2608000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icdb421367f6b418eb556790e87e553b9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTUtMTktMS0xLTA_a44738ab-c277-417d-ae2f-e057a0d385b1"
      unitRef="usd">8000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTUtMjEtMS0xLTA_30a9dcee-e252-4804-97c4-bd93cb902fda"
      unitRef="usd">2616000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ideecb37c5c654bbdb1037b8614cfe6db_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTYtMTEtMS0xLTA_4e3ef893-ad6a-45b6-82ae-93ae17d80c2d"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i089823aad76040799b9222c0960ec021_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTYtMTctMS0xLTA_badf5ed0-52de-4b6a-b97a-572d56156956"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTYtMjEtMS0xLTA_802440cc-362d-4eaf-967c-83aa7fc6980c"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if60108fc7b4e4965bb4dde5e421bbbe9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTctNS0xLTEtMA_7610e972-fe5a-4b0c-834e-51991e1dc7ce"
      unitRef="shares">106000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5d5516dfdf124b3a8d81163650685d21_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTctOS0xLTEtMA_c89cf32f-8c32-492a-bdcf-776e706cea8d"
      unitRef="usd">713000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i089823aad76040799b9222c0960ec021_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTctMTctMS0xLTA_51cb287d-4b69-4ee2-9eff-844ae3f457d1"
      unitRef="usd">713000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTctMjEtMS0xLTA_99944aa5-69ce-4d68-836b-56e07e822bc5"
      unitRef="usd">713000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if60108fc7b4e4965bb4dde5e421bbbe9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtNS0xLTEtMA_d39215e2-687e-43b2-9e02-e5031f504dd1"
      unitRef="shares">4950000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if60108fc7b4e4965bb4dde5e421bbbe9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtNy0xLTEtMA_badaf7ed-9b75-478a-a4cf-65085a8f3abb"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5d5516dfdf124b3a8d81163650685d21_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtOS0xLTEtMA_b4a7163c-fe3f-4362-a666-139ecd1f8201"
      unitRef="usd">9678000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i089823aad76040799b9222c0960ec021_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtMTctMS0xLTA_836d486e-4fd3-4dde-a86a-6a5c9bebd737"
      unitRef="usd">9683000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMTgtMjEtMS0xLTA_f6df84bb-2ce9-4ef2-a93f-a26d380a9a0a"
      unitRef="usd">9683000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesOutstanding
      contextRef="if7d90e607a71431f993c74e5ab4a5440_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMS0xLTEtMA_3e9f478d-9268-4785-ad71-b528630bb1e3"
      unitRef="shares">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7d90e607a71431f993c74e5ab4a5440_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMy0xLTEtMA_4eb6a1ce-7b30-41d0-b92e-96a9976b533b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ie28f9e36c9ac490fbe91763704341b93_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtNS0xLTEtMA_dfb96164-c469-40a7-9aa3-efb55833680c"
      unitRef="shares">15585000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie28f9e36c9ac490fbe91763704341b93_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtNy0xLTEtMA_d4d156d3-e249-4cd7-8ed2-a5822d35fcc4"
      unitRef="usd">16000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81c0cb854ba944e884bf1b00aa79f1f3_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtOS0xLTEtMA_dfa3eb8d-f446-451c-8913-6d77af946e7b"
      unitRef="usd">449302000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6473bb916b34426eadad2eb4a6da4c45_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTEtMS0xLTA_ba0a404f-27f5-4d0c-8a7a-721e7be9a3ba"
      unitRef="usd">-7000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i35b49c8bd3db41caab9d777b94e006fa_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTMtMS0xLTA_da46828b-a07d-4818-92dc-8cb1c140638b"
      unitRef="usd">-414792000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4ddd050588b49a880ea307c34a8a2e7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTUtMS0xLTA_08d77b2b-9ec2-4504-93e0-63ceaaa09a99"
      unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd6315550f8948388dc33311dd0f3a47_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTctMS0xLTA_3b653dfb-907f-43e9-838c-79d4157bdefb"
      unitRef="usd">33811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9cceac2b4239467bbd9c4ba097a4cca3_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMTktMS0xLTA_9e9d5f6b-4aba-420c-9b76-7aab2b0ff913"
      unitRef="usd">-255000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjE2NThlYjUyYzVjNzQxNzI5YWYxN2UwZDU2OWIzNGYwL3RhYmxlcmFuZ2U6MTY1OGViNTJjNWM3NDE3MjlhZjE3ZTBkNTY5YjM0ZjBfMjEtMjEtMS0xLTA_eba908db-2d01-4629-89ab-b1e4ca0f2f82"
      unitRef="usd">33556000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ia26c7702fea34fd481006912dd3c74c9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMS0xLTEtMA_3d30f967-0fdf-4c61-a011-1961262fc83b"
      unitRef="shares">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia26c7702fea34fd481006912dd3c74c9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMy0xLTEtMA_3a1d9abe-4d3c-426f-9a15-afa56f3970ae"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i40ffe924ff214949875e811de6652307_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtNS0xLTEtMA_2c0663e6-f948-4f5d-bc1d-28d183dc2d0a"
      unitRef="shares">9866000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40ffe924ff214949875e811de6652307_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtNy0xLTEtMA_905a3761-7f3f-4106-9ddf-4e983cee02a8"
      unitRef="usd">10000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i029555c24dfb4f87ba3330c27022e676_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtOS0xLTEtMA_a4a2363e-ab45-4003-af0c-5dd336ae4b2d"
      unitRef="usd">436433000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i689a47bf1d5b4d35ae49c687b8e5350e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTEtMS0xLTA_b1adb4ff-af7d-4ddd-8acb-0be4b554f8f8"
      unitRef="usd">-32000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ca7c31d550e476ca25f4b1ee88a810a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTMtMS0xLTA_ad330e79-9280-4181-997e-7ef419b474c8"
      unitRef="usd">-397977000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i853de77024f446ae9c1994c45de246d9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTUtMS0xLTA_c9dc0d7b-cace-4323-8b2f-79d2a57c6898"
      unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3e54a78a6c1475c81756074222ed700_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTctMS0xLTA_9f653f42-52e9-4166-b932-1881607d1a3a"
      unitRef="usd">37726000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf7a5efcf6464b84b6908c5a79f851df_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMTktMS0xLTA_17e14844-64ad-4de2-9a2a-5844b78b8d5a"
      unitRef="usd">-272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12238a4194304af292dc658a465a9869_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTMtMjEtMS0xLTA_2956d0c4-e6b4-4658-940b-11720134960c"
      unitRef="usd">37454000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i154ad1efb34e44c493e4cd358f0e3a5e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTQtMTMtMS0xLTA_43dde4de-e502-4e2e-be65-fe9c11f27ba0"
      unitRef="usd">-62000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2f96be1df6e4c74b5d8378edbdd33e5_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTQtMTctMS0xLTA_d6442a6e-7ee1-4ad5-b596-ca80c7ddf0e3"
      unitRef="usd">-62000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifaa90470a948448e99d1c0fd28e4ae2f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTQtMjEtMS0xLTA_41eb4121-6760-4ab5-b5c0-92d0a20c0391"
      unitRef="usd">-62000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i2d54e245b2e5412195f8068f0ed21f5d_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTUtMTMtMS0xLTA_b33643dd-dccd-48a8-b18a-d4affac3b9f6"
      unitRef="usd">-9507000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i92147aaa2f774770bf474845fc45022b_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTUtMTctMS0xLTA_0439ae61-bc94-4d56-90c8-482b626fcd5b"
      unitRef="usd">-9507000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2055b13cfd8546fe94673210f1f9a5a1_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTUtMTktMS0xLTA_5bb2800b-7b5f-4d66-b2ce-808171d5b65a"
      unitRef="usd">5000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTUtMjEtMS0xLTA_81387881-d2e5-4ec8-a5a3-0d57f52392ca"
      unitRef="usd">-9502000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iaec8a33e801747fba17f3eb0f6415905_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTYtMTEtMS0xLTA_009671ae-9fc0-479f-9603-63d2e0556b28"
      unitRef="usd">32000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i92147aaa2f774770bf474845fc45022b_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTYtMTctMS0xLTA_58c23fc9-4cbf-4d0c-8f8c-96e0ddf43ae3"
      unitRef="usd">32000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTYtMjEtMS0xLTA_8052e570-025c-411e-817f-91f450fabf0c"
      unitRef="usd">32000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5ab690b1ab2746df8e3a13c32d2e3d2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTctNS0xLTEtMA_bee8c361-300c-42a0-99a9-ca1d20558677"
      unitRef="shares">96000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0091c8c5e99c4b7285f64866343c8242_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTctOS0xLTEtMA_7a126c7e-c572-45d3-aeee-9db97bc0dc3a"
      unitRef="usd">663000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i92147aaa2f774770bf474845fc45022b_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTctMTctMS0xLTA_ff8de438-a84a-465f-8c0c-464f57593cf5"
      unitRef="usd">663000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTctMjEtMS0xLTA_2b4259f4-a8a9-4800-a124-229880dface3"
      unitRef="usd">663000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5ab690b1ab2746df8e3a13c32d2e3d2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTgtNS0xLTEtMA_12b92fb3-8e72-4db7-b315-05b47e4769b8"
      unitRef="shares">451000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0091c8c5e99c4b7285f64866343c8242_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTgtOS0xLTEtMA_5c890289-60e1-4e00-b8b1-f37ad755ad56"
      unitRef="usd">1037000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i92147aaa2f774770bf474845fc45022b_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTgtMTctMS0xLTA_61325578-ed88-4dfb-8ec9-34efb334b973"
      unitRef="usd">1037000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMTgtMjEtMS0xLTA_fa873d66-6850-4f67-92fc-1587b2053a98"
      unitRef="usd">1037000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesOutstanding
      contextRef="idf716bf4e64c42eb93f27e30efd66f84_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMS0xLTEtMA_55b7e3d1-c55e-4477-8681-da805a5d78eb"
      unitRef="shares">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf716bf4e64c42eb93f27e30efd66f84_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMy0xLTEtMA_c70b398b-ca6a-4277-8411-788698aa3b2b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i4a228f73f8ea40d091b343b12607676d_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtNS0xLTEtMA_b810d1f8-f79d-423d-addc-3d64322bee67"
      unitRef="shares">10413000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a228f73f8ea40d091b343b12607676d_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtNy0xLTEtMA_5b2c1fb9-6e22-43dd-801a-7661f0e9fe82"
      unitRef="usd">10000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia45d7e7fa98744c99e820d7277685eb7_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtOS0xLTEtMA_d4e19ed0-0c9c-48a5-ad0e-95a4977ac4a5"
      unitRef="usd">438133000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa36c77971f34e0e8b157159bb4fe935_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTEtMS0xLTA_7f202de9-8acb-441f-b82f-64aeba7ea788"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic17110eb863e4e77a7720e0ac50759c1_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTMtMS0xLTA_bdd18281-cf02-4810-947e-e05876e26cbc"
      unitRef="usd">-407546000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85327901e88841e5a13ea69126435f01_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTUtMS0xLTA_9067bee2-5256-48c3-ad28-0bb28813c89b"
      unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i075dc3333dea40c2b3dea37dbfd62c23_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTctMS0xLTA_53c5bfd8-704f-456d-b1ce-a9c6dc9ec051"
      unitRef="usd">29889000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3039884f741e48f9b0efd984a250fb4f_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMTktMS0xLTA_43a3ce51-c681-45fc-86b7-467ced0697f2"
      unitRef="usd">-267000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec42dab4bf014f308c2e8b7cb3366e6a_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjFhMWQ1MmM3NGJlZjQzZjI4N2ZmMGI0NGRhYTIwMjY5L3RhYmxlcmFuZ2U6MWExZDUyYzc0YmVmNDNmMjg3ZmYwYjQ0ZGFhMjAyNjlfMjEtMjEtMS0xLTA_29c2cb9a-ca68-482c-b058-4c2a4c1a9074"
      unitRef="usd">29622000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ie90a881e895f4066aca8e8f3ef8d2873_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMS0xLTEtMA_a4754b60-8dd8-4447-93b3-aca1135f0513"
      unitRef="shares">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie90a881e895f4066aca8e8f3ef8d2873_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMy0xLTEtMA_eb744426-c0e0-419d-bee3-07ef13ecf07b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i0bdde77f835d486ca4fed2229c62a8a4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtNS0xLTEtMA_c2dae4b6-feb0-4cd2-9440-3501780f1eb6"
      unitRef="shares">10639000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0bdde77f835d486ca4fed2229c62a8a4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtNy0xLTEtMA_b4b28567-dfb1-43c9-a9a7-473e3f9ab98f"
      unitRef="usd">11000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd6ef19f18054f819eeb15b3287fbe0a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtOS0xLTEtMA_3236e522-fe8d-42ea-beb0-9d60e29ebee5"
      unitRef="usd">439330000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id046043ef8e444678382caffe7cd0326_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTEtMS0xLTA_699954bd-a691-489e-8515-7807275089ba"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f3e93561fbd44bca60dac0ff1dfeb64_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTMtMS0xLTA_9f7b3bc3-f098-483f-ba81-095bf9150837"
      unitRef="usd">-421390000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i08e9560f917440508f3a6e5bb1608f07_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTUtMS0xLTA_ad8f0c20-6cd6-4bb8-871b-37b5f19d2782"
      unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie704db0571b14cf290b0bd0ffc4cf0df_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTctMS0xLTA_0e49b18a-37b7-4bd1-871d-bc0c72e5649c"
      unitRef="usd">17243000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5460b9db956c4914aca35e670e270e39_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMTktMS0xLTA_d857906f-cdba-436d-8b2d-e6931eff9f68"
      unitRef="usd">-259000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f8b8e70272d4ce4a1797485ee724b54_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTMtMjEtMS0xLTA_6bb9580f-1d36-46e8-8cdb-672db5257914"
      unitRef="usd">16984000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i0bf22901ac704008bb0379111f81d35d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTUtMTMtMS0xLTA_00280bfa-e4bb-4914-a79d-bf9118cd86cb"
      unitRef="usd">6598000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTUtMTctMS0xLTA_e12c4a92-013e-4cc0-ac31-9dfa153f828b"
      unitRef="usd">6598000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iad1bde95aa094ca19a60db89e9eea0f6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTUtMTktMS0xLTA_de2723ad-3c5b-4ed4-ab70-f9605b1717c7"
      unitRef="usd">4000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTUtMjEtMS0xLTA_d3248a06-190b-4938-b854-11db92bf8576"
      unitRef="usd">6602000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if8f7c328741c458db2fcb7810eb691bd_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTYtMTEtMS0xLTA_d5bda29b-eddd-48ff-a92c-6d090cbdaca5"
      unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTYtMTctMS0xLTA_03058e71-2b78-4270-a00b-99282f47f5cc"
      unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTYtMjEtMS0xLTA_ada83dc4-9351-420c-a14e-383125e6e080"
      unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i52b5ff024d164f15800522b18c9be2f1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTctNS0xLTEtMA_c3be2519-7c21-4f8c-81f4-4f7e5fb83bd4"
      unitRef="shares">-4000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i590dc48391b942189240efd0d0206942_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTctOS0xLTEtMA_625e22a1-f559-4da3-8b70-3e0e0b8764fe"
      unitRef="usd">294000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTctMTctMS0xLTA_1f3cab4e-ddc5-4d4b-8cb7-1c09ee93903f"
      unitRef="usd">294000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTctMjEtMS0xLTA_7414e066-b4ab-474f-97ce-efc0f0dc03d8"
      unitRef="usd">294000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i52b5ff024d164f15800522b18c9be2f1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtNS0xLTEtMA_a827f166-89fa-44fd-a242-4503d745dd11"
      unitRef="shares">4950000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i52b5ff024d164f15800522b18c9be2f1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtNy0xLTEtMA_f1d16fc4-e931-4244-8030-5e8dbec3bfa0"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i590dc48391b942189240efd0d0206942_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtOS0xLTEtMA_3c93fa77-f6e5-494c-8ad7-bb318838ac90"
      unitRef="usd">9678000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ida8ff8de032a46f2a483fafd87d64e4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtMTctMS0xLTA_68539e3e-14aa-462c-b3ad-2283cfaf3a3b"
      unitRef="usd">9683000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMTgtMjEtMS0xLTA_ee111432-0d5a-45b0-bb74-16461bb8e96c"
      unitRef="usd">9683000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesOutstanding
      contextRef="if7d90e607a71431f993c74e5ab4a5440_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMS0xLTEtMA_941fd74b-d9a4-4fd3-971b-d4a270e14b55"
      unitRef="shares">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7d90e607a71431f993c74e5ab4a5440_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMy0xLTEtMA_2dc39c7a-fb01-4f0b-a556-65716355277c"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ie28f9e36c9ac490fbe91763704341b93_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtNS0xLTEtMA_69f05fad-6884-417d-8306-645d03650ad2"
      unitRef="shares">15585000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie28f9e36c9ac490fbe91763704341b93_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtNy0xLTEtMA_89eb89d6-e14a-455d-ae12-6910fb177d3a"
      unitRef="usd">16000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81c0cb854ba944e884bf1b00aa79f1f3_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtOS0xLTEtMA_7328abbb-bfba-4d5a-ad54-f7fff471d5ac"
      unitRef="usd">449302000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6473bb916b34426eadad2eb4a6da4c45_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTEtMS0xLTA_0c6a0abe-9e0f-47c3-a67d-4a1405ccf28f"
      unitRef="usd">-7000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i35b49c8bd3db41caab9d777b94e006fa_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTMtMS0xLTA_ed6ec286-28cc-4f80-889f-9c305399583b"
      unitRef="usd">-414792000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4ddd050588b49a880ea307c34a8a2e7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTUtMS0xLTA_36c8c32d-331a-481e-9b0a-806416a68d35"
      unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd6315550f8948388dc33311dd0f3a47_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTctMS0xLTA_1ad890f7-72ff-4b71-a94e-177806273a41"
      unitRef="usd">33811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9cceac2b4239467bbd9c4ba097a4cca3_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMTktMS0xLTA_72cfb328-c5b0-4b64-8ee1-f9e0f76c25b6"
      unitRef="usd">-255000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOmY0MDcyZTA2ZDFjOTQ5NmRiOWU2NGEzOWI5MDU5YWE5L3RhYmxlcmFuZ2U6ZjQwNzJlMDZkMWM5NDk2ZGI5ZTY0YTM5YjkwNTlhYTlfMjEtMjEtMS0xLTA_fdc4fea7-419d-4fab-9fb8-7c06cf656323"
      unitRef="usd">33556000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ib05a707433594a25a0606a9575997357_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMS0xLTEtMA_ec23a9ad-52ca-4685-bcf8-762841e8dfc8"
      unitRef="shares">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib05a707433594a25a0606a9575997357_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMy0xLTEtMA_7fdc6deb-40ee-46bc-bb95-9e8462412c6b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i6668795c6a884dada418bd8caf1a7f54_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtNS0xLTEtMA_c545ae6c-13c7-47fd-93cf-2ee6a5b47282"
      unitRef="shares">10393000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6668795c6a884dada418bd8caf1a7f54_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtNy0xLTEtMA_b6e9c6cb-df1e-425d-9da4-84c128d9a6f7"
      unitRef="usd">10000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic320af918fb24539b5a45cf9f2d8e810_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtOS0xLTEtMA_ea180e44-ca46-485a-ad41-3bbc6f2742f0"
      unitRef="usd">437850000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc243f82141e47c286e480f5a84eb2eb_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTEtMS0xLTA_91dc31c2-5f32-4cef-9bcf-becf5f405051"
      unitRef="usd">-18000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ddf56079b524d5fbfac58c6fecb5f39_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTMtMS0xLTA_f2867dc3-6133-45af-a38a-f9cd9a4dd964"
      unitRef="usd">-402406000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id07a4c5e1fc340b1b770d4937c2a3c08_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTUtMS0xLTA_4d5897c0-88d9-40cf-9c4d-7e8db3d71cfb"
      unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1aaeabe181a943b6a69e23bdc1cfd7d0_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTctMS0xLTA_0de8f567-d470-41d5-8809-f124845695b9"
      unitRef="usd">34728000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6dbf5e9d75a470d9afc9bc9527aa4d6_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMTktMS0xLTA_16ed0387-8f6c-42e2-b116-4ba003f1c3a9"
      unitRef="usd">-270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic32d3c882e084aa79bd397aa974b4613_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTMtMjEtMS0xLTA_065bdd41-4f7a-435e-bb0c-538f4459ff52"
      unitRef="usd">34458000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iaa079d11b5954062bd47deae009f8794_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTQtMTMtMS0xLTA_114fc2c0-7f05-453e-9bc2-ab05bca6feb0"
      unitRef="usd">-5140000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia192e319dcd6445490a592f325146563_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTQtMTctMS0xLTA_e4e89d19-a954-410d-b928-db8681eb7e3a"
      unitRef="usd">-5140000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5b882abb91484bcfb43daf1e92edb3c7_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTQtMTktMS0xLTA_a9867bbe-4c01-4f2f-8043-12c3d3b1ceb5"
      unitRef="usd">3000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTQtMjEtMS0xLTA_c0d35883-ca5d-4821-a2d8-85d23de9fd9b"
      unitRef="usd">-5137000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i2baaf7ccbcd1454fb5493e534db9c3e5_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTUtMTEtMS0xLTA_7bef9126-57d0-4cbf-8739-b07140cb72b4"
      unitRef="usd">18000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia192e319dcd6445490a592f325146563_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTUtMTctMS0xLTA_03c2e249-dead-45ee-9cdc-b6e05ca5bb2c"
      unitRef="usd">18000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTUtMjEtMS0xLTA_c4eb4cac-c47a-4f39-b10b-acd2586ee30f"
      unitRef="usd">18000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2010021fc3d045089492ab8ba091452b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTYtNS0xLTEtMA_0fcec855-66a6-4824-ad9e-17b597950d58"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8caa352b6c734881a00e24477692efc9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTYtOS0xLTEtMA_d658f8ee-7f93-4ba6-b219-0aeb30421b52"
      unitRef="usd">246000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia192e319dcd6445490a592f325146563_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTYtMTctMS0xLTA_8b410123-3c7a-4777-a16a-b3f8b53239e7"
      unitRef="usd">246000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTYtMjEtMS0xLTA_da657785-37c7-4319-b180-7da2d554246e"
      unitRef="usd">246000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i2010021fc3d045089492ab8ba091452b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTctNS0xLTEtMA_945f1d0a-a356-400e-89e8-a57e617142b7"
      unitRef="shares">20000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8caa352b6c734881a00e24477692efc9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTctOS0xLTEtMA_c12eb8f8-1169-46b9-a817-9f2e9b8f1604"
      unitRef="usd">37000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia192e319dcd6445490a592f325146563_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTctMTctMS0xLTA_5290d44c-bdd2-4b35-abcf-122067405b8f"
      unitRef="usd">37000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMTctMjEtMS0xLTA_6230c563-d9ff-48f0-8802-f83e5316027a"
      unitRef="usd">37000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesOutstanding
      contextRef="idf716bf4e64c42eb93f27e30efd66f84_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMS0xLTEtMA_17358e71-c37a-4c74-8470-1b7223c93ebe"
      unitRef="shares">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf716bf4e64c42eb93f27e30efd66f84_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMy0xLTEtMA_6c35c977-965b-432d-98b5-09f933e1836a"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i4a228f73f8ea40d091b343b12607676d_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtNS0xLTEtMA_330de0bf-9999-41b9-ab0d-e180a1385ea9"
      unitRef="shares">10413000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a228f73f8ea40d091b343b12607676d_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtNy0xLTEtMA_36fec857-43c2-4b5a-9d5c-3dc0321018f9"
      unitRef="usd">10000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia45d7e7fa98744c99e820d7277685eb7_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtOS0xLTEtMA_21abdbd2-8b55-4ecf-bcea-e74dd1f69f03"
      unitRef="usd">438133000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa36c77971f34e0e8b157159bb4fe935_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTEtMS0xLTA_7115d125-812f-483a-a5be-f5657f8ad2bb"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic17110eb863e4e77a7720e0ac50759c1_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTMtMS0xLTA_1dc826bd-ba8a-4c3c-96d1-3e9920a18832"
      unitRef="usd">-407546000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85327901e88841e5a13ea69126435f01_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTUtMS0xLTA_4d2a754c-fdcd-4bda-82b3-132b3514f66c"
      unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i075dc3333dea40c2b3dea37dbfd62c23_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTctMS0xLTA_42bc659b-0265-4610-9895-d505833e5af6"
      unitRef="usd">29889000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3039884f741e48f9b0efd984a250fb4f_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMTktMS0xLTA_e1937e97-a139-495a-957f-b86b2a49c428"
      unitRef="usd">-267000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec42dab4bf014f308c2e8b7cb3366e6a_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8yOC9mcmFnOjg5YzRlNjMzY2JkZjQ1OGNhYmUzOTlhZmM5OTNhYzJiL3RhYmxlOjhlMTM5MzFkNjAwNTQ3YWM4NDA2M2I5MDc5MzE2OWM2L3RhYmxlcmFuZ2U6OGUxMzkzMWQ2MDA1NDdhYzg0MDYzYjkwNzkzMTY5YzZfMjAtMjEtMS0xLTA_dd5206c3-29e5-490a-b682-a6f4383568cd"
      unitRef="usd">29622000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMy0xLTEtMS0w_65062eff-e05e-4690-86f7-16ee1d92680b"
      unitRef="usd">2616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMy0zLTEtMS0w_fe317975-c91a-4c9f-ac27-673dc5b28a1d"
      unitRef="usd">-9502000</us-gaap:ProfitLoss>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfNS0xLTEtMS0w_a3c447d6-3814-42d2-afed-d6d7f9e0fc4a"
      unitRef="usd">861000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfNS0zLTEtMS0w_99cbae1f-0d09-430d-bb6f-d0f634252021"
      unitRef="usd">793000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:DepreciationAndAmortization
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfNi0xLTEtMS0w_24591008-81bf-41c2-b717-f3c68d64a214"
      unitRef="usd">30000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfNi0zLTEtMS0w_c34518ba-cfc7-4215-b11f-40076e98a132"
      unitRef="usd">35000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfOS0xLTEtMS0w_5eb6ad85-e0fa-4973-9cdf-d91e501be93b"
      unitRef="usd">-40000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfOS0zLTEtMS0w_e0ada0b6-463c-48a1-bbed-2719755f4a63"
      unitRef="usd">-133000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTEtMS0xLTEtMA_7e314445-1f3e-4865-8546-0d55424cb8c2"
      unitRef="usd">920000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTEtMy0xLTEtMA_57bfc394-c239-49ae-ab42-439b11a6e913"
      unitRef="usd">110000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTItMS0xLTEtMA_974d7ebd-59dc-4c8e-8145-b1ab068083e9"
      unitRef="usd">-308000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTItMy0xLTEtMA_fc848dd7-815a-4b74-89ba-fb07163d9568"
      unitRef="usd">-181000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTMtMS0xLTEtMA_38bd304a-c06c-41a6-8329-ef67c8314f64"
      unitRef="usd">-2673000</clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities>
    <clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTMtMy0xLTEtMA_4605bbcb-dbc3-4338-8373-5f0a5b1005b0"
      unitRef="usd">-1735000</clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTQtMS0xLTEtMA_54c1bf76-5680-4183-80d3-35993788b118"
      unitRef="usd">262000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTQtMy0xLTEtMA_19d3a354-5cd4-4a1c-a528-0063d5f0968f"
      unitRef="usd">-10205000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTYtMS0xLTEtMA_f884f7c2-0f76-4f02-936a-81dc7e34cf30"
      unitRef="usd">8235000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTYtMy0xLTEtMA_0a00c9c3-89c4-4c7e-83fa-8a5108bd11ae"
      unitRef="usd">25969000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTctMS0xLTEtMA_c715bb89-2230-4977-af09-be1b8aafd317"
      unitRef="usd">11104000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTctMy0xLTEtMA_0b6d6154-fee0-4fde-8f42-bcf941d858d7"
      unitRef="usd">36721000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTgtMS0xLTEtMA_9d9c1148-5777-412b-942f-c258888bf40a"
      unitRef="usd">14000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTgtMy0xLTEtMA_10fc3f64-9b6e-4af1-961b-09f8a47e6043"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTktMS0xLTEtMA_0996f8d8-c026-4429-8401-309de5682b72"
      unitRef="usd">2855000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMTktMy0xLTEtMA_1351b05c-d820-448c-bf44-abcb70baff52"
      unitRef="usd">10752000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjItMS0xLTEtMA_01898859-4806-47db-9817-1bfee0142943"
      unitRef="usd">148000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjItMy0xLTEtMA_7c1176b4-d993-4133-90a6-cdd4955a3505"
      unitRef="usd">130000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjMtMS0xLTEtMA_370aaab1-740d-43bd-8aec-155db2ab4de4"
      unitRef="usd">9683000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjMtMy0xLTEtMA_78ae9a01-6719-4140-994b-86bc04e1a206"
      unitRef="usd">1038000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjUtMS0xLTEtMA_cb2c4ba3-b579-4a18-96c6-bacbec484e3e"
      unitRef="usd">9535000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjUtMy0xLTEtMA_0a7449b3-a43e-44f3-b464-c314c824b136"
      unitRef="usd">908000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjYtMS0xLTEtMA_6225e180-45c1-4016-859f-34585233d85f"
      unitRef="usd">12652000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjYtMy0xLTEtMA_ac891cc1-5f23-4f4f-9c5a-f6cadccb2163"
      unitRef="usd">1455000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjctMS0xLTEtMA_d5308ba8-e311-463a-a69f-93be8800dc7d"
      unitRef="usd">14032000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i12238a4194304af292dc658a465a9869_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjctMy0xLTEtMA_729794b3-9e9b-428c-887c-bd20864cdbe6"
      unitRef="usd">10299000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjgtMS0xLTEtMA_a7ab5224-ecea-475d-b13e-23d23333096d"
      unitRef="usd">26684000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="iec42dab4bf014f308c2e8b7cb3366e6a_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zMS9mcmFnOjVhMzcwZGY2N2Y4NTRjYjhiODhmZjEzMTg4YWFjNWQ3L3RhYmxlOmU5M2M4ZjVmYzExZjQ0YzI5MjdhYzNmMWYxYjJkZDdlL3RhYmxlcmFuZ2U6ZTkzYzhmNWZjMTFmNDRjMjkyN2FjM2YxZjFiMmRkN2VfMjgtMy0xLTEtMA_96e33449-5fde-42a8-9723-55f3e9caf440"
      unitRef="usd">11754000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <clbs:BusinessTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zNy9mcmFnOmE2MmQ0NjAyMmVlOTQ2ZDVhZDE1MzNkMDI2NjUzYWY3L3RleHRyZWdpb246YTYyZDQ2MDIyZWU5NDZkNWFkMTUzM2QwMjY2NTNhZjdfMTE5MTM_9193c624-9e29-4d2f-8397-7d6789704624">The Business&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Caladrius Biosciences, Inc. (&#x201c;we,&#x201d; &#x201c;us,&#x201d; "our," &#x201c;Caladrius&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of cellular therapies designed to reverse disease and/or promote the regeneration of damaged tissue. The Company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. The Company's technology leverages these cells to enable the body's natural repair mechanisms using formulations unique to each medical indication.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company's leadership team has decades of collective biopharmaceutical development experience and world-recognized scientific achievement in the field of cardiovascular disease, among other therapeutic areas. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The Company's current product candidates include CLBS119, an emergent CD34+ stem cell therapy responding to the COVID-19 pandemic and the potentially permanent damage the virus inflicts on the lungs of many patients, as well as three other developmental treatments for ischemic diseases based on its CD34+ cell therapy platform: CLBS12, recipient of SAKIGAKE designation and eligible for early conditional approval in Japan for the treatment of critical limb ischemia ("CLI") based on the results of an ongoing clinical trial; CLBS16, the subject of a recently completed positive Phase 2 clinical trial in the U.S. for the treatment of coronary microvascular dysfunction ("CMD"); and CLBS14, a Regenerative Medicine Advanced Therapy ("RMAT") designated therapy for which the Company has finalized with the U.S. Food and Drug Administration (the "FDA") a protocol for a Phase 3 confirmatory trial in subjects with no-option refractory disabling angina ("NORDA").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Ischemic Repair (CD34 Cell Technology)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The CD34+ cell was discovered as a result of the deliberate search for a stem cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels after injury. A CD34+ cell is a stem cell that has the ability to stimulate new blood vessel formation. No other native cell discovered to date has demonstrated this same capability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s proprietary CD34+ cell technology has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is restricted. Through the administration of CD34+ cells, the Company seeks to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. Caladrius believes that a number of conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology, including but not limited to, CLI, CMD, NORDA and COVID-19 induced lung damage.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;CLBS119 for Treatment of COVID -19 Induced Lung Damage&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;COVID-19 appears to damage the vasculature of the lungs and Caladrius believes that repair of that vasculature will prove necessary for patients to achieve a full recovery. Survivors of COVID-19 often remain debilitated even after leaving the hospital due to the damage caused to their lungs, and while many developmental therapies responding to the COVID-19 pandemic are appropriately targeting the SARS-CoV-2 virus itself or the manifestations of the acute phase of the illness, Caladrius is aware of no therapy that has demonstrated the ability to repair COVID-19 induced lung damage. With consistent clinical and pre-clinical evidence that CD34+ cells can repair multiple organs, including models of severe lung inflammation, the Company sought and received FDA authorization for its investigational new drug (&#x201c;IND&#x201d;) application for the study of CLBS119, a CD34+ cell therapy for repair of COVID-19 induced lung damage. The planned study, with enrollment expected to commence in the second half of 2020, will target patients with severe SARS-CoV-2 infection who, after ventilatory support due to respiratory failure, had otherwise recovered but remained debilitated due to persistent pulmonary damage. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;CLBS12 for Treatment of Critical Limb Ischemia&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company's open-label, registration-eligible study of CLBS12 in Japan for the treatment of critical limb ischemia ("CLI"), a disease with no currently available approved therapy and a higher combined incidence and mortality rate than all cancers but lung cancer, has shown strong results to date. The initial responses observed in the subjects who have reached an &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;endpoint in this open label study are consistent with a positive therapeutic effect and safety profile as reported by previously published clinical trials in Japan. Although the study's enrollment, which is targeted for completion this year, has been slowed by the pandemic's impact in Japan, the Company is encouraged by the patient pre-screening pipeline that has been identified and hopes to conclude trial enrollment rapidly once the coronavirus abates. While the final outcome of the trial will depend on all data from all subjects, data from the concluded Buerger's Disease cohort and the data to date in the no-option CLI cohort remain very encouraging.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;CLBS16 for Treatment of Coronary Microvascular Dysfunction&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In 2017, with the assistance of a $1.9&#160;million grant from the National Institutes of Health (Award Number R44HL135889), Caladrius initiated its program for CLBS16 for the treatment of coronary microvascular dysfunction ("CMD"), a disease that potentially afflicts millions of patients with no current targeted treatment options. That study, titled ESCaPE-CMD, was a Phase 2 proof-of-concept study that enrolled patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. In June 2019, the Company announced the completion of enrollment in this study. Results of the first 17 of 20 patients enrolled in this trial who reached 6-month follow-up were presented as a rapid fire oral presentation on November 16, 2019 at the annual meeting of the American Heart Association in Philadelphia, PA by one of the principal investigators, Dr. Noel Bairey Merz, FACC, FAHA, FESC, the director of the Barbra Streisand Women's Heart Center at Cedars-Sinai in Los Angeles, CA. That data set showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian Cardiovascular Society Angina Class and Seattle Questionnaire score, as well as an acceptable safety profile. The full data from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May 14, 2020 and we now expect to initiate the next CMD trial, a Phase 2b study, by the end of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;CLBS14 for Treatment of No Option Refractory Disabling Angina (NORDA)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company acquired the rights to data and regulatory filings for a CD34+ cell therapy program for refractory angina that had been advanced to Phase 3 by a previous sponsor.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Based on the clinical evidence from the completed studies that a single administration of CLBS14 reduces mortality, improves angina and increases exercise capacity in patients with otherwise untreatable angina, this product received Regenerative Medicine Advanced Therapy (&#x201c;RMAT&#x201d;) designation from the FDA. The Company, working closely with the FDA, has finalized the design of a confirmatory Phase 3 trial which, in combination with previously filed Phase 1, 2 and 3 data, will be considered for the registration of CLBS14. Notably, this study design includes a 6-month primary endpoint and, with the benefit of the RMAT designation, the biologics license application ("BLA"), once submitted, is expected to receive a 6-month review. The Company has substantially completed the preparatory work for initiation of this trial. Caladrius will not, however, commence enrollment of patients until sufficient capital is acquired and dedicated to this program such that the Company has confidence that it can fund the trial uninterrupted through completion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Additional Out-licensing Opportunities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company's broad intellectual property portfolio of cell therapy assets includes notable programs available for out-licensing in order to continue their clinical development. Its current long-term strategy focuses on advancing its therapies through development with the ultimate objective of obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to realize potentially meaningful value increases within its own proprietary pipeline if the Company is successful in advancing its product candidates to their next significant development milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Coronavirus Considerations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, a novel strain of coronavirus (SARS-CoV-2), which causes COVID-19, was reported to have surfaced in China.  In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects.  While the disruption currently is expected to be temporary, there is uncertainty around the extent and duration of disruption, and any future related financial impact cannot be reasonably estimated at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim financial information. Accordingly, they do &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#x2019;s financial position as of June&#160;30, 2020, and the results of its operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2019 and 2018 included in our 2019 Form 10-K. Operating results for the three and six months ended June&#160;30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amount of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly, actual results could differ from those estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Consolidated Financial Statements include the accounts of Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</clbs:BusinessTextBlock>
    <us-gaap:GrantsReceivable
      contextRef="i435d817d085a4640b5a6c1464fc2d6c6_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl8zNy9mcmFnOmE2MmQ0NjAyMmVlOTQ2ZDVhZDE1MzNkMDI2NjUzYWY3L3RleHRyZWdpb246YTYyZDQ2MDIyZWU5NDZkNWFkMTUzM2QwMjY2NTNhZjdfNDM5ODA0NjUyMzQ2NA_0baf9d70-79d6-452b-9a49-74f04b1b6118"
      unitRef="usd">1900000</us-gaap:GrantsReceivable>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80MC9mcmFnOmYxNTBhYWRkNWMwZjQ0ZWY4ZDEyODg4NWY5NmRkNmM0L3RleHRyZWdpb246ZjE1MGFhZGQ1YzBmNDRlZjhkMTI4ODg1Zjk2ZGQ2YzRfNTU0NA_d474bdcc-60da-4d21-9751-95fa3a9b78f0">Summary of Significant Accounting Policies&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In addition to the policies below, the Company's significant accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included in its 2019 Form 10-K. There were no changes to these policies during the three and six months ended June&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Concentration of Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States.  Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Share-Based Compensation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company expenses all share-based payment awards to employees, directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#x2019;s restricted stock and restricted stock units is based on the closing market price of the Company&#x2019;s common stock on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires that a lessee recognize lease assets and lease liabilities for those leases classified as operating leases. The guidance was effective for interim and annual periods beginning after December 15, 2018 and was adopted as of January 1, 2019. The Company adopted the standard using the modified retrospective transition method, with an immaterial adjustment to accumulated deficit upon adoption. The comparative information has not been restated and continues to be reported under the accounting standards that were in effect &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;for those periods. The Company concluded that the adoption of ASU 2016-02 was non-cash in nature, did not affect the Company's cash position, and did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#x2014;Credit Losses, which will require companies to present assets held at amortized cost and available for sale debt securities net of the amount expected to be collected. The guidance requires the measurement of expected credit losses to be based on relevant information from past events, including historical experiences, current conditions and reasonable and supportable forecasts that affect collectability. The guidance was effective for fiscal years and interim periods beginning after December 15, 2019 and early adoption was permitted. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2018, the FASB issued ASU 2018-07, "Improvements to Nonemployee Share-Based Payment Accounting," which supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payments arrangements related to the acquisition of goods and services from both employees and nonemployees. For public companies, the amendments are effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual periods. Early adoption was permitted, but no earlier than a company's adoption date of ASC 606. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2019, the FASB issued ASU 2019-07, "Codification Updates to SEC Sections", to codify the SEC releases that clarify and improve the disclosure and presentation requirements of a variety of codification topics, thereby eliminating certain disclosure requirements that were redundant, duplicative, overlapping, outdated, or superseded. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In October 2019, the FASB issued ASU 2019-12, which affects general principles within Topic 740, Income Taxes. The amendments of&#160;ASU 2019-12&#160;are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company believes that the adoption of this new accounting guidance will not have a material impact on its financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80MC9mcmFnOmYxNTBhYWRkNWMwZjQ0ZWY4ZDEyODg4NWY5NmRkNmM0L3RleHRyZWdpb246ZjE1MGFhZGQ1YzBmNDRlZjhkMTI4ODg1Zjk2ZGQ2YzRfNTU0Ng_224b4cf3-26f4-44a1-909c-bbfd9f6e0be6">&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Concentration of Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States.  Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80MC9mcmFnOmYxNTBhYWRkNWMwZjQ0ZWY4ZDEyODg4NWY5NmRkNmM0L3RleHRyZWdpb246ZjE1MGFhZGQ1YzBmNDRlZjhkMTI4ODg1Zjk2ZGQ2YzRfNTU0MQ_7879e279-c2b4-47c8-a51a-038575f49339">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Share-Based Compensation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&lt;/span&gt;The Company expenses all share-based payment awards to employees, directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#x2019;s restricted stock and restricted stock units is based on the closing market price of the Company&#x2019;s common stock on the date of grant.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80MC9mcmFnOmYxNTBhYWRkNWMwZjQ0ZWY4ZDEyODg4NWY5NmRkNmM0L3RleHRyZWdpb246ZjE1MGFhZGQ1YzBmNDRlZjhkMTI4ODg1Zjk2ZGQ2YzRfNTUyNg_fcd36c92-3886-46e7-ae94-c073f00caf62">&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;New Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires that a lessee recognize lease assets and lease liabilities for those leases classified as operating leases. The guidance was effective for interim and annual periods beginning after December 15, 2018 and was adopted as of January 1, 2019. The Company adopted the standard using the modified retrospective transition method, with an immaterial adjustment to accumulated deficit upon adoption. The comparative information has not been restated and continues to be reported under the accounting standards that were in effect &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;for those periods. The Company concluded that the adoption of ASU 2016-02 was non-cash in nature, did not affect the Company's cash position, and did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#x2014;Credit Losses, which will require companies to present assets held at amortized cost and available for sale debt securities net of the amount expected to be collected. The guidance requires the measurement of expected credit losses to be based on relevant information from past events, including historical experiences, current conditions and reasonable and supportable forecasts that affect collectability. The guidance was effective for fiscal years and interim periods beginning after December 15, 2019 and early adoption was permitted. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2018, the FASB issued ASU 2018-07, "Improvements to Nonemployee Share-Based Payment Accounting," which supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payments arrangements related to the acquisition of goods and services from both employees and nonemployees. For public companies, the amendments are effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual periods. Early adoption was permitted, but no earlier than a company's adoption date of ASC 606. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2019, the FASB issued ASU 2019-07, "Codification Updates to SEC Sections", to codify the SEC releases that clarify and improve the disclosure and presentation requirements of a variety of codification topics, thereby eliminating certain disclosure requirements that were redundant, duplicative, overlapping, outdated, or superseded. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In October 2019, the FASB issued ASU 2019-12, which affects general principles within Topic 740, Income Taxes. The amendments of&#160;ASU 2019-12&#160;are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company believes that the adoption of this new accounting guidance will not have a material impact on its financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RleHRyZWdpb246MWI1ZjNiM2M1NDYzNDhkOGEyYTI5YmNjNTliNDcxNmJfNjM4_612a8fc9-622a-4db5-a3d6-5c3d8840c1f0">Available-for-Sale-Securities&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.00pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:94.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sovereign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:360.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:70.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:70.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:361.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:70.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:70.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Greater than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RleHRyZWdpb246MWI1ZjNiM2M1NDYzNDhkOGEyYTI5YmNjNTliNDcxNmJfNjM0_3b1b5304-7998-4db4-9f66-5311b8732467">&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.00pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:94.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:46.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sovereign government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibc9cdd25bf88475f8e513d4db47ee846_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0xLTEtMS0w_5ec9da01-b44b-403b-abf5-781aff9a9841"
      unitRef="usd">6430000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibc9cdd25bf88475f8e513d4db47ee846_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0zLTEtMS0w_7e572201-57d8-4be8-a6f4-cfd4462a6191"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibc9cdd25bf88475f8e513d4db47ee846_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy01LTEtMS0w_6f465176-484d-41dd-98c0-84cda9138b0d"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc9cdd25bf88475f8e513d4db47ee846_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy03LTEtMS0w_a7bf0b95-c08d-4e7f-821e-5526db0a5db9"
      unitRef="usd">6425000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i51276a8f169f436da9ec48301dcd051a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy05LTEtMS0w_28f6c7b0-5698-4d39-9dd6-4e2be0d5d08f"
      unitRef="usd">11673000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i51276a8f169f436da9ec48301dcd051a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0xMS0xLTEtMA_132e0417-9220-47fd-b1c1-842dda1b1978"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i51276a8f169f436da9ec48301dcd051a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0xMy0xLTEtMA_11ea3b82-9306-4cbc-bd69-d783d7929c63"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i51276a8f169f436da9ec48301dcd051a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfMy0xNS0xLTEtMA_ceb9bcb1-37c4-4bbd-8438-1f3e6745254f"
      unitRef="usd">11675000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6b8db529f1db479582f2818c75225c64_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0xLTEtMS0w_eb7c5ed2-cfbb-4bd8-9fa1-e213dd0ef994"
      unitRef="usd">5019000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6b8db529f1db479582f2818c75225c64_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0zLTEtMS0w_d13fa779-3605-45f2-9783-b97a5549dcbd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6b8db529f1db479582f2818c75225c64_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC01LTEtMS0w_a1a80cd4-849d-4f33-852f-045e067af3e0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b8db529f1db479582f2818c75225c64_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC03LTEtMS0w_855184e7-98f9-4191-8f2e-b8c4751694d6"
      unitRef="usd">5019000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC05LTEtMS0w_2531e988-736a-4ce1-8097-30d309418a4b"
      unitRef="usd">11093000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0xMS0xLTEtMA_0729ba07-ab6c-4aa0-9fc3-00190cba4105"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0xMy0xLTEtMA_e2dc6084-15db-422d-be74-d16138792ed8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i22aeacadb2114d60a80e627b5cdf3e7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNC0xNS0xLTEtMA_a894b3a6-2f24-42ab-b19b-1d8789681533"
      unitRef="usd">11093000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i411233e5c6644b1299e6cd2602fff077_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0xLTEtMS0w_8616ac2a-259e-4b43-8d39-3d60e6e05e25"
      unitRef="usd">20975000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i411233e5c6644b1299e6cd2602fff077_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0zLTEtMS0w_c6cb6b61-3806-416f-85eb-5161678aeb1f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i411233e5c6644b1299e6cd2602fff077_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS01LTEtMS00MTg_1e2a09a0-5bdb-4293-a0e2-37a514fe3ab4"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i411233e5c6644b1299e6cd2602fff077_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS03LTEtMS0w_04b0f527-92d7-4ee6-9523-697aab3109bf"
      unitRef="usd">20973000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie09e7b16df084c27894b034b50301fc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS05LTEtMS0w_2f4c66b5-12cd-4fb2-a3b6-40eaaaabbd07"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie09e7b16df084c27894b034b50301fc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0xMS0xLTEtMA_869aaf9c-33d2-483b-8e48-3cabbdc10e96"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie09e7b16df084c27894b034b50301fc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0xMy0xLTEtMA_2c78e4fa-6ea0-4bf1-8d34-f8a301a40b62"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie09e7b16df084c27894b034b50301fc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNS0xNS0xLTEtMA_2051f026-e55d-4ceb-99cc-f869c691c4ee"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i52a8a4bbf7814421a7344fbca72e4db2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0xLTEtMS0w_d166b5fa-02a9-4c19-9713-39c2c9e965cb"
      unitRef="usd">197000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i52a8a4bbf7814421a7344fbca72e4db2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0zLTEtMS0w_f94d10d6-ee10-49ac-90f0-49458214a19d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i52a8a4bbf7814421a7344fbca72e4db2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi01LTEtMS0w_38bcd6ce-35f5-4893-b0d6-339e1ee132a2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52a8a4bbf7814421a7344fbca72e4db2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi03LTEtMS0w_c032e921-b74a-406c-8c4f-e42d478655c3"
      unitRef="usd">197000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi05LTEtMS0w_f10298b6-fb52-40e0-b167-03b9cc9b7db3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0xMS0xLTEtMA_079789a2-d07b-4ee2-8e18-2264772a69cb"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0xMy0xLTEtMA_27619e23-fa49-4242-a411-c516a6febfb7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i99fd1884eb454ed79d1ffe6c21a2318d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNi0xNS0xLTEtMA_e53c4b94-c5bb-4aec-8bb4-0abc22e9f590"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0xLTEtMS0w_018c7607-ada7-47d4-8aad-205f9c65dbf3"
      unitRef="usd">32621000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0zLTEtMS0w_9c6fdcb2-df0a-4748-b849-5fa4fc4afdd2"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy01LTEtMS0w_53bb8395-f761-4282-9414-f5cfb5997d5f"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy03LTEtMS0w_752c50b1-73ef-4978-831c-8afdd376845f"
      unitRef="usd">32614000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy05LTEtMS0w_2f65c715-7f0e-4499-88cb-f5736c724062"
      unitRef="usd">22766000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0xMS0xLTEtMA_3e779d58-ccfa-4238-ac86-9b5822c950f0"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0xMy0xLTEtMA_8ce30841-38bc-47e6-9f66-74e5bb6f81f1"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjdlOTNhNzJhN2FiMDRjZGFhODViMDQwZTllMzRiNmQ3L3RhYmxlcmFuZ2U6N2U5M2E3MmE3YWIwNGNkYWE4NWIwNDBlOWUzNGI2ZDdfNy0xNS0xLTEtMA_3633b5f9-33c8-4a7d-a272-9f03c5cb3357"
      unitRef="usd">22768000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RleHRyZWdpb246MWI1ZjNiM2M1NDYzNDhkOGEyYTI5YmNjNTliNDcxNmJfNjQ0_804bde8c-dd2a-4507-b234-0106ac3775d6">&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:360.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:70.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:70.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:Cash
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMS0xLTEtMS0w_0e187adc-1b91-4475-8bb6-1c89c8dc0b82"
      unitRef="usd">24407000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMS0zLTEtMS0w_97b969e7-2287-4a0a-b6c4-d220c6ed3448"
      unitRef="usd">11643000</us-gaap:Cash>
    <us-gaap:MarketableSecurities
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMi0xLTEtMS0w_37eff920-fdd9-4470-b227-477ebf735bbc"
      unitRef="usd">8207000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMi0zLTEtMS0w_c4e81c16-0c98-4ef8-8119-bc1d512f3a7b"
      unitRef="usd">11125000</us-gaap:MarketableSecurities>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMy0xLTEtMS0w_7cce0f06-70bf-4ceb-9d34-99787b2f6665"
      unitRef="usd">32614000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjczZWY4ZDY3NjY5MTQyMDI5N2JkYWYwYmMzMmViY2UzL3RhYmxlcmFuZ2U6NzNlZjhkNjc2NjkxNDIwMjk3YmRhZjBiYzMyZWJjZTNfMy0zLTEtMS0w_6d8db7bf-c881-4a80-afcc-4cc65e92ce18"
      unitRef="usd">22768000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RleHRyZWdpb246MWI1ZjNiM2M1NDYzNDhkOGEyYTI5YmNjNTliNDcxNmJfNjMw_20f1a1cc-102a-4398-a36b-1b33b8d42618">&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:361.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:70.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:70.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Greater than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfMi0xLTEtMS0w_382ad7c3-4e39-4a85-895a-fa4e639c89f6"
      unitRef="usd">32621000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfMi0zLTEtMS0w_49d4695f-9256-4fca-98e5-f815e767fb16"
      unitRef="usd">32614000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfMy0xLTEtMS0w_0281cc22-f963-4e57-b2bd-029857b39ccc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfMy0zLTEtMS0w_d003f425-7e90-4720-b184-cc5bfb1a4db8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfNC0xLTEtMS0w_aef75846-205a-4738-9521-7cdcae8d2ca6"
      unitRef="usd">32621000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80My9mcmFnOjFiNWYzYjNjNTQ2MzQ4ZDhhMmEyOWJjYzU5YjQ3MTZiL3RhYmxlOjE2YTQyNzIyNTAxNjRkODNiZDUxOGYyZWEzY2YxMWQwL3RhYmxlcmFuZ2U6MTZhNDI3MjI1MDE2NGQ4M2JkNTE4ZjJlYTNjZjExZDBfNC0zLTEtMS0w_34ced489-9ec4-4109-8122-badfa4f50891"
      unitRef="usd">32614000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RleHRyZWdpb246OWVkYjA0YTZjNmVmNDFmNmFmNTI1YWQzZjE1YzhmZTRfMzg0ODI5MDY5Nzk5Mg_a2d607f9-6a1e-455e-a203-a7d3a71cf348">Income (Loss) Per Share&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For the three and six months ended June&#160;30, 2020, the Company reported net income in each period.  However, no common stock equivalents were utilized in the calculation of diluted income per share since any conversion as of June&#160;30, 2020 would have been anti-dilutive. For the three and six months ended June&#160;30, 2019, the Company incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive.  At June&#160;30, 2020 and 2019, the Company excluded the following potentially dilutive securities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:65.789%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.666%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.813%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RleHRyZWdpb246OWVkYjA0YTZjNmVmNDFmNmFmNTI1YWQzZjE1YzhmZTRfMzI2_386c99b0-b931-4b22-85ca-64a577a96cdc">At June&#160;30, 2020 and 2019, the Company excluded the following potentially dilutive securities (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:65.789%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.666%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.813%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i380bbd1c1ef540988fa905c4d3a9bbd9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfMi0xLTEtMS0w_373b96ae-691e-4691-af3e-47d8be92b282"
      unitRef="shares">1161000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i038f7c88311e4f759817629c9442fb4e_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfMi0zLTEtMS0w_b50f32b5-708c-4dbc-9ca6-19013dec9777"
      unitRef="shares">1101000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6840633376a8464bb5028c503efbd70d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfMy0xLTEtMS0w_73172ecc-5166-4262-89d5-dfd75ee0d223"
      unitRef="shares">2154000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id489cdfd5a324069840e47683d89ebd3_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfMy0zLTEtMS0w_c6b3cbea-733d-4863-aee8-fd2b567a6b05"
      unitRef="shares">30000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6aaa04fcbbd04e748061483302747deb_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfNS0xLTEtMS0w_86832cf7-da69-4d37-8e9e-56f577006b6e"
      unitRef="shares">313000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7481b7eaae714c60a1ff50e6a622db4d_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl80OS9mcmFnOjllZGIwNGE2YzZlZjQxZjZhZjUyNWFkM2YxNWM4ZmU0L3RhYmxlOjc3MmQwZmI5NGU1MTRkM2NhYzE4ZWY3Yzk5NmM4ODFkL3RhYmxlcmFuZ2U6NzcyZDBmYjk0ZTUxNGQzY2FjMThlZjdjOTk2Yzg4MWRfNS0zLTEtMS0w_d134cb9b-7be5-4591-96e7-b20f543dd94d"
      unitRef="shares">240000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RleHRyZWdpb246YWYxMWJiMzViYmYyNGI4Y2JkMGI3NmU0OWZhMjkwMTVfMTQ3Mg_994d3f0b-7520-437d-9bba-a6ccfcf9e6c7">Fair Value Measurements&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of financial assets and liabilities that are being measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price). The Company is required to classify fair value measurements in one of the following categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 1 inputs are defined as quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 2 inputs are defined as inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 3 inputs are defined as unobservable inputs for the assets or liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table sets forth by level within the fair value hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of June&#160;30, 2020, and December&#160;31, 2019 (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:115.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:12.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Marketable securities - available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RleHRyZWdpb246YWYxMWJiMzViYmYyNGI4Y2JkMGI3NmU0OWZhMjkwMTVfMTQ3OQ_769eb8ee-c328-4304-b147-4312765edb65">&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table sets forth by level within the fair value hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of June&#160;30, 2020, and December&#160;31, 2019 (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:115.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:12.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:42.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Marketable securities - available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i60d3cfe6b6ff47e5a543fcfdc2245182_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0yLTEtMS0w_48dab390-37e2-4d30-9608-841cffb980bd"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i19e4029dd45d4a2e993c6cc753ebd83e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy00LTEtMS0w_376dc702-ac44-4b3e-86dd-8c8ed69158b9"
      unitRef="usd">8207000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i57debf008f6741c6a70e1068fc6fe3c0_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy02LTEtMS0w_13b47d99-023d-455a-96bf-0ccf016f6dc2"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9d727b490abb4a08b6bc611450220f08_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy04LTEtMS0w_f1d3d746-b190-4151-815e-1408c211f239"
      unitRef="usd">8207000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie87a77d2f0f048cda7eb6a19d339ae3f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0xMC0xLTEtMA_2158d5f9-1772-404d-bafb-1de40149966f"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibcebce19867e4bf9b34357c8eedd8e33_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0xMi0xLTEtMA_5958ff54-f4df-4a52-88c4-4b93ab84cfaa"
      unitRef="usd">11125000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idcb791e9b72843fcb667122a6a337f82_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0xNC0xLTEtMA_154730ab-2ed2-4b48-a204-fe846a23e755"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i523ce19cd95244908556f420c606e80b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfMy0xNi0xLTEtMA_db039636-3203-4e2d-b1d6-1238a296200e"
      unitRef="usd">11125000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i60d3cfe6b6ff47e5a543fcfdc2245182_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0yLTEtMS0w_5e0dbfea-d5a2-4a8a-a445-8ebeb835bca5"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i19e4029dd45d4a2e993c6cc753ebd83e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC00LTEtMS0w_f6945713-6d94-48f7-86c6-8ff0056e4fcf"
      unitRef="usd">8207000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i57debf008f6741c6a70e1068fc6fe3c0_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC02LTEtMS0w_a849a8a3-a336-42c0-88da-4787471da98c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9d727b490abb4a08b6bc611450220f08_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC04LTEtMS0w_a27e7976-7676-4663-8521-3f13ab2dcb7c"
      unitRef="usd">8207000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie87a77d2f0f048cda7eb6a19d339ae3f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0xMC0xLTEtMA_4908f4c4-82fe-44a1-aa76-cba9fad98615"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibcebce19867e4bf9b34357c8eedd8e33_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0xMi0xLTEtMA_73bf0ef5-f332-4a4a-bd17-21208cbafdbf"
      unitRef="usd">11125000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idcb791e9b72843fcb667122a6a337f82_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0xNC0xLTEtMA_8f72d5d8-0905-433b-aa67-26f4ec208296"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i523ce19cd95244908556f420c606e80b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81Mi9mcmFnOmFmMTFiYjM1YmJmMjRiOGNiZDBiNzZlNDlmYTI5MDE1L3RhYmxlOmEzYjcwYmNhMDE2MzRmYTJiOTQ4NGQ0YjE2MDcxNjY4L3RhYmxlcmFuZ2U6YTNiNzBiY2EwMTYzNGZhMmI5NDg0ZDRiMTYwNzE2NjhfNC0xNi0xLTEtMA_6fbe1c32-8337-40e1-aa91-ba45eb69655a"
      unitRef="usd">11125000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RleHRyZWdpb246ZWIxNzhlMmUyMmQ2NDBhMThiYTQ0ZWIwYzNlZWEyZWNfMTEw_6bbdefcd-d59b-4253-b1cf-22facf4cad6e">Accrued Liabilities&lt;div style="text-indent:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Accrued liabilities as of June&#160;30, 2020 and December&#160;31, 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.75pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:313.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:97.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:88.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Salaries, employee benefits and related taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liabilities -- current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;CIRM upfront funding -- current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RleHRyZWdpb246ZWIxNzhlMmUyMmQ2NDBhMThiYTQ0ZWIwYzNlZWEyZWNfMTA2_75fe1c29-f983-40be-8025-d303af793ee7">&lt;div style="text-indent:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Accrued liabilities as of June&#160;30, 2020 and December&#160;31, 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.75pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:313.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:97.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:88.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Salaries, employee benefits and related taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liabilities -- current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;CIRM upfront funding -- current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMS0xLTEtMS0w_5ffdf98b-bae8-470f-a8b3-c7c59398cc7b"
      unitRef="usd">1441000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMS0zLTEtMS0w_1e3f65ab-f78c-4adb-a4a1-f7518f60b53b"
      unitRef="usd">1834000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMi0xLTEtMS0w_4944899b-6a5e-4574-b800-3f61e37265a6"
      unitRef="usd">349000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMi0zLTEtMS0w_bc69031b-0e7b-4b2f-942e-805f0c59a66c"
      unitRef="usd">354000</us-gaap:OperatingLeaseLiabilityCurrent>
    <clbs:AccruedGrantFunding
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMy0xLTEtMS0w_c8076d04-9af0-4e24-8b55-26ce9267028e"
      unitRef="usd">229000</clbs:AccruedGrantFunding>
    <clbs:AccruedGrantFunding
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfMy0zLTEtMS0w_c7df8f95-8ddb-4c2a-9490-434dc602f816"
      unitRef="usd">1600000</clbs:AccruedGrantFunding>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfNC0xLTEtMS0w_d8b5183d-c4c5-44c1-8e11-0d982cb5df18"
      unitRef="usd">869000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfNC0zLTEtMS0w_ed884ba8-d1c2-444a-8fdb-55c1865df34c"
      unitRef="usd">698000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfNS0xLTEtMS0w_0964ec9e-0937-413a-90c7-948d8aa5b240"
      unitRef="usd">2888000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81NS9mcmFnOmViMTc4ZTJlMjJkNjQwYTE4YmE0NGViMGMzZWVhMmVjL3RhYmxlOjdlZmM5Mjk2MmVjZTQ5NWU4YjgwMGY3ZmQzNGI4N2U0L3RhYmxlcmFuZ2U6N2VmYzkyOTYyZWNlNDk1ZThiODAwZjdmZDM0Yjg3ZTRfNS0zLTEtMS0w_208533d2-168f-4450-b586-9d2090d45f4c"
      unitRef="usd">4486000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTM0OQ_15d589d3-9ba5-4876-a5bc-52ff6812cd85">Operating Leases&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has operating leases for two offices with terms that expire in 2022 and 2023. The Company estimates its incremental borrowing rate, at lease commencement, to determine the present value of lease payments, since most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases include options for the Company to extend the lease term and/or sub-lease space in whole or in part.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:325.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:88.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:88.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Right-of Use Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Right-of-Use Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating Lease Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Operating Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of June&#160;30, 2020, the weighted average remaining lease term for our operating leases was 1.6 years, and the weighted average discount rate for our operating leases was 9.625%. Future minimum lease payments under the lease agreements as of June&#160;30, 2020 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:448.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:60.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: Amounts representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <clbs:NumberOfOfficesUnderOperatingLeases
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfNzA_95a4c3ba-8926-49ac-84af-42e353eb0881"
      unitRef="office">2</clbs:NumberOfOfficesUnderOperatingLeases>
    <clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTM0Nw_b1679151-5621-416e-adde-a6cab4915d13">Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet were as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:325.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:88.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:88.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Right-of Use Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Right-of-Use Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating Lease Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Operating Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if91087121ec44256b8962731a81173e2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfMi0xLTEtMS0w_4bcc1684-3437-493b-8dca-5831e075d1c9"
      unitRef="usd">731000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i899c54667f134030ae5390e6bdd1b0f3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfMi0zLTEtMS0w_5339fdad-3709-43d2-83ee-d76cb8bb0961"
      unitRef="usd">906000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfMy0xLTEtMS0w_6906f8e0-3583-43b1-ab04-0508268f2314"
      unitRef="usd">731000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfMy0zLTEtMS0w_066eb194-171f-4faa-af1d-cfb2620d9bba"
      unitRef="usd">906000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5f781bdb8e5f41e99cf7d9a445cea06c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfNi0xLTEtMS0w_f67dc510-b580-46b8-a6e5-7d62041d7682"
      unitRef="usd">349000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i20af34c4f7754a0cb76befe079bbf0c6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfNi0zLTEtMS0w_800ca813-34ff-4132-b25f-3adbcf077ab1"
      unitRef="usd">353000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic00237ce125744ceb6a8b4882def3994_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfNy0xLTEtMS0w_6441576f-b768-4151-a9a0-e62c644aac34"
      unitRef="usd">445000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iabb27bf045414866879a04335d6c62eb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfNy0zLTEtMS0w_841496e1-ba55-4e13-8245-85ec05730e43"
      unitRef="usd">624000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfOC0xLTEtMS0w_b78a173a-daa5-4774-8dcd-9829ceed70e8"
      unitRef="usd">794000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjRmNDhmYjE0MmUwZTQ5MmFhMTgyYjMwYmUxZWMxNjk5L3RhYmxlcmFuZ2U6NGY0OGZiMTQyZTBlNDkyYWExODJiMzBiZTFlYzE2OTlfOC0zLTEtMS0w_2547f61b-562f-4553-a3e3-a66a99672654"
      unitRef="usd">977000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTE2Mw_71b7bffb-3580-4653-a9fb-2a3e04786c4f">P1Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTIzNQ_65691802-055d-49e6-a3fd-b2e3e6a6d0aa"
      unitRef="number">0.09625</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RleHRyZWdpb246OGYwYzZiMWM4MGRmNGExMzhiMDY2MGY1Y2NlNTIwYzJfMTM0MQ_a90df96e-9bd2-4f99-8231-4557244552b2">Future minimum lease payments under the lease agreements as of June&#160;30, 2020 were as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:448.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:60.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: Amounts representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfMi0xLTEtMS0w_1bfa45ae-4da4-4f39-b58e-d004f0832986"
      unitRef="usd">204000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfMy0xLTEtMS0w_21d046e4-3a11-4da2-8326-e92522c28e6e"
      unitRef="usd">414000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfNC0xLTEtMS0w_a81e9d9d-ae48-4c80-91dd-64047c075462"
      unitRef="usd">239000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfNS0xLTEtMS0w_cf7987b4-b8b7-4bb2-8e38-3af781fbbbf5"
      unitRef="usd">27000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfNi0xLTEtMS0w_d2e1d3ff-9d0e-4248-8ad6-095c1fca1a8e"
      unitRef="usd">884000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfNy0xLTEtMS0w_f125d3b4-d2a2-4e86-9474-020144047b00"
      unitRef="usd">90000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl81OC9mcmFnOjhmMGM2YjFjODBkZjRhMTM4YjA2NjBmNWNjZTUyMGMyL3RhYmxlOjM0OTY0MGUyNTYzMTQxZThiMmRhNGRlY2E3MzA5MDIxL3RhYmxlcmFuZ2U6MzQ5NjQwZTI1NjMxNDFlOGIyZGE0ZGVjYTczMDkwMjFfOC0xLTEtMS0w_e73f519e-f434-4b80-b71b-962cc773be15"
      unitRef="usd">794000</us-gaap:OperatingLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjY0NA_0da353bb-a3ff-4718-a47c-c1b006d53ad6">Stockholders' Equity&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Equity Issuances&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Purchase Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In March&#160;2019, the Company and Lincoln Park Capital Fund, LLC (&#x201c;Lincoln Park&#x201d;) entered into a purchase agreement (the &#x201c;Purchase Agreement&#x201d;) and a registration rights agreement (the &#x201c;Registration Rights Agreement&#x201d;), pursuant to which the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Company has the right to sell to Lincoln Park shares of the Company&#x2019;s common stock having an aggregate value of up to $26.0 million, subject to certain limitations and conditions set forth in the Purchase Agreement (the &#x201c;Offering&#x201d;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional 181,510 shares of common stock as commitment shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pursuant to the Purchase Agreement, Lincoln Park purchased 250,000 shares of common stock, at a price of $4.00 per share, for a total gross purchase price of $1.0 million (the &#x201c;Initial Purchase&#x201d;) upon commencement. Thereafter, as often as every business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase Agreement the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to 100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln Park&#x2019;s obligation under any single such purchase will not exceed $2.5 million, unless the Company and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a &#x201c;Regular Purchase&#x201d;).&#160;If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln Park in an &#x201c;accelerated purchase&#x201d; to purchase an additional amount of common stock that may not exceed the lesser of (i)&#160;300% &#160;the number of shares purchased pursuant to the corresponding Regular Purchase or (ii)&#160;30% of the total number of shares of the Company&#x2019;s common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement. Under certain circumstances and in accordance with the Purchase Agreement, the Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company controls the timing and amount of any sales of its common stock to Lincoln Park.&#160;There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than 9.99% of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Purchase Agreement does not limit the Company&#x2019;s ability to raise capital from other sources at the Company&#x2019;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of June&#160;30, 2020, the Company had not made any sales of common stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Common Stock Sales Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In February 2018, the Company entered into a common stock sales agreement with H.C. Wainwright&#160;&amp;amp; Co., LLC ("HCW") as sales agent, which was subsequently amended in August 2018 (the "Sales Agreement"), in connection with an &#x201c;at the market offering&#x201d; under which the Company from time to time may offer and sell shares of its common stock having an aggregate offering price of not more than $25.0 million.&#160;In&#160;March&#160;2019, subsequent to the filing of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the "2018 Form 10-K"), the aggregate market value of our outstanding common stock held by non-affiliates was approximately&#160;$52.8 million. Pursuant to General Instruction I.B.6 of Form S-3, since the aggregate market value of our outstanding common stock held by non-affiliates was below&#160;$75.0 million at the time of our 2018 Form 10-K filing, the aggregate amount of securities that we were permitted to offer and sell at such time was reduced to $17.6 million, which was equal to one-third of the aggregate market value of our common stock held by non-affiliates at such time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the terms and conditions of the Sales Agreement, HCW will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell the shares from time to time, based upon the Company's instructions, including any price, time or size limits specified by the Company. The Company has provided HCW with customary indemnification rights, and HCW will be entitled to a commission at a fixed commission rate equal to 3.0% of the gross proceeds per share sold. The Company has no obligation to sell any of the shares and may at any time suspend sales under the Sales Agreement or terminate the Sales Agreement. The Sales Agreement will terminate upon the sale of all of the shares under the Sales Agreement unless terminated earlier by either party as permitted under the Sales Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the six months ended June&#160;30, 2020, the Company issued 681,034 shares of common stock under the Sales Agreement for net proceeds of $1.3&#160;million. As of June&#160;30, 2020, the Company has issued 907,168 shares of common stock under the Sales Agreement for net proceeds of $2.3 million since inception. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Registered Direct Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In April 2020, the Company entered into a securities purchase agreement (the &#x201c;April Purchase Agreement&#x201d;) with certain investors (the &#x201c;April Purchasers&#x201d;). Pursuant to the terms of the April Purchase Agreement, the Company agreed to sell to the Purchasers an aggregate of 2,162,166 shares of its common stock at a purchase price equal to $2.3125 per share. In a concurrent private placement, the Company issued to the April Purchasers warrants to purchase an aggregate of 1,081,083 shares of its common stock. In connection with the registered direct offering and concurrent private placement, the Company received gross proceeds of $5,000,009. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.2500 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In May 2020, the Company entered into a securities purchase agreement (the &#x201c;May Purchase Agreement&#x201d;) with certain investors (the &#x201c;May Purchasers&#x201d;). Pursuant to the terms of the May Purchase Agreement, the Company agreed to sell to the May Purchasers an aggregate of 2,084,850 shares of its common stock at a purchase price equal to $2.0625 per share. In a concurrent private placement, the Company issued to the Purchasers warrants to purchase an aggregate of 1,042,425 shares of its common stock. In connection with the registered direct offering and concurrent private placement, the Company received gross proceeds of $4.3 million. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.0625 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Stock Options and Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.865%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.638%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.638%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.052%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.638%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.638%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.227%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Aggregate Intrinsic Value (In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Aggregate Intrinsic Value (In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,044,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Changes during the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;245,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,123,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(123,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,153,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested at June 30, 2020&lt;br/&gt; or expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,131,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,153,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;829,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,153,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:2.25pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:2.25pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock for services as follows ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:483.75pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:322.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:72.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:4.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:73.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Number of restricted stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;123,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Value of restricted stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:2.25pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock units for services as follows ($ in thousands, except share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:498.00pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:343.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:72.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:73.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Number of restricted stock units issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;195,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;184,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Value of restricted stock units issued &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The weighted average estimated fair value of restricted stock issued for services in the six months ended June&#160;30, 2020 and 2019 was $3.19 and $4.93 per share, respectively. The fair value of the restricted stock units was determined using the Company&#x2019;s closing stock price on the date of issuance. The vesting terms of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement
      contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDMw_0b69ff9d-eb57-4cb0-8535-20501341b18b"
      unitRef="usd">26000000.0</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration
      contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjQy_84907f69-1979-464c-9858-ef92c553691f"
      unitRef="shares">181510</clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNzUx_c3c26955-7ee7-4d67-a981-42cdf642fc56"
      unitRef="shares">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNzky_f689d078-07a8-4d1f-93e5-e4989f679b6e"
      unitRef="usdPerShare">4.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfODQy_7a30db6e-07ec-4833-a39f-4c0b4fe29ce2"
      unitRef="usd">1000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <clbs:TermOfAgreement
      contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMTAyMA_3f76bc4b-3d87-4aa0-896e-55472b58727d">P36M</clbs:TermOfAgreement>
    <clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase
      contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMTIwNQ_da974373-8a47-4a16-b2df-ddd1c00d1003"
      unitRef="shares">100000</clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase>
    <clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase
      contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMTM5OQ_c8666206-a3dd-4b96-89ff-fc4d60be1bce"
      unitRef="usd">2500000</clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase>
    <clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase
      contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMTk0NA_16ab8680-f493-41e7-8634-980d5b5ab6e3"
      unitRef="number">3</clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase>
    <clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod
      contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMjAzNA_2f705670-b51f-4414-b9cd-e28283041afb"
      unitRef="number">0.30</clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod>
    <clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty
      contextRef="i832251079f054ea08f5f541fc8a5f428_I20190331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMjkzNg_c798c149-b8f1-4379-86a9-cedcecdf6fcd"
      unitRef="number">0.0999</clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty>
    <clbs:TermOfAgreement
      contextRef="ia0fb7dce6e7749c2b5a099bda24df0c6_D20190301-20190331"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfMzM0NQ_3f76bc4b-3d87-4aa0-896e-55472b58727d">P36M</clbs:TermOfAgreement>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement
      contextRef="i27dbcb6ac24e46399fb67838c65e5bbe_I20180831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDA3Mg_64e86d4b-01d2-48ad-aff7-1cbc225d9608"
      unitRef="usd">25000000.0</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <clbs:AggregateMarketValueOfCommonStockNonAffiliates
      contextRef="ic32d3c882e084aa79bd397aa974b4613_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDMxOA_0572c545-cc31-4456-829f-338fd3b06b8f"
      unitRef="usd">52800000</clbs:AggregateMarketValueOfCommonStockNonAffiliates>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement
      contextRef="if6ee95ae2dee4705b58d1a3b61eaf330_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDYyMA_6a04ebed-64c4-419e-a7d7-d0bb7ab6cdd7"
      unitRef="usd">17600000</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <clbs:SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent
      contextRef="i0dc34b6e97fd4ee8b4dd911463597ac5_D20180201-20180228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNTIyMw_b7de56cb-7bc9-4122-9d4d-f76ba456fc1d"
      unitRef="number">0.030</clbs:SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="id6b5f2a163bb41f395f2f166843dc9c1_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMTcyMw_8b91cdc4-76a4-46d8-88ca-d7a161c107b8"
      unitRef="shares">681034</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="id6b5f2a163bb41f395f2f166843dc9c1_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMTcxNA_0c2f4f53-1bb2-413d-8664-62cb085ded5e"
      unitRef="usd">1300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i3d2f30f90a5e4e7c836f63de04b42380_D20180201-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNTcyMg_5d705aa0-cd11-481e-a9c0-eebc6614ed39"
      unitRef="shares">907168</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i3d2f30f90a5e4e7c836f63de04b42380_D20180201-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNTc5NA_6f6972ac-c223-4800-adf5-7c98aa094414"
      unitRef="usd">2300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i06ddd3f40ce1488cb4db1f51b16d53a5_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYxNg_21092f4c-31a3-4823-83b2-ea96fb8a41a5"
      unitRef="shares">2162166</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i848cc63cd4a84516a987b6158ef085e8_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYyMg_477a1758-920a-40d5-8d9f-64dcb6210acf"
      unitRef="usdPerShare">2.3125</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i848cc63cd4a84516a987b6158ef085e8_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYxOQ_4e354696-e036-4cb8-97a5-9a63fa453c89"
      unitRef="shares">1081083</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i06ddd3f40ce1488cb4db1f51b16d53a5_D20200401-20200430"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYyOA_2ca12bef-29c5-44aa-9179-fe9ee5fed23b"
      unitRef="usd">5000009</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i848cc63cd4a84516a987b6158ef085e8_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYyNQ_76042a68-d762-43f6-8261-6748f39b29e1"
      unitRef="usdPerShare">2.2500</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="icfde3833e9e746b7bb672ba96a4b144d_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYzMQ_615a189d-5219-4849-ae0e-17e7e80165c6"
      unitRef="shares">2084850</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYzNw_023a3e20-8dff-4e5d-9b6f-29fc4052a6a9"
      unitRef="usdPerShare">2.0625</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzYzNA_89ab9c41-1da8-43e3-a225-3b5384a6d2a5"
      unitRef="shares">1042425</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="icfde3833e9e746b7bb672ba96a4b144d_D20200501-20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzY0Mw_d9967dcb-dd9b-4306-86f9-87c61b7926f1"
      unitRef="usd">4300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i3d8158e52f8e4d34b7f31c9ebdaf4eb2_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDk0NzgwMjMzMzY0MA_8d74c731-e328-4c1f-a094-babf96181a79"
      unitRef="usdPerShare">2.0625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjYzNQ_5c89cb5f-3627-4429-95c4-b99c4dadac6e">The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.865%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.638%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.638%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.224%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.052%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.638%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.638%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.227%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Aggregate Intrinsic Value (In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Aggregate Intrinsic Value (In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,044,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Changes during the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;245,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,123,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(123,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,153,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested at June 30, 2020&lt;br/&gt; or expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,131,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,153,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;829,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,153,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i798ecf9e15c5435a90a4a4a6b80c21e8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0yLTEtMS0w_e2e4d5b4-b9ab-46ec-99c4-02258b5bb7b6"
      unitRef="shares">1044417</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i798ecf9e15c5435a90a4a4a6b80c21e8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi00LTEtMS0w_af5fcc6d-7f9b-4e04-8073-35246a23edab"
      unitRef="usdPerShare">18.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="idccb2e05fee74cb3b8743e49713e31b6_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi02LTEtMS0w_aa1b3239-652d-4980-91ed-a487090c1bcb">P6Y21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i798ecf9e15c5435a90a4a4a6b80c21e8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi04LTEtMS0w_1dccd5b5-8f6e-415c-bf46-848384a7dd54"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <clbs:CommonStockWarrantsShares
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0xMC0xLTEtMA_1a3ba13e-fa98-4b9a-9855-b713f737d584"
      unitRef="shares">30000</clbs:CommonStockWarrantsShares>
    <clbs:WeightedAverageExercisePriceWarrantsOutstanding
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0xMi0xLTEtMA_c8ae571a-cafd-4841-b4aa-8e21977849f5"
      unitRef="usdPerShare">5.89</clbs:WeightedAverageExercisePriceWarrantsOutstanding>
    <clbs:WeightedAverageRemainingContractualTermwarrantoutstanding
      contextRef="ic0f802c6ed3941c18eac0365a12a53e3_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0xNC0xLTEtMA_af706cec-da43-405e-9c28-cf569e00283c">P3Y2M8D</clbs:WeightedAverageRemainingContractualTermwarrantoutstanding>
    <clbs:AggregateIntrinsicValueWarrantsOutstanding
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMi0xNi0xLTEtMA_0cf09da0-6524-4da0-8866-5853a3d0d704"
      unitRef="usd">0</clbs:AggregateIntrinsicValueWarrantsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNS0yLTEtMS0w_a44d0392-30b0-4e7f-9490-345f12bfe9e4"
      unitRef="shares">245776</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNS00LTEtMS0w_7336d552-fbff-4325-b466-bd529f0c6d5d"
      unitRef="usdPerShare">3.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsGranted
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNS0xMC0xLTEtMA_c5a07fe3-95ca-4393-a74e-0bc8b386fe31"
      unitRef="shares">2123508</clbs:WarrantsGranted>
    <clbs:WeightedAverageExercisePriceWarrantsGranted
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNS0xMi0xLTEtMA_f13b54cd-5a7c-44c9-bd9d-5fca29b4d133"
      unitRef="usdPerShare">2.16</clbs:WeightedAverageExercisePriceWarrantsGranted>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNi0yLTEtMS0w_c1a39001-9c53-4f8f-8a46-51e3bce38251"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNi00LTEtMS0w_4ff01433-1072-409f-9d82-0a7df447ff84"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsExercised
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNi0xMC0xLTEtMA_ba55ed8c-6f6c-4247-8c4c-398a1cdd7a09"
      unitRef="shares">0</clbs:WarrantsExercised>
    <clbs:WeightedAverageExercisePriceWarrantsExercised
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNi0xMi0xLTEtMA_1312f8f8-f43e-429b-8b5b-e8bb11f97241"
      unitRef="usdPerShare">0</clbs:WeightedAverageExercisePriceWarrantsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNy0yLTEtMS0w_c026c0f6-c733-4c48-ac2f-eb3154f64f9d"
      unitRef="shares">5400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNy00LTEtMS0w_8129c70d-f4d3-44db-afed-44de01faf019"
      unitRef="usdPerShare">3.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsCanceled
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNy0xMC0xLTEtMA_da4842ee-0111-48e9-994f-84d5fe5f73eb"
      unitRef="shares">0</clbs:WarrantsCanceled>
    <clbs:WeightedAverageExercisePriceWarrantsCanceled
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfNy0xMi0xLTEtMA_a14de76e-fdc6-4931-a299-e9790994ea2d"
      unitRef="usdPerShare">0</clbs:WeightedAverageExercisePriceWarrantsCanceled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOC0yLTEtMS0w_e31bad3f-b3e1-4624-a157-6c20ca9d6c94"
      unitRef="shares">123584</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOC00LTEtMS0w_fa147b5a-2324-4792-a895-293b1a52ba04"
      unitRef="usdPerShare">21.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsExpired
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOC0xMC0xLTEtMA_a7fe56e0-6377-4f45-b50e-52181bae5e3a"
      unitRef="shares">0</clbs:WarrantsExpired>
    <clbs:WeightedAverageExercisePriceWarrantsExpired
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOC0xMi0xLTEtMA_a94840f9-cc97-4b46-8e04-19f7aa8f1a98"
      unitRef="usdPerShare">0</clbs:WeightedAverageExercisePriceWarrantsExpired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0yLTEtMS0w_c1b1b691-cc44-49df-a862-88bafa7b299d"
      unitRef="shares">1161209</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS00LTEtMS0w_9dde6ad6-6a77-4fd9-aad6-00a99422f183"
      unitRef="usdPerShare">14.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS02LTEtMS0w_76cf6452-e4f7-49f5-b48e-a7750f1be183">P6Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS04LTEtMS0w_2d710b97-4885-4a34-bfa9-55c7804b5246"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <clbs:CommonStockWarrantsShares
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0xMC0xLTEtMA_ffb6af30-2b17-4164-b915-41e7e2e2e469"
      unitRef="shares">2153508</clbs:CommonStockWarrantsShares>
    <clbs:WeightedAverageExercisePriceWarrantsOutstanding
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0xMi0xLTEtMA_db0b5ed1-daf1-43f7-9d1a-c95d027926f7"
      unitRef="usdPerShare">2.21</clbs:WeightedAverageExercisePriceWarrantsOutstanding>
    <clbs:WeightedAverageRemainingContractualTermwarrantoutstanding
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0xNC0xLTEtMA_c9fd5601-a036-4449-b5c4-b8c518287250">P5Y3M29D</clbs:WeightedAverageRemainingContractualTermwarrantoutstanding>
    <clbs:AggregateIntrinsicValueWarrantsOutstanding
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfOS0xNi0xLTEtMA_ed490965-b74b-4ee8-bf47-ae2caf433db0"
      unitRef="usd">0</clbs:AggregateIntrinsicValueWarrantsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMi0xLTEtMA_8380f686-a2ae-473f-ac0e-b0cde8301d17"
      unitRef="shares">1131822</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtNC0xLTEtMA_7e39ce3e-ab90-4c16-b485-597d7cf98fb8"
      unitRef="usdPerShare">15.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtNi0xLTEtMA_98d5faa8-efba-4543-b12a-47ab7af65b80">P6Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtOC0xLTEtMA_2e5c9899-3e79-4f31-90cb-edf24ceae00a"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <clbs:Sharesvestedandexpectedtovest
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMTAtMS0xLTA_d23a64ba-aebf-488c-9dec-140870ca22cc"
      unitRef="shares">2153508</clbs:Sharesvestedandexpectedtovest>
    <clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMTItMS0xLTA_44ba308c-f7c8-4672-8d0d-ee040ea02d76"
      unitRef="usdPerShare">2.21</clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest>
    <clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMTQtMS0xLTA_2f00393f-858f-4348-9283-b0ba284b4b9e">P5Y3M29D</clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest>
    <clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTAtMTYtMS0xLTA_df3c6c1d-bf79-4a2f-95cf-39e185ca8ae0"
      unitRef="usd">0</clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMi0xLTEtMA_705fe819-3d08-4da4-80fa-e26a158e09b7"
      unitRef="shares">829034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtNC0xLTEtMA_9fa130d4-b2af-43fe-a865-cd2376be7e73"
      unitRef="usdPerShare">19.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <clbs:OptionsVestedweightedAverageRemainingContractualTerm
      contextRef="i1ba48a8862f74b1e8a0147ac6d79f71a_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtNi0xLTEtMA_b89a810a-ea83-4b33-b914-8928a3b51fa9">P6Y2M1D</clbs:OptionsVestedweightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="icde65320b8824859b7fc2395f13c2799_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtOC0xLTEtMA_b46b23fd-fc70-4534-aa7b-f59811626c0c"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <clbs:WarrantsVested
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMTAtMS0xLTA_74381b17-0c4d-4c91-9ef7-9d4dc08b871a"
      unitRef="shares">2153508</clbs:WarrantsVested>
    <clbs:WeightedAverageExercisePriceWarrantsExercisable
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMTItMS0xLTA_557171cd-eb21-4eab-82ef-0a8d50614d1b"
      unitRef="usdPerShare">2.21</clbs:WeightedAverageExercisePriceWarrantsExercisable>
    <clbs:WeightedAverageRemainingContractualTermwarrantsvested
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMTQtMS0xLTA_cbcf4242-facc-49c9-8afc-4084fab6af9c">P5Y3M29D</clbs:WeightedAverageRemainingContractualTermwarrantsvested>
    <clbs:AggregateIntrinsicValueWarrantsvested
      contextRef="i6d039286e7ad457e9448ba787ec1cf9d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmQyMzZmNWRhYWIzNjQwMzZiNGNjNTEzOTQwZGExZjBhL3RhYmxlcmFuZ2U6ZDIzNmY1ZGFhYjM2NDAzNmI0Y2M1MTM5NDBkYTFmMGFfMTEtMTYtMS0xLTA_bdd8c7b9-72b2-4b65-b0fe-78b1855e5aae"
      unitRef="usd">0</clbs:AggregateIntrinsicValueWarrantsvested>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjYyNA_8c48c8c2-73dc-4ba0-a23f-4faee8dd1cab">&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock for services as follows ($ in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:483.75pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:322.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:72.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:4.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:73.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Number of restricted stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;123,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Value of restricted stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmUyZjQ5Njg4ZDgzNjQ4NTU4ZDY0OGQwNWU3ZTc4MjMyL3RhYmxlcmFuZ2U6ZTJmNDk2ODhkODM2NDg1NThkNjQ4ZDA1ZTdlNzgyMzJfMi0yLTEtMS0w_0725bf2c-5f1c-470c-9f85-8ed1981c2180"
      unitRef="shares">156184</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i3f6a0bbceb0d475db409f328331721e3_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmUyZjQ5Njg4ZDgzNjQ4NTU4ZDY0OGQwNWU3ZTc4MjMyL3RhYmxlcmFuZ2U6ZTJmNDk2ODhkODM2NDg1NThkNjQ4ZDA1ZTdlNzgyMzJfMi00LTEtMS0w_17fa7b38-223b-49aa-9871-2e544de61761"
      unitRef="shares">123564</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmUyZjQ5Njg4ZDgzNjQ4NTU4ZDY0OGQwNWU3ZTc4MjMyL3RhYmxlcmFuZ2U6ZTJmNDk2ODhkODM2NDg1NThkNjQ4ZDA1ZTdlNzgyMzJfMy0yLTEtMS0w_8c0ae7b6-d453-4f9a-b291-bfafeb9dd0ed"
      unitRef="usd">512000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i3f6a0bbceb0d475db409f328331721e3_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmUyZjQ5Njg4ZDgzNjQ4NTU4ZDY0OGQwNWU3ZTc4MjMyL3RhYmxlcmFuZ2U6ZTJmNDk2ODhkODM2NDg1NThkNjQ4ZDA1ZTdlNzgyMzJfMy00LTEtMS0w_49f346ae-6655-49c7-a500-1c217ac97ae4"
      unitRef="usd">612000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjYzMA_7998bbba-d8bc-4ed1-a006-e67c433b8a21">&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock units for services as follows ($ in thousands, except share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:498.00pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:343.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:72.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:73.00pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Number of restricted stock units issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;195,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;184,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Value of restricted stock units issued &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmFmOWFmMTJmZGIxZDRkM2Y5NDBhMjFlMGQ2NDU1NWE4L3RhYmxlcmFuZ2U6YWY5YWYxMmZkYjFkNGQzZjk0MGEyMWUwZDY0NTU1YThfMi0xLTEtMS0w_ebb5bf24-f571-49a4-a457-bbc80b4e40e2"
      unitRef="shares">195320</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i9ff3343eb5e7446abb32c279fd9ef744_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmFmOWFmMTJmZGIxZDRkM2Y5NDBhMjFlMGQ2NDU1NWE4L3RhYmxlcmFuZ2U6YWY5YWYxMmZkYjFkNGQzZjk0MGEyMWUwZDY0NTU1YThfMi0zLTEtMS0w_f5be701b-95a1-433f-aa01-799a1916d072"
      unitRef="shares">184454</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmFmOWFmMTJmZGIxZDRkM2Y5NDBhMjFlMGQ2NDU1NWE4L3RhYmxlcmFuZ2U6YWY5YWYxMmZkYjFkNGQzZjk0MGEyMWUwZDY0NTU1YThfMy0xLTEtMS0w_9f10e18e-d140-41d9-9513-13525837d918"
      unitRef="usd">623000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i9ff3343eb5e7446abb32c279fd9ef744_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RhYmxlOmFmOWFmMTJmZGIxZDRkM2Y5NDBhMjFlMGQ2NDU1NWE4L3RhYmxlcmFuZ2U6YWY5YWYxMmZkYjFkNGQzZjk0MGEyMWUwZDY0NTU1YThfMy0zLTEtMS0w_b4d58f33-9b82-4ad1-b25d-011e94606c5e"
      unitRef="usd">909000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjMzMA_0488ce92-fe21-4dff-805b-004aacd75a9f"
      unitRef="usdPerShare">3.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3f6a0bbceb0d475db409f328331721e3_D20190101-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNjMzNw_7f007936-d7f2-48ff-8a72-5886f5bd0a3d"
      unitRef="usdPerShare">4.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82MS9mcmFnOjg2ZTY1NmFiMzhmNjRhYWRhMGY5ZTlhZGQ3MjhkYjY1L3RleHRyZWdpb246ODZlNjU2YWIzOGY2NGFhZGEwZjllOWFkZDcyOGRiNjVfNDM5ODA0NjUxOTc3Nw_9ada1948-28f6-4b83-b39b-fa1327bbd928">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RleHRyZWdpb246NzE0YTBmMDA0NzhiNDY3NDk2YmJkYTZhNDgwZDIyZmZfMTE1Mg_e13d80e7-e740-4356-8174-1a3b33f275d6">Share-Based Compensation&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We utilize share-based compensation in the form of stock options, restricted stock, and restricted stock units.&#160; The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:45.067%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.463%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.826%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.463%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.826%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.463%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.826%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.466%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Total compensation cost related to non-vested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2020 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:66.081%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.956%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.824%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.956%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.824%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.959%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:378.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:61.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:3.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:61.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average estimated fair value of shares granted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Valuation Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of stock options and warrants at the date of grant was estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#x2019;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RleHRyZWdpb246NzE0YTBmMDA0NzhiNDY3NDk2YmJkYTZhNDgwZDIyZmZfMTE0MQ_ce45ba2b-0ee4-4380-8c00-84977741dc9d">The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2020 and 2019 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:45.067%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.463%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.826%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.463%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.826%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.463%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.826%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.466%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i26dc6f410bb34ef1b20a17e4d3226752_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMi0xLTEtMS0w_73de261c-97c0-4447-9087-51fd43b80792"
      unitRef="usd">56000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i573aeb998eaf418389958e830a4fd5b6_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMi0zLTEtMS0w_32ea3d4b-f000-4bc7-8565-280a832b92ff"
      unitRef="usd">50000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6fe2517ab39b4e1aa621db4c39dbf740_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMi01LTEtMS0w_1a1c737d-67ea-4871-b9a8-ab0b96e99ecb"
      unitRef="usd">181000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibee88ce40a3a47fdab9f0302d0f48d88_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMi03LTEtMS0w_21d53b3b-4de4-4c2f-8dce-eaadf55ef8cf"
      unitRef="usd">174000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia1a63f2bc4e742469418ccdee39935e5_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMy0xLTEtMS0w_13b72a0c-b922-4ced-b5a1-873a07757837"
      unitRef="usd">239000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if73c2d1f89dc4b9eba1e9511f636f5fa_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMy0zLTEtMS0w_762ea57b-6fac-477e-b542-3d56e2900033"
      unitRef="usd">195000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8f90fb65ff524ed98e292273fda18895_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMy01LTEtMS0w_45c4ea8b-5653-451c-a498-f6cdc661160b"
      unitRef="usd">680000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2a5da1d8176f41c3abcf0352434e0dff_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfMy03LTEtMS0w_dc85c5fa-f4fe-4f78-9949-984e98f347f8"
      unitRef="usd">619000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfNC0xLTEtMS0w_34b83b17-65fb-43c6-8652-d77bf88350d0"
      unitRef="usd">295000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfNC0zLTEtMS0w_cdf7033d-8ed2-4444-98cf-22b92a0a4a1c"
      unitRef="usd">245000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfNC01LTEtMS0w_16a28d71-7146-4a8d-b70a-b57ff16dcb29"
      unitRef="usd">861000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmM5ZDU5NDkwMzVmNDQ0MTQ4MjRjZjFjNWFkOGZmYTk1L3RhYmxlcmFuZ2U6YzlkNTk0OTAzNWY0NDQxNDgyNGNmMWM1YWQ4ZmZhOTVfNC03LTEtMS0w_85d0d63b-c313-4b45-b62b-72be597e1d98"
      unitRef="usd">793000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RleHRyZWdpb246NzE0YTBmMDA0NzhiNDY3NDk2YmJkYTZhNDgwZDIyZmZfMTE0Mw_921ca58d-adca-40cd-9e79-8adc70fc136d">&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Total compensation cost related to non-vested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2020 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:66.081%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.956%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.824%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.956%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.824%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.959%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i3e40117026924a3da318f41263045d8c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMS0xLTEtMS0w_c13aa52f-01e3-4783-88a9-2efa61489220"
      unitRef="usd">734000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ieac73b68636a4e2d89630fe927e17eb8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMS0zLTEtMS0w_f0185051-3dea-4966-b718-32bfd5a14619"
      unitRef="usd">188000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i9da5c1afc9a24304ab6103f6095e3e85_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMS01LTEtMS0w_6d6b90f8-55d8-4394-8bb9-9807fc4db321"
      unitRef="usd">172000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i36becd2504164b3aab52d7e8b2b6c31d_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMi0xLTEtMS0w_4d50063c-2fba-469a-b73a-e7d245e3bcfa">P1Y9M29D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia26cda16e9fd46ffb54423ae9d9dfa38_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMi0zLTEtMS0w_8ff0493d-e8b0-465f-8116-726629e663f8">P0Y7M28D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOmYzYzVmZDE3ZWMzZjRkZThhMGMwYzYzODA5OTJhZjdjL3RhYmxlcmFuZ2U6ZjNjNWZkMTdlYzNmNGRlOGEwYzBjNjM4MDk5MmFmN2NfMi01LTEtMS0w_6fb4795e-73aa-4bf2-9a7c-22947ee0b9a0">P0Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RleHRyZWdpb246NzE0YTBmMDA0NzhiNDY3NDk2YmJkYTZhNDgwZDIyZmZfMTEzMQ_347fa720-022f-4c86-b5a9-71dbeb772abb">&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt;"&gt;&lt;tr&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:378.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:61.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:3.25pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td style="width:61.75pt;"/&gt;&lt;td style="width:1.0pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average estimated fair value of shares granted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i36becd2504164b3aab52d7e8b2b6c31d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOjkxMzQ1NzdhNzQxNTRmYTNiZTVlNDhhOWJlNWNlY2VjL3RhYmxlcmFuZ2U6OTEzNDU3N2E3NDE1NGZhM2JlNWU0OGE5YmU1Y2VjZWNfMy0xLTEtMS0w_ad9cb5f1-c7da-4a22-89af-9455ff7dc1f7"
      unitRef="usd">515000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i2e481ed9443b4a88befbcf284f32660a_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOjkxMzQ1NzdhNzQxNTRmYTNiZTVlNDhhOWJlNWNlY2VjL3RhYmxlcmFuZ2U6OTEzNDU3N2E3NDE1NGZhM2JlNWU0OGE5YmU1Y2VjZWNfMy0zLTEtMS0w_1ffca62e-5f4a-42bf-9175-0969836d47bc"
      unitRef="usd">378000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i3e40117026924a3da318f41263045d8c_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOjkxMzQ1NzdhNzQxNTRmYTNiZTVlNDhhOWJlNWNlY2VjL3RhYmxlcmFuZ2U6OTEzNDU3N2E3NDE1NGZhM2JlNWU0OGE5YmU1Y2VjZWNfNC0xLTEtMS0w_dcb23dff-d268-41dc-80a4-cf42f9753b51"
      unitRef="usdPerShare">2.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="id59dd6e8c9f64370960e3b4a0b377a6a_I20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82NC9mcmFnOjcxNGEwZjAwNDc4YjQ2NzQ5NmJiZGE2YTQ4MGQyMmZmL3RhYmxlOjkxMzQ1NzdhNzQxNTRmYTNiZTVlNDhhOWJlNWNlY2VjL3RhYmxlcmFuZ2U6OTEzNDU3N2E3NDE1NGZhM2JlNWU0OGE5YmU1Y2VjZWNfNC0zLTEtMS0w_f00d8893-a0ab-4552-994f-8990dc7bc2ba"
      unitRef="usdPerShare">3.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfMTEzOQ_c2e0bd56-7794-4c3f-8561-1b11273366c2">Research FundingCalifornia Institute of Regenerative Medicine Grant AwardIn February 2017, the California Institute for Regenerative Medicine ("CIRM") awarded the Company funds of up to $12.2 million to support the T-Rex Study. The funding is based upon the achievement of certain milestones related to the proportion of subjects enrolled in California, as well as manufacturing and development costs incurred in California. Based on the actual number of subjects enrolled in California, the total amount of funding was revised to $8.1 million. The Company received $5.7 million in initial funding in May 2017, a $1.9 million milestone payment in December 2017, a $0.3 million progress payment in March 2018, and a $200,000 progress payment in May 2019, of which the total will be amortized over the estimated award period through July 2020 as a reduction to the related research and development expenses. As of June&#160;30, 2020, $0.2 million of the funding received was recorded in accrued liabilities.  During the three and six months ended June&#160;30, 2020, the Company amortized and recognized $0.7&#160;million and $1.4&#160;million in credits, respectively, to research and development related to CIRM funds received. During the three and six months ended June&#160;30, 2019, the Company amortized and recognized $0.7&#160;million and $1.3&#160;million in credits, respectively, to research and development related to CIRM funds received.</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:GrantsReceivable
      contextRef="i67413a83b057456c9a1af22965e51368_I20170228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfMjA0_d711f981-0b2c-4ad2-865a-3c721b2491de"
      unitRef="usd">12200000</us-gaap:GrantsReceivable>
    <us-gaap:GrantsReceivable
      contextRef="icd5ddb34eb58439ca82e6cd0adcb36c0_I20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjIwMA_a7e83f04-58cb-44b3-bab3-2ef1701ac307"
      unitRef="usd">8100000</us-gaap:GrantsReceivable>
    <clbs:FundingOfGrantAwardCashReceived
      contextRef="i407cfd607b264cfb8ff9e7af6c462f5a_D20170501-20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNTk5_3041ef0d-2210-4215-be70-f0c4738d0a00"
      unitRef="usd">5700000</clbs:FundingOfGrantAwardCashReceived>
    <clbs:MilestonePaymentOnGrantAwardCashReceived
      contextRef="i1fbf17ede593415fbc33607b4bbe3350_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNjM2_2a11809f-bd74-448d-bfb5-bc669163764a"
      unitRef="usd">1900000</clbs:MilestonePaymentOnGrantAwardCashReceived>
    <clbs:ProgressPaymentOnGrantAwardCashReceived
      contextRef="ifb77f2e7779642d2a6eb659130a096f8_D20180301-20180331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNjc3_bafd3660-f955-4272-b5c7-e87216ba727f"
      unitRef="usd">300000</clbs:ProgressPaymentOnGrantAwardCashReceived>
    <us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
      contextRef="ifcdfcccad39e4c2fa35c49cd9d022159_D20190501-20190531"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNzE4_940c8958-eb9c-46d3-a917-d02384759d7c"
      unitRef="usd">200000</us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred>
    <clbs:AccruedGrantFunding
      contextRef="i928a14f6fa8847b7afd1d223a9a29cc4_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfOTEz_ca96c8d2-2853-49f1-8526-28a237743e6f"
      unitRef="usd">200000</clbs:AccruedGrantFunding>
    <clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense
      contextRef="ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjYxNA_c8479528-af01-4b82-b899-92cafabd5d84"
      unitRef="usd">700000</clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense>
    <clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjYxNw_b96a6363-9f17-4348-aa49-6c489bd32546"
      unitRef="usd">1400000</clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense>
    <clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense
      contextRef="i399de42232e340bdada57acc3912526b_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjYyMA_cccccc19-25fd-46ff-83ae-190daa79896a"
      unitRef="usd">700000</clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense>
    <clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense
      contextRef="i313e137488dd4926a350384fb9ce8fed_D20190101-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl82Ny9mcmFnOmQ1ZWE4OGRlY2Y4MjQ1ZjJiYWY5MzQwNDk4ODk0ZjkwL3RleHRyZWdpb246ZDVlYTg4ZGVjZjgyNDVmMmJhZjkzNDA0OTg4OTRmOTBfNDk0NzgwMjMyNjYyMw_5c325bc2-6392-4933-b78e-5fe67b5889bd"
      unitRef="usd">1300000</clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfMzg0ODI5MDcwMDc4Mw_56bb9257-e011-43e4-b356-46acf296b775">Income Taxes&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In assessing the realizability of deferred tax assets, including the net operating loss carryforwards ("NOLs"), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets.&#160; Based on its assessment, the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, the Company had approximately $246 million of federal NOLs available to offset future taxable income expiring from 2030 through 2036.&#160;In accordance with Section 382 of the Internal Revenue code, the usage of the Company&#x2019;s NOLs could be limited in the event of a change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences become deductible.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company performed an analysis and determined that it has had ownership changes of greater than 50% over a 3-year testing period.  The last ownership change was determined to be in 2015.  Based on a market capitalization of $124.5 million and using an applicable federal rate of 2.5%, the annual limitation would be approximately $3.0 million. Post change losses generated after June 2, 2015 would not be subject to 382 limitations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company applies the FASB&#x2019;s provisions for uncertain tax positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with certain tax positions as a component of income tax expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of June&#160;30, 2020, management does not believe the Company has any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in future periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For years prior to 2016, the federal statute of limitations is closed for assessing tax. The Company&#x2019;s state tax returns remain open to examination for a period of three to four years from date of filing. &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In December 2019, the Company received preliminary approval from the New Jersey Economic Development Authority ("NJEDA") to participate in the Technology Business Tax Certificate Transfer Program (the "Program"). The Program permits qualified companies to sell a percentage of their New Jersey net operating losses ("NJ NOLs") to unrelated profitable corporations. On April 21, 2020, the Company received final approval from NJEDA to sell $11.5&#160;million of its NJ NOLs, which was subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $10.9 million.  The net proceeds have been recorded as a benefit from income taxes in the consolidated financial statements.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i29dd98104b1c4e8e92246825600cce61_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfNTM0_e0352524-c335-440f-84d0-553814162172"
      unitRef="usd">246000000</us-gaap:OperatingLossCarryforwards>
    <clbs:MarketCapitalizationUsedInNetOperatingLossAnalysis
      contextRef="i5714f756c7ef49ebbeb8c792722bd60f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfMTE4MQ_a969213e-874e-4989-90d0-c75a174a7837"
      unitRef="usd">124500000</clbs:MarketCapitalizationUsedInNetOperatingLossAnalysis>
    <clbs:NetOperatingLossAnalysisAnnualLimitation
      contextRef="ic0f802c6ed3941c18eac0365a12a53e3_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfMTI3NQ_b8735654-9171-41b8-870d-d6fa4603f9f5"
      unitRef="usd">3000000.0</clbs:NetOperatingLossAnalysisAnnualLimitation>
    <clbs:SaleOfNetOperatingLossesNJEDAProgramValue
      contextRef="ia7aa8c0b4d6d4e7395c1bdb89f3a9231_D20200421-20200421"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfNDk0NzgwMjMyODYzNQ_b2649af3-9d99-4989-b1a0-ec709e541b45"
      unitRef="usd">11500000</clbs:SaleOfNetOperatingLossesNJEDAProgramValue>
    <clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram
      contextRef="ia7aa8c0b4d6d4e7395c1bdb89f3a9231_D20200421-20200421"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83MC9mcmFnOjA0NzRlM2Y5ZGQ2ZTQyOWRhOWVhOTQyZTA2MGE0ZDA0L3RleHRyZWdpb246MDQ3NGUzZjlkZDZlNDI5ZGE5ZWE5NDJlMDYwYTRkMDRfNDk0NzgwMjMyODI0OA_e33f1309-7831-4da8-814c-1433040d0cd4"
      unitRef="usd">10900000</clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83My9mcmFnOmMzYzYxNDlkNmE4YTQwYjJiNWNlZWI2ZTJjMjQ4OWQyL3RleHRyZWdpb246YzNjNjE0OWQ2YThhNDBiMmI1Y2VlYjZlMmMyNDg5ZDJfNDM5_a726c07e-e98f-460e-8477-842dc8d9a342">Contingencies&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt;text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;From time to time, the Company is subject to legal proceedings and claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not &lt;/span&gt;&lt;/div&gt;believe that the outcome of any pending claims will have a material adverse effect on the Company's financial condition or operating results.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i993879b12e9c46ef87314fc725152301_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMzg0ODI5MDcwNTU3OA_a574539a-3e18-41ae-8f4e-14ef18733d32">Subsequent Events&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Private Placement Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On July 10, 2020, the Company entered into a securities purchase agreement (the &#x201c;Private Placement&#x201d;) with certain investors (the &#x201c;Private Placement Purchasers&#x201d;). Pursuant to the terms of the Private Placement, the Company agreed to sell to the Private Placement Purchasers an aggregate of 969,694 shares of its common stock at a purchase price equal to $2.0625 per share, along with warrants to purchase an aggregate of 484,847 shares of its common stock. In connection with the Private Placement, the Company received gross proceeds of $2.0 million. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.0625 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Common Stock Sales Agreement&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent to June&#160;30, 2020, the Company issued 2,779,299 shares of common stock under the Sales Agreement with HCW for net proceeds of $6.9 million.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ib917b042859f49cd9af5962cf0b25fe8_D20200710-20200710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfOTM1_5b60df07-61f8-4a20-9743-9b7c0d391906"
      unitRef="shares">969694</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfNDk0NzgwMjMyNzMwOQ_9e503136-5dd3-4289-a56c-2e76c73e4548"
      unitRef="usdPerShare">2.0625</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMTExNw_24c98156-f81e-4d5e-a9f5-44906e9f21bf"
      unitRef="shares">484847</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ib917b042859f49cd9af5962cf0b25fe8_D20200710-20200710"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMTI3MQ_dd2c0242-ec67-49fb-9828-fa915cc8c628"
      unitRef="usd">2000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMTMwNw_9d6355cf-1fc7-4d85-b215-83e48a451f0d"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i669ac4164c3a4aca9afb03a13773ca45_I20200710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfMTM3Mg_99356038-321a-46b0-b709-9170a2b1dd69"
      unitRef="usdPerShare">2.0625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i5da6f23879be4c3f9b9ff3c489d244ba_D20200701-20200806"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfNDk0NzgwMjMzMjU2Ng_2959dfd2-d320-487b-9a76-6653a2ccc72d"
      unitRef="shares">2779299</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i5da6f23879be4c3f9b9ff3c489d244ba_D20200701-20200806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjZjA2MWZiNDYxMTRlMWY5MWNmMDIzZTUyM2FkYjRiL3NlYzoyY2YwNjFmYjQ2MTE0ZTFmOTFjZjAyM2U1MjNhZGI0Yl83Ni9mcmFnOjk2ZWJiNDQ1YzlkZDQ1YzM4MTJkNzhiMTQ5NDY5ZTFlL3RleHRyZWdpb246OTZlYmI0NDVjOWRkNDVjMzgxMmQ3OGIxNDk0NjllMWVfNDk0NzgwMjMzMjU2Mw_bf0f1415-99ed-4fe2-8939-d7ecbb458e26"
      unitRef="usd">6900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138396392872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Aug. 13, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CALADRIUS BIOSCIENCES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-2343568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Allen Road, 2nd Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Basking Ridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">842-0100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLBS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000320017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,323,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138400189848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 26,684<span></span>
</td>
<td class="nump">$ 14,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">8,207<span></span>
</td>
<td class="nump">11,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">1,735<span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">36,626<span></span>
</td>
<td class="nump">25,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">772<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">37,481<span></span>
</td>
<td class="nump">27,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">2,888<span></span>
</td>
<td class="nump">4,486<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,480<span></span>
</td>
<td class="nump">5,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">445<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,925<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at June 30, 2020 and December 31, 2019, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, authorized 500,000,000 shares; issued and outstanding, 15,585,194 and 10,528,689 shares at June 30, 2020 and December 31, 2019, respectively</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">449,302<span></span>
</td>
<td class="nump">438,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 11,080 shares at June 30, 2020 and December 31, 2019</a></td>
<td class="num">(708)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(414,792)<span></span>
</td>
<td class="num">(417,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Caladrius Biosciences, Inc. stockholders' equity</a></td>
<td class="nump">33,811<span></span>
</td>
<td class="nump">20,816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="num">(255)<span></span>
</td>
<td class="num">(263)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">33,556<span></span>
</td>
<td class="nump">20,553<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Liabilities and Equity, Total</a></td>
<td class="nump">$ 37,481<span></span>
</td>
<td class="nump">$ 27,153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138404076296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PreferredStockLiquidationPreferenceShare', window );">Preferred stock, liquidation value</a></td>
<td class="nump">0.001<span></span>
</td>
<td class="nump">0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PreferredStockSharesDesignated', window );">Preferred stock, shares designated</a></td>
<td class="nump">825,000<span></span>
</td>
<td class="nump">825,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">15,585,194<span></span>
</td>
<td class="nump">10,528,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">15,585,194<span></span>
</td>
<td class="nump">10,528,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (shares)</a></td>
<td class="nump">11,080<span></span>
</td>
<td class="nump">11,080<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PreferredStockLiquidationPreferenceShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Liquidation Preference, Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PreferredStockLiquidationPreferenceShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PreferredStockSharesDesignated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred stock, shares designated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PreferredStockSharesDesignated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392407848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,818<span></span>
</td>
<td class="nump">$ 2,988<span></span>
</td>
<td class="nump">$ 3,317<span></span>
</td>
<td class="nump">$ 5,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">2,474<span></span>
</td>
<td class="nump">2,358<span></span>
</td>
<td class="nump">5,032<span></span>
</td>
<td class="nump">4,912<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">4,292<span></span>
</td>
<td class="nump">5,346<span></span>
</td>
<td class="nump">8,349<span></span>
</td>
<td class="nump">9,938<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(4,292)<span></span>
</td>
<td class="num">(5,346)<span></span>
</td>
<td class="num">(8,349)<span></span>
</td>
<td class="num">(9,938)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Investment income, net</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before benefit from income taxes and noncontrolling interests</a></td>
<td class="num">(4,270)<span></span>
</td>
<td class="num">(5,137)<span></span>
</td>
<td class="num">(8,256)<span></span>
</td>
<td class="num">(9,502)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">(10,872)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,872)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">6,602<span></span>
</td>
<td class="num">(5,137)<span></span>
</td>
<td class="nump">2,616<span></span>
</td>
<td class="num">(9,502)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Less - net income attributable to noncontrolling interests</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to Caladrius Biosciences, Inc. common stockholders</a></td>
<td class="nump">$ 6,598<span></span>
</td>
<td class="num">$ (5,140)<span></span>
</td>
<td class="nump">$ 2,608<span></span>
</td>
<td class="num">$ (9,507)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Basic and diluted income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Caladrius Biosciences, Inc. common stockholders (in usd per share)</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="num">$ (0.49)<span></span>
</td>
<td class="nump">$ 0.22<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted shares</a></td>
<td class="nump">13,151<span></span>
</td>
<td class="nump">10,393<span></span>
</td>
<td class="nump">11,880<span></span>
</td>
<td class="nump">10,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138396074392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 6,602<span></span>
</td>
<td class="num">$ (5,137)<span></span>
</td>
<td class="nump">$ 2,616<span></span>
</td>
<td class="num">$ (9,502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Available for sale securities - net unrealized (loss) income</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive (loss) income</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">6,593<span></span>
</td>
<td class="num">(5,120)<span></span>
</td>
<td class="nump">2,607<span></span>
</td>
<td class="num">(9,471)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to Caladrius Biosciences, Inc. common stockholders</a></td>
<td class="nump">$ 6,589<span></span>
</td>
<td class="num">$ (5,123)<span></span>
</td>
<td class="nump">$ 2,599<span></span>
</td>
<td class="num">$ (9,476)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138389367752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adoption of new accounting standard</div></th>
<th class="th"><div>Total Caladrius Biosciences, Inc. Stockholders' Equity</div></th>
<th class="th">
<div>Total Caladrius Biosciences, Inc. Stockholders' Equity </div>
<div>Adoption of new accounting standard</div>
</th>
<th class="th"><div>Series B Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Adoption of new accounting standard</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Non- Controlling Interest in Subsidiary</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">9,866,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 37,454<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
<td class="nump">$ 37,726<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 436,433<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
<td class="num">$ (397,977)<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
<td class="num">$ (708)<span></span>
</td>
<td class="num">$ (272)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(9,502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,507)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,507)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,413,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2019</a></td>
<td class="nump">29,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">438,133<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(407,546)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(267)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,393,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Mar. 31, 2019</a></td>
<td class="nump">34,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">437,850<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(402,406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(270)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(5,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,413,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2019</a></td>
<td class="nump">29,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">438,133<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(407,546)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(267)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,529,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">20,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">438,911<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(417,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">2,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">9,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">9,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">15,585,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2020</a></td>
<td class="nump">33,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">449,302<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(414,792)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(255)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,639,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Mar. 31, 2020</a></td>
<td class="nump">16,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">439,330<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(421,390)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">6,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">9,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">9,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">15,585,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2020</a></td>
<td class="nump">$ 33,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 449,302<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (414,792)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (708)<span></span>
</td>
<td class="num">$ (255)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392283128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,616<span></span>
</td>
<td class="num">$ (9,502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Share-based compensation</a></td>
<td class="nump">861<span></span>
</td>
<td class="nump">793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion on marketable securities</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other current assets</a></td>
<td class="num">(920)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities', window );">Accounts payable, accrued liabilities and other liabilities</a></td>
<td class="num">(2,673)<span></span>
</td>
<td class="num">(1,735)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">262<span></span>
</td>
<td class="num">(10,205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(8,235)<span></span>
</td>
<td class="num">(25,969)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Sale of marketable securities</a></td>
<td class="nump">11,104<span></span>
</td>
<td class="nump">36,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">2,855<span></span>
</td>
<td class="nump">10,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Tax withholding payments on net share settlement equity awards</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">9,683<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">9,535<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">12,652<span></span>
</td>
<td class="nump">1,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">14,032<span></span>
</td>
<td class="nump">10,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 26,684<span></span>
</td>
<td class="nump">$ 11,754<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387993592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Business<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_BusinessTextBlock', window );">The Business</a></td>
<td class="text">The Business<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; "our," &#8220;Caladrius&#8221; or the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of cellular therapies designed to reverse disease and/or promote the regeneration of damaged tissue. The Company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. The Company's technology leverages these cells to enable the body's natural repair mechanisms using formulations unique to each medical indication.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company's leadership team has decades of collective biopharmaceutical development experience and world-recognized scientific achievement in the field of cardiovascular disease, among other therapeutic areas. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The Company's current product candidates include CLBS119, an emergent CD34+ stem cell therapy responding to the COVID-19 pandemic and the potentially permanent damage the virus inflicts on the lungs of many patients, as well as three other developmental treatments for ischemic diseases based on its CD34+ cell therapy platform: CLBS12, recipient of SAKIGAKE designation and eligible for early conditional approval in Japan for the treatment of critical limb ischemia ("CLI") based on the results of an ongoing clinical trial; CLBS16, the subject of a recently completed positive Phase 2 clinical trial in the U.S. for the treatment of coronary microvascular dysfunction ("CMD"); and CLBS14, a Regenerative Medicine Advanced Therapy ("RMAT") designated therapy for which the Company has finalized with the U.S. Food and Drug Administration (the "FDA") a protocol for a Phase 3 confirmatory trial in subjects with no-option refractory disabling angina ("NORDA").</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Ischemic Repair (CD34 Cell Technology)</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The CD34+ cell was discovered as a result of the deliberate search for a stem cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels after injury. A CD34+ cell is a stem cell that has the ability to stimulate new blood vessel formation. No other native cell discovered to date has demonstrated this same capability.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s proprietary CD34+ cell technology has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is restricted. Through the administration of CD34+ cells, the Company seeks to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. Caladrius believes that a number of conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology, including but not limited to, CLI, CMD, NORDA and COVID-19 induced lung damage.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS119 for Treatment of COVID -19 Induced Lung Damage</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">COVID-19 appears to damage the vasculature of the lungs and Caladrius believes that repair of that vasculature will prove necessary for patients to achieve a full recovery. Survivors of COVID-19 often remain debilitated even after leaving the hospital due to the damage caused to their lungs, and while many developmental therapies responding to the COVID-19 pandemic are appropriately targeting the SARS-CoV-2 virus itself or the manifestations of the acute phase of the illness, Caladrius is aware of no therapy that has demonstrated the ability to repair COVID-19 induced lung damage. With consistent clinical and pre-clinical evidence that CD34+ cells can repair multiple organs, including models of severe lung inflammation, the Company sought and received FDA authorization for its investigational new drug (&#8220;IND&#8221;) application for the study of CLBS119, a CD34+ cell therapy for repair of COVID-19 induced lung damage. The planned study, with enrollment expected to commence in the second half of 2020, will target patients with severe SARS-CoV-2 infection who, after ventilatory support due to respiratory failure, had otherwise recovered but remained debilitated due to persistent pulmonary damage. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS12 for Treatment of Critical Limb Ischemia</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's open-label, registration-eligible study of CLBS12 in Japan for the treatment of critical limb ischemia ("CLI"), a disease with no currently available approved therapy and a higher combined incidence and mortality rate than all cancers but lung cancer, has shown strong results to date. The initial responses observed in the subjects who have reached an </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">endpoint in this open label study are consistent with a positive therapeutic effect and safety profile as reported by previously published clinical trials in Japan. Although the study's enrollment, which is targeted for completion this year, has been slowed by the pandemic's impact in Japan, the Company is encouraged by the patient pre-screening pipeline that has been identified and hopes to conclude trial enrollment rapidly once the coronavirus abates. While the final outcome of the trial will depend on all data from all subjects, data from the concluded Buerger's Disease cohort and the data to date in the no-option CLI cohort remain very encouraging.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS16 for Treatment of Coronary Microvascular Dysfunction</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2017, with the assistance of a $1.9&#160;million grant from the National Institutes of Health (Award Number R44HL135889), Caladrius initiated its program for CLBS16 for the treatment of coronary microvascular dysfunction ("CMD"), a disease that potentially afflicts millions of patients with no current targeted treatment options. That study, titled ESCaPE-CMD, was a Phase 2 proof-of-concept study that enrolled patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. In June 2019, the Company announced the completion of enrollment in this study. Results of the first 17 of 20 patients enrolled in this trial who reached 6-month follow-up were presented as a rapid fire oral presentation on November 16, 2019 at the annual meeting of the American Heart Association in Philadelphia, PA by one of the principal investigators, Dr. Noel Bairey Merz, FACC, FAHA, FESC, the director of the Barbra Streisand Women's Heart Center at Cedars-Sinai in Los Angeles, CA. That data set showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian Cardiovascular Society Angina Class and Seattle Questionnaire score, as well as an acceptable safety profile. The full data from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May 14, 2020 and we now expect to initiate the next CMD trial, a Phase 2b study, by the end of 2020.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">CLBS14 for Treatment of No Option Refractory Disabling Angina (NORDA)</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company acquired the rights to data and regulatory filings for a CD34+ cell therapy program for refractory angina that had been advanced to Phase 3 by a previous sponsor.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on the clinical evidence from the completed studies that a single administration of CLBS14 reduces mortality, improves angina and increases exercise capacity in patients with otherwise untreatable angina, this product received Regenerative Medicine Advanced Therapy (&#8220;RMAT&#8221;) designation from the FDA. The Company, working closely with the FDA, has finalized the design of a confirmatory Phase 3 trial which, in combination with previously filed Phase 1, 2 and 3 data, will be considered for the registration of CLBS14. Notably, this study design includes a 6-month primary endpoint and, with the benefit of the RMAT designation, the biologics license application ("BLA"), once submitted, is expected to receive a 6-month review. The Company has substantially completed the preparatory work for initiation of this trial. Caladrius will not, however, commence enrollment of patients until sufficient capital is acquired and dedicated to this program such that the Company has confidence that it can fund the trial uninterrupted through completion.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Additional Out-licensing Opportunities</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's broad intellectual property portfolio of cell therapy assets includes notable programs available for out-licensing in order to continue their clinical development. Its current long-term strategy focuses on advancing its therapies through development with the ultimate objective of obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to realize potentially meaningful value increases within its own proprietary pipeline if the Company is successful in advancing its product candidates to their next significant development milestones.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Coronavirus Considerations</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which causes COVID-19, was reported to have surfaced in China.  In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects.  While the disruption currently is expected to be temporary, there is uncertainty around the extent and duration of disruption, and any future related financial impact cannot be reasonably estimated at this time.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Basis of Presentation</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim financial information. Accordingly, they do </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of June&#160;30, 2020, and the results of its operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2019 and 2018 included in our 2019 Form 10-K. Operating results for the three and six months ended June&#160;30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amount of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly, actual results could differ from those estimates and assumptions.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Principles of Consolidation</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Consolidated Financial Statements include the accounts of Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_BusinessTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Business [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_BusinessTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138386347864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to the policies below, the Company's significant accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included in its 2019 Form 10-K. There were no changes to these policies during the three and six months ended June&#160;30, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Concentration of Risks</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States.  Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Share-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company expenses all share-based payment awards to employees, directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">New Accounting Pronouncements</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires that a lessee recognize lease assets and lease liabilities for those leases classified as operating leases. The guidance was effective for interim and annual periods beginning after December 15, 2018 and was adopted as of January 1, 2019. The Company adopted the standard using the modified retrospective transition method, with an immaterial adjustment to accumulated deficit upon adoption. The comparative information has not been restated and continues to be reported under the accounting standards that were in effect </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">for those periods. The Company concluded that the adoption of ASU 2016-02 was non-cash in nature, did not affect the Company's cash position, and did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#8212;Credit Losses, which will require companies to present assets held at amortized cost and available for sale debt securities net of the amount expected to be collected. The guidance requires the measurement of expected credit losses to be based on relevant information from past events, including historical experiences, current conditions and reasonable and supportable forecasts that affect collectability. The guidance was effective for fiscal years and interim periods beginning after December 15, 2019 and early adoption was permitted. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, the FASB issued ASU 2018-07, "Improvements to Nonemployee Share-Based Payment Accounting," which supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payments arrangements related to the acquisition of goods and services from both employees and nonemployees. For public companies, the amendments are effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual periods. Early adoption was permitted, but no earlier than a company's adoption date of ASC 606. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, the FASB issued ASU 2019-07, "Codification Updates to SEC Sections", to codify the SEC releases that clarify and improve the disclosure and presentation requirements of a variety of codification topics, thereby eliminating certain disclosure requirements that were redundant, duplicative, overlapping, outdated, or superseded. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2019, the FASB issued ASU 2019-12, which affects general principles within Topic 740, Income Taxes. The amendments of&#160;ASU 2019-12&#160;are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company believes that the adoption of this new accounting guidance will not have a material impact on its financial statements and footnote disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387854680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale-Securities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Available-for-Sale-Securities</a></td>
<td class="text">Available-for-Sale-Securities<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.00pt;"><tr><td style="width:1.0pt;"/><td style="width:94.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gains</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Losses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gains</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Losses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,425&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,675&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,093&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,093&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Municipal debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,975&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,973&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sovereign government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">197&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">197&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,621&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,766&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,768&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"/><td style="width:360.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:70.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:70.75pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,407&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,643&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,768&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"/><td style="width:361.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:70.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:70.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less than one year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,621&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Greater than one year</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,621&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387881352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Income (Loss) Per Share</a></td>
<td class="text">Income (Loss) Per Share<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the three and six months ended June&#160;30, 2020, the Company reported net income in each period.  However, no common stock equivalents were utilized in the calculation of diluted income per share since any conversion as of June&#160;30, 2020 would have been anti-dilutive. For the three and six months ended June&#160;30, 2019, the Company incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive.  At June&#160;30, 2020 and 2019, the Company excluded the following potentially dilutive securities (in thousands):</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:65.789%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.666%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.813%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock Units</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387877736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of financial assets and liabilities that are being measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price). The Company is required to classify fair value measurements in one of the following categories:</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 1 inputs are defined as quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 2 inputs are defined as inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 3 inputs are defined as unobservable inputs for the assets or liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth by level within the fair value hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of June&#160;30, 2020, and December&#160;31, 2019 (in thousands).</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"><tr><td style="width:1.0pt;"/><td style="width:115.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:12.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketable securities - available for sale</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138386087784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">Accrued Liabilities<div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accrued liabilities as of June&#160;30, 2020 and December&#160;31, 2019 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.75pt;"><tr><td style="width:1.0pt;"/><td style="width:313.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:97.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:88.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Salaries, employee benefits and related taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,441&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,834&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities -- current</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CIRM upfront funding -- current</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">229&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,600&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">869&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,888&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,486&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138388461320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">Operating Leases<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has operating leases for two offices with terms that expire in 2022 and 2023. The Company estimates its incremental borrowing rate, at lease commencement, to determine the present value of lease payments, since most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases include options for the Company to extend the lease term and/or sub-lease space in whole or in part.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"/><td style="width:325.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:88.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:88.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Right-of Use Assets:</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">731&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">906&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Right-of-Use Asset</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">731&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">906&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Lease Liabilities:</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">353&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">445&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">624&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Operating Lease Liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">977&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of June&#160;30, 2020, the weighted average remaining lease term for our operating leases was 1.6 years, and the weighted average discount rate for our operating leases was 9.625%. Future minimum lease payments under the lease agreements as of June&#160;30, 2020 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"><tr><td style="width:1.0pt;"/><td style="width:448.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:60.25pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Years ended</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Leases</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">204&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">414&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">884&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amounts representing interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(90)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of lease liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387715720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Equity Issuances</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Purchase Agreement</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In March&#160;2019, the Company and Lincoln Park Capital Fund, LLC (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Company has the right to sell to Lincoln Park shares of the Company&#8217;s common stock having an aggregate value of up to $26.0 million, subject to certain limitations and conditions set forth in the Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional 181,510 shares of common stock as commitment shares.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pursuant to the Purchase Agreement, Lincoln Park purchased 250,000 shares of common stock, at a price of $4.00 per share, for a total gross purchase price of $1.0 million (the &#8220;Initial Purchase&#8221;) upon commencement. Thereafter, as often as every business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase Agreement the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to 100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln Park&#8217;s obligation under any single such purchase will not exceed $2.5 million, unless the Company and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;).&#160;If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of (i)&#160;300% &#160;the number of shares purchased pursuant to the corresponding Regular Purchase or (ii)&#160;30% of the total number of shares of the Company&#8217;s common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement. Under certain circumstances and in accordance with the Purchase Agreement, the Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company controls the timing and amount of any sales of its common stock to Lincoln Park.&#160;There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than 9.99% of its common stock.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Purchase Agreement does not limit the Company&#8217;s ability to raise capital from other sources at the Company&#8217;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of June&#160;30, 2020, the Company had not made any sales of common stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Common Stock Sales Agreement</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In February 2018, the Company entered into a common stock sales agreement with H.C. Wainwright&#160;&amp; Co., LLC ("HCW") as sales agent, which was subsequently amended in August 2018 (the "Sales Agreement"), in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock having an aggregate offering price of not more than $25.0 million.&#160;In&#160;March&#160;2019, subsequent to the filing of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the "2018 Form 10-K"), the aggregate market value of our outstanding common stock held by non-affiliates was approximately&#160;$52.8 million. Pursuant to General Instruction I.B.6 of Form S-3, since the aggregate market value of our outstanding common stock held by non-affiliates was below&#160;$75.0 million at the time of our 2018 Form 10-K filing, the aggregate amount of securities that we were permitted to offer and sell at such time was reduced to $17.6 million, which was equal to one-third of the aggregate market value of our common stock held by non-affiliates at such time.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the terms and conditions of the Sales Agreement, HCW will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell the shares from time to time, based upon the Company's instructions, including any price, time or size limits specified by the Company. The Company has provided HCW with customary indemnification rights, and HCW will be entitled to a commission at a fixed commission rate equal to 3.0% of the gross proceeds per share sold. The Company has no obligation to sell any of the shares and may at any time suspend sales under the Sales Agreement or terminate the Sales Agreement. The Sales Agreement will terminate upon the sale of all of the shares under the Sales Agreement unless terminated earlier by either party as permitted under the Sales Agreement. </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the six months ended June&#160;30, 2020, the Company issued 681,034 shares of common stock under the Sales Agreement for net proceeds of $1.3&#160;million. As of June&#160;30, 2020, the Company has issued 907,168 shares of common stock under the Sales Agreement for net proceeds of $2.3 million since inception. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Registered Direct Offerings</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In April 2020, the Company entered into a securities purchase agreement (the &#8220;April Purchase Agreement&#8221;) with certain investors (the &#8220;April Purchasers&#8221;). Pursuant to the terms of the April Purchase Agreement, the Company agreed to sell to the Purchasers an aggregate of 2,162,166 shares of its common stock at a purchase price equal to $2.3125 per share. In a concurrent private placement, the Company issued to the April Purchasers warrants to purchase an aggregate of 1,081,083 shares of its common stock. In connection with the registered direct offering and concurrent private placement, the Company received gross proceeds of $5,000,009. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.2500 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In May 2020, the Company entered into a securities purchase agreement (the &#8220;May Purchase Agreement&#8221;) with certain investors (the &#8220;May Purchasers&#8221;). Pursuant to the terms of the May Purchase Agreement, the Company agreed to sell to the May Purchasers an aggregate of 2,084,850 shares of its common stock at a purchase price equal to $2.0625 per share. In a concurrent private placement, the Company issued to the Purchasers warrants to purchase an aggregate of 1,042,425 shares of its common stock. In connection with the registered direct offering and concurrent private placement, the Company received gross proceeds of $4.3 million. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.0625 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Options and Warrants</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2020:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:21.865%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.638%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.638%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.052%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.638%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.638%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.227%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (In Thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (In Thousands)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,044,417&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.31&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.06</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.19</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes during the period:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">245,776&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,123,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,400)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(123,584)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.85&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.98</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.33</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested at June 30, 2020<br/> or expected to vest in the future</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,131,822&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.14&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.92</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.33</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested at June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">829,034&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.17</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.33</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:2.25pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restricted Stock</span></div><div style="text-indent:2.25pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock for services as follows ($ in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:483.75pt;"><tr><td style="width:1.0pt;"/><td style="width:322.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:72.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:4.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:73.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of restricted stock issued</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156,184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">123,564&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value of restricted stock issued</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">512&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:2.25pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restricted Stock Units</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock units for services as follows ($ in thousands, except share data):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:498.00pt;"><tr><td style="width:1.0pt;"/><td style="width:343.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:72.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:73.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of restricted stock units issued</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">195,320&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">184,454&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value of restricted stock units issued </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">623&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">909&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div>The weighted average estimated fair value of restricted stock issued for services in the six months ended June&#160;30, 2020 and 2019 was $3.19 and $4.93 per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138388015016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Share-Based Compensation</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We utilize share-based compensation in the form of stock options, restricted stock, and restricted stock units.&#160; The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2020 and 2019 (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"/><td style="width:45.067%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.463%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.826%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.463%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.826%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.463%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.826%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.466%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General and administrative</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">195&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">680&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total share-based compensation expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">295&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">861&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">793&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total compensation cost related to non-vested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2020 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:66.081%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:7.956%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.824%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.956%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.824%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.959%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock Units</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized compensation cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">188&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">172&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.83</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.66</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.50</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2020 and 2019 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt;"><tr><td style="width:1.0pt;"/><td style="width:378.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:61.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:3.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:61.75pt;"/><td style="width:1.0pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total fair value of shares vested</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">515&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average estimated fair value of shares granted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.18&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Valuation Assumptions</span></div><div><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of stock options and warrants at the date of grant was estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387696376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Funding<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research Funding</a></td>
<td class="text">Research FundingCalifornia Institute of Regenerative Medicine Grant AwardIn February 2017, the California Institute for Regenerative Medicine ("CIRM") awarded the Company funds of up to $12.2 million to support the T-Rex Study. The funding is based upon the achievement of certain milestones related to the proportion of subjects enrolled in California, as well as manufacturing and development costs incurred in California. Based on the actual number of subjects enrolled in California, the total amount of funding was revised to $8.1 million. The Company received $5.7 million in initial funding in May 2017, a $1.9 million milestone payment in December 2017, a $0.3 million progress payment in March 2018, and a $200,000 progress payment in May 2019, of which the total will be amortized over the estimated award period through July 2020 as a reduction to the related research and development expenses. As of June&#160;30, 2020, $0.2 million of the funding received was recorded in accrued liabilities.  During the three and six months ended June&#160;30, 2020, the Company amortized and recognized $0.7&#160;million and $1.4&#160;million in credits, respectively, to research and development related to CIRM funds received. During the three and six months ended June&#160;30, 2019, the Company amortized and recognized $0.7&#160;million and $1.3&#160;million in credits, respectively, to research and development related to CIRM funds received.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138388003512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In assessing the realizability of deferred tax assets, including the net operating loss carryforwards ("NOLs"), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets.&#160; Based on its assessment, the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the Company had approximately $246 million of federal NOLs available to offset future taxable income expiring from 2030 through 2036.&#160;In accordance with Section 382 of the Internal Revenue code, the usage of the Company&#8217;s NOLs could be limited in the event of a change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences become deductible.&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company performed an analysis and determined that it has had ownership changes of greater than 50% over a 3-year testing period.  The last ownership change was determined to be in 2015.  Based on a market capitalization of $124.5 million and using an applicable federal rate of 2.5%, the annual limitation would be approximately $3.0 million. Post change losses generated after June 2, 2015 would not be subject to 382 limitations. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company applies the FASB&#8217;s provisions for uncertain tax positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with certain tax positions as a component of income tax expense. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;30, 2020, management does not believe the Company has any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in future periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year. </span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For years prior to 2016, the federal statute of limitations is closed for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from date of filing. </span></div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In December 2019, the Company received preliminary approval from the New Jersey Economic Development Authority ("NJEDA") to participate in the Technology Business Tax Certificate Transfer Program (the "Program"). The Program permits qualified companies to sell a percentage of their New Jersey net operating losses ("NJ NOLs") to unrelated profitable corporations. On April 21, 2020, the Company received final approval from NJEDA to sell $11.5&#160;million of its NJ NOLs, which was subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $10.9 million.  The net proceeds have been recorded as a benefit from income taxes in the consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138386367704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Contingencies</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From time to time, the Company is subject to legal proceedings and claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not </span></div>believe that the outcome of any pending claims will have a material adverse effect on the Company's financial condition or operating results.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138386376504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Private Placement Offering</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On July 10, 2020, the Company entered into a securities purchase agreement (the &#8220;Private Placement&#8221;) with certain investors (the &#8220;Private Placement Purchasers&#8221;). Pursuant to the terms of the Private Placement, the Company agreed to sell to the Private Placement Purchasers an aggregate of 969,694 shares of its common stock at a purchase price equal to $2.0625 per share, along with warrants to purchase an aggregate of 484,847 shares of its common stock. In connection with the Private Placement, the Company received gross proceeds of $2.0 million. Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.0625 per share. The warrants are exercisable immediately upon issuance and will expire five and one-half years from the issuance date.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Common Stock Sales Agreement</span></div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent to June&#160;30, 2020, the Company issued 2,779,299 shares of common stock under the Sales Agreement with HCW for net proceeds of $6.9 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138386346744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Risks</a></td>
<td class="text"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Concentration of Risks</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States.  Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Share-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;</span>The Company expenses all share-based payment awards to employees, directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">New Accounting Pronouncements</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires that a lessee recognize lease assets and lease liabilities for those leases classified as operating leases. The guidance was effective for interim and annual periods beginning after December 15, 2018 and was adopted as of January 1, 2019. The Company adopted the standard using the modified retrospective transition method, with an immaterial adjustment to accumulated deficit upon adoption. The comparative information has not been restated and continues to be reported under the accounting standards that were in effect </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">for those periods. The Company concluded that the adoption of ASU 2016-02 was non-cash in nature, did not affect the Company's cash position, and did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#8212;Credit Losses, which will require companies to present assets held at amortized cost and available for sale debt securities net of the amount expected to be collected. The guidance requires the measurement of expected credit losses to be based on relevant information from past events, including historical experiences, current conditions and reasonable and supportable forecasts that affect collectability. The guidance was effective for fiscal years and interim periods beginning after December 15, 2019 and early adoption was permitted. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, the FASB issued ASU 2018-07, "Improvements to Nonemployee Share-Based Payment Accounting," which supersedes ASC 505-50 and expands the scope of ASC 718 to include all share-based payments arrangements related to the acquisition of goods and services from both employees and nonemployees. For public companies, the amendments are effective for annual reporting periods beginning after December 15, 2018, including interim periods within those annual periods. Early adoption was permitted, but no earlier than a company's adoption date of ASC 606. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, the FASB issued ASU 2019-07, "Codification Updates to SEC Sections", to codify the SEC releases that clarify and improve the disclosure and presentation requirements of a variety of codification topics, thereby eliminating certain disclosure requirements that were redundant, duplicative, overlapping, outdated, or superseded. The Company determined that the adoption of this new accounting guidance did not have a material impact on its consolidated financial statements and footnote disclosures.</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2019, the FASB issued ASU 2019-12, which affects general principles within Topic 740, Income Taxes. The amendments of&#160;ASU 2019-12&#160;are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company believes that the adoption of this new accounting guidance will not have a material impact on its financial statements and footnote disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138388457128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale-Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-sale Securities Reconciliation</a></td>
<td class="text"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.00pt;"><tr><td style="width:1.0pt;"/><td style="width:94.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:46.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gains</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Losses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gains</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Losses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,425&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,675&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,093&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,093&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Municipal debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,975&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,973&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sovereign government securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">197&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">197&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,621&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,766&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,768&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"/><td style="width:360.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:70.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:70.75pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,407&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,643&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketable securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,768&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Investments Classified by Contractual Maturity Date</a></td>
<td class="text"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"/><td style="width:361.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:70.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:70.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less than one year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,621&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Greater than one year</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,621&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387889416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">At June&#160;30, 2020 and 2019, the Company excluded the following potentially dilutive securities (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:65.789%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.666%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.813%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock Units</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138386367704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth by level within the fair value hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of June&#160;30, 2020, and December&#160;31, 2019 (in thousands).</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"><tr><td style="width:1.0pt;"/><td style="width:115.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:12.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:42.25pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketable securities - available for sale</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387643064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accrued liabilities as of June&#160;30, 2020 and December&#160;31, 2019 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.75pt;"><tr><td style="width:1.0pt;"/><td style="width:313.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:97.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:88.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Salaries, employee benefits and related taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,441&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,834&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities -- current</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CIRM upfront funding -- current</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">229&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,600&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">869&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,888&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,486&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138386087784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock', window );">Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet</a></td>
<td class="text">Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt;"><tr><td style="width:1.0pt;"/><td style="width:325.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:88.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:88.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Right-of Use Assets:</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">731&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">906&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Right-of-Use Asset</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">731&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">906&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Lease Liabilities:</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">353&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">445&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">624&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Operating Lease Liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">977&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Lease Agreements</a></td>
<td class="text">Future minimum lease payments under the lease agreements as of June&#160;30, 2020 were as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:512.25pt;"><tr><td style="width:1.0pt;"/><td style="width:448.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:60.25pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Years ended</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Leases</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">204&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">414&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">884&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Amounts representing interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(90)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Present value of lease liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138389079208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text">The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:21.865%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.638%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.638%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.224%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.052%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.638%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.638%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.227%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (In Thousands)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aggregate Intrinsic Value (In Thousands)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,044,417&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.31&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.06</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.19</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes during the period:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">245,776&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,123,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,400)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(123,584)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.85&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.98</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.33</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested at June 30, 2020<br/> or expected to vest in the future</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,131,822&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.14&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.92</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.33</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested at June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">829,034&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.17</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153,508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.33</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Nonvested Restricted Stock Shares Activity [Table Text Block]</a></td>
<td class="text"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock for services as follows ($ in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:483.75pt;"><tr><td style="width:1.0pt;"/><td style="width:322.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:72.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:4.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:73.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of restricted stock issued</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156,184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">123,564&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value of restricted stock issued</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">512&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June&#160;30, 2020 and 2019, the Company issued restricted stock units for services as follows ($ in thousands, except share data):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:498.00pt;"><tr><td style="width:1.0pt;"/><td style="width:343.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:72.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:73.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of restricted stock units issued</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">195,320&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">184,454&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value of restricted stock units issued </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">623&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">909&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387699496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule Share-based Compensation Expense</a></td>
<td class="text">The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2020 and 2019 (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"/><td style="width:45.067%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.463%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.826%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.463%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.826%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.463%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.826%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.466%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General and administrative</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">195&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">680&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total share-based compensation expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">295&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">861&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">793&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Total Compensation Cost Related to Nonvested Awards</a></td>
<td class="text"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total compensation cost related to non-vested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2020 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:66.081%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:7.956%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.824%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.956%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.824%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.959%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock Units</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized compensation cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">188&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">172&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.83</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.66</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.50</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Share-based Compensation Awards</a></td>
<td class="text"><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2020 and 2019 were as follows (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt;"><tr><td style="width:1.0pt;"/><td style="width:378.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:61.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:3.25pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:61.75pt;"/><td style="width:1.0pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock Options</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total fair value of shares vested</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">515&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average estimated fair value of shares granted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.18&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392309368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Business - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants awarded</a></td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_IschemicRepairCD34CellTechnologyMember', window );">CD34 cell technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_IschemicRepairCD34CellTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_IschemicRepairCD34CellTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392105064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 32,621<span></span>
</td>
<td class="nump">$ 22,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">32,614<span></span>
</td>
<td class="nump">22,768<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">6,430<span></span>
</td>
<td class="nump">11,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">6,425<span></span>
</td>
<td class="nump">11,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">5,019<span></span>
</td>
<td class="nump">11,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">5,019<span></span>
</td>
<td class="nump">11,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">Municipal debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">20,975<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">20,973<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtMember', window );">Sovereign government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 197<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138386223560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 24,407<span></span>
</td>
<td class="nump">$ 11,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">8,207<span></span>
</td>
<td class="nump">11,125<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total</a></td>
<td class="nump">$ 32,614<span></span>
</td>
<td class="nump">$ 22,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138388975640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis', window );">Less than one year</a></td>
<td class="nump">$ 32,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">Greater than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">32,621<span></span>
</td>
<td class="nump">$ 22,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue', window );">Less than one year</a></td>
<td class="nump">32,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Greater than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total estimated fair value</a></td>
<td class="nump">$ 32,614<span></span>
</td>
<td class="nump">$ 22,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138391632184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">1,161<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">2,154<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392086760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details) - Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">$ 8,207<span></span>
</td>
<td class="nump">$ 11,125<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">8,207<span></span>
</td>
<td class="nump">11,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">8,207<span></span>
</td>
<td class="nump">11,125<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">8,207<span></span>
</td>
<td class="nump">11,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138384847640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries, employee benefits and related taxes</a></td>
<td class="nump">$ 1,441<span></span>
</td>
<td class="nump">$ 1,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities -- current</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AccruedGrantFunding', window );">CIRM upfront funding -- current</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">869<span></span>
</td>
<td class="nump">698<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 2,888<span></span>
</td>
<td class="nump">$ 4,486<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AccruedGrantFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Grant Funding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AccruedGrantFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138387746856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>office</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_NumberOfOfficesUnderOperatingLeases', window );">Number of offices under operating leases</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term for operating leases (in years)</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate for operating leases (percent)</a></td>
<td class="nump">9.625%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_NumberOfOfficesUnderOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Offices Under Operating Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_NumberOfOfficesUnderOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392172888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Balance Sheet Presentation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract', window );"><strong>Balance Sheet Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 731<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">794<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract', window );"><strong>Balance Sheet Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">731<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract', window );"><strong>Balance Sheet Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract', window );"><strong>Balance Sheet Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, noncurrent</a></td>
<td class="nump">$ 445<span></span>
</td>
<td class="nump">$ 624<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138404721192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Minimum Lease Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2020</a></td>
<td class="nump">$ 204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Amounts representing interest</a></td>
<td class="num">(90)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 794<span></span>
</td>
<td class="nump">$ 977<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392686136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Equity Issuances (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">26 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateMarketValueOfCommonStockNonAffiliates', window );">Aggregate market of common stock held by non-affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember', window );">Lincoln Park Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement', window );">Aggregate offering amount authorized per agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration', window );">Commitment shares issued as consideration per agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross price for stock transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_TermOfAgreement', window );">Term of agreement (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase', window );">Number of shares allowable to direct for Regular Purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase', window );">Maximum obligation per directed purchase transaction for Regular Purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase', window );">Maximum shares allowed in Accelerated Purchase as percent of shares In Regular Purchase (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod', window );">Maximum shares allowed in Accelerated Purchase as percent of shares traded during specified period (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty', window );">Maximum beneficial ownership allowable per agreement (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember', window );">H.C. Wainwright Sales Amended Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement', window );">Aggregate offering amount authorized per agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross price for stock transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent', window );">Commission on gross proceeds due to third party (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">907,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AprilPurchaseAgreementMember', window );">April Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,162,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.3125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,081,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_MayPurchaseAgreementMember', window );">May Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="nump">2,084,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="nump">$ 2.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of stock</a></td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants issued</a></td>
<td class="nump">1,042,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="nump">$ 2.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration term</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateMarketValueOfCommonStockNonAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Market Value Of Common Stock, Non-Affiliates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateMarketValueOfCommonStockNonAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Issued As Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_TermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_TermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AprilPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_AprilPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_MayPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_MayPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392590776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Options and Warrants (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Warrants, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_CommonStockWarrantsShares', window );">Warrants, Outstanding, Beginning of Period (in shares)</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsGranted', window );">Warrants, Granted (in shares)</a></td>
<td class="nump">2,123,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsExercised', window );">Warrants, Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsCanceled', window );">Warrants, Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsExpired', window );">Warrants, Expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_CommonStockWarrantsShares', window );">Warrants, Outstanding, End of Period (in shares)</a></td>
<td class="nump">2,153,508<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsWeightedAverageExercisePriceRollForward', window );"><strong>Warrants Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsGranted', window );">Warrants, Granted (in dollars per share)</a></td>
<td class="nump">$ 2.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExercised', window );">Warrants, Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsCanceled', window );">Warrants, Forfeited (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExpired', window );">Warrants, Expired (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding', window );">Warrants Outstanding, End of Period (in dollars per share)</a></td>
<td class="nump">$ 2.21<span></span>
</td>
<td class="nump">$ 5.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding', window );">Warrants, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 3 months 29 days<span></span>
</td>
<td class="text">3 years 2 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsOutstanding', window );">Warrants Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_Sharesvestedandexpectedtovest', window );">Warrants, Vested and expected to vest (in shares)</a></td>
<td class="nump">2,153,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest', window );">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</a></td>
<td class="nump">$ 2.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest', window );">Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 3 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest', window );">Warrants, Vested and expected to vest, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsVested', window );">Warrants, Vested (in shares)</a></td>
<td class="nump">2,153,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExercisable', window );">Warrants, Vested, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 2.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermwarrantsvested', window );">Warrants, Vested, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 3 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsvested', window );">Warrants, Vested, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_StockOptionsActivityAxis=clbs_UsEquityPlanMember', window );">US Equity Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, Outstanding, Beginning of Period (in shares)</a></td>
<td class="nump">1,044,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options, Granted (in shares)</a></td>
<td class="nump">245,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options, Forfeited (in shares)</a></td>
<td class="num">(5,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options, Expired (in shares)</a></td>
<td class="num">(123,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, Outstanding, End of Period (in shares)</a></td>
<td class="nump">1,161,209<span></span>
</td>
<td class="nump">1,044,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, Outstanding. Beginning of Period (in dollars per share)</a></td>
<td class="nump">$ 18.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, Granted (in dollars per share)</a></td>
<td class="nump">3.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options, Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options, Forfeited (in dollars per share)</a></td>
<td class="nump">3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options, Expired (in dollars per share)</a></td>
<td class="nump">21.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, Outstanding, End of Period (in dollars per share)</a></td>
<td class="nump">$ 14.85<span></span>
</td>
<td class="nump">$ 18.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 11 months 23 days<span></span>
</td>
<td class="text">6 years 21 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options, Vested and expected to vest (in shares)</a></td>
<td class="nump">1,131,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options, Vested and expected to vest, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 15.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options, Vested and expected to vest, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 11 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options, Vested and expected to vest, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options, Vested (in shares)</a></td>
<td class="nump">829,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Options, Vested, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 19.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OptionsVestedweightedAverageRemainingContractualTerm', window );">Options, Vested, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 2 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options, Vested, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants vested and expected to vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CommonStockWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Warrants, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CommonStockWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OptionsVestedweightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options, Vested, weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OptionsVestedweightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_Sharesvestedandexpectedtovest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shares, vested and expected to vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_Sharesvestedandexpectedtovest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Canceled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants, Vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Weighted Average Exercise Price [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Canceled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Vested And Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term warrant outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermwarrantoutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermwarrantsvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>weighted Average Remaining Contractual Term, warrants vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermwarrantsvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_StockOptionsActivityAxis=clbs_UsEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_StockOptionsActivityAxis=clbs_UsEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138392517880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock issued</a></td>
<td class="nump">156,184<span></span>
</td>
<td class="nump">123,564<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Value of restricted stock issued</a></td>
<td class="nump">$ 512<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value of restricted stock issued</a></td>
<td class="nump">$ 3.19<span></span>
</td>
<td class="nump">$ 4.93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock issued</a></td>
<td class="nump">195,320<span></span>
</td>
<td class="nump">184,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Value of restricted stock issued</a></td>
<td class="nump">$ 623<span></span>
</td>
<td class="nump">$ 909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138388281032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 861<span></span>
</td>
<td class="nump">$ 793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Total fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 515<span></span>
</td>
<td class="nump">$ 378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted average estimated fair value of shares granted (in dollars per share)</a></td>
<td class="nump">$ 2.12<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 2.12<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="nump">$ 680<span></span>
</td>
<td class="nump">$ 619<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138388788248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Funding (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_FundingOfGrantAwardCashReceived', window );">Funding of grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MilestonePaymentOnGrantAwardCashReceived', window );">Milestone payment received on grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_ProgressPaymentOnGrantAwardCashReceived', window );">Progress payment received on grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred', window );">Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AccruedGrantFunding', window );">Accrued grant funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense', window );">Amortization of accrued grant funding to offset expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AccruedGrantFunding', window );">Accrued grant funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AccruedGrantFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Grant Funding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AccruedGrantFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Accrued Grant Funding Liability To Offset Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_FundingOfGrantAwardCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funding Of Grant Award, Cash Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_FundingOfGrantAwardCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MilestonePaymentOnGrantAwardCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone Payment On Grant Award, Cash Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MilestonePaymentOnGrantAwardCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProgressPaymentOnGrantAwardCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Progress Payment On Grant Award, Cash Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProgressPaymentOnGrantAwardCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138388963752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Net Operating Loss Carry Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 21, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis', window );">Market capitalization used in net operating loss analysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_NetOperatingLossAnalysisAnnualLimitation', window );">Annual limitation on usage of net operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfNetOperatingLossesNJEDAProgramValue', window );">Sale of NOLs, value</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram', window );">Proceeds from sale of NOLs</a></td>
<td class="nump">$ 10.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Market Capitalization Used In Net Operating Loss Analysis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_NetOperatingLossAnalysisAnnualLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Operating Loss Analysis, Annual Limitation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_NetOperatingLossAnalysisAnnualLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Net Operating Losses, NJEDA Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfNetOperatingLossesNJEDAProgramValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Net Operating Losses, NJEDA Program, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfNetOperatingLossesNJEDAProgramValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140138391630456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 10, 2020</div></th>
<th class="th"><div>Aug. 06, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember', window );">H.C. Wainwright Sales Amended Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from stock transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="nump">969,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="nump">$ 2.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants issued</a></td>
<td class="nump">484,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from stock transaction</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares called by each warrant</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="nump">$ 2.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration term</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | H.C. Wainwright Sales Amended Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,779,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from stock transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>57
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MX  /H90* RZ<G-K_"]@Q9]#A+W(7E\+B<B.>O ;QBLP#?X5-9UKD!8H[^T?
M?$C.E-P&L5<>4EQS^A5#*Y(%Q2W^(]I,)IJ'Y*]@<WF>X(K6]2WJS+1(&Q1W
M^ZP?AU#(7D;!!6XM=$84.8+BQOXH/8C);"UCS) K1&XZK&E1"PU-D2$H;N\O
M@8;D()>$LE\6OQ)7>*F":)5BX4J.C"(P'U=+[_6*;+@B6QZF@OQLM2"'D T4
M25D)B6$7B83B&0"2K&^FEKN/%C(LI:U((8\C%ZM%BUS!<#<_18R,W[PUCZ%4
MOI33*H2F0_=^B-5MK$@-K%9J<%*E3$5R*$.R<(%?I*4U?(7BCX^5_WNR(B6P
M6BEA$D,]>5BDF0*.GU!+R7#%"K+"^UDM[S>U$F1XL-655*73H$)G*N,F]SQ8
MBD+=(/R#($98F#^K9?YNQ,.0C-($;B?E?8GK5!3CK+!\5LORQY%0*S.ZOH""
M7H/'1AL>E\<.%ZRJ>UGA^ PW[%.LU@)BA0'A,I5 A?,SW+1/4Q(&N8(4,(&U
M\!OY791#X5(6_-D,//4:(RLR *OP[:-+/ 2)24X_!#@WMK"JD&LV*6O:%$,K
M7)[A)IVOJ<[9'N!B^;#'Q:J6^X7CVQ7U^P>JXV+T(E>%W#/#J K/MW&''@*2
M?\ *^:J4 Q>H&NMV8?)V+9-_7Q"XV?81>4HUU(6Q2=YE6S='Y6ZF;'89MP-Z
M:S.;6C#8M^=4[;-M+6- V6Y?0CRS-COL<.57\QW%8;:/UBX>/VQ'?N/&OQ(2
MBB4TM5K7\'IUV.$[G&BYR3;)%E)K&66':\%]H<P#<'\II3Z=F!?D^ZR#_P!0
M2P,$%     @ 68$-43IACEG(!0  C!4  !@   !X;"]W;W)K<VAE971S+W-H
M965T,BYX;6RM6&UOVS80_BN$46 MX,0B]>HT,="X'=9AW8(ZW3XS$F,3D427
MI)QFOWY'R9%DD5(R;!\24]+=\;DC>?<<+Q^%?% [QC3Z4>2ENIKMM-Y?+!8J
MW;&"JG.Q9R5\N1>RH!H>Y7:A]I+1K%8J\@7QO&A14%[.5I?UNQNYNA25SGG)
M;B1255%0^73-<O%X-<.SYQ=?^7:GS8O%ZG)/MVS#]+?]C82G16LEXP4K%1<E
MDNS^:O8!7ZQ);!1JB3\Y>U2],3*NW GQ8!X^9U<SSR!B.4NU,4'AY\#6+,^-
M)<#Q_6ATULYI%/OC9^L_U\Z#,W=4L;7(_^*9WEW-DAG*V#VM<OU5//["C@Z%
MQEXJ<E7_1X]'66^&TDII41R5 4'!R^:7_C@&HJ> @Q$%<E0@KU7PCPI^[6B#
MK';K(]5T=2G%(Y)&&JR901V;6AN\X:59QHV6\)6#GEZM1:E$SC.J68:N:4[+
ME*&-,:?0&?JV^8C>OGF'WB!>HMN=J!0M,W6YT#"ST5^DQUFNFUG(R"R_5N4Y
M\KTY(A[Q'.KK:?6/+ 5U;-3Q\E1] ?ZV3I/6:5+;\T?L?=AL/MUN)@SYK2&_
M-A2,18^J'8*0H-0,V/>*'VC.2NT,46,JJDV9TW58D2A*@LO%H1\)6PH'GD]:
MJ1.<08LSF,3YA<H'INE=SI!B:26YYLR)L3$3]F9/B!</(-I"&&,2NB&&+<1P
M$N*-9'O*LSJ:0N^8A-TO)<024:68.Z*A#23VPP%:6RC!(UBC%FLTB?56:)J_
M E]D3>U'$8D& &TI$B[CD16/6XCQ"^&$3"_U4QU/LS'WD'OU')5,NY#&=I#\
M 4Q;!'N>&V32@DPF0?Y1K_-X_!)KRK@7EP:6+8.]!+MQ+5M<RU>L[SBNI;VN
M<=";M$%F2Y$8A[X;&O:ZA.U-)J_?.+WCN>,$G]KK%0 \Z>R'-!45I"RTIT\F
M0SBS.[9\"9?#E7 (X6 YLD5PEZLQ>0F?K* XY6-^'R$2.]Q)D@PQVE)!D$0C
M&+LR@*?KP&E"> FI;V^?(/&&2&TIR IC2+M"@*<K07/D<E%NSS23Q8M8[5P?
M!,,,ZQ"*2#""M*L'>+H@-#%]"9^=W?TEL0#:4E$TEKQP5P7P=!E8BZ+@VN15
M5:=9X%*:EUM6IF-H)^T9QGZA]C1E5S.@Y(K) YNMD),N_7=#ISYW907'D]EG
MHT7ZL!-YQJ3Z"7V"PJ*?I@QWI0!/UP*H__<,SD^&E)EBCFBE=T+ROUEF>-_<
M\^H_I'847$(;)B'(Z!JEHCQ H>.&VX V@R['#/>GYF ? 51@N:9U (Y6L3GR
MSCT/-_:0N =#10$?C[._@:\84J)LI-^CA(3]^3.F^+8TK/D]XDJ9!%4SETHK
M#0/8!G.$3Q!3C8 &LY8&U_+ ;%EQ!R?RF=W.P0FU9W5SDS\Y-Y%=\:S<,25R
MNCY=2<33-7%MA:<?G_YRH= ;+M=$C,)YF(1SO SJ;Q"RD"3S*%G^[V&SRS$>
M,C&7S B5(%V])MYT_<HR;K8=)#-#<,^@DTKIGD-R<\$\&CM-N$O?&Q9;EYR?
M+$?A=G2 3-.!6\FHJN13>PPUG REWR.,YU[R+W>STT.;)IS%WK!0OR1UZEVO
M\7N13%1%E=?=+C3[/.5..DQLFG 6X""V.(];, [&B@OI* 69IA1]I,=^2!20
MU7;F"N7 T-M<*/4.^G)X[>1LQ"809\-.SB$STG>0CF&0:8;1U.TUS6DF>04I
MF@L%!;%,F9JCSR5T\NJDAC!'#3EZ8/,*WT_PD&<[Q BT "-4B70$A$P3D-\%
MQ+;44N3P90N1!L+$E+LC(#;#."/AD(<XI:*1CH!T/(2\IAU]=50=7:D?AL-<
MZ! C7CC6OI".0)#IQK37OM0YHZ$0<U0[X<0;6S<BKF[+(>9JMQ:]JS)S3_F%
MRBTO%<K9/>AYYS$X+)NKO^9!BWU]>W8GM!9%/=PQ"D$V O#]7@C]_& NY-H+
MV-4_4$L#!!0    ( %F!#5&S5Q@1,@,  ),+   8    >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&ULG9;?;]HP$,?_%2O:0RMU) X$0@5(+56U39J$RGX\3'LP
MB2%6'3NUG=+NKY_MI&E2 @%X@#BY^][G+F=\DRT7CS+!6(&7E#(Y=1*ELFO7
ME5&"4R1[/,-,/UESD2*EEV+CRDQ@%%NGE+J^YPW=%!'FS";VWD+,)CQ7E#"\
M$$#F:8K$ZRVF?#MUH/-VXX%L$F5NN+-)AC9XB=7/;"'TRJU48I)B)@EG0.#U
MU+F!UW/8-P[6XA?!6UF[!B:5%>>/9O$UGCJ>(<(41\I((/WSC.>84J.D.9Y*
M4:>*:1SKUV_J]S9YG<P*23SG]#>)53)U0@?$>(URJA[X]@LN$PJ,7L2IM-]@
M6]@&VCC*I>)IZ:P)4L**7_12%J+F  =['/S2P3_6H5\ZV,JY!9E-ZPXI-)L(
MO@7"6&LU<V%K8[UU-H29U[A40C\EVD_-YIQ)3DF,%([!+:*(11@LC9P$%PLD
M,%,)5B1"5%Z"S^ 3<(%,]&TY<94.;T3<J QU6X3R]X3ZEK,>Z'M7P/=\K\5]
M?MC]#D?:'1IW.&ZZNSKI*G._RMRW>OT]>DNE<]8-J0!?@WO"=.8$4;#@DM@&
M^W.SDDKH-OM[(%B_"M:WP09[@BUT<V(A=(WU&XT>K\HB I2KA OR#\=M]2PT
M ZMI]N/S3.].^YFXS_7*'6'8P!Y4V(/3L"EYRDVSF (](YKC-NQ"<U2C\7J>
M!S\P=UDU@(,*.#@-.$.B  47A(%<QB##HJC^91M[(1\VJ3ZB=Q@UR(<5^?"L
M#HFQ)!MFMF<;[G#GQ8=^L-L?G68-Y%&%/#H+F4B9M^..=CA@2S=W635@PPHV
M/ M6'VU2(183MFDC#H\B[K)J$(\KXO%!XCE/4[W-SFSD0GO<L0F[K!K@T'L_
M5+P3T(_ZKRL5ZS4,O/9_NZ-,F^2UXQ">3KZ_H4NUQIL/@C" X\%'Z!9++_##
M83C>P_Q^D$'_9.:KKL8N-8\A;[$\3/Y^*L+#Q^(//7G*7+P6[."B8&_M9[A[
MQD'HA3N]T656D+JUB<F,J]^1V! F <5K[>?U1EI %!-@L5 \LT/4BBL]DMG+
M1$_-6!@#_7S-N7I;F+FLFL-G_P%02P,$%     @ 68$-4; %J^4"!0  PQ,
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M$E\3SH0$_H7\QVZ_T;KO28@3^:P;I?OO+&T8@Z8%9/"T8"X3/:DH\"#1+Y
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M)?3>1!H O-\*H5\F)D'7S<__ 5!+ P04    " !9@0U11>O,NHH(  #=,0
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MTSK!Q(JV9<6SUEAXD"7Y[C'\IQV( P-$- :X-<"2 7$U!J0U()*!XV@,:&M
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M=6C?Y7-5-75Q7[. 6O*PVU>]&]'2>U4C#Z&J0))DJ4HH<2DA?=D*\(=(_EQ
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MF-I*^@%"(/T %?9TL]?A&'*^/PRBCI*0&9-&X2!2&6;J(+5Z@#*J; NC9%>
M3%/C40=.R$Q.+P"%2*4H.?,6(S0KLZ8?7\=BZ'DP-L0L2"4J76)W0(7,1'4,
M&"(5FK!<)19C1,L!4?\HHF,O_%+L-3326&4G;&N+ .[@"9OAZ=OH$*M<I*SN
M$9JE6=,/[> @Z"BR.HH+\<AS($AFXD+<X04VX\4SN!"KK !Q(2A3N1 /G^$
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M<Z?8@?+4&9<F8PH&N5+0"_6JWJD9]!R_7))N='Q2& ?^^. S#L"C@/]R($?
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M.WIYN<!JAO'3>W(QKF*B@I[0Q,@%8((>F\Y*BGH.NESKYW[71\;*;,!WX8]
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M<E*6'5Q*>R^=]GA[BNXWM 9\B</'ZVQL+#]T<TTL+ Q.\X^:F=-UE?0.M'S
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MO2'J 7320'I(57_%:!K7PT.\T>3@:QQ3Q8.9-Q5OO@&S3.1=H%L\85%SJ\<
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M+ND=A]HQT/Y<*;M=. 6[E^'P/U!+ P04    " !9@0U1U%Q2714#   C!P
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M<VAE971S+W-H965T,3(N>&ULI5;;;MM&$/V5 5NT#N"*$F7'KB,)\*5&&\2
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M8%F:T'@17 W:1$YJ3LHG;^E6DIY?W IIX8M0#<(="M=8I(A[-XL]@;-(G'5
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M;/MV:S?>U.&]E!I/KZ^P+.FYBY8%Z+XP-.RZ#1L8'M"+_P%02P,$%     @
M68$-48+F--^4 @  IP4  !D   !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
MI51-;]LP#/TKA+'#!J2U8[N9$R0!DG;#.JQHT>[C,.R@V'0L5)8\26[2?S]*
M3KQT:X,!NU@BQ??X*(N<;I2^-Q6BA6TMI)D%E;7-) Q-7F'-S*EJ4-))J73-
M+)EZ'9I&(RL\J!9A'$6CL&9<!O.I]]WH^52U5G")-QI,6]=,/RY1J,TL& 9[
MQRU?5]8YPOFT86N\0_NEN=%DA3U+P6N4ABL)&LM9L!A.EJF+]P%?.6[,P1Y<
M)2NE[IUQ6<R"R E"@;EU#(R6!SQ'(1P1R?BYXPSZE YXN-^SO_>U4RTK9O!<
MB6^\L-4LR (HL&2ML+=J\P%W]9PYOEP)X[^PZ6(3RIBWQJIZ!R:[YK);V79W
M#P> +'H!$.\ L=?=)?(J+YAE\ZE6&] NFMC<QI?JT22.2_=3[JRF4TXX.U_D
MN6ZQ@$^<K;C@EJ.9AI:(W7&8[TB6'4G\ LD(KI2TE8%WLL#B*3XD0;VJ>*]J
M&1\E_-C*4TBB <11'!WA2_HJ$\^7_'N5\'VQ,E;3J_AQ)$':)TA]@O3_KO$H
MB>N_B6E8CK. &LR@?L#@6>E[GSCP,0.J!+HX["\.F"S@ G.L5Z@A&3KO< P;
MU.C"2R6H)0V\YA)LI5I#X>;-Y ^.O_%W3#!-*0> =2/4(R*L4&+)K?$9-0IF
M29UE6]+U"H:#-!WZ-4M2N&Y0,\OE&@12-SVIX>2$GKS6*"TDZ1B2LQ3.+V^O
MH&U*30\,RE86#GD0%\=C(AY%$5S;BE1FHS&,QAE\5I8)2AH/LBRC-1VDV0B>
M^]/A0?/4J-=^1!C(52MMUT>]MY]"BZ[Y?H=W(^R*Z367ABHK"1J=OCT+0'=C
MH3.L:GPKKI2EQO;;BB8I:A= YZ52=F^X!/ULGO\"4$L#!!0    ( %F!#5%K
MZBRNA00  (@*   9    >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;*56;6_;
M-A#^*P>AQ5H@L6Q9<6+#-I"D';:A18*TW3 ,^T!+9XLH16HD%27[];VC9,6.
M$^_#/E@FI;OGGGLEYXVQWUV!Z.&A5-HMHL+[:A;'+BNP%&Y@*M3T96UL*3QM
M[29VE461!Z52Q<EP.(E+(76TG(=WMW8Y-[574N.M!5>7I;"/5ZA,LXA&T?;%
MG=P4GE_$RWDE-O@%_;?JUM(N[E%R6:)VTFBPN%Y$EZ/95<KR0>!WB8W;60-[
MLC+F.V]^S1?1D FAPLPS@J"_>[Q&I1B(:/S384:]25;<76_1?PZ^DR\KX?#:
MJ#]D[HM%=!%!CFM1*W]GFE^P\^>,\3*C7'A"T\J.2#BKG3=EITP,2JG;?_'0
MQ6%'X6+XBD+2*22!=VLHL/P@O%C.K6G LC2A\2*X&K2)G-2<E"_>TE=)>GYY
M4Z$57NH-?$)RSLUC3ZC\+<XZA*L6(7D%80*?C?:%@X\ZQWQ?/R8V/:5D2^DJ
M.0KX6ZT',!Z>0#),AD?PQKV+XX W?@6O=0S^NEPY;ZD*_CZ"F?:8:<!,_T?8
MCB)PL\U<)3)<1-1-#NT]1@>P\+5 N#9E)?0C%,*!Z054*T!M";XQ8-9KF=&^
MD;X C[9TX OA 1\J:1&DYF@F('3.B_%@#QF=EU3@I"X]_71FD?K."P4K8RDR
M;(_,X@D08C ,F2E)) MR)^ -=0);)2?)+D)P27NX%ZI&(M=I5>*1%=P).+*"
M4!KG^:M_(O.3V[J6&]#&$Y2YESD2=9!EI60F?2##>A9];?6^,Q8SL]'R7^R
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MX%W0-[4C:^[]#&C<8#]NX -23:\HD^,1OQE-X:XC!-^(T&4@-(,;8F"W]-[
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MDG% \%:G-Q &7(.9&UDH<2OC4M'N,B?21\'"'R-HXQB<>\"]U;^ 1?0D5*8
M8(I8)S !"699+6&61MI=6@ R,+?80.',S0YK=[7TZWJM##BJ%>*+"^(8Z DG
M<KH#.6=%8IS-N)MNWV\T_ UF'ZJ*!(\<L_"AR7+BS2?CC@)[RI).>;I@MMTB
MGTYN++:/D]Z9M<]%(IB/O?%XWWF>D 6YJ-$AF^-HYF-MKHQ;[[$F)(XE][\Q
MF;6M.[>;)JWQ>IJ^2B$U-M;L-HY=YEA)?"B$)['OB_<;Q(Q<0^<>*2'#MY2^
MJ%ME'L2JM$ #G![)![$V6>)B@Y:++%6#YUF,#$JF(UXB\K?*3X<,,94,)_#3
MZ>))0N L0#6IM^QPIKW1XCG6"N1BMA0^6<$:<6BS&+QH&QKEDBQ.WN'GK5][
M=#O2AA;T;(O;C0U<^$S&AVU\IR&4+1'H,LE*2 !R4+;EL'3\AW'&EU;&'<OR
MDZY[5AN5?89%V2TBI@^5#0)DJUC?N& ":$+!I"PZ >29DT:$.SB.2+-"J/M0
M@=Q1X,];*"C3F,QZ$)Z3LBAE'#\X5"2%U&SR/M0 .BF36G:(Q0Q4S#1\'"L9
M;F"N#IB6L31;SNN+JQ[H53:R^XW492(MDQ7Y['H? &CVKQ0;'ASRPBFD&#+C
MN46ZA19&:I)K>^EG78U7=!%V+Y#V 8]XW.6AQ%9:ZU&&(2I+ "MLF_=UV=-2
M'R9;8_6T4VP03G1LQV&((W(2I]9C?8)R:/P-W][2=HN+^0!2P\Q@04XZ01@,
ME2@ @\>:27]3!X8#Q5T&_6Q*1(ZFR(E*3C!2V%R%>JV)+>2<#)CD#"#S/-:A
M7'7]E/%,/BKM^>(WCKW&XMJ$96(+5Q21T<E2(42/Z);#B2\Q?->>E3IP0H*Z
M7^>089<KV%I6*PDUH1A2"6"<4T)S(IRU,*C@G>;AJEQ11!T_88 !>K$%"''[
M&N\GY2K?(&7#DX"BE/$X &IN' 0VB= YW@!U;"%R3C=F^SP'>OMTN2H)@^EH
MI#>PSQA8*6RE*%=LEQ&4,SB]=>':L0DI*I24COMUG($I][#UK0-^@FI8,M94
MSK%M;@HXQJ/6S3^GY(X2=M3 F@B@$RTA*PC"1XC!WOZ52M5:AYK!/;M+2>(D
M<]9(Q;E_?O[-+CZ<Y^Q(W%&F+ OB3+TK3.5*Q]0[0!0C-7:'5>W/F3W#%GA$
M!M(40+M)##*]QSB5%\Z%CG< L7M.P'NR4^U<B5;=!&Y_D$8S)%P3$KPW,K72
M->['@ 7TV:B$#AC;H^P8EU%='^FJ2ZIC"+Z#+("'"#E41FZFP#640=E>'<VN
M%0G%C=:36'^"GZD0<%9H!2DJ8'-%E4A<Q^NJM6%)MLL;NX&_U8Y0<:93HK"G
M/*.*%AN;Z@M1%F:V ?J*,%?]X ']LVKZY[[;;V3$^D\ UGUX>:37[V#.>5 3
MJ,."U*?#B33WM>(=']AK6K]7*U-*E,3H6Y=]?@=]9X])QWH;?0SU/_J7OO@(
M%[QSVOU6)ODSD/.K)G?TX^7'T0DGFVH[^X_K&>_H=KFR\ '<I>H+A"/G>1?E
M#:$CL>@:@M% DM$)N2&Y6%H-G9BA3M505&63^:0(WGLM6Z7B[=YUJ_SF&.+=
MK@KZ#(#M:E7KL]NJF'VB@:&C8-ZV/_YPKM!JJ/:_-0 &U$ ',"(NTA2U*^J-
M'*F<,)XF:"CHG_R5\XK;8$,L>5"2FE+2\&N%KHFJCNG$ZRJ9OS8$2,=<1#2B
M5-ILFF]B("L+POS(17Q7%PK O"($2I_(-7$-$I;-CK+$9*AG<0-V/YH'_K)5
M0+=7_0$ ;L#[%?***9VAK_Q7_H).9T;?/9EZ5(J'Z@_B=4735'%TUC%2#=SL
M(!7IONHJ(PWUU^D@&K!SL'Z'XHGJB9S J2C<%&#@=UC&!3H?2ZPA5LO0+3V:
MG$$I3=?31AA\1_+T!5WNDV*C350#YV%5/48]789\\:Y-3*P<2+(U:JF.'@2S
M)X 3KH8I 79U5"E396YJQ5#44]Y0:RI9JW&++1HDHCTIS8[CI@1DO?%!.<TA
M-67<9AJU:>K+'1WWB@M\GC%TP.$[R^5-Y8:VFP8).CBZO<HGD./UOY4K$VRG
M@EH]]%/(,%$U/;%3" 1S@VG":XW035+0";N3/->=-?I#\0>=Z")V;N% '!FZ
M\EH)Q[Q74?<NI^;&2Z9^VY]4XQJ349=D.[4LE9?;O"--=IKV6M/TM*)7*9SX
M)53MI%FX$734V*M-@,/\18C62]^#!8ZKX2[63+NO,2S/*JAJP>,^C_LYJ.<)
M-374,-+$&JMA6Z4Y.^?2H *4MA/->PGZXG5;ZUA]7Q<[#J@/%!?5L'"QG'CC
MZ6S?-&"_()0=4D1]8U\WB)NV0/R(^L;6;)R/S[S)8OF5V A:-BILIW]<XOK"
M#:FY4'GM6LAZ(&LI>5X@$.,=S Z*FPX ?V:^[@@>F+*[.*UJ<8V:%S(;>X"&
ML>TL:#B9=;!9>>.^HP<_-]#MJ#MI[]:.Q@[+$1' 5/2W.%3*N+EN?U;;P 19
M:!+,6TQP'2#!,M1J2(78<4OGY;$,#\ZZMP4UE'D-^I+";DUXNG+ \\G[E],#
M<C!CPS*1^X'6C:I)1%.H54GKD9)@K]*W(#/ 2W+D.8U5\7?NBS>2,S*+10VW
MNJ?\9CFK41#0%-K!Z]9('^RLE2Q*AY[USEU&">;=Z;M#PT:51+M[JD:*C;2K
MP1@3FTZ.3F305/<Y=(.D<5N-NE%$;&2\YF*RSIW='I ZLZJ&??B:04CDOBP$
MNQ0>'8"[CWU,^/6/VQ&"X^7,6\['7Q*"X\57#,'_(OAF@3<#!W_6X)MUD]G_
M)/R&!OD_A9_K_7_-V]G\QYH)XJCS\Q8SXMX20;WJ!B7\]@:-L$@M3@59AU0C
M3]U>'BY:G@ZX:3AYY[SF([_,@5T7M^CT;I1X4ZOW+:MWZ_FUHA=@B/M+&NF"
M6]+_>_K%[?COI)83!&KMIU=8@:)=A^(#-S?'\,?WFZRTD 0+_PP\_-KI21'P
MP];\G -MYLTF9^)(3);(NV(!1\,%#PR#9Z1J^O'N2,S]Y3DJ>.QI'UYN9'H#
M&3L3-?<3P5/Q QF"?N&=S;VSLP5V!@'5!L'4FX^7(O GBT8344-PWR=ZWS7J
M7ZP\GGNS\?B$Z"VWEKUAE\8B/F8Y.Q'!Q)]MKQNHI>=34,ED,?&",0DZF?G+
M.51RONQ(#2GF3HHCR!%,H)KIM//\ Q($F-A%&'I':B#"<W\R(\+!5R"\#,ZY
M3 ?9<V1ID&5[/I;L-<C"%8FT"Z='-PT<L]NOJ%38;UJZ+M(YYI6YY6Y9V@HK
MD$F/W$"X=EN$-8[MOHHT.)9=]V_-;UM;!U4,3.8+;[*<"?:&Q:P*D0,;X.43
M,L@"_[>T\EM*&>B/TDW)U!^IH69J[Y(*@%E^N=(<![7JSN?>E'P6A<1L?DAU
MO6U074"N=8[HV?5JUFGG#;=$F1M^CX_2>ID6[F6WYF[SJN"%>T.N7>[>,_Q%
MFAL@GXC5&EO'_ME\Y*86]461Y?R^W"HKBBSAKQLET2K2 CQ?9UE17] !S0N4
M+_\#4$L#!!0    ( %F!#5&GZ@-J; 0  %,+   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;*U666_C1@S^*X2[*%H@L679<9S4,9!LMQ>P;1#O\5#T
M82S1UB#2C'9F9,?]]24I69%S;5KT930'^?&F.-M:=^LSQ !W16[\12\+H3P?
M#'R28:%\WY9HZ&5E7:$"'=UZX$N'*A6F(A_$4309%$J;WGPF=]=N/K-5R+7!
M:P>^*@KE=E>8V^U%;]C;7]SH=1;X8C"?E6J-"PP?RVM'IT&+DNH"C=?6@,/5
M1>]R>'XU9GHA^*1QZSM[8$N6UM[RX=?THA>Q0IAC$AA!T6>#;S'/&8C4^-)@
M]EJ1S-C=[]%_$MO)EJ7R^-;FGW4:LHO>M <IKE25AQN[_04;>TX8+[&YEQ6V
M->TDZD%2^6"+AIDT*+2IO^JN\4.'8?H<0]PPQ*)W+4BT_%$%-9\YNP7'U(3&
M&S%5N$DY;3@HB^#H51-?F"\RY?#XBNQ*X:TM*-9>L;MF@T#H3#-(&J2K&BE^
M!FD"[ZT)F8=W)L7TD'] 6K6JQ7O5KN(7 7^K3!]&T1'$41R]@#=J31T)WNA%
M4Y=BZK7:468%N'1.F37R_@A^MR91/H-W=^P&A#\OESXXRIN_7I ^;J6/1?KX
M?W#T?T."9Q\^(U1!Y_IO!-]Q0M*ET09"AL!E#G8%E'C)+=B2W_P1E1]Y0B>!
MN.3E")1)']U"932U"/@@0#D5O#9K"&J98U/UI((7.2S;&G*[%VG/:85-*$@M
M80N90Q397M]!42<<<L(!I0NVZ2(D<30\@^_$,%MYNO'?GY-NC-!-U7O.!6$^
M_2*8@G>_NT&/RB69R$IQ0PVNE*1Z R<37B):AM,AKZ=C^!D-.I4+M4JIE#4G
M%_<DB$=G,#P[@<DT@@DA?["!"+_JE#<0$Q.M8UZG$Y9T>C9JV ]8$NL#A2M7
M'*M@P5ASO*'HT4EME4L]W038(1,E=FTH3JEHRD[?2FO#]%AMR((U0HE.6^*Q
M=(9MILD'3-<@;=&AZ)@TPI9X@!H>N%7HE6\RQC^*V$)2ZX\Z%=GK^YRK'SYR
MSCUUW9'YV!?DJ=%8XC.5^,12]<+_C+E<(3L*N"3L8\!'=@[[TQ%$_<F$%DJ%
M.B@KI1UL5%YAF_8>]H%XX&[8RZ=G74CD[ME]AW]-/4Q>FR)Y;6G\.\>_ICB^
M;B25Q9"S=70ZI;;T"D.?L),ROC^,&:0_G,(GHJKC<.FIR33:2@LZ!.EV-'$"
MI2LC>DY)]EM*HIE2Y-"K[RA4>6EE1'65J^3V>)%D-N<H"!Z4E'M,4-@4\[H!
MMA6PL51VU'W##K2'NIXK:GZ040>PQ$@NZ]"0 BR&&[@RNV^_F<;#TQ]\K?X#
MY(#4K/=1WUMV*,,N/;I-[1]"II]91>+(*H+)5<ET2PQ;1// ?'80WJ%+M)?;
M/3R+4WD.6)2YW2'ZEW1J/7RH5/T#,/)O%76P_NET6?I/_7,'G4&G0+>6<<X3
M5F5"/?.TM^W$>%D/2O?D];CY7KFU)GMR7!%KU#\]Z8&K1[CZ$&PI8]/2!AK"
M9)O1U(N.">A]96W8'UA .T?/_P%02P,$%     @ 68$-4<82ZDL&!   [ D
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ME2.V:5HV/!?1QP0^7SM'NR 6&"?M\C=02P,$%     @ 68$-4<PCWC%. P
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M)3KEW]G][SCD<Q'X"JM<_,*^]\TO$R@ZYZT>P*Q 2]/_Q<-0AR/ (OL"(!\
M>=3=!XHJ?Q->K)=D]T#!F]G"(*8:T2Q.FK I6T^\*AGGU]MNY_!CA\;#[3U_
MW3+U3!L6TV*@N.XI\B]0S.&--;YQ<&M*+)_B4Y8S:LH/FJ[SDX2O.S.%\VP"
M>99G)_C.QQS/(]_YM^8(?UWMG"<^$7^?H)^-]+-(/_N>$OY/"MB0O!<>8:-$
M@3HLO*TJ)&EJ>&O@=:<>X6RHT 1\@W!C=2O,([ K$I8@C;<@P&'1D?02';0=
M%0T?8! U8<_Y<T#^],,BS[,7GT6,]K,7O_")] T42)[O.//>(Y]*<J?!L!FB
MD3OP3(/-=8(765H LU+MP%9Q\AG%T[RBZ#(@^4JK \.IN"#XTM<,JX,'1[F<
M7T[FES-PC2",<257NK!:<WO@G(H[$)YK-A:J)5D@\,:(&/#'?)K-\PMHD7J.
M"0AE>4=B@?:"2(2M8\]/I?Z7A-EB-EG,GIV0,(57A@W&#&TK<G]#?0@+Y/Y6
M0DW6\6:3+;A>,430S;U#*>:;PJTH1K$@'> #4B&=V"D$;O)@#?;R O1I<4P)
M%0K?!>F<V8#\>IVF\ <K'0L4N(^C2JVQE)P;'^JNY7#2A6-28(RX9^'LWDI&
M59QA-++(7QNA*GA$P3M=D=6Q&B.R9+II*$Z0OXWRMT*Q[JO#X?^OFY\>-5*-
M5,?G(NQ/9WS?4T?K^")=]8WXDWO_G+T15$OC0&'%T&SZ["(!ZI^(?N)M&]OR
MSGIN\G'8\*N*%!QXO;+6'R8AP/A.K_\!4$L#!!0    ( %F!#5$\UGD\2 @
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M Y2Y7AFHZ-I8VS56/DMG\LD('P$*;3MU\@8]#@G-QN<84\;]O396A%Z4$S,
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M.AF]Q2MHR%\8\P_TLWS5@^PD7\GEBC1F;UZ YQQT]X,=;#_S7OP;4$L#!!0
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M[CP W?6%;F%5XVMQK2Q5MI]6U$I1NP Z+Y6R^X43Z)OS_#=02P,$%     @
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MS#*C21N%)J#[)>=JN]$"^ME]_C=02P,$%     @ 68$-43CJ;*#G P  ?@H
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M#7K7U#U4/>W4&R/7;L)82D/SBOO-:4!$907H?B6EV6VL@7;DG/X/4$L#!!0
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M,F4B"?V7K,$791Z=DWO*,ZQUWR9H(\)N<L.*W/ R<M_5->ED-[3ZOAJWZ'5
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M<='E%=+H]GII$ZO6_H0NE,7S[L,*;V30K@#W2Z7L>^(.?7_'Y_\ 4$L#!!0
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MXM1;3+28YP?'L=#F&)H/9^9+ :4U,-<G0NC5Q)Y%JV^/P3]02P,$%     @
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M/5F>E8RC_%N+5I#4:_B";,[!6[@1UJ<V""?72$(V[G46$]?RB+@8>"][WO0
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M:A#VH(8M:O@1*NI"#8]049QVHT8M:O01*NY"C8Y123<I:4G)2=*3-)03[KZ
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MX-I O4\8DX>&#M#<@R?_ E!+ P04    " !9@0U1';JD-K8"  !<!P  &0
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M \S[C1#ZU+'GR^8/R.Q?4$L#!!0    ( %F!#5%M'0KC8 (  &0-   -
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MD [,-7?PE]'=1JAUJ,:_Q12]1A^'_787Q'/S?\*H5RM1P;6NNA:4V\71@ R
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MU@2%K D*61,4LB8H9$W^DZSO6J_^^C=/N\:U*INC/^O^I<T_ 5!+ 0(4 Q0
M   ( %F!#5$'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ 68$-43GMCQ[N    *P(  !$
M     ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 68$-49E<
MG",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    " !9@0U148_QUD4%  !S%0  &               @($-
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 68$-43IA
MCEG(!0  C!4  !@              ("!B T  'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( %F!#5&S5Q@1,@,  ),+   8
M  " @883  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !9
M@0U1L 6KY0(%  ##$P  &               @('N%@  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ 68$-4=FIT?V( P  V0L  !@
M         ("!)AP  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( %F!#5%%Z\RZB@@  -TQ   8              " @>0?  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !9@0U1NT B,B0%   2$P
M&               @(&D*   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ 68$-4=Z(,;5T%   EC,  !@              ("!_BT  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( %F!#5$<> VM]@D
M "P:   8              " @:A"  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " !9@0U1 7(<2>0#   E"@  &0              @('4
M3   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( %F!#5'4
M7%)=%0,  ",'   9              " @>]0  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ 68$-45++3UEV!   3 L  !D
M     ("!.U0  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %F!#5'&$NI+!@0  .P)   9              "
M@2ER  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ 68$-
M4?5O<_-G!@  SPX  !D              ("!9G8  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " !9@0U191WSR'H"  !U!0  &0
M        @($$?0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( %F!#5',(]XQ3@,  +,'   9              " @;5_  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ 68$-43S6>3Q("   \A4
M !D              ("!.H,  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " !9@0U1J^2E+C\$  "3"P  &0              @(&YBP
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( %F!#5'HL,_1
MCP(  '(%   9              " @2^0  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ 68$-4;A2'7O? @  DP8  !D
M ("!]9(  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !9
M@0U1_:K(,:("  "H!0  &0              @($+E@  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( %F!#5%734D'20,   4(   9
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M970S,"YX;6Q02P$"% ,4    " !9@0U1>H>JYFD"  #O!0  &0
M    @($4K   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M %F!#5$J#Q NG (  ','   9              " @;2N  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ 68$-45T4/ S0 @  1PD  !D
M             ("!A[$  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " !9@0U1."'8TP\#  "'#   &0              @(&.M   >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( %F!#5'30M22I (
M ! '   9              " @=2W  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ 68$-43N]M3H\ @  4@4  !D              ("!
MK[H  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !9@0U1
MT_M5[],"  #E"0  &0              @($BO0  >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( %F!#5%@48>1EP(  #X'   9
M      " @2S   !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ 68$-44&!/TQL!@  ^!P  !D              ("!^L(  'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " !9@0U1R.U;XE0&   )(P
M&0              @(&=R0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( %F!#5&RCR-"0P,  #P*   9              " @2C0  !X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 68$-46^?-69\
M!   PA,  !D              ("!HM,  'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " !9@0U18#T?E_(#   3#P  &0
M@(%5V   >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( %F!
M#5$=NJ0VM@(  %P'   9              " @7[<  !X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ 68$-4;I,FN2) P  C P  !D
M         ("!:]\  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M    " !9@0U1;1T*XV "  !D#0  #0              @ $KXP  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( %F!#5&7BKL<P    !,"   +
M  "  ;;E  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( %F!#5'/0UUG\0,  !T>
M   /              "  9_F  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" !9@0U1N#;$W*D!   N&P  &@              @ &]Z@  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !9@0U14]DK*;(!  !3&P
M$P              @ &>[   6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
..-0 U &H.  "![@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>161</ContextCount>
  <ElementCount>306</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedStatementsofEquity</Role>
      <ShortName>Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - The Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/TheBusiness</Role>
      <ShortName>The Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105103 - Disclosure - Available-for-Sale-Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecurities</Role>
      <ShortName>Available-for-Sale-Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeLossPerShare</Role>
      <ShortName>Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113105 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119107 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2132110 - Disclosure - Research Funding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ResearchFunding</Role>
      <ShortName>Research Funding</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2134111 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2136112 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2137113 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Available-for-Sale-Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecuritiesTables</Role>
      <ShortName>Available-for-Sale-Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/AvailableforSaleSecurities</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeLossPerShareTables</Role>
      <ShortName>Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/IncomeLossPerShare</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/FairValueMeasurements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/AccruedLiabilities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/OperatingLeases</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/StockholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2330307 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/ShareBasedCompensation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - The Business - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/TheBusinessNarrativeDetails</Role>
      <ShortName>The Business - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails</Role>
      <ShortName>Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails</Role>
      <ShortName>Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Income (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeLossPerShareDetails</Role>
      <ShortName>Income (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/IncomeLossPerShareTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - Operating Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeasesNarrativeDetails</Role>
      <ShortName>Operating Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2422409 - Disclosure - Operating Leases - Balance Sheet Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails</Role>
      <ShortName>Operating Leases - Balance Sheet Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - Operating Leases - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Operating Leases - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2426411 - Disclosure - Stockholders' Equity - Equity Issuances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails</Role>
      <ShortName>Stockholders' Equity - Equity Issuances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2427412 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails</Role>
      <ShortName>Stockholders' Equity - Stock Options and Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2428413 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails</Role>
      <ShortName>Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ShareBasedCompensationDetails</Role>
      <ShortName>Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2433415 - Disclosure - Research Funding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ResearchFundingDetails</Role>
      <ShortName>Research Funding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/ResearchFunding</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2435416 - Disclosure - Income Taxes - Net Operating Loss Carry Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails</Role>
      <ShortName>Income Taxes - Net Operating Loss Carry Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="clbs-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2438417 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/SubsequentEvents</ParentRole>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="clbs-20200630.htm">clbs-20200630.htm</File>
    <File>clbs-20200630.xsd</File>
    <File>clbs-20200630_cal.xml</File>
    <File>clbs-20200630_def.xml</File>
    <File>clbs-20200630_lab.xml</File>
    <File>clbs-20200630_pre.xml</File>
    <File>clbs-ex31120200630xq2.htm</File>
    <File>clbs-ex31220200630xq2.htm</File>
    <File>clbs-ex32120200630q2.htm</File>
    <File>clbs-ex32220200630xq2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "clbs-20200630.htm": {
   "axisCustom": 1,
   "axisStandard": 13,
   "contextCount": 161,
   "dts": {
    "calculationLink": {
     "local": [
      "clbs-20200630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "clbs-20200630_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "clbs-20200630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clbs-20200630_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clbs-20200630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "clbs-20200630.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 371,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 3,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 8
   },
   "keyCustom": 46,
   "keyStandard": 260,
   "memberCustom": 6,
   "memberStandard": 30,
   "nsprefix": "clbs",
   "nsuri": "http://www.caladrius.com/20200630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.caladrius.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105103 - Disclosure - Available-for-Sale-Securities",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecurities",
     "shortName": "Available-for-Sale-Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Income (Loss) Per Share",
     "role": "http://www.caladrius.com/role/IncomeLossPerShare",
     "shortName": "Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113105 - Disclosure - Fair Value Measurements",
     "role": "http://www.caladrius.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - Accrued Liabilities",
     "role": "http://www.caladrius.com/role/AccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119107 - Disclosure - Operating Leases",
     "role": "http://www.caladrius.com/role/OperatingLeases",
     "shortName": "Operating Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Stockholders' Equity",
     "role": "http://www.caladrius.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - Share-Based Compensation",
     "role": "http://www.caladrius.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132110 - Disclosure - Research Funding",
     "role": "http://www.caladrius.com/role/ResearchFunding",
     "shortName": "Research Funding",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134111 - Disclosure - Income Taxes",
     "role": "http://www.caladrius.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136112 - Disclosure - Contingencies",
     "role": "http://www.caladrius.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.caladrius.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137113 - Disclosure - Subsequent Events",
     "role": "http://www.caladrius.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskCreditRisk",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskCreditRisk",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306301 - Disclosure - Available-for-Sale-Securities (Tables)",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecuritiesTables",
     "shortName": "Available-for-Sale-Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Income (Loss) Per Share (Tables)",
     "role": "http://www.caladrius.com/role/IncomeLossPerShareTables",
     "shortName": "Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.caladrius.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Accrued Liabilities (Tables)",
     "role": "http://www.caladrius.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - Operating Leases (Tables)",
     "role": "http://www.caladrius.com/role/OperatingLeasesTables",
     "shortName": "Operating Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.caladrius.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.caladrius.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "icd5ddb34eb58439ca82e6cd0adcb36c0_I20180331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GrantsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - The Business - Narrative (Details)",
     "role": "http://www.caladrius.com/role/TheBusinessNarrativeDetails",
     "shortName": "The Business - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i435d817d085a4640b5a6c1464fc2d6c6_I20171231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrantsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "role": "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails",
     "shortName": "Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails",
     "shortName": "Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails",
     "shortName": "Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i380bbd1c1ef540988fa905c4d3a9bbd9_D20200101-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Income (Loss) Per Share (Details)",
     "role": "http://www.caladrius.com/role/IncomeLossPerShareDetails",
     "shortName": "Income (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i380bbd1c1ef540988fa905c4d3a9bbd9_D20200101-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i9d727b490abb4a08b6bc611450220f08_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i9d727b490abb4a08b6bc611450220f08_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - Accrued Liabilities (Details)",
     "role": "http://www.caladrius.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "clbs:NumberOfOfficesUnderOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "office",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - Operating Leases - Narrative (Details)",
     "role": "http://www.caladrius.com/role/OperatingLeasesNarrativeDetails",
     "shortName": "Operating Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "clbs:NumberOfOfficesUnderOperatingLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "office",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422409 - Disclosure - Operating Leases - Balance Sheet Presentation (Details)",
     "role": "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails",
     "shortName": "Operating Leases - Balance Sheet Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - Operating Leases - Future Minimum Lease Payments (Details)",
     "role": "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails",
     "shortName": "Operating Leases - Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i6d039286e7ad457e9448ba787ec1cf9d_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ic32d3c882e084aa79bd397aa974b4613_I20190331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "clbs:AggregateMarketValueOfCommonStockNonAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426411 - Disclosure - Stockholders' Equity - Equity Issuances (Details)",
     "role": "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
     "shortName": "Stockholders' Equity - Equity Issuances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ic32d3c882e084aa79bd397aa974b4613_I20190331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "clbs:AggregateMarketValueOfCommonStockNonAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Operations",
     "role": "http://www.caladrius.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i5714f756c7ef49ebbeb8c792722bd60f_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "clbs:CommonStockWarrantsShares",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427412 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Details)",
     "role": "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails",
     "shortName": "Stockholders' Equity - Stock Options and Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "clbs:WarrantsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428413 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)",
     "role": "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails",
     "shortName": "Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "iaf5101c2431a47e8a1b88dd93624d188_D20200101-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - Share-Based Compensation (Details)",
     "role": "http://www.caladrius.com/role/ShareBasedCompensationDetails",
     "shortName": "Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "icd5ddb34eb58439ca82e6cd0adcb36c0_I20180331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GrantsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433415 - Disclosure - Research Funding (Details)",
     "role": "http://www.caladrius.com/role/ResearchFundingDetails",
     "shortName": "Research Funding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i407cfd607b264cfb8ff9e7af6c462f5a_D20170501-20170531",
      "decimals": "-5",
      "lang": "en-US",
      "name": "clbs:FundingOfGrantAwardCashReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i5714f756c7ef49ebbeb8c792722bd60f_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "clbs:MarketCapitalizationUsedInNetOperatingLossAnalysis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435416 - Disclosure - Income Taxes - Net Operating Loss Carry Forward (Details)",
     "role": "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails",
     "shortName": "Income Taxes - Net Operating Loss Carry Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i5714f756c7ef49ebbeb8c792722bd60f_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "clbs:MarketCapitalizationUsedInNetOperatingLossAnalysis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "id6b5f2a163bb41f395f2f166843dc9c1_D20200101-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438417 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.caladrius.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ib917b042859f49cd9af5962cf0b25fe8_D20200710-20200710",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ifa883ac05b0e47b4aee351733bef41a8_D20200401-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ia26c7702fea34fd481006912dd3c74c9_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Equity",
     "role": "http://www.caladrius.com/role/ConsolidatedStatementsofEquity",
     "shortName": "Consolidated Statements of Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "ia26c7702fea34fd481006912dd3c74c9_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:BusinessTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - The Business",
     "role": "http://www.caladrius.com/role/TheBusiness",
     "shortName": "The Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:BusinessTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20200630.htm",
      "contextRef": "i993879b12e9c46ef87314fc725152301_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 38,
   "tag": {
    "clbs_AccruedGrantFunding": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Grant Funding",
        "label": "Accrued Grant Funding",
        "terseLabel": "CIRM upfront funding -- current",
        "verboseLabel": "Accrued grant funding"
       }
      }
     },
     "localname": "AccruedGrantFunding",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails",
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants Outstanding",
        "label": "Aggregate Intrinsic Value, Warrants Outstanding",
        "terseLabel": "Warrants Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsOutstanding",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants vested",
        "label": "Aggregate Intrinsic Value, Warrants vested",
        "terseLabel": "Warrants, Vested, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsvested",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants vested and expected to vest",
        "label": "Aggregate Intrinsic Value, Warrants vested and expected to vest",
        "terseLabel": "Warrants, Vested and expected to vest, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsvestedandexpectedtovest",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateMarketValueOfCommonStockNonAffiliates": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate Market Value Of Common Stock, Non-Affiliates",
        "label": "Aggregate Market Value Of Common Stock, Non-Affiliates",
        "terseLabel": "Aggregate market of common stock held by non-affiliates"
       }
      }
     },
     "localname": "AggregateMarketValueOfCommonStockNonAffiliates",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortization Of Accrued Grant Funding Liability To Offset Expense",
        "label": "Amortization Of Accrued Grant Funding Liability To Offset Expense",
        "terseLabel": "Amortization of accrued grant funding to offset expense"
       }
      }
     },
     "localname": "AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AprilPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "April Purchase Agreement",
        "label": "April Purchase Agreement [Member]",
        "terseLabel": "April Purchase Agreement"
       }
      }
     },
     "localname": "AprilPurchaseAgreementMember",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_BusinessTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Business [Text Block]",
        "label": "The Business [Text Block]",
        "terseLabel": "The Business"
       }
      }
     },
     "localname": "BusinessTextBlock",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/TheBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clbs_CommonStockWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock Warrants, Shares",
        "label": "Common Stock Warrants, Shares",
        "periodEndLabel": "Warrants, Outstanding, End of Period (in shares)",
        "periodStartLabel": "Warrants, Outstanding, Beginning of Period (in shares)"
       }
      }
     },
     "localname": "CommonStockWarrantsShares",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_FundingOfGrantAwardCashReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Funding Of Grant Award, Cash Received",
        "label": "Funding Of Grant Award, Cash Received",
        "terseLabel": "Funding of grant award"
       }
      }
     },
     "localname": "FundingOfGrantAwardCashReceived",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_H.C.WainwrightSalesAmendedAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "H.C. Wainwright Sales Amended Agreement [Member]",
        "label": "H.C. Wainwright Sales Amended Agreement [Member]",
        "terseLabel": "H.C. Wainwright Sales Amended Agreement"
       }
      }
     },
     "localname": "H.C.WainwrightSalesAmendedAgreementMember",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities",
        "label": "Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities",
        "terseLabel": "Accounts payable, accrued liabilities and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_IschemicRepairCD34CellTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ischemic Repair CD34 Cell Technology [Member]",
        "label": "Ischemic Repair CD34 Cell Technology [Member]",
        "terseLabel": "CD34 cell technology"
       }
      }
     },
     "localname": "IschemicRepairCD34CellTechnologyMember",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]",
        "label": "Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet"
       }
      }
     },
     "localname": "LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clbs_LincolnParkAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lincoln Park Agreement [Member]",
        "label": "Lincoln Park Agreement [Member]",
        "terseLabel": "Lincoln Park Agreement"
       }
      }
     },
     "localname": "LincolnParkAgreementMember",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_MarketCapitalizationUsedInNetOperatingLossAnalysis": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Market Capitalization Used In Net Operating Loss Analysis",
        "label": "Market Capitalization Used In Net Operating Loss Analysis",
        "terseLabel": "Market capitalization used in net operating loss analysis"
       }
      }
     },
     "localname": "MarketCapitalizationUsedInNetOperatingLossAnalysis",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_MayPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "May Purchase Agreement",
        "label": "May Purchase Agreement [Member]",
        "terseLabel": "May Purchase Agreement"
       }
      }
     },
     "localname": "MayPurchaseAgreementMember",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_MilestonePaymentOnGrantAwardCashReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Milestone Payment On Grant Award, Cash Received",
        "label": "Milestone Payment On Grant Award, Cash Received",
        "terseLabel": "Milestone payment received on grant award"
       }
      }
     },
     "localname": "MilestonePaymentOnGrantAwardCashReceived",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_NetOperatingLossAnalysisAnnualLimitation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Operating Loss Analysis, Annual Limitation",
        "label": "Net Operating Loss Analysis, Annual Limitation",
        "terseLabel": "Annual limitation on usage of net operating losses"
       }
      }
     },
     "localname": "NetOperatingLossAnalysisAnnualLimitation",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_NumberOfOfficesUnderOperatingLeases": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Offices Under Operating Leases",
        "label": "Number Of Offices Under Operating Leases",
        "terseLabel": "Number of offices under operating leases"
       }
      }
     },
     "localname": "NumberOfOfficesUnderOperatingLeases",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "clbs_OptionsVestedweightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Options, Vested, weighted Average Remaining Contractual Term",
        "label": "Options, Vested, weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Vested, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "OptionsVestedweightedAverageRemainingContractualTerm",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_PreferredStockLiquidationPreferenceShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Preferred Stock, Liquidation Preference, Share",
        "label": "Preferred Stock, Liquidation Preference, Share",
        "terseLabel": "Preferred stock, liquidation value"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceShare",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_PreferredStockSharesDesignated": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Preferred stock, shares designated",
        "label": "Preferred stock, shares designated",
        "terseLabel": "Preferred stock, shares designated"
       }
      }
     },
     "localname": "PreferredStockSharesDesignated",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds From Sale Of Net Operating Losses, NJEDA Program",
        "label": "Proceeds From Sale Of Net Operating Losses, NJEDA Program",
        "terseLabel": "Proceeds from sale of NOLs"
       }
      }
     },
     "localname": "ProceedsFromSaleOfNetOperatingLossesNJEDAProgram",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_ProgressPaymentOnGrantAwardCashReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Progress Payment On Grant Award, Cash Received",
        "label": "Progress Payment On Grant Award, Cash Received",
        "terseLabel": "Progress payment received on grant award"
       }
      }
     },
     "localname": "ProgressPaymentOnGrantAwardCashReceived",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty",
        "label": "Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty",
        "terseLabel": "Maximum beneficial ownership allowable per agreement (percent)"
       }
      }
     },
     "localname": "RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_SaleOfNetOperatingLossesNJEDAProgramValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Net Operating Losses, NJEDA Program, Value",
        "label": "Sale Of Net Operating Losses, NJEDA Program, Value",
        "terseLabel": "Sale of NOLs, value"
       }
      }
     },
     "localname": "SaleOfNetOperatingLossesNJEDAProgramValue",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement",
        "label": "Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement",
        "terseLabel": "Aggregate offering amount authorized per agreement"
       }
      }
     },
     "localname": "SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase",
        "label": "Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase",
        "terseLabel": "Number of shares allowable to direct for Regular Purchase (in shares)"
       }
      }
     },
     "localname": "SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent",
        "label": "Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent",
        "terseLabel": "Commission on gross proceeds due to third party (percent)"
       }
      }
     },
     "localname": "SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase",
        "label": "Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase",
        "terseLabel": "Maximum obligation per directed purchase transaction for Regular Purchase"
       }
      }
     },
     "localname": "SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase",
        "label": "Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase",
        "terseLabel": "Maximum shares allowed in Accelerated Purchase as percent of shares In Regular Purchase (percent)"
       }
      }
     },
     "localname": "SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period",
        "label": "Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period",
        "terseLabel": "Maximum shares allowed in Accelerated Purchase as percent of shares traded during specified period (percent)"
       }
      }
     },
     "localname": "SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_Sharesvestedandexpectedtovest": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "shares, vested and expected to vest",
        "label": "shares, vested and expected to vest",
        "terseLabel": "Warrants, Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "Sharesvestedandexpectedtovest",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Issued As Consideration",
        "label": "Stock Issued During Period, Shares, Issued As Consideration",
        "terseLabel": "Commitment shares issued as consideration per agreement (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedAsConsideration",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_StockOptionsActivityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Options Activity [Axis]",
        "label": "Stock Options Activity [Axis]",
        "terseLabel": "Stock Options Activity [Axis]"
       }
      }
     },
     "localname": "StockOptionsActivityAxis",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_StockOptionsActivityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Options Activity [Domain]",
        "label": "Stock Options Activity [Domain]",
        "terseLabel": "Stock Options Activity [Domain]"
       }
      }
     },
     "localname": "StockOptionsActivityDomain",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_TermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Of Agreement",
        "label": "Term Of Agreement",
        "terseLabel": "Term of agreement (in months)"
       }
      }
     },
     "localname": "TermOfAgreement",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_UsEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "US Equity Plan [Member]",
        "label": "US Equity Plan [Member]",
        "terseLabel": "US Equity Plan [Member]"
       }
      }
     },
     "localname": "UsEquityPlanMember",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_WarrantsCanceled": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants Canceled",
        "label": "Warrants Canceled",
        "negatedLabel": "Warrants, Forfeited (in shares)"
       }
      }
     },
     "localname": "WarrantsCanceled",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants Exercised",
        "label": "Warrants Exercised",
        "negatedTerseLabel": "Warrants, Exercised (in shares)"
       }
      }
     },
     "localname": "WarrantsExercised",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsExpired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants Expired",
        "label": "Warrants Expired",
        "negatedTerseLabel": "Warrants, Expired (in shares)"
       }
      }
     },
     "localname": "WarrantsExpired",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsGranted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants Granted",
        "label": "Warrants Granted",
        "terseLabel": "Warrants, Granted (in shares)"
       }
      }
     },
     "localname": "WarrantsGranted",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsVested": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants, Vested",
        "label": "Warrants, Vested",
        "terseLabel": "Warrants, Vested (in shares)"
       }
      }
     },
     "localname": "WarrantsVested",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsWeightedAverageExercisePriceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants Weighted Average Exercise Price [Roll Forward]",
        "label": "Warrants Weighted Average Exercise Price [Roll Forward]",
        "terseLabel": "Warrants Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "WarrantsWeightedAverageExercisePriceRollForward",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsCanceled": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Canceled",
        "label": "Weighted Average Exercise Price, Warrants Canceled",
        "terseLabel": "Warrants, Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsCanceled",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExercisable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Exercisable",
        "label": "Weighted Average Exercise Price, Warrants Exercisable",
        "terseLabel": "Warrants, Vested, Weighted Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExercisable",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Exercised",
        "label": "Weighted Average Exercise Price, Warrants Exercised",
        "terseLabel": "Warrants, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExercised",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExpired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Expired",
        "label": "Weighted Average Exercise Price, Warrants Expired",
        "terseLabel": "Warrants, Expired (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExpired",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsGranted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Granted",
        "label": "Weighted Average Exercise Price, Warrants Granted",
        "terseLabel": "Warrants, Granted (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsGranted",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Outstanding",
        "label": "Weighted Average Exercise Price, Warrants Outstanding",
        "periodEndLabel": "Warrants Outstanding, End of Period (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsOutstanding",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest",
        "label": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest",
        "terseLabel": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest",
        "label": "Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest",
        "terseLabel": "Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermwarrantoutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Term warrant outstanding",
        "label": "Weighted Average Remaining Contractual Term warrant outstanding",
        "terseLabel": "Warrants, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermwarrantoutstanding",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermwarrantsvested": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "weighted Average Remaining Contractual Term, warrants vested",
        "label": "weighted Average Remaining Contractual Term, warrants vested",
        "terseLabel": "Warrants, Vested, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermwarrantsvested",
     "nsuri": "http://www.caladrius.com/20200630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r78",
      "r83",
      "r124",
      "r194",
      "r195",
      "r196",
      "r210",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r78",
      "r83",
      "r124",
      "r194",
      "r195",
      "r196",
      "r210",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r78",
      "r83",
      "r124",
      "r194",
      "r195",
      "r196",
      "r210",
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Accretion on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails",
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "terseLabel": "Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r14",
      "r38",
      "r39",
      "r40",
      "r318",
      "r334",
      "r335"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r37",
      "r40",
      "r41",
      "r75",
      "r76",
      "r77",
      "r228",
      "r330",
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r12",
      "r197"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r194",
      "r195",
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r167",
      "r191",
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r71",
      "r99",
      "r101",
      "r105",
      "r123",
      "r224",
      "r229",
      "r245",
      "r302",
      "r317"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets and Liabilities, Lessee [Abstract]",
        "terseLabel": "Balance Sheet Captions"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r34",
      "r71",
      "r123",
      "r224",
      "r229",
      "r245"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r237"
     ],
     "calculation": {
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Assets, fair value disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r110",
      "r130"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails",
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year",
        "verboseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "verboseLabel": "Greater than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "Greater than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r108",
      "r111",
      "r130",
      "r305"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "totalLabel": "Total estimated fair value",
        "verboseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails",
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r169",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails",
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r234",
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails",
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "auth_ref": [
      "r298",
      "r299",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by project.",
        "label": "Project [Axis]",
        "terseLabel": "Project [Axis]"
       }
      }
     },
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r20",
      "r337",
      "r338"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r1",
      "r20",
      "r66"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Available-for-Sale-Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r61",
      "r66",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r61",
      "r66",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Cash and cash equivalents at end of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r61",
      "r246"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Stock Options and Warrants [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of shares called by each warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Number of shares called by warrants issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r156",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Schedule of Stockholders' Equity Note, Stock Options and warrants [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r28",
      "r141",
      "r306",
      "r323"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r142"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r75",
      "r76"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r11",
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value, authorized 500,000,000 shares; issued and outstanding, 15,585,194 and 10,528,689 shares at June 30, 2020 and December 31, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r44",
      "r46",
      "r47",
      "r53",
      "r312",
      "r328"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to Caladrius Biosciences, Inc. common stockholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r44",
      "r46",
      "r52",
      "r222",
      "r223",
      "r233",
      "r311",
      "r327"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r44",
      "r46",
      "r51",
      "r221",
      "r233",
      "r310",
      "r326"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r97",
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r158",
      "r165",
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredRevenueArrangementByTypeTable": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of deferred revenue disclosure which includes the type of arrangements and the corresponding amount that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date.",
        "label": "Deferred Revenue Arrangement, by Type [Table]",
        "terseLabel": "Deferred Revenue Arrangement, by Type [Table]"
       }
      }
     },
     "localname": "DeferredRevenueArrangementByTypeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredRevenueArrangementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Revenue Arrangement [Line Items]",
        "terseLabel": "Deferred Revenue Arrangement [Line Items]"
       }
      }
     },
     "localname": "DeferredRevenueArrangementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r64",
      "r135"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r169",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Schedule of Total Compensation Cost Related to Nonvested Awards"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Caladrius Biosciences, Inc. common stockholders (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Basic and diluted income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r93"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Salaries, employee benefits and related taxes"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected weighted-average period in years of compensation cost to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r80",
      "r85",
      "r87",
      "r94",
      "r124",
      "r146",
      "r153",
      "r194",
      "r195",
      "r196",
      "r210",
      "r211",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r330",
      "r331",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r238",
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r237",
      "r238",
      "r239",
      "r240",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r158",
      "r159",
      "r164",
      "r165",
      "r238",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r158",
      "r159",
      "r164",
      "r165",
      "r238",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r238",
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r241",
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r242",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Minimum Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Amounts representing interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r116",
      "r117",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r131",
      "r132",
      "r133",
      "r134",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrantsReceivable": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.",
        "label": "Grants Receivable",
        "terseLabel": "Grants awarded"
       }
      }
     },
     "localname": "GrantsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails",
      "http://www.caladrius.com/role/TheBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": {
     "auth_ref": [
      "r219",
      "r221"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less - net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r73",
      "r99",
      "r100",
      "r103",
      "r104",
      "r106"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before benefit from income taxes and noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r204",
      "r206",
      "r207",
      "r212",
      "r214",
      "r216",
      "r217",
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r72",
      "r86",
      "r87",
      "r98",
      "r203",
      "r213",
      "r215",
      "r329"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Benefit from income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Investments Classified by Contractual Maturity Date"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r237"
     ],
     "calculation": {
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Marketable securities - available for sale"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Lease Agreements"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r24",
      "r71",
      "r102",
      "r123",
      "r225",
      "r229",
      "r230",
      "r245"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r17",
      "r71",
      "r123",
      "r245",
      "r304",
      "r321"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Liabilities and Equity, Total"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r26",
      "r71",
      "r123",
      "r225",
      "r229",
      "r230",
      "r245"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r307"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      },
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails",
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r32",
      "r71",
      "r123",
      "r245",
      "r303",
      "r320"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r61",
      "r62",
      "r65"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r42",
      "r45",
      "r49",
      "r65",
      "r71",
      "r79",
      "r81",
      "r82",
      "r83",
      "r84",
      "r86",
      "r87",
      "r88",
      "r99",
      "r100",
      "r103",
      "r104",
      "r106",
      "r123",
      "r245",
      "r308",
      "r324"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net (loss) income attributable to Caladrius Biosciences, Inc. common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r153",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non- Controlling Interest in Subsidiary"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Nonvested Restricted Stock Shares Activity [Table Text Block]"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r99",
      "r100",
      "r103",
      "r104",
      "r106"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails",
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities -- current",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails",
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r259",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate for operating leases (percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r258",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term for operating leases (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesNetOperatingLossCarryForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r4",
      "r6",
      "r7",
      "r25"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r234",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r35",
      "r36",
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized gain (loss) on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r46",
      "r48",
      "r50",
      "r146",
      "r247",
      "r252",
      "r253",
      "r309",
      "r325"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r35",
      "r38"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Available for sale securities - net unrealized (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Investment income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Caladrius Biosciences, Inc. Stockholders' Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Tax withholding payments on net share settlement equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at June 30, 2020 and December 31, 2019, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r2",
      "r18",
      "r19"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Sale of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r0",
      "r42",
      "r45",
      "r60",
      "r71",
      "r79",
      "r86",
      "r87",
      "r99",
      "r100",
      "r103",
      "r104",
      "r106",
      "r123",
      "r221",
      "r226",
      "r227",
      "r232",
      "r233",
      "r245",
      "r313"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity",
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProjectMember": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Planned program of work.",
        "label": "Project [Domain]",
        "terseLabel": "Project [Domain]"
       }
      }
     },
     "localname": "ProjectMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r8",
      "r9",
      "r136",
      "r322"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Research and Development [Abstract]",
        "terseLabel": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government.",
        "label": "Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred",
        "terseLabel": "Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFundingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r200",
      "r339"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "terseLabel": "Research Funding"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ResearchFunding"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r13",
      "r153",
      "r197",
      "r319",
      "r333",
      "r335"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r80",
      "r85",
      "r87",
      "r124",
      "r194",
      "r195",
      "r196",
      "r210",
      "r211",
      "r330",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Gross price for stock transaction",
        "verboseLabel": "Proceeds from stock transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock, Name of Transaction [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price of shares sold (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Securities Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r114",
      "r115",
      "r118",
      "r119",
      "r120",
      "r121",
      "r314",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r167",
      "r190",
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule Share-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "auth_ref": [
      "r201",
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.",
        "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r169",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r174",
      "r183",
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Share-based Compensation Awards"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r29",
      "r69",
      "r95",
      "r96",
      "r143",
      "r144",
      "r145",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting terms (years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value of restricted stock issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Warrants, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Options, Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Options, Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r176",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options, Outstanding, End of Period (in shares)",
        "periodStartLabel": "Options, Outstanding, Beginning of Period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options, Outstanding, End of Period (in dollars per share)",
        "periodStartLabel": "Options, Outstanding. Beginning of Period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Options, Vested, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Options, Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average estimated fair value of shares granted (in dollars per share)",
        "verboseLabel": "Options, Vested, Weighted Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails",
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r185"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options, Vested and expected to vest, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options, Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options, Vested and expected to vest, Weighted Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r166",
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r68",
      "r169",
      "r172"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Vested and expected to vest, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending Balance (shares)",
        "periodStartLabel": "Beginning Balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SovereignDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities that are issued or guaranteed by a national government.",
        "label": "Sovereign Debt [Member]",
        "terseLabel": "Sovereign government securities"
       }
      }
     },
     "localname": "SovereignDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r31",
      "r75",
      "r76",
      "r77",
      "r80",
      "r85",
      "r87",
      "r94",
      "r124",
      "r146",
      "r153",
      "r194",
      "r195",
      "r196",
      "r210",
      "r211",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r330",
      "r331",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r94",
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r10",
      "r11",
      "r146",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock issued (shares)",
        "verboseLabel": "Net proceeds from issuance of common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity",
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r146",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Number of restricted stock issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r10",
      "r11",
      "r146",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r10",
      "r11",
      "r146",
      "r153",
      "r178"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Options, Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r10",
      "r11",
      "r146",
      "r153"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r10",
      "r11",
      "r146",
      "r153"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Value of restricted stock issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r10",
      "r11",
      "r153",
      "r168",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r11",
      "r15",
      "r16",
      "r71",
      "r107",
      "r123",
      "r245"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Caladrius Biosciences, Inc. stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r75",
      "r76",
      "r77",
      "r80",
      "r85",
      "r123",
      "r124",
      "r153",
      "r194",
      "r195",
      "r196",
      "r210",
      "r211",
      "r219",
      "r220",
      "r231",
      "r245",
      "r247",
      "r248",
      "r253",
      "r331",
      "r332"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets",
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r70",
      "r153",
      "r157"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r254",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r254",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r254",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r254",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r263",
      "r265"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r116",
      "r117",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r30",
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r30",
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r30",
      "r154",
      "r155"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost; 11,080 shares at June 30, 2020 and December 31, 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r158",
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "Municipal debt securities"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants expiration term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Basic and diluted shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27340-111563"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(a)(32))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6806780-109447"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "http://asc.fasb.org/subtopic&trid=2197926"
  },
  "r341": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r342": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r343": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r344": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r345": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r346": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0000320017-20-000085-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000320017-20-000085-xbrl.zip
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MNR7Z__N?DN#TCUZE[YO^_*33]I5V'@)?C2'"YB!R6$5WO<XI^?8U_8GH0FS
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MER ,*PM*EB%'@+L\2;3%(?& 60)8P[JXE]TBZ,.2N^:/NV2P05J$$FHQ*,5
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M HQNBODIP%?"#2;3NU_-[HOIR=T=3^J?98+;,-K/A_XS(OU,2/_JFSK: FR
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MXI,7A $OK$<#-Z#&%<+M4A((/&FPK)F7^&':M%G"&+;[O0I]!OUNM_2RU2E
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MV*@*-(IE9+5\[ ")NTWWR<W2'_ENJ_^C/:=%.5T7$(?1$)JHMT>VX@8$__N
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M.C[5ZX_*[4?]"AO'FYU^!*F5.SW?BQW?+>]1_G!2WFVX\=U1^- ?=JJE]&P
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M\@_R#_(/\L^R^*>HP:;03%3.*QEHM!JBBEJ;E"@UUJ%]4VN2V:L(9DPT6V^
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M2(90D#(F3IR4E A%F;$T,PBZ,EO6M6A2+68$2C1=T'1!T^7QF2[W)U@T4NI
MO1,C)<C K=*&I!P8D2(ZXITW1!H!(CL?G,V%>AG2+M(NTB[2+M+N"FDW)@V9
MN<PL53);Y@ "4T%P:W( ZN=AUR(CKX*1]R?&L.!"@^*\&,,V$<G!DU"9Q2YI
M"MQ! %!KFU*X=2%P(P]I&6D9:1EI>96TG*C45%;[=B"EU,8*RZ//&4Q,5'"-
M&WD-9.2]BHW'K+SU1COGE R)>.V*D6P=$*N8(L92PXVBU@6/.WE(R4C)2,E(
MR0L;LI]FX&2>!3BAJE+S2<H0O:;)1YHS2QF"OL5#/2PC53ZAS5Q_AMZ[9&B7
M31 A"I*ILX6A12;!6T:H4R$[5BA:F&(T<[8NW'6C^>?ZK\7:X1>2<W/)&8.1
MEL9#U()3FA8,,E+2@D-9> TJA+)Z;*;F#CR$9%,+LGEU238^E9F+G!(=DR8R
M!$NL88$($U1F+G%C^=JFH1:)!HGF21,-6H%H!:[RA(6A,@6J"C@S&3-W--"0
MBA$8RV\T9=PO;2X=QTLZIB!=8-97_&L*'2=6T7$B(=)H."@M75S;9&:=2X'.
M6:1EI&6D9:3E51K%2FH:7 K%,H[2,>FC%PJTH<#+_X5#H[@I+/S^DH635<91
MG4E,P1,I="(V\$1 .\&*_+NL[=HF5]</\*!1C.R+[(OLB^R[%*/89!MLL8RY
MX4E&D)X99Z15 (;+H.9R.!;I>"5T_&XJ9"D4[<K23%@2FD@-EMC"S$2760^*
M%ZYFLAC%>MU9B4;Q FD9"R5B4VS:R*:-SEZ_"OAK0U7C(?9/8%$1!]>'[TE$
M')R'%L^?E^<]GC45S >8R\M(&8N+ A<%+@I<%+@H:C!^N"AP4>"BP$6!BZ(F
MXXF+ A<%+@I<%+@HZK^Y2$/FW%'FHZ&E:S8$*HQCC&7+DE#IS?9X<U%21L8?
MM*#WWF5\.>CGSJ@J^HX[A3/M%+[ZYN@DI=R6:?,$9 BD"L<BWE2YRG.9-QN3
MU3&L;>IUY:Z?9T&<1)Q$G$3E 1<%+HHYY%'R-F>;@ KNI<[EAQ79YV1-TA*D
M1^6A)LK#Y.P-,!ZE=YQ0)H#(&"GQ43#B4O9,B6RY1>4!<1)Q<IXXZ1,+"9SR
MGCH9/7-5<IM@'3@ 3[.^ TXB&,X-#*>.0  W7/A$1%3%DH)4+*E@*,E.4Q68
M829626@0"!$($0CG 8396RM\+(N+@C1!>@"AF!$B0);,6U08ZX&14W'I27!I
M/=6$.5IYFX0EP2I)&$O!\9"M,KI2&#7EB).K"TM?_.&DIL6VONH-H+S 5TBM
MM[[3:Q5D.O&#]S ^PM(:0CP==$8=&-8CUU;#,']AGK/[C5I-1;!>ASY1P%'
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MK90OC-'&8L:9UYQ)ZCAE5DL#OUP[DF!_=N2F6^7X>.J.W*0:?G([$U..7?
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MLD1E_1C0ZRA?-*,2U"Y?@.;%A)<Z9'5)P13AF=?,)^5K59CKXX*Y'):T<+)
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M?8%P[ARVDN0BTR <KN?X?);X0P?,]!QV?_(8SH3U*XGUU\H"P-1A6C AK&6
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MS!!L%U"@\9JU*Z$)<_%3]]\Y2"^P#19[-'KUPN1,/[FP]2?*#F&<MTX'Y1W
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MSM3RJJM?=(>Q,1:W9IJ%F<35<F3]HL.IF8_K,-2F/$&':6LQ(4QK[5F,!H,
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MXC*&"R0)R1 KO$4:&XP$(]8JK+$LQ-I&(H!$ (D 'CT!7,<-\- ,D-P /\0
M)TL&P$Y1+0B2- /IWVB#M,TELH6@MI!$FIQ>Y A.CH $_@G\'P_X]]L.E!P!
MMX3\>TO9WS@MM=$8T<(PQ+2V(/93@;"G+B\8)YRU%J#D"_AQ#KB+- <?_WND
M:0Z[Y<2=M >B>FA_>4(<N>UAO,K2NV0<5QC8<RVLYD1Z')RZD@OBB<#"%)P0
M;G*6@OS[#?![6YT@?Z<+PYTER'BM =ZM0-(KC!S!U-HLG,3&UC;X>BP%=>?H
M?K,MUE-D^@$)_PX0.Z%AG]'PJYN65E5'R?3= W1<QK];3+TJ"HEHGG'$N"=(
M%H(B+0O%.9/6:!LV>CR:+^%CPL>$CZN!C\DP_ /XN(P/5UB)S%B&!& A8IY2
M)#CQ*&/<97FA/'59PL>$CPD?^Z1-)S/I[>#@,EY:<(X%<P62PDO$L,1(>.*0
M%H85'.>2V3QIT0D%$PI>@H*$**>,LII@#'LE ['"Y:30W%B0(8H4--Q_-.P$
M#7.*G10"%317B!D':)C) M',TDPR+!33T664R?N(&4MPF."P#U-W[W"8C(H]
M@L=N/&U6$*E55B"E<X.84AF2WE"4P:1F1BN&,Y[4YH20"2%7#"&36?&'$'(9
M;^J(-7DF&,+<:L0(L4B[@B&+<QQ.NR7.BH20"2$30O9)I4Z&Q5M"PD[\I1*2
M::IR1#QA@(1*(XVE1MB*0LA<8$YI4J9['7_YJ,M,[P($F>&Q&GVOS/1MX?O-
M(H ?'[XS#-A-'3=YSIC&1$J7&TORC, &S8HBA6'V'.</.F&8(L>Y,D0APJ5#
M3#.*1"BV0(&X7>XR[@A?VR#9NDQ1]H\CTRK!81_A,)E,>P2/RSA,DQN=ZQPC
M*D+Z*<X]$MQIQ#'@9B&4T]C?ISD@X6/"QSY,W75R\6\.D,DV^N!0V(9<9KN'
M[]]A1U0F58:XCL9129'*'$&T4!PS[ZC2#(3%E(R?(/#Q0V"_->9D$;T=_%N&
M6F9,9YZ34(O*%H@YER/)"46Y+)32%&=2^T933@6I$@PF&#P'@RZ3KM XMSX3
MS) B.!@RRC3/:(:](7?J.D\VPQ]$PDZ8I6? 9)HC3$Q(OM$$*:I!/<Z<@O^T
MMEF1E.($A0D*^PF%R6AX)SZ53IRER*527AI$J26(":J1<$P@:@(Z&IPYF2>$
M3 B9$'+%$#+9$G\((9=QEL04@(A>H=RI##'M<? [,^2%@OE5+-,Y20B9$#(A
M9$\0,AD4;PD$.R&6)./89R1'CG,;\A4UDM(8 ,%<FEQBPYQ+(-CO&,M'7>/R
MH(3W@,=-!N_#;Y.QF]Q'I&6*I&\J&1,54I:U+P1FC&!54,:\-JH@CEE-;LES
MGDRC/X3IPTXXI<7!, IB;4:4!$3'$LD"4T2E(4:"UL]-R$"718J83ZE#"?!N
M#_"26;2GV+B,I?2269Q9D'8=!I5?*H-DYL-OC(.$RQ26J:9EPL>$CZN&C\DH
M^@/XN*QI284V-C<.4>XY8D)2I -<4BH=!LRD1-VK233A8\+'/DQ=#Q3F9/R\
M';!;1E.:C!(G"4:Z8 JQ+#=(&.:18\2R0N2<&YH4Y01T">@N!#HIO<5",*<9
M9\X6TF+O76X \@C%PJ90RC[#X#*4TN.,2*%SY#4G(8 R0QKG!<JHEL9(75A-
MD\R7H#!!83^A,-D,[\2?<JIDI2R$5 39K- A[88@X;! A.2L*(C*9?"H)(1,
M")D0<J40,ED-?P@A.Z&418ZE(Q16&Y.($4:08A@CPW&N<N^TU_>:CI,0,B%D
M'Z:NMPB9K(FW!(*=4$K'J6%:,D"]<)RL<@8)K1G*E#:$..FY3 >"]3R4\N:Q
MY_F3@O<_FO*PG*G1W<;K?F/ =#FU;AH? ",SJ,K1T X6[U!_V3R-PO>VG -B
M+1J<P_Y>C>P_'BX*^G:&=>49-+<9E43DKE"6\<))QH16A2B<P<9+FXJ"]IQ.
M3SI1K%DX!C /QX1852!6A',VE;*(9-Q+DW.K/5W;H&0])[AW:0FWN2%[!W3]
MS.Q*')8X[*?FL.0S>'#V6L89 T-Y:S1!UF<*V(L)I 63B'O%O&'*6TO6-A)Q
M)>)*Q)6(J[?$=9T2NP_-7,F7\P/,M8P YU1K025'OL@Q8D00)!EFR'/C-9>R
ML-RO;8@^U==-I)5(*Y%6(JV5L!@FQ]OM,-8RC+_@Q/!,8U10YQ&3A4""8H-$
MT+)HD0L6&"M8"C%+"E?BKL1=B;L> 7?Q C-?\-P4SC/IM'9:F$*2@A!M\\S?
MP1&GR=MUNQS6+6>=<U-@C@J?.<28E$@(HT'K*BC,,&%9*$5(R'J1YXG#$H<E
M#DL<]E-S6/)V/3A[=3-DJ"L*:;E QGB%&*$"*2-R)#47A!C),Y^!#I:H*U%7
MHJY$77VEKNOXNQZ:NY*_ZX>X:YF[)(RCF6#A?%UM$"O"H6H^SU'!'-<Z]P)[
M?%&L1O)X)=I*M)5HZ^&'M=]6P^3QNB7.ZJ2:T9Q2S;U$E!J!F"HL4C"'0%P9
M-=QH2GG1V O/AVHDI>L!\M1^FX4M ?_:X:>-=DKVYF-XEMGX)WS8=K\SB!_F
MU6SH3]H7W/BGGOZVL;AUO-&I^YQ-**6BD!H3)PW+G1<%A;UO"L(Q)S3#[[:C
M<QMG&"V]W*>W\JZ:?G2QX\MM>P@/>#8JS<?5W+4C]Z^7)V]?VV--6+[[>@>_
M_; WW"6[&/KX=6_[Z./^'\]/WASN\#?C<+\1]-U\V1O_V^]]^#M[)S*FK1,&
M64L48CPKD":4(1C%7!E:%-SF:P,'P'8<IG(Z=VOG)W<XL6X"2U? \KQ\MB^5
M<BY>>:>7ZY57^7*SX.R"W3(:3APZJO_&)/+><^CE..@C Z^&T\$G-9K#W4L_
M4"WN(Z *5 &T=XYI&*BI&[QW$S=5H]')0*L*;@!4=0S+-ERN9PH>!?><EF-8
MQF-8SV:H1O%[V.UPI^FGT/+)X/#( 1>-1N7G\'E<G(-J/AZK*;Q%-9C!UV:D
MJFKH 7DB'4+?PJ??[M\0VLVG@ZUR$O$HON S-5(3XP8'1\[-JL$OT&9V5,YA
M^&SUZ]/3&_'B'6Q@HMWT=^C<^^$D(E[($6W^;#".UQ#6O$DSZ34*PJ2.U''E
MGK:__&Z'U?%(G3P=3N+4Q(O.PBP\YO?/0SL[>LHQ?L*SYO[3+LS7W^,GV852
M;OTMS;,GA'^CP;<O__:W15;GR_[_[+WY5QO)D@;ZK]1AYK[I/H>D<U_L^SB'
M-K;'_:Y$V\;M []P<C7"6AA)F.6O?YE5VA!B$2"0(.>.:9"J*K,R([\O(C(B
M<A'/1HM[]'S=OB5#^8Y+>Z'5&QZ6+WUKAP<+X/&/HI%3:"6>@-O_.FG[@L#U
M(O'E?0S4/+]+/;_;WOJ6\=V"H#3'2"UQN8$YAW,FNR]Z/-_IWF$1R;*PZ1?_
M?R>-J"U$@;ER:--R.%?N[CMYEM%<5N?)W7TCSS)LRQ4._*ZLS?,B'!_V8O_[
M7KQNC]2/8I]V/Y_'/K$Z_NOGWO>]T[U6[:+6^J>QA[]=7'%\7-2;^T>'/^M'
M%M>/?I[5MS^=UHY^DKW6E\/]HS\;>Q>U:*+%=]^MA]$F<UD4P",9Y\8"9!0"
ME J6*NQP@*Q45CH+C4QA4G2=PJ<HVKVP1;1\X).=\IDW,F\\GU,]\\;\O#&1
MCB^,XLH+@+$4@&JH@>&6 H<QM-P[$HE^;1.A=4Y7+$9I!7ECI4_ ?99!'+OA
M7]+!M\N.ZD]@#<S:7\DH/P_*3QY\2R+]!H4A",ZI9!U 8#!.Q<.$-T$09HQ=
MVY3K^$F,@X55WUP6',\UB%\>YCV!)ILQ[^&8-]9L+?426<0!M$H"ZH,$$B$%
MC$6.(1R(%J;4;!%F&?264WE]RIK#SS*.KZ/H<';N+":B<MDY\XEV#=*_]^,M
MM*VV^WK8Z?9W?;?UJ?W+]_JM]'%FTGF8=++@L(C2#P/D0$ 3 +7> .4(!4K%
MJ30X<,Y9+B.R+#R<-Q\R@2W3HEEE GNB[8M,8(L@L+$IR)UT1D3NLE(B0+6$
M0 =K(Y59SKS"UB.9<P*6A<#ND11PM[CQI\\2F%B][P:1U][]>?XN-I/$ZT0W
M:[J?/#WGV[KO=],KO]XD@MKI 88!:117)H(IB8 H"33A!B!#B)&.8AX7:CE+
MC?:)=UL)8(-4BCNM.1>6.J^U)5PI%.=#"$XP?>%)![<$_:?(_>/()?&21N?V
M7 1S7H[N0#B+UD Z[Q/@OR+C-P5 ,^$F_3T0NC)OXM(K'W=ZC?3AFZYOQF]_
M^4&&093 ?[T=M$7Q*#9^UIW:1%0_Z?NW QR'DX^8(;&7 HR7?'P1F1K;B9^'
MW3&/_O# =+W^&9DYOM4;W3S5Y[VU/RZ]?*O1!E,C>F6@'CH:(=QG-*9CLF<.
M1CEW40WL=$LI>A,USTC>Z;+4=[UR?2X.NXDH_ZN!;8 <!4,Y0M2CH%#\ !,?
M:5([0\V!6-O\%.\[^_<?>G.6.#PX16AJ@5;4":U6L4N1(*RBD16T8(1ZZ7"0
MCN$0KKOO5D99SI2DQ>;VP(<D'3U?2M(<W5Z!E"254U86EI(T7*R1^/TM^4(S
M+UT!\7G.C*?YXH277+9&!5Z+5.'UJ?/='F$HLV@L2C3&2> ?4A+X/RD)?(GW
MR5<AR/,_OI>RUV-_(MX6YUYWEW/'/.\GO/)LAV<_-&/@38Q_??$MG1Q;W9WP
MH9'V#?;BLGFQ=<G?X[W=S^?UBT_G]=VML_K1EY\[V_7&_O:WLYV/>^?[W]]?
MQ+Z<U;Y_/IW>4XC/.:QO?R*UHT^HMOT>US]^IC7\U\_Z[GNZ?_17<V^W'OO[
M_FQ_^\^ID%J)M1.6 .J)2GL*#$C%=)1$ZCE15JK 5_,4WF6G@[SGG2DH4]"*
M4E!2BDN=.#//?,PSWLVFRE&N6  *,PYHL!HHZ1D($C$ON @&\=4,QUI!YLDI
M>_,.XL>NC^9Q]V:#+J>O+"4O7/ANQY7YUO>DA$ZS&<<S$<'N:6?W,+[DC\,/
MC5\^6R8/XX?)<%V();(68Q 43^8)2Y48C0,0*\F$B;:)M0G+)$;X;<Y\>3KK
M(Z?[9;Q\)+S,:O0]87*L1CL(2:"8@3BY$%"!(3!(4F M,U&%UM09F6%RR57E
ME[WQD;,#7YTGZA4E5SR#J^J5'-/Z-&Q:?S=A=&@?!).4 PR9CFQ*)% ,(R"L
MLSK%W%F]HMLA+S'%(N^79!I;ID63:2R?&_0,]#4V!@FUWE&I@/*6 HJ@ A)A
M#(QV0=/ H%1H-?=47B)]7<X0O)*<,^.3N^<IS4H2?-"-Y4*\-4."JK752J<2
M<V>XU#M]7]"B]*B@M\6"4R_?ZVX[BG7O;]_]>JB[2Y-7N?-U"(W-9OSLM/XQ
MPMW%?G/_Z//9_M'^X?[1M_/Z]P\_:Q'BZM]K=+_U#4[G5>Y\_R>VOP7W=O>/
MZJU_6O7M#ZUZ*_[;_83VOG^^B!"']BX.6_N[7T+MX@?<V?[$:MM[K'[QD]5^
M'&CL.!1! :Z1!Y0Q#S2&!&CAB!91,@F]DF6)H.3&6$28H-2G0B#$$RF=9I1Q
M+=5TEN6GMNVT?/%;.HOU]R).0E'.PM74NJEDW*O9.+>VO"HK9HX$Q)>5HAJU
MEO*8J?YAU_ORU(M>XZQHQ1L/>X6/K^:*E*Q1#<0P8V.]O.5=IQ5?[+SH^I3$
M&B]L^W[1J&2KT2Z\MH?%<>Q6QVT4Q?]V3GUDR/6BW2D/RNJD$8DK?O)\C>+4
M=WUQTF^4)P4795JK+R*EVG24\.!,+-=(V9ANV%!LH.@EZ8W]3H=>I0Y%.8U-
M]=(-NCSCZ^H;%*>=DZ8K#O4O7QCOXX51M$'Y[,8OOU'<8UB0NCPLL3LGW>Y@
M6)IQJ:7CQ.*#XC7=\@#D1QN*]/")@=#E<6+GY=EE4Z^U:&#_:@^].VGZG; 5
M&QZV.U:"WY_9YDD<O _=3BN-TTF_?)F=D!EAR B?\ &1W"IE(#"*($!-U'4E
MLQIPJID06G'K[!4.D YSB^+\04*9Q#(@91DR7EI(9>*,RQRPU9^U*I)\7I5D
M/YBU\L-Q/OMQU!EB%\J3\893/9FO?B4O_29ZF<PDOF].Z:UCL)C<4*4V)"/_
MNB$U]%_79CERMB&DNO[[&V^^^4NRP3F_Y\UP ]WT)2/XGO?>UF6)R!UO7L".
MU>*S_I;;=,O9K _+9GW^1-8L]8_E;\^9E@\:Y^<X:C*GWBZU0.1S*1\XA%]+
M(W'G."F\"SM'90$9 RL?@5B:U;VIK24BH3$.6>0#HU!)&;2"S%)'M(I?J)G6
M\GWWF!YF3&^UXMOWEV8#ZIXV];!$):FU/I_NMSZQ^L?XW-TO\;KZX=[%>[K_
M?8_L7?QDL9=T9_O#SZLE*NWY_O:?L8\_8_^^G=4_?K[8PQ^.:KN'L6UWM+/[
M,_;C!ZU]_S)]0@LQBFL/N$H^V?@3Z$#B;\))XQ4V.)W?B-817['PB65'O.6,
MCLA0^\10"XD,PDI)$/*IY*^22'"<"H=1' SU"6J1&D!M_"5#[8I![7BOWS 8
M"#8,""@MH,Y8H*SF($TOB5.FA! EU,(,M:L8$_ZRTR>_ZVY7SS@H/F< /3XI
M<$DCT!,BN):44Q.1 TO+(/'!. %=UK]7FA0NG7%"D,#>6L 0YX!BCH%4C@$7
MG&#>0X<Q6=O$ZX@]1?S7B\\%RBF3+Q(P4PBEC4N&:8(C=*J(GYX*+HF3RAM'
M[J!%9U1\=E2<.$.1&V*-UT 0X@"5G #MO03!1?V9"\T-3"<_P0R)"U>%'[JK
MMS)[A2_<P_[%]_K=ADTQ596S_5M$U"5QM;]L<N)::TB#-<9!Z@65D",J"8%8
M4.&\N8,VG\GI><FI_G5"99=1K\ V". T5X Z(H#TR@/& Q,BSI_A/I)3.H!B
MR;PXRXY1V2?^6C QHB RPFOM!:*60XU"8-!SS3%VAKJLL*\")DX4-4&$6J,,
M$,8S0)E"0'&?"D#!P"AQ3E&WMAEMLXR)BT]#&YTE=>7LJ.7.U[@N(^5NF6P,
MOXY,-O94F6RC6D_;C9YM=GHG$<:7)'<!U1H#@&Q]:-5V/S3VCFIHK_57JQ:?
MM_,Q)>W^V:A'P*QO-UOIU+_:]GLTG;NP]STE\_[5J%W\T]AK[9W7/WZB>_BO
MG[6/GT@] NK.]_W#VM'/T]KN/Z&V^YG4?ARH"&,DP AS#$- B7! &:.!YM8&
M&Y3G5DQG+[@XO(P8+SG6J6AJA$0BK%32<Z*#L-/9"^/C&XJ:UVG4RW,<[Y'!
M=FO+J[)27FT&6WG(8I*'7Z4\=$(1&FW=M@W=+'2OY_M5VE6SH4VC666F] ]U
MOTR/,CXELK0J$7+E=:-LMO2]\_%9Z?<RI2HEPASJ]@]?'$?I\M5CJD0RX^.-
MUD?%RA7]3M'SS=AXNVJ_Z'2+8]THO^AWXZL&WRWTJ$,I4RQ=6^X>-\^K2P8*
MHO']TY2=UM+=G_%!QSJQ<^,X[3$.<\)B5]KIH^;PHMBG]'EKO"X*IR,F_N;/
M&OVJY[]O%+N3F6J]V/G_.VETJ\[;ZC34\\E1G7A:V7*J#1M'^G)"D(W-_.AT
MXPB_]$,H7]8*^H__Y9L%BO,:E?_>M.#_WTDG+8=2<'K%;R=M[=)[>?=[*;BV
M3/NJ9*^7ME0CKJ:T,#M>?O&S*ZLO24ZUU)+DI!OB0C@<K+/APHC"J*.FVNM=
M)]0;6<Y6Z TK.</7R-G@TT[*CZT*4%^6O AS51;B::-_&"5O*+4C,.^8V+%?
M98)?&*3OSA3 ]<(WRD9<1#S;CY";A+8]_"O+U"J]824%Y!J9.FE/",7@DAME
M8Z/X<)ORD)JPHP/#"Z-[\6>G(N-(A+[7+YIEIR(_EDU6$AI)MA?'-=YD(WV7
MNL!EQ64"VR[1<VG)B+>]LC^]7HE] ^H=/]"6=*P'&L))4W>';=_4SI#V>\71
MB?M1?I+>MJ7/"QU"7 WEO>FV4<YY_XJV==TP5:GN\<KCIK95<X.5._6,PX;O
MZJX]/*_&K7?+ EQM>9VU(I_(1-TJ)VI@+[F=]I?D HS:XX^RO.)KMEIW/A\(
MKKR1W@-+L(Q6*Z3 ("KB;P@+SKPSG+W&T^H'2EW_,!T_7^':;:MXHG3 __2N
M&F.5U93*6T3=+GF4(WPF3(Z?3@)+5"V3255):$+91N_::A[K)=IL1P.L97QW
M\!VJBG),E2&X$[O/<;CU8@Z;QAMX^/RY#YM&B"WNU.8%'@A-QR^=NYV[_0S=
M7N"S\W#G;C]RMU?J3/-EZ U&N:;)W#5-BCM6<EC.$,BGO#2+^(J)^-!>*(:F
M0A;S>>*'ET'>E[4WN5C,@U;FP+6?"PAEF9B2"9QE(LO$E$R0+!-9)FX^ERTK
M#"][TK/"D&4B*PQ9)K+"D&7BX0K#2B=.JQF;_8L>PBJRY,W2)B4^6ON+7<AY
M</+@Y,')@Y,')P].'IP5&9R5KI+Y',IBK4P5&D27C@Z+ H4>'J1;1H/V=-,O
M6U6ZYYO2I9K 1SW7^B&EPVZJ[_$< S//P=30$1L\-SP$*CS3C))@@[,84X8D
MOMO!U!>^VW&Z=S@=\O^I_<OW^F6RYHP$]66IX''?4/^J@D?K_<7>D3W=:]4/
MTVG2M8LO\9J_&CN[GVG]XV>X=Q0_V[9G]:,].EW!8V^W'I_[9V,/OS^M[>Y=
MU#_N']92)9#M'W!_^TLC?G9:OWB/ZT>'J>3>^:B"!Y5.&Z(@(,+C5-4( L6A
M!)(B&X)1$AJ74CPD1OCM*M?=>X[5LYR52#/F9\Q_),Q'RE.(E7.4.:JQ5XI8
M;JU@Q!LGB;\;YM]8J#H#_V,"/YPX 88[*R &VE(*J"$>2.X<D%9ZQQ5BTJBU
M3;F.H<BPGV$_PWZ&_1'LLU2_-$ H Q=13^1:0(\@E\'RX(F%6=5?'L3'(\1'
MQ%#AE (0I^K:C.FHZIL H+4!(AXB'^"LZF?,SYB?,?\JYBLGL#!406T,U5 :
M;FRJR<@@QC! F57])0-^.@+^@!QQ@G)@D(* (H: 1,P#1*&T&*& 25;U,^QG
MV,^P?P7VO11:"(=#Q'@JK=/"&ZZ1<H0H[4E(L(\4P@1E5?^Y$?^L]FYP7L'6
M 49,.A840$)@0"%UP.A@ '*>0D25XCQD93^C?D;]C/I74=]8'_\?*<F%IR8H
M0RAAPDKOG9.>D+NA?E;VGQ#Z&R/H9XK)$!@%@;H J&882&F3CU\1;22U0>NU
M3836$689^3/R9^3/R#\^4M,:H9!71F"9XG<,YP)AK+DF1(0JBB?K^TL"^O6Q
MOH\8%01J [!W4=\W5 *-8>0 +RG7F'C!6-;W,^IGU,^H/V-#%Y.D[ENG&*94
M0<D8#Q1#RR'W$IJL[R\=](_U?6<@49QP0# D@'KL@$&.@SA=4F/%,80^Z_N/
MAOSSUA!;K1R2IZ.@QTMM&7PY:(W$[UWG)&5=7)O[LE0R]J@$-M\IB(\SK"M/
M?XM-7:A2R3/I/8STHJTSSEI@'CH3O :.Z6CM:*F!II0!Z8TWDC!C]9-:.\^W
MZI8.S9;S,.=,5)FH7@!1/4&^16:K1V*K<:I%X(HR@0C@3E% 91! <LN!# %"
MQCV-NL;3Q5]EKLI<E;EJ19;,"G/58I-$,DT]$DV-\T.TI"I:4@1H0CB@V$(@
MI=. "BFH0$XK:;-1E8DJ$U4FJI=$5$^0V9+9ZI'8:IS4HK'P0@D.!(\_*.<$
M2(81( $1;7"*8['9J,I<E;DJ<]7+X:K%IN-DFGHDFIK,Q$GA-(%:"B0.'E"J
M$= Z4I8U6@7ME.0H[U5EJLI4E:GJ15'5$^009;YZ-+X:AQ,*8@+T@8% 2(JM
MH!H8AP2(] 1E)*W@3'C"<,),5YFN,EVMR))98;I:;.)39JK'8JJ)G"<9!';,
M20 59( 28J)EQ2-3\4"]C6R%%<^65::J3%69JEX253U!ME;FJT?CJ[%EQ8/Q
MR$:C2D:5 E#HDR=0(6 T9=YPQ1E[RL(,F:YN3?/ZHSS4)?[7-7YM#J>D?M**
M;=GJ[[0P&^T37<[1O\O+JH>8[A^;HP>6G\<?H_GJ]!KICC==WXRW_O)O3QNN
M?_@&P0A+AX/WQAN"50,UZTYMXA2<]/W;P:##R4=<ON?J&9A3@W_'<;H\N'>>
MD_'4(CAC;IN-M@>#=T:X[#RBET=N\F=ZKQ)XL V0HV!HVJOW*"@4/\#$1W34
MSE!SD!+>!S<==L<KY8<'INOU3Z!#'(HWNGFJSWMK?UP:L5:C#::FX<KH/G0(
M0[C/$$X?)SIS!,L)C\C>Z99R^2:225R>Z;+4=[UR?2X.NXGX_NOV.1=KFY_B
M?6?__D-OSI*AV:OBZ*37;X3SI5D68NY)K7?ZON 5C)4&#WH[P+1+F#45^**(
M%,H@[)6EW <I"*+!"LQ0'%"(#K;+P!<$$1A'P$SI"=;&\>GW_M;G"2FWVBY^
MTCWQ[C\-;1K-\B"LL?*P&YO^L]FQ/Y]9=ZA_'>H._T2^MG1_]Z]F[>BOG_6C
MSZ=[N^_I7NL]K'^,WWVL7>Q__R?R^S]'40]H^O_]<K[_W1T;3/G^]T]G]8O#
M9JT5^]+ZC.O;?Q[6=@\;>[N?8?SN-&H&S?WO[^/U]1#[<WK C7$^6 <<4P90
MS @P47P!QD';0*UVW%>*7N03[[:2FN:XIEX+)C%4-#DHI%7Q(1)%#4()'/4[
M']6QXR3-<=#7-@>#7TR,_E76FN*DZPEKBMX&<W9;ES87+')?[:%W)TV_$ZZ*
MVFX2PM<K95OX0+ 0=4RL0%"21!W3>" A9L 12'00BG@OIJ7F"BHV(K*T(^S(
MJWK:LJD*0XEOCH6@T+VB$XJ_3MJ^PD "UXLD385NNV+;6]\ROCOX"J6OD"I.
M?=>G&T.GV>R<]HK?&NVB?]@YB9USO=_?7*O)7=6M6KK[(ZH/25%.>L/@SX&6
M-E#H!F<%#H:T4I[CD#7U<<^_&?[RUC5ZQTU]_J;1+E^\O&E:.X_-#%03!L5(
M81R4)Q@T,%!=-N!,;TCU+4%D ]YTP<VWW_RM$HM[-AJ]]*,_6LIYNCUO78A;
MSZM?9)6(^QB,MW9XL  >_TS/:052/(%)F."C&"+'?1R9>7Z7>GZ'/% ,*6">
M(B^+]R _9#AG<N>BQ_.K;NIN9-_UPK>.FYUS[POCVSXT^KV2=TM/1R3JOCY+
M2NDBW5B/=D3R<HWPLCK>[^Y7?Y9AFZ<.C(-$8<F]T(XRX16ETF@AA;?14E/N
M$3)!W@\6QY=J.4S8+N].NMT(L$OC8+^G^5(YV(]<<[]58[6CGSA]OK_[F=6_
M?Z-[1S].:Q_WR'[K\T7]XR=:Q]_@M(.]CO]I[5W\/-_9W4MF3;.^_1/M1Y-G
M9WOK=/_(M?:W:S ^A^SO?@FUKP/G>ED4)@07K1X#C/824 $#T-(08(5EBD0[
MU0JSMHG6*46KY5U?=NC/F[V94S*G7)L&CV@0C%OA U7>I )55B@L,#:.PSMF
M;&1.>4I.N1B?F>A)X$P;$(2T@&IG@$X9''%&D0P<&D9*3I&$9DYYWL*;]QK1
M!91G7J)!W#GV:;.H_:-H>MWSEYRD !2V0H=KB1L_]MC>I1#L-8.[RA1P?[/B
M,LZ/IO,_:3:','^>0?X>(-^8,!QHFA"E#.":>1!GB (C(001^B/^"QP)@*]M
M$JI6N7KRLJ#X$A3.SP"W-#IN!KC% =Q8BS66*TB0 = + ZC! 2B*T\XP"] R
MI3FW$>#84^BP+Q[@\M;!O(/X[M.76G%R'+JQG2+$ZY/&NGC]=#YKZ@7#]T/U
M4]LTO3>#0(R/7=WN?ZCF, /V/(!]/J&16@E%G!4*E XP'>E!@32, <RM5Y@+
MB*5?V\3X*332^RV39<6:Y?159TA;&HWT5J]K1KO'0;NQ>FJ%"S(H!J1S43VU
M6$?U5$7<(]19#G&0B"<G*X<PX]UR*J@OW(_:/_3=["9=<C5TY$5(LW4U-CQ[
M$>:'Z5&R?8)I%U50)$F<<6H9H-0B(#U" #HEL37,!237-B7/;M+L)LT MT@W
M:0:X1P2XL1[JG934: D<LC@"'-5 AJB1,F:1Y!'?"+5KFUS)#'#+J86^;#?I
M;J>OF\L9.?V()4UR&-QB:IHL.SD^0>QUILQ'H<S)F&NH./56>0!5*FF"B 8*
M6@$4E4YJS0RF<&T3KTOY%*2YI!5-EH5RE\#1G>DJT]6+H*LG".O.=/5(=#6V
M\#"4C!"' >(R1 N/06"8Y$ Y#!6,>D=(%AY=IY)GNGINNEI,!:X[UHZ2:YNO
MH620>/J20?_QO9[WET/]>LM2LV7GW0#1C@Y;$;7PWM&'HYWM/W_N'WTYK.W6
M(CIMX?K1GZWZ]_I1V=;'VOETS9:=CWNG>Q?[C=KW&JU]_-*J?WQ_5KLX;-2V
M]W!$-K2'(V+MIMHM?X7X3+CS^0 QQZ1R!"BC&:!2<!!U9PL8#H%+A*V3;+HV
M$!%<B,@]D"$;@<Q*:*E$W%JIN> Z3%=Y&2<#5$/^V(6!;NW/JBRE:RK-#%?*
M77_N'OKB7:<5W^B\.$PE:2XG8Z12,]WB6HVC$T+#^D>QD3_5/US2.N((V*1Y
MG$;.Z/GVI;B&* S&=W?"3ME\[UO"BZFE.M(^X"M;J_6+K0/%-+7$:" 5YH J
M;8&D.JH2V)-T"#N4$JUM]D\[5]2'HIK17G':Z!\6?=]M]8K^H>X7_NRXT?5%
MHYTJC>"R5D+\A6P4DP+DXQ*)\Q=O3_44&FW;]:VH">IF$9F_VSE-8A4GR:\7
M\8E5LH_MM.(EMKQNO>AWHD2D5J-@QW9]<=SU<?+[Q:]4WS752ZKN.M;GZ8;>
M>M&+K?BBU>GUT[?]<6?^IS>48-<IVIU^?%3G5\/YV/6BT3IN-FRC7W8FW=?U
M_9-N^_++=",C_6C'M3=X4!H"WX[_C0L@%2?LZK3N0%J#A=&]1EP[424JNU!=
MG]YCH_@0UT_UM_[1]>5[]HJR1(EW<8CB&\<+NO&"7F(<5Y3U'LNG:-<Y+I=;
M[.!NYSB2G*1X??(="]_TMBQ7T2ET5>.N7*]Q1L%H>(\[[;+-V$+'-LKJ%N7D
MIBD:C%":S1G7I]>,4];TTU]N%.^U/;QVP..4-$_B2%?=KR!DLM>QMQ$L?&ST
M\F"E?OP1K^V=F$'W(]+:4NA.#SNQ&_&[^/NQ[O8W[E+JZH5"]FM^]<4H?26I
MS-+X_M1-'?'EZZ'W_;\K*"IUB:6JX/<<VF#]], @+A1B"#".$:"(>Q"MM_B#
M6VUH_,8A<J52I(3*6FZ]XR;JCU&-U"39-LP9C!6QUVN#5U-#RW(])01W CA)
M^%I6 Z]JY"7PCK9F0M@29*J">>E!\?$5*D7TZIQT(W274USTTAS?7F#O%FWT
M807W9I>RO&W,%E2H#Z$-!N]=J ^S9:EXEPOUY4)NSU_(+1?J>]GS^_2%^DSP
M].6&D7P9,'OQ+3)[=<['FWMM$\XU3/,529IW%3W)'"[_X.3(_GD70QE*.=!O
M%QN^-\^H+=<8/>IN\T/B&E=YOS@H!*5 &'E+*6;<2,5QM*.U1$@0C^]7 Z;$
M\IT0D;P$\J79&+ZGX3S8&(Y&\O9A;.<]K+6^G::-X5KK0[SOQ_G>4>UTK_7M
M;/][[:Q^])-=V1C^N =W/D9C>_?S^?[NGVEC^'SO^_NSG>V_&K6+/QNQS_%=
MWN.=W>94"1AC+>*2 D)3'),B!DAG-6"2( ]%M+BM6MN,\Y5#?Y\N#FF!N0T9
MVS.V/QJV2Z4LHYR+@ B%!&K/B(*>&^>0@>&&D\XSMB\,V\=!/XP0%9QV@ BH
M $WA/Y)X#YS@UDACH.)H;5/!IPCY>?'8GNWQ>0>Q3.LHAE8Y&%GECREV"[1&
MEVLP'Y7/KHY:KF>\H&*6F>P>0':3E8-XY+$@/02$I?._B$% &T@!9%!B+D-4
M0NA3&3(+6S_+ASL/L'(6Z*G,E)$I8PDH8S'E03-E/(@RQO81Y-P;I"A  @5
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MQA5VCW6W?[[;&0[W%__CI*F[PS]?+>O6=C^=UC\?.*T$)8( J6D2:,2!P2X
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MD\B<9 9K_JNH1"%)R)6%-_9F'4\YPFRG&R\X3LLCTN;T>BJBY?M;8\6E;/"
MR&YNZ,S^>AP;#(URIZ;1<:]8[(ZV+J+8X2 @XP("PU T>"FBP"CK@,<22P(I
MTL$DL9LA=0/UJO*.S$+\6S<"^^7$%*Z<F8C_O>'D)!],G)VB4R&T/CYN-FQ9
M4'@$I*5]J^^TZ;-1?"LUN!$E-+KVI-7KEU%0)2LD*+=Q0;CT4:5M/H09)@%_
M,!RQA=9)L]\XCN\PBRMZPW?MZ624Q8%)0Q+-^NSTOX?3?W=BDA(T=3O-2L6*
MIFZU]>PFN+?4[",*E$*;;.#+0GIY%V]CU$+7%XU>I.AHW":78:E9#&>Q,D!&
MGL2*T:=TNEX_I9^7/L8KC8[KA,^207.2+*#4M/^5#/W2 AD(FO')A+^Z^9A,
M^=)--&DL5=V,;S'00775^]#LQ$Y57X[7Y WKZU-\>*G$#1;5U662-)E2T1O#
MPVTC/3$(,Z*X&ND!Q6GG)+YK?&!<6ZF#E^XWONU#PS9*U;ES6I[8T>I4L]&>
M\^2%^W$:O<1IDQ%B58#8: @''/?GJ,<[IVW?[1TVCD=^B&B839IDKYFY?E[4
M?QQ8H:1%5 $C P*4"!45)JV ]<[ZM+<3K$MG,JBKQ:'^-4O\,M#>$VAG>!Y=
MQ_?*)5^!XBQ%8)!ME!9]5S?BW780YUFZ)COQEHB=G?CH1-&S'S'EJEPO3:7C
M?@6VO\VP!:OOD^WW^TR *B,]!I&C\>-_=+=1*AWI*)1BPD=2_!85#Q=7:OLF
M6%Q/5GKSQ T]\HU!X/60<B+*5D77(]#\BHN]C# MO?;=XM>PZ1*$7>'+V&W0
M;/R,B.QM.M&CX>-;#%2G[,9_)BBZJ,'ZYWN[\8MR/'N##9WI79M91#NIV%R)
MRTO; 8UV>L(U&P)ITSK>./+W1P7"=GHCBW#PX R$CWZ$V'C*7 DTK6CW7%8[
M[Z@(S9C4"BI'NMOT7E^>S9OCH-]5 U\Z"HJOY73D_(Z'Y7=\\*9[HKOG<0$@
M>7D!3&5G7)+Z:BV,-?S2#/_?C7<;Q?=(WJ<ES U:TJWCM_&9&X-\D+7_??=]
M[??2&S!X1DF_57I%.F4MZ@*]2*'QT^1$;Y4GQR3BWCKYD<RPU,]J!W]M2@+6
M?D\LGLBT[2OJ+WLUX??M#QS?W9\^&9.7(DH'"W><YC$<ABO;KZ4*4MY=^;%O
ML91F15 /VQYO?I5(,[)WYMF6BGQEK.':8NHI)TH%PX4DTG+FF3&^M'8DE#FD
M^LE"JK=([<<!3Q587%0T($H'F$GM@ Y! &2-C?:I4QS*%,QV0Z3*<'>G7?WW
M2B[6>*D,U8(0%?4H5E&@TBF&6^WV2:27+_ZXTRW='=$N;14(@O^O]&14-Z19
M*D])K YI*K:]]:5_D*#UR=56_CIZ0%ILI;MO)-.#935*#BB/43SI)R^#JS3G
MR47AFZXP29-OIU&)O8Z/J$Y9U,?'W4ZTL.,'S?/J;>=9#I9@1ZR4V$,9M3L1
M-6>BA$Y[W2D'A3QTEW:T!FKE^_Z37G<G5,Q4Q7AVVENC-WK%BZ!VMK-U )G
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M[J1[[G5W)M*:VY'6S(VT7WQ+-]KQ\W?Q7=+:/]'-7=]MX8RU=\%:/#X%CMO
M*</ TQ"Q5H5T"IST("(O@P$97V(MWU"C,(6!%&TN&TYD536KJD^OJCZ*B@K(
M(]5IOKOF^BG"9J/=:]A_=/-DK*N2C)]WP4\ZPD_L!((F[>Q(R0#5A (3M *,
M62$A-0Q3OKP).UE;S1[JE4';F1YJ7IX!+KD7VE$FO*)4&BVD\!;9H-Q#/-3E
M-GE$VE:G79X0,MP5_SKH2+;OY\',R4BA$ S7@4" #8K0B7A$384B?B(O/([_
MHUR59S"RY3R#,>-FUMZS]K[ZVOLUCN;[D<K\AUE.Z..93>9EDW&(E3/0,.\0
M<#H@0$D00#FD@57,P6AU81Y$.M 2HTPD+YY(LKMXH>[B>P6FWN(NGH67USEX
M3ROH[$PB9\;+.^!E?>($=!4<XW&&-"0<4$H5,,Q&%5Q:AB26<3+AVB;;("3[
M?+/6F+7&6WR^]],6;_/YEJ"X]>-'U__0?7_977N3_I@]N'?$P['^Z!U54'$&
MC* &4.\E,($*H#VV.E!"HH*9?;A/I$(N5T6>%=#6_O&]J#9=#=TVW3\VBTZW
M\&?'WJ8K^IWB5[RV:+2+_J$OPDFJ[+RTN1-/FE VL89(7$.N<V*:_G4XT%<A
MQ+L2\:VV>S^0Y=U.^BA'?C^$!&N[6_T))XHD$@8N.=!8>T %"4!;Z(&!44)D
MM.P<$F7L-T'K$N.ERU2[VQ)>4@Q?SCRV)Z/<.>%WJ:;N4<VKQ8G\RI#4TH=_
MWTY&.2K\$2EJPF\E/%'6$P^T41!0BWB*562 *>%$M+1E,#)2%-M 5RO297IZ
M<?2T..MP8:;"TLWLJD:&SPW"U^TGH S#=X/AL:6@I&-!:PE\,!I01@DP",??
MA#9"!\Z,A&7(.'Z4[8.LX&8%]X4IN"L5-'X[U%ZS2Y&W).;$V)VQJHL]LTHJ
M!8@7"M! $%#0&N!=P-1Z[2%<XE)J6=G-?O$50N3G"2ROHLA_E>@:<72X3=/O
MI(^RFV!>3W;Z]S7AY]:!PT1S&G53[4U(B3D6J#@# %$H!;0:8VN?-KH\PV?6
M]+.F_PHU_6<.,+]&=\_L,C>[?!JQ"XW,0F#DE""L!)0+#*2##G@/*?0:8B?X
MDT6;9V)9%KT\.Z%?9+SY92350R3M#W TH^>=T//S"#UQ@)'Z2 "2R:B;$RI!
M)$("##0:2VJH4?X18\^S2IE5RA>F4BY-]/EMKHOL]KTK/.Z-71>!6&Z1 R8D
MOZ_& 2AF R#*(\FLEMH_:2CZZ]8O<RWQ.<?PNECT)4L;>_8B+3-6Q^#;07NO
MS=N^PE'H \>+CG.5H]#O08#O)Z/0!63!2Z0 <5 "ZC0%$@8-/.8:,>EAE(RU
M38G5.B1/$>3W+"M\2<%].?/]GR,%^%'@>ZGF=CF2A!^^:%:&!5<US'V"[7*8
M^R-RX$28NPH:$>@H,%@G%UGPZ10.!JS#1'#CA1>I_+G:P$M=_CPSX&NI>+,
M:V;IIOZI ^5+!]PE*#Z]VX9%QMN[X>W8YC!2:8E@-#*T)( :0E(QRFAX*"PU
M,0P%K5(\.Q*Y'$[6A5<!5%=/%WX)$?$3JG&.B'\<E)Z(B#>4&TR" \$*""@C
M%&@M# A,280XYA;:E2C2D_7B[.5_I5[^A<?47X[6R4Z(>1WQ$T'T@A*)4G5V
M:*D#U"H$E"\KZU)GH30R&C8K4J(](VZV/[+]D>V/Y8W3GS =,FG-35KCV'S&
M!!+(.N -1H!Z;8#$/@"HI6.0(^J06?Y*\)FOLN?\=7C.GSNZ__12*&L&W#L"
M[CB<WQH;**8X"I"U@"JK@-0A_@8E#3H=\J1L+B6?==?5@=75TUV7+"$@.[GG
MQM-Q_+]Q3EIA%!#88$!-*DH/@P="&B09\TQKG[W<2Z/#E@D"?_23W;99SD9:
MB8WV2;FA%#]QC5^;_XX_AB\P,8[6QS7;';[A9EFN??3LF?<UVB[>\P:E=Y]X
MT-%)K]\(Y_=X4K2#V(W/NI:(9P_1Y7&]\W2,9Q7!X;26#;]I]&.W[*6)%O')
MS4;;@\/J;X1+J/X2H2=J%2GYH#RJ\W'>?]98/K8V>WEKLMYI5R@Z?J'R?:IB
M,5MQF?]J],]WD\#MQG;_;,;O5A-FF_Y_OYSO?W?'!E.^L[W?K!]]PPEJ=S[N
MX7J$S@BOI_M'S>;.]P\_][?M^<['+XWZT3^A?K1W7M\ZD)9**RT&@KBH;QH-
M@<8D@*AV>B^=0U:;M<)'+CI.T]X]B;AYSR7U?,M@ MUF"/WV223A'^5A#KW&
M6=&*=QSV"A_?R97Y-Q5@#9-P"MUV\1>DULL[TM:W;I\7C5[O)%[?'2^@7A*X
MI P4L6._&C;V6/?BW\UFY[17_/;?U0$2G9/8=]?[_<W-2^T2V+5T]T>C7?)#
M6GB#/P>$P"J\+\%T-.(59<01;>KCGG\S_.6M:_2.F_K\3:-=CDMYTS0IQ6;>
MGC9<__ -E61##)_?G23%ZGNT 6<: ]6W!.,->-,%-]]^V[?#CCWZH\4 WQ;Q
M;+K ;I-Y1ON6%+T[+MDG<BXM0V_4@UQ=MW9XL-(?/YU136&B> *-[VM$U5J%
MJN]'J)JR&N_@O!@B5%06_"UB,?/2!>2>+E[:EF?J*NZ[O]OY67'BZ5?FPLXO
M?8ZYOV_*\4/F_!$&, O$X@0"J9=SR-ST"#Z%[Z/*;"XZX:JA4!D0RU:=Y[&"
M_^Y= &/N57.3R_DYIGR^T#X=&(+(8DJ0IL)+C8R,5K@B'%.'I)SI^[AW)G\2
MO$^EW%4V\-_Q13NN<I),>4[*P.V/W4ZO]T(B*[Z=[Q]]9O6C'W1_^T=R3-/Z
M[K?X^Q[<^?CYM/[]&]G?M;1V5#N_XIC>_:M5W_Z)=[8/?^YL)\?T#U3?/?R9
MGK&_O87V=UVS?O'CO';Q5Z@UX'D9>?T5GAY @9D)V (6D 540 M4D Q([Y"2
M<=91.O$!,;Z.Y%(?O?.@ U*?8Q$N>='##*Y/ JXD< V-L=Y 1P5SAD(5"):$
M((&1)PE<D1J :_PE@^O2@RL<@2L200M#),"8&$"5UD!)$6?2,TJ=YTAP%,$5
MDW7&,[CFBE_+-89E ,!CVP4YS&>.,)_GF/77$.:S5&K!U3"?!QI<*=[G3KQ?
M+O#;:7^U@WV>B/;/)VPJ::'VPG#@*". !J6!P0H!$W3P1CD'O5O;9.@I3MI>
MUBB?)5$*,FUEVEJJ1;/"M/5 4S;3UK/0UMA:I7&V*-<><,Y8"O@70#,(07("
M"FV5T)ZN;?),6\]/6Y>#4\OHK.D<C!QB>O\0T^);1+G>Y5&X&@(\,2['G5XC
M??BFZYOQVU]^$)V&8'S^H"V*1X%5L^[4IM=IGO3]VX&<PLE'S(AOG!5JO*S1
MC*F\UJ6QG/AYV!T#Q0\/3-?KGT"'^%9O=/-4G_?6_KCT\JU&&TR-Z)6!>NAH
MA'"?T9@5N'YE,,JYBZ37Z992]"82:@2G=%GJNUZY/A>'W43^_]7 -D".@J$<
M(>I14"A^@(EGF.BH"I@#L;;Y*1TH\>\_].8L<7CD2.[)M5HI LHS;YU@PG--
M R'*!XYCI[&6R%JC*G4FWN/=5O*F.T\\801SAP6%P6N-/-4TWB-%P%0L(/]Q
M2O^QA]Z=-/U.N"YVO,2I'#I>A8Y?I"+C2DECC 9.&@NH=PCH.+; <V$I(49J
MC'+H^/U#QY/ZW[MK /EZX<^L3UL':8.I<+JO5R.F7,E1G/(]8LKI7%'.RQ/X
MO<AX]9<6^)U#K5]$J/4RB%(.!<VQP5D@<FSP,KJ>;H@-KC3!6R(!<A#9TT3H
M8FZ=1MRKX"@/P3!*H]GME5,N:)(C=!_-+1^?^_U#J[;[5RL^[VQ_^\O/&MY+
M91\.:T<?FK6/GW%]^QNJ?W]/I]WR>_$=XK^S6FL_/O/#S_K'SQ?[1S]A[>/[
M\]KW;Z?)M5_?_8;V=@_#Z-2LY);WQJ0(70H"$R@%D5&@*1/ &"NAH9Y"C].9
M(6R=)/[+063+L%^<(W1?#+BJ$$BTZ;UA7E#*M3$$ITKUP:6BN93F"-V5 ]>+
M$;@&9KR R #%= 170@+0.LZD4$HCA;B#(H&KI.N4Y0C='*&[7&-X?83NI'9>
M+'9C/D<<K7:\P\JP\XQ V8?9/3GBZ!G8]WS"M%$!08^D!PY1""AR*O(P(@ 1
MAIDDPBDDUS8Y)CGBZ+FY.0?*9MI:JD6SPK3U0(LRT]:ST-;8:#34,1FG$"@C
M,:#:(6 P<P BY!7ED%OFUS855)FVGINV[A H>V-@YV)"9U<TLFAV6-WM87*[
MA[X8'G%;Z*IL?Q%A*>)9^B3H1K?X=4NRZ>68HS+*:+[XIN)4]XK_OL=!,0_,
MQGN\T]O?_]])HW_^J1W'YR1]V-N)8]#=/=3MP>&5'\M2W9_:%?I/G9-0?KD=
M!_Q#'.[+1U:NJ-?P ;&"M10K"*F4UBL,@D\GRK@0@(3,  BIUBE05*NPMDDV
MT%4<+Z7J/L+TP!R9+$Q+*4SUTP,1(!01$X"+H >H3,*D!09,2AZ8<5 3M[9)
M-]156[8X]MTJ1'(]H5\Z=[;QRS?/-XH$G)?1,:'>-<Z^A&_.]WVW%9';%2>]
M813H(*:SK"POWO8*V^R4WU4W'Z?#JHI.!:@N3FEJ)F&N;EM?=2&%'I</B\_N
M7>MN'-W4*U*TYP_?CJ+2;)X7-T5)W\N#,^.4F-.HNO1\^]&61_GCG^J]JQ6
M7IM<;]?8SO86C->?[>Q:$F5<Z3A5BDJ 9>" &DF (<I$;0,1+(QQ"LNUS4[;
M%^G0GFE%:[V(#'YR/) T;0\;_E<Y!TFBXA(H9S6*#S!I,HJHP,3ACP_K;5Q5
MT8K'4+.N4]C*:;XUG8'3M9N#F)=-J9N9^W1C.DJ]$]% %25PH+<WKN-'R';8
M;O02,IUT_4Z87*U?4DI56L"]?N_*8NTM2[Y#_=UP>=JS>KFDMD[KVY:F>^L7
MGUF]]5<C+C6\M_N91J/T/!J=K>GE6;]X#_=V_XS]B<ONXC#UDZ1,SKW67S_W
M=O</Z]L_HE'ZZ7R_M9].%T&U'P<>$2>A%\"+_[^];_]J&TG^_5=TV-V[R;V6
M1^]'\KTYAP#),!M, F1RDU]R6E(+*\B65[)YY*^_5=6MAU]@$R &-&<F$[ E
MM;KK79^JP@BJ:3NJI[N6JC,S,,W8 !/#F:UKL0+-Y &'+X2A%3@.@\/3&1R)
M9P2.ZVJS]1&TZ2KMNM(\F*5CGTJF6+,^Y\9U;3RGK5MWN'QG;ZZ1>';>YQ>N
M3,9)"I<(8TGJB;"Q;Z5?B*H$M8HP3C)AT';FS)8.F?&+S:FN<"/O6^C5)5Y[
M@U&:77%^+'S<)99+"J*._G88'X'4/AW"=D3"0"$!^8S%H7;PZ7O(+3M@!OAP
MG%L@#CU-]4(-_K!\UW4M/0K]:%8<^FC6@%=FFIX#+IGKQ5$4<,,*8\,'THMF
MQ2$9Y53P1#:QJ#^:# 8LA[,HB/Z0)L%R ?5$5+B,6ODE_IW(E2X;]W/.B2;7
M"FR\F!W:<8-8_K6"J\6EE3?MX?T4:OE^U]7<?UU3I_6OY6,N[*[FN,L_O_;B
MZS_4NI9CWO)BK:M?]Z%G.+>\MEWR9BSYFCM/7?P(*I<>:Q'<;-'[0]2BG)!L
M_UUE<"T-/04::@LIGU_=W.^@L[:0LB6(ZPLI6R'P#,Z\%0(M03S9:NJ%4<?[
MWL(C7G"6AWV*W43\G*?9"+,8]UM!=&<,MUF;>:= UGNKN[H.IOI;MFT-G*KA
M1*$36[H6!*;%8STP-*:[W(I,PW!<VY#Q;6OE\@H9ON;1XNCVGHB';@PP]99!
M; E,/;"_[7ZV>[MG%P<__Q[T=C]I!_B]'T?PK'<_>E_>G1V^_S;X>G*FSP%3
M?Z9GO9,S[?!D^V?ORU<-KKWL[9Y>]=[#>WTYT+]^^61]&WSK'Y[\/5TJ[IH1
M-QP]5'TWU%3+LES5USQ7M?4XLLS TUS?V'IC.T^VD/&W<-1FEHFW.J35(1N@
M0VS79#SP?8\ST"2>Z?F^[7'/U)@51W;@2,"CM7*M0ZM#[D.'U,4-IL&9&5F!
M&@-)J%80NJIG.[9J>!KS3"/PC3@&'?)T.XVT.J35(:T.V20=XL3<L'67(=C4
MXCICCJ%'@16:?A3$KJ6M7>;=ZI#[T"%Z/?>0Z:%KNI'JN)RI%HX\#'SFJ2S0
M M_AOL_# +NJZ*T2:95(JT1:)?( 2B3@',N]+(V9S'+CB 5^K)F:$6FQY46B
MC&^MHNM6B=R'$C$K)0(ZWC8#G)L;(98S-&+5BT*N<L:BV+9Y[(4QCA9YNFVY
M-D6)/.J^7+]E$]^+XC?*\[!HD R38IS38*#[:I6[7A^ 7VC8N.ERGNG,,6,C
M""WN6H;E^);NA6'$N>G[ILWM-FFQ 7*^V01*-P/78%H(+H)A@)SGD1I@,T;/
M-9GF(IC<=+?>&.;F==/8="FTF6V<6HEWQQ(O=LW0B/38\Z/0"GP>,)W[MJ['
MCNG$=LS:$/M&2+PZQ.XZ!F>V&ZA.S$+5<ET.$L\R5#.R'6[X0">F21V]6XG7
M2KQ6XLU+/"_VM3AP[#BV#8M'O@=<8QBN"5Z][GF^W0:$-T+BU0%ARP9SG'F!
M:CNVJ5JV'JK,\CTU=L(H=!P=N#;8>N-X#Y%5;"5>*_$VX^S6@>(Q&V1;Y.DN
M O)"DP5AK)D@_4R+:U$<M]'+C9!X=?0R"CT[!.-;C:V8JU;L>JKO6[[J>Q;W
MO=BTW!A;&R_H+=9*O(T(4#YM)/I)-F;IC9T)6EQZF\K;0&48,\\S6:C9@<8M
M-[ 8YZ:MNZ89<%".S&M#O+]?&?9V&B%>$WO%!;JK@LL6J)89.JKGV(8:N6X0
MPUG:6J1MO3$>).#QO%-Y+1ZD52*M$J%.O+X?<<LP3(.;EA9$+&*VR\+0]'7#
M-IR@C9IOA!*IH^9A%+N::4:JQR,#BYLL<*;"6#40D\XT9C$]!"5BM4JD52*M
M$FF5R(-,<KE-!\A6B3RT$FD@TQUF>)&KJZYN.:K%O$@-7(VI@>W&L>Y$86#X
M6V\\IT6FMTJD52*M$GD03T0WN6ZZ%DZ5L7S#8::MF9X5!W[(O9A';6YG(Y1(
MG=OQ[$B+'#-00S@ZU0HL6PT<(U!=(^"V[W(]\KVM-^Z"41^M$GG0Q$_50!Q6
MNUG-R>YM9==/>-O<=6_NRMH=;7?TV>SH]+S$N<F(*_20OV8>Q</-C[EQ[E.Q
M;/#3LQZ@</'=-_20V> 5LRADJJ6%D>ISUU<]^-G5XE WG;F!"$]LSHB 1DS!
M(<*L&"NYF$.DC#,%J%C%H6@XSA*)IH#?C)4KCE\JAW)0[=>X,?E2+2=?CFA<
M1Z%D\+-RT4_"OIB()>YTP7-.^(M0/BS@4W<=+YH%01>Q0LZE*.9'0MSI"(A[
M&N7@V>;M1CDX3E?S;MV4_[H/W:YOK]JP?^T9 ]9]S!AXG"OVG\Y0A-_9;_97
M8&B_I:$]S5N2 T?;!M-/[GSKV?.*..K/.%JK/>@G?] M.O>7MO/SL&'QS5FB
M+2JW36-L8AJ#6YJNNYKA^(;%S(B9NA=;N@&NNF5'7OA]?[44^$J#$'O94#A@
MY+07Y+,U/\=AB+UL_)6/ZS&)3R3A\?7GUY]_#[[M[IG?OAS\_/;CZ.S;2;]_
M\/[@ C\YW-VV#T_^ZG_[$?V837A\^]'[T?OR[>S@)((U]P:]]T?I(3S_Z\^W
M\,F!=;![9A\,W@UZ1B\^.&[@=\'M9\PV8E73N:E:KF>JGL=\U> Q<W3+\PU#
MVWKCFFTKGC9KWJJ;5MT\A+KA+'3-P/$<TV$6-R+/!\T2<]]PN>[RP&O5S2-3
M-S72-]9TS]9L734C;!_J.XX:N+JGFD801S;3+4?WL7VHUZJ;5MVTZJ95-P^!
M](V8'>HL#GUF6.#1L,#1-3-V--_F)O?L5MT\,G538X*=R E\+?94&]Q4U3)]
M2_6" $OU-3<.K2@P#1T;C1JMNGE\=?SW'SC>H"W=*]/&2W+.2C)4KCC+"R6+
M%V2X9Y/-*Y@"]W(DO]#C9?/.Y#K4B^D$/(P,6[-TQPI,Q@+;B%SN!4;@A*8>
M+42]Q%D^8&.X&O:KX.&K:)+CF3Z8HOE(I/0NR^6O\'MZJW-NUCG-26U69.-Q
MAJH1!^#B.#X#%\=D*G<CPP*+(@AC!CJGZU488DE ;]KLV;,2$<QPPHCI#O?C
MR'+B.+ MRS 9]R,_BIGIM2+B:8F(.@KBQ;%F^6:D@C[00$38L>KINJ.ZAN,8
M/G<<$SM(:5W':47$\Q81L0WL'X);JC,+K >F!UA*Y)N.846ZUXJ()R8B&IYK
M'%BN;W,53 >P(H+84'WF@E%A^$ (7 M\IJ&(J*?U+101TZ!OPHC.?GTS(=_'
M89]'DW0*\-T$<Q,61<++_F:I0+%O%\5D('YW@J_\C!'?/P\^?<=.A,PU-%4S
MC%BU0L_!]ON^ZNI1P /7-5@0/ O$=\R27#D'*N'H'5-KO$(I4=XS6&ZE]*OA
MXV1 L/#Z\J)Q_6G.AO1IEM,-BN12&<"*^H7"8<^B16!N?!@6>CX!5+>MFUU-
MD_=?#.M>&.T7GYJNUS7L:[YP_>77?^KH7?>^[FUNT+(7F%OE&8)DYIOSU4>
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MG<_^WN\LOW4V>+.V\TY-@5\9<OBHM#WH35*V=])^P9B#U-S4.7%9X\029B.
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M6D+*SH>WQSJVF<!T'RSU%+\OV+0 >XIX2+[S%8T#R 0^7DJNG<._]W=5L(Z
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MM-9CU>R@51SR>UIPP,$)DPMUFU.;)>40&2S<0KF_LSO9L.CKA$LY@YQFL(@
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MM;8S,VM.K^.,=.[$&Q%5$K_9D+^U'=\&1;;>O BF@B([=7QZ'TU S*KNE(X
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M.1FY FM"^O \P%AP X/G(6@(<!0!=;#Z,U@.3QB80ED)EA6#?5 B>!LQ:-4
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M!V$+)]H)^JIK\0JIPUKRR4M\YZE!*37"B.PUP?>?<C>'E GRARK>ZB6O$JN
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MP:G&G51[J.9>L?-BNH:Y+MR!;NK\]^CZZ#L,$6],CKO21W@32O@P A=;N#(
MV/L@E_X-M=4'-9>4/(3SEX5/'N[\=*'A*/T821=H]2"#AT2.OX!_L,S]BWF[
M1T5D=Y,%$PA[?<RV%64V"RH'&T,FVC\@]@,+I7I+_FE=P%#CS2,-FT">_&,\
M&IY-80YUP(G5OT8C(E"0;&R\<+G>E;</FG]T8@VH0S5+D>W.E;,/$XR]']0R
M6M9;%2+61-O_ N%,!TXIBA<Q<INJD?BS%CO4VU?JW2CT]=/_ 5!+ P04
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MC(:ID/@Y_AGU\^$$8-IO-^I5C562PEI8+Z52^KSH=32)-QX:%>)-NHMOCGR
MT>S3P5E//GK_:?!FZ,-P-)P.H1\HR80 S@GELLP[IHC35I 4LA8R)&F5OBF<
MQ4AF1,V^#S.V+II^6H3V%$;3_N*3F1@)90O2_F,)AKD(JPSGQ5G7X=HUT-*
M"3D2ABL,D8%%XJ7WQ.H,-&=N-'>-1[6 <G-PUQCRK(M'DRY!AXORDZ,O4);0
MQ?H\Q^6[>(<Z-U>'Q1-/^[/3TUF;9#B%TXOOE\6ZCMZGDZH"G^L5P>^J^+?3
M$^BN@?E],HX+/%('[1A0HIFVB$=YXI36!'&:R#C/GC8AP&I(ZQ"!?V-$J*2
M:H1XUO>X9@ZT#T)'0TF2J"3I B?>F4!LDMEF(646390_[[[.("XFEK(N1NTS
M"08')"&A2V31%;)"9=20!J-SN[$<X"*VA8YOTW9["5=CZKMN\@FZZ?D[M/73
M9^/TZM]GPT_%[?X=I@.A3*:@)3%*X6+*;2)>LU 0)668B4HWX>]]H YI^:I
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M%VU-&1AO>",Z+$=T2 ME?494T$*+U0]=YR46W$0E E".=KN@RKHD&@4:=!Y
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MES"P*"V/*Z(OL94,3(K@\ =MLB5CCV,\I!FY)4\W=\X>AR&5HPH$OEA5GF/
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MAUEA\_HR;EYNFKO&32M"]N4@L00&0RW+D)O2.1(S,.J8$8DUF?7K0SRDZ/6
MV7Y[X6C$@9H%%NNNGXX)1UD(Q,L<"?Z'D7?T@H@0 I?1&I^;I$ZWC38>^>W;
M-\_173G0FJ.OAV,_CK=LO)$>X06BF0$BA0,2K%0XI9(35":MZ#XYN@3B(9U
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MKFBJB2 >)/\BQ5%^!+2_/W_W_U!+ P04    " !9@0U1N(Z/8T4Z  "G9P(
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MV_]\GA>@'7W"1XX6_^KZU-5Z66IFH=L4YCA)[%98<N]<XY%-?.JT95E;%4S
M86T-D2R77D ",%QGBC%NE6-5%MS3I^N:+/K)LW4;RU9IX3+\,AABF'/7%9WE
M?"VG3C@,;%B.D<@L&&H)_9>4N(W41.EBE=;#*U$=/E0XGL'OM89IRUH5]O1^
M'?3A^Z]^^ >,WTSZZ0H5E]3GA,Y(-)YC4*,Q0E8:2B\;;QS3.;$J%3R+X?S
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M=7N3<BS]9DJY?6JC= 6;C)LEZCQ?M?&[ G&3.0J@34ZAM $OO< 9ND4A247
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M?GS]I4'_0QG5Y;[WYM#M'EF5=EY<S6+[J6#.ML)Y$,I$1W'JHV"]S]2'$,"
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M.,[ZGBKB+8N$4BM<UE(FJ%)5O1F\8R75CLN@971NSY(UY]_;7OY]O+.MDDW
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MO:MSX=&1Y'WJ079@SIQ2AYJU8O\VZ']M9I [IY:93I$;2HPWB4A%/0G4!*)
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M)89WN9')KU^^K-16J[Q9\$_+^6PU8V3^94WY['FFPT[*7\0C%<64)5!Q2IR
M2 A%*FF4 41A!F26Y#+E/,MH9$,J9L..C5Q^62]F;/9$Y@$7=!64@JT+);NM
MH]L0<S.>Z1])SWSSZY>@ECA0%G:PE3EH"QV\T?A^V>(;?*W5Z-&<L<.M3T8R
M''E09K)#XY"A+.]V8RJUE7N<52N['N?U<J&I4"R8^GKL;*S=<5$DPPQE4.I8
MM$PQ%LV5011CH/Z78(8RDM#$AK'LAA\;<^W):\=6EKB;L98_-#VS5TOPBK_V
M1&_MP3P=X[GAUB=[64HP*(NYH7/(9HY/<6.U&\8*47FG'I?%:O;/RE-U*_5
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M',<0X!P3G1], ,IC!%C"4P9)',4HLJN:M#_ V"R0IOS/3DC+_*F3(':_UWU
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MBGQZK*&/B3LU/G$.W'V]:_[1^P5;%D_+HMJB5CD,E4.G^/YZR<4TE6&.>(I
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M7U:D6!FR1M]RVKQ)A]+Z>ZE.5WY_)>YG"QW%J?,?Z_*O]FD7_F8<QI*S)(J
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M$ZO7I'SX5"R?9USP5]]_5=NO]XMWLP59,&5.W+#5[+DZI9U"%&>8"P90RCF
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M$ 28Q RD<00QI4A LPHPYP88&YT=[($=^W(>P6A&3M> X]OK>ZIP_N .A',
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M3RC;%4"TA*NSHJ'ILX8K46BIW5[-0=M[W>S&UAJAO7G'.YY8)$F8A@+@G#,
M=0(,DI0"QA&#$6**U&.;K>6E <>VT6S;.CJ6NI9R4C?VL[,<+V)M9CGVB:!G
MXCX-7G^FHBD4?9J*%\<<U%0T1>#05#2^S\%4U)U/M]DXRU(-0.;?RYGZ[V*M
MWM?9XZQ92*,DC!-,* CC/ &01!E (N$@SE@"*691E!CM2:U&'9NQ6,NG]J,;
M ;61N"YU0X>E#!:Z7?$NTU'I9;I?M9L* [O1!\">^4?'@K=R\Y30P4;J2=
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M5HY>=\Q[I>%YX1:2;M?^P%=+J_/2LRU]SN\! ZT'M2L[H[DB@F(#DR1-[$Y
M%U 89&!&LH)()4ABDJC+03WP=%>#II,_^%JPFX9(2T$'<">S$M2R#P1PY'6@
M ]"36P:N 1Y_%7B!6N]%8/>\::T!+[0,7@)>WM^Q>_:/A\7J6>O?]/K)/OS\
M;N73:EG%J\J-R:8\JFO^_FZUV7Y:;?^EMU^T7'U;.@;07;74NOZ1NRZ=Y:E"
M!4\)% @KB A*(+7["<@**O)44IUPKP.1UQ%_:JO1NUT$^,_Z?8&\_IH?JKI
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M/WZLEF4=;UW5:&21"*2)72!T 5&6<L@81C U*DVD,20K>!A%P,D8(:9A'!J
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M$0CFW(**B-&0*Y; @O*"*Z15KH+.^5O&FIH-J==,*VN,7M%M(/M9D$C0#6Q
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MQ:WW[P0,U3\PCI+KR-CX>;Z>KK_^,IWAJ[-/$9<3F7WAWC+@B;QQY8CLZ*(
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M]_537,PF*I"M4DF"%L6#<JF0!(P'Z80169:(E@^ @!LOW4W]'1]Y'B["3@S
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MAMA 'GC];M#H^,!S"+%VA8QM=<.6"6\D9\G2!B@)V4IG!3[:#()KK0J7W#;
MQC4"=D-'QX>@PXAV9'P\(P[RAHM9^#"1KB8(>0G:%0JQ45"(G36'J+DV.N;B
MXA!GXC=>NAL..C[K/%R$?;B9BT^?:C;R(OWCW4<2V>KUV;J6,->KGDDV%"X)
MQR%S94 I[^M5OX*B;?&A.!=PN!S-QRC9#27='W0.)NS!H////]Z1Z$OZP1$%
MY?/58C;-M5_ 3_3K>4(*PW"]NDGYK@7F#SULJ(+SG8@]L@#]; 4?0O@\V>38
M54/QNOPRG=/+IK1M++9%95?X4J&6% 421*0PU0</3F0#P4=6I$G<1WEWQ5TL
MN!)6<:/P\W=N5QW.UJN+G]Q>?OL0=ZBQN7C'L]6*9'O)JF'!::L]1,=9K: K
MX%518!)QF0-#'NXQ+L>S>I.,<8K;FV'BPN8,(/,1MZ<+ZI^'U<=G\US_^/D_
MSZ9?PHQ$M7JV?AZ6RZ]D,_\]S,YP(E)FUMJ:G8ID.)&8<L*3'<6D+?/*RW+/
MR<CQ0-J)NG'Q=8SZ%ZUUT0' ?@O+?^ ZQ!F>YS1,<371+(@@502&3H-**D,,
MT=7Z"6-\8<JJ>ZYJCL?3?<2,TVVA 7R.EG0':'FSQ,]AFG_^\S/.5TB+X?7Z
M(_F&&R%=7%H7QI1W10-:^J*05H'SLB;2JYR$347B/3<ZQX-G!]K&:=+0 $M#
MZZ$#:-TDG@OMG:!]7A7M0 66P&E:)K(([DD\0M_7M&$HUV@?N Q^YM\ +H?+
M]G!@+-9A-I#-67S&Y?KK&PI/U@3UNO=^KA[C*UQ/DF?)<2%(($*"RM5^&N'!
M1&FM9H8;=4\F\Q#&YF&BQNGRT,3*#"3Y#LS+-0/Y:C%/YTM!&(DYAYJM:2FP
M",C %[OISX<YLBRCN"=#Z7CXW$O-.!TA&N#F>%EW )@M_1-GT NREA1K%H(Y
M)@D^6 ,&I3<NF2)2PQA]G+8/S7:@O:39P=;S<AKB=+;QU,G\;4XM/RYF)/15
M-87KKY>BD4(5KVW=0SGQ9;F"8%"!D)QIE$R8TF0;VI7 <8.HYF<\3?34@0VZ
MSM?E*N2*7#86 '4*H+1'<%E9L"7$8HOEC#4YZ[F'EG%/=MHH_1%D':*!#D#T
M+*7:9&?U)GRMAP\740"SLB8 !C!!T'I3*,FNAP LF]IUA_PWT<1DW4]./U Z
M2,NW=[OC1=X'<)9G]-8KX5PP(B/7Q B"2*[Z<]J""SF#I64F8@G"W%<_.@AV
M[J=HW/VM 7P&$'P'"+J' RVBB+5KI%+2TA<7(#(2CBBHM&+:8,R-MZ\N#@.'
MQLR1HN[ V=Y$C=?8N!8Z,D7[=/8.D$PDP=[4.Q568P=18LBI$#/-PO1[21KW
M:'!H\ PD^KXLSH0"3<NL,\ \=[6%3^TG2'LN,T76'$4FL4DFP34:QCT*;&AC
M]A)N!\:EYAU-UY\V%[;S_'PQK^6X2)$HL2*CU\$R =$H@KC'5 OY.7 1;0Q<
M,!5T"YP\0E,__DRSR&HHC71@=!Z1$#EFQMO@(-JZW)C@X*WRX))DV2FOU'VM
M0(?(9CKJ*.@D;D\S: VDCPZ0]>;BO1N6M@DFR3%DRDF0NG8/,(YVY)(*),Z,
MPDI%:76_?IN6L5/'AE'SW;OUHV3> 6RN9=ENZ:^YNM:6!"EP6QL)D&1*89 1
M78BVR'Q?NY]AMKCKA(Q]#MT$,$=)NP.T/,MY<Q0?9F_"-/\Z?QX^3\GOFI04
M+$?:A7DDY6[Z#?AB,CBGN!8L,F[:7'W=3\^X&U<C[ PA^PX@]'Z)876V_'IM
M$<@B=5394:08$RCA/'%0*\^#\IIEG[5J8G+NDC)NK-X(.$=*?'_,^"UFYOBA
M%@N\'PPZ;W$=IG/,/X?EG"* U;.4SCZ=S>I+7F"9INEZ$H+70C$+H3;Q5K71
M>^ R@:$0@5D5:EOO%E#Z-FGCQO>-H#6P1CHP3]<XV!QUU98(2_R(\]7T"]:A
M%)_PY6*U>H7KU^5]^',2>!+*VPS)9U8KGRUXH0L8'HNR(CO'[FEL-<C]QCYT
MCILPU&I';*BK#J!X5VH3)82.T1O(L?;VTK96U-6U%95,&LEI-$W0=I>4<=.-
M&@'J2(EW<'CYVW2^6%YTB<,5B8,K990)X"+23N^$ H=<@*5X5&=E:^EM"\3<
M)F2<(3.-\7*4M+NT,&0U9V>UPO9-;4-)REFOE]-XMJE%>;^HESV+^9JHH"=^
MN.2:J4*K@'B5+I%=I14#Y$$ZX#HF"F)=%<EIK-(AY(\SV^;DEJRY9CNP?M\Z
M,IYH5$%9&2A65B12*00$G7SMR>T+,Z+VJADC^;*?.^*3I,<=K9O!L':RDOXW
M&TU\Q/64_M6P!?ZW'MVXW/\Q1DY9_&^-3@F5@R3(.U,R,HHPR9DO.6J>>/3D
MZ+?9=-H7_]^\5]AVOWAVMOY(SL9_89ZXQ"4R3H&+JNWYF*R]?IW=-,X)#)4I
MN4E>[^-DC7W#,S!F'K_K.4HG(WI^U:S<8N7EE.QOWBAJ^PO<K'7B;R($#YD)
M#YA$E5>M"W6J0"Y6A.1C3*)\RVSM]<:Q+WT:8:B=U#L((F[R1=O#Z^5&D'ES
MU/P&EUNNG-4>LV+@DR.NDC$0N*4@"1FY#\$R*YJ<S.Y&WM@W1B<U7H/HJ"\C
MMK7'+W U_3"O?$V\E!1M$QR2J2-7D"(7Q\E535K$H)7C1J@#3-?M]XQ]870Z
M@W64A+LS4UMN?EVMSHB3%*VQAN02ZU1ZI;B%4.O)BLE6&N$5FB:NY,,DC7U9
M-((O=8 N.D75]3YU#*-57'(PSI!;Z&3U"$4!J; X$R)7MDG"Z#?H&OLZ: 1\
M':J5#D!V+6OHP:T[H[%2,@5<Y0+UV Y<#@@Z,J\)(W68<>.TK:-\JX9718W!
M-K1V^@+<G4 7R1,D7ER]R@^@A#00C5=0A&2TY2>&IDE.Z2,TC7VW=#J ':6-
M'H%UONOG$J4.B."-YJ",]!1X1 71RH .I4=U3S/E!J#:P_UJ>"5T:D =H(4>
MP71]BP_"%JV1@\=Z52&=@)AD %D3;7.QT<LF]]Y'-V;F@X\:&P]7ARJD W#=
M2)K<<C/)+);H30'A0YVLQR/$B!ED]D*I*'S.37I=WD/+;E!ZNJ?MQXK_2?3\
MOI3B:E%>?\;EYNE'WPT^\-3AKP5W(7^@&\%M,M_E"R\AAB$[R1.KDY0]**TT
M!7+H@ 7/,P5RBF&3DYL'Z#FZKGTKQ?F'\VZ=5[6X*#,35D3@'LEZ!N/)SR-C
M*H+,.GF116ARY?<@1>/>]@V!ASN5[8,(OX.MZRWI@@BH#:A?X!><+3:-&,^Y
MFF 6M V3IDD:"93W 7S0 83A-:,QL\";I, \2M6X:!I(\W=RXX=20P>8>H>;
MQ+"_X9Q$-2.6GN5/T_FTBJE.(K[@RBJA!$\:K*WKCS,#CD6$6*1D13E/;EZ3
MI(R=R!OW=KD-RAHHI@.XW9'5)#LNM3 1=,SG\ZV=B0Z<T\FRS$HN34X([E R
M[DUQ&Q =)^X.$C\O&;BJ^IC$+&HN#EG87!M@!:$I_' <L-3F:L@SMTTZC]U#
MR[B&IZFS=*# .\#,J\5\<9.+BQ[Y%P+R5F-1&D$95IM7,T4!)]G0R*,HTAGG
M0A,$?9.R<6U0"SP-JXP>=K!:D/8@5Q.?I,\H B2)%E3!1.X?.8*:8R&+BSZI
M-O'<HV2-ZX8/C('[&I<-HY .X/4P(UR$D(/1H!/Z;=5(D$:!4)I'(Y,)N<G]
MW'&@:K;YM075,&KH8#.\VL9_(1%N6VR=$5-7YWH_85DLSZMJWX<_<76[^(UB
MCYM/V=9U_(;KCPOZS1?ZR.:P<"*L3(D%"3S7Q+'B.<0<:=M@)3KI9!*F2;.]
M$_(X;EI@BPVZ5X!T8(LO63Y?^S]1+%ZF)&YCHDHE@/&UMX^1AL2=)9"TE904
M02%OXCX^0,^X.87M,'F<X#O SYOE@JC>A% Z)^NE"I"-)LHI:@>OL@)NM):2
M*Y)6D\/9*Q+&S0QL@9(#Q?LD-N7'BGA_WDQ1G@B4+//"01M+/"==,X2< U26
MW).@1/!-,E"'('[<S,%QMM&!5=J!?7N%ZVNG1.1JDYR$ RY+(N,L4BUH1PB"
MN5PO]65I8N)N4#%NQF"3 Y2#A=R!H;MH'W61+_M36$U3O3>;SLXNFON\F*[2
M;+$Z6UX[\U;<2NZTA&04+03-:D.?R,$(8E_R$H-O$NL>2.^X:84M4'<*Q75@
MP;[!Y@0CHE=.@/8I$CN9@R]1@+-:I>B%T[Q)&LHWZ!KW..\DV-@/CWLIJ@/<
M_1VG'SX2W<^^D'?P 5^=?8JX?%WN)%=>K>5<LBSD&9A(QE^)VHE(QT("=$[)
M+)/')D6V^Q(Z<B9L"U/85%>=8_$:>[=77%(F9EZC+1:)R^P5A! L\!QK4P3R
M5UV3CG6'D3NNQ6P+H3WP.I ^GUP2[HT&DILX8<!<W+L/;YN2^PUFAN_5L[6J
MFPD==_IP7B6%.PI5:WVOJ\W$-D-EZJY>8]>8E5)>Q=0D0VP_.@<\TXM642B6
M$F"(F1:I=;77LH9H<V'!<EI(3;I;[WFF=XI:@<$1\LA9WSYB[V![?:B![>_S
M)899K?7[M\6L&N2_A>F\,OAZ_@[3V7+;4&TY7=&O7M!?YQ_(]YTN\F736YL<
MN2^2W.E2LW(<>=)1H :-T41;-%>R"?Q:,=1-BZ#F8.X"$ATOC1N]G7T)P6?R
M2THVA99[I)4>-:$20_)<%ZW:C-4>K/GV*9H+C0;9@U75P>'D/>Q<L')83U5F
M4N:"G';M2+[)9@@Q*N I<&9]$#HUJ2(<F(]N.A\U!_68 .@;_SNQZY6ODT$M
MF$T/84X;3?#%0LZD$2Z=(D_LQ'@?#-^G:,$T)KX'5W '[L0C[$Y\M,$+)T Z
M6X=FVP(^<P3-O,J,\9QO-[QLCM5N6C6-B<.]%/,DFD-?/ZDY[P$^X%G3]:[B
MS0Z8[B-[^%.E1]J1,ZT8MXE#277:@E 4XB=>:Y:8$3$7I]OT8]B)NN-G,YR_
MY'TUOI.<F&?D.$.*I0X#\ 5<HE4@'0^>6\MBFPG5-\GHYB1I(%3<'9MPL- [
MV-DNJ=]*I-K3Q;RNU6=_3E<3)*)*80I0UKM/(0/X0AMVMCP8G9VQNM'LH$>H
MZ@10!ZC[(>0<+?L.@'2+AQ>+3V$ZGPCC3;">EE-4]>K'V-JDD_9@;WQ()OC$
MFK08O)>:3H!SO+9O9S <+?H.\+.=$?$;UBO%B>+"!<\,*!/K<4^RY!QF"4RB
M,EA$L*E))Z[K1(R<"7.\3F_?<QPJX![ <:,YZSD/402A9*JC9%2F&%(2#\04
MQ.@]\6$B;S,"]CYBQ@7+X:I]M GN 7+N "O7.LJ=,Y!\LI*(A\R4( :\ !=M
M H&\1!NU5&UZ==^A9-Q[J,%0<IR$#X;(%US&1=NAY.?L$*ZU0UYG&V<RL[4Y
M*GEW%D1R%F6)/F*3[>=1JL:]$1H,/,-)O@-;L\,TV7/&;"RZEO'2IJUIA1A>
M)Y6Q0BL$C5.:!2^:]*+9F<)Q[V:&@U<3C70 M=MCL\^YT"HF@Z9.U."L>H0&
MO!(<4#LRN\2>DTTB]/O)&?<"9# 0#2#K#A!SHQ_J!0N6NR"X([4Z#BIF#PX1
MH024*E@RLJ')D> ]M(Q[23$85HZ5<@= N?^.[L),.L^$9IF,8RGU%J7FQ%D&
M*(JDR""A#JX%8AXC:EP_>OC0?# %C BFU7(]>;[=>FL/P5(PK;<Y9*_+L[SX
MO-%./>ER/"HB6A$#BM69K0:<2AFP=I)G3@>V4Y=U>M\U,-'?;@-I5X(Z20X\
M_#BYB>0[1]+YHE-<6:/)<T/FZOQ?,MR1:08YUMN<()'MU#MT$"R-><;<!@)[
MX.L ?72.L&?Y_YQMF\N<VV&>L@F( 3 ;$IW":H>3@,1CK+V_.,==CAN'L5NW
MB.L7=8< 8Q^[=HR6.G"]+LW_2XHW?J5O5Y/D??+:;LH(6>TM5KN %0?D/TBB
MGEG#FUR9W26EDQSD 2]:#Y-R!SCY=9YJG($O</OGK_.[V0QOR7W\9;'\(RSS
M1",SCA<)5M;##<\#!*\L^9 V1R^M,]CDN&E/.CNYD3T0%G?[M#3340<0O#N>
M!X5)F=D$/H=:&6\E1/0:;+$I*IUDTFWRBPX;DM0*1DWU?MN2':6$@U'T>;/M
MTGI9K@?:]FX+Z+"L^!0TTT(#=\2V0NTA&($@1(C)>4PN-"H,'8+\T3M\GPZU
MIU=W-U"_5EXJM4'A?*V#1PV*ZP*!Q0A99/)_)6<L-CE*V[.JMV43\)-![D"Q
M=[#//E8/]^Q+F,[J&B$1O0LSO%:[>1D(7>:_BZ PIL@K+&0=]HD04-6F.-YH
MQ1(OHHEU'(J!T1OBG@RLHZB\ ZAO)+H=)'J]Z'CKY%PT8\)-\0B)9:/Z20J%
M8>5)EYJ-I+.!:),":R3*5+3TK(D1/8#6T;OGGG:#;ZC(?K&ZF=G]((<.12D9
MM L%E%,>8N89>*A5;SE*$YM4ANU/ZN@=?,=&ZE!J[!>HV[7X"O_8_&HUT3:P
M[)V 8$4@(9H,D=QK2(85G1)SR!L50NU"WNA=?,<&Y#'JZB+#\K&%=L66#3H[
M7RBDBZ'>"]3C>LT,>$9+SC)C4VXS_&\7ZD;O^#LV"(]05@^&\,Y9F0Y>9"8%
M&"44N1RI5@1;\I9U]$(%48)LTD?ZL /+EEU]1SRPW$<)1Y[B_#S//1U7RD+!
M&*(!&:.O?1 9+1TKP05/D9F.09DV\#O=<673_JM/[;QR'WT/BO23];X,JX^_
MS!9_#-OS\O*AC7M=WD_\\-T(+E]T66ZN%8\9R? YRVN^J?#@<K:@)<N:Z124
M:&0('B9J@(D-]9EOEHLO4Q+?3U]_ISCJU_GET,]G:3W]LCVWNA!#%-HI5QBX
M9&@G0)\AU*FQ2@=:H[GD7-JDENY-:B?WU,=BZ9X!$"UUUH$/>.T:H-B:0"L1
M#/-$KZ>M(902P? L1(ZE</%=]U1MK>R'+V#VD7P'F+DZ5U^]7[Q%VMG3=(8W
MAJ6\7^PKRB(T8B+9491$L9,(Y ;$P"'QK(IDQ?LVH4<+9D:>SGE:'(^.A@Y6
M1(W_PSSA>0^=9_/\][!<!A))O93"Y9=IHAAO^7P6II]6DUBBC%EY$,(2<T5S
M<)XX+#S1GTS8W*9Z=B\JQ[7%XX/J=NY:,PUW -\72&].TZUVY_G9IQK#_=?V
M<%]8JZ7+!8S 3*P4A& I1A-2\%H@*@5KTAO@$9K&-:_=07,H[74 Q&<I+7'#
MQS4F7I<ZT6AQ5CL!S?.;)7Z:GGU:79]MFZ)G.6E;N[W2]A62HN7&&%ARH)QU
MS@;?JG;\ '+'S3'J#KXGT/G^R/9;9,_Q0ST5>=\P3?U2K.=]'J[)%'T4)D*@
M(*#N(74@)?/ M(\VEA1-LXG>.Y(X+I!/[.8VTEP'1O<N9[3>/H=I?G%.S_DD
M:%J(FSRL9ZL5T@*TQ8N8R+.)3)5:SZL@2&X@NX0ZBIAU.A$^=R&WMPSX8<#S
M38P.KLFN36GEZ6K];YGC%GD67H/(R=*:YPBNU/9+F=0HN-(J-SE#W8V\WE+<
M3P3+HS4U/@SK?<T]G)$WL_%:WH2O]>JK.C=GE^MN=;'P7DY#G,XVF],D<66<
M)$<F%<W(D<G$=H@!BO&)&\E))K<"K+M714,1TUOZ^Z!P'$5C'>SONSM*DYAL
M<LYQ<JKS9O8A V\8L:>E%%X8S5V34:>[D]A),XKQ+IKVTE$'DTX>X&P;RMWO
MIF>%(7-AZRF%(7_$18C!&!!!8RG%9Q+F"5'X"*F=%("?"(U#Z:P#FTC&_OP(
MY%GZS[/I$G\+RW_@)EOEJGZ$9.BP1*LA^:QK27TF:28)++OB%.TWS#4!XD[4
M=7E9.AA$[O1F'EI?XWN0URZ"$V)>_4)"K@5,Y'+\%M:5IZ^OR[U\)N.T=6$S
MJ84\9>\D1$TPTM$RJUQB2C>IF]B;TBXO0IMAM*D>>S2:Q#$Y*.NO;V9AOB9V
M:RK@Y_J1"2II8O0&]&;W45R!PT1;D".NA).IV":W^;N3V.7AY<G,YS":Z\>&
M[B[/2<; >& 1F',4O267*'H+"@**FGAM$I--ZGIV)[&;*9!C>95[Z:C?&.>7
MZ3S,T_VKV=$B9M%D2,I$4"%ZB*D@)'3!B<*$BOJ$*'R$U&YF-IX$C4/IK*/M
M^BUNNGV_7[P/?_Y]NO[X<3O@NN:MW%_/*84L@CL-&$H&95"26&, %K0VH1@G
M;).;G4,)[C(2&@Q(#VSE3;7:S\9^W:F^S,':]'EX?3XK<>)\YA)5!DS,U=D:
MY!B1%,%[49!SYGEIXVM^D[0NPY]FP!Q64QT8T-T%.#$^^E#;-%#H)LEK+H*<
M<^4A:U]2MC*X-IT,=B>QFY&W8VWC>^FH Z>RLE7_KVOG"ZVBC<TGB4T3&=CZ
M"PK;;O[@VB>WY<EW+[O.B_1^_C-]#/,/^):TLNT;.PD%A2@<0;C:Y]_*#*%.
M4<>(D2?/M0I-'-+3LCENVX1FJZ!CK#SUE31Q-F2)F9A5IM3;7D4:4@YX4<P$
M@4XT&E]^#-7C=F;H$^=[:;*;]HA'L7RYB%],5Y\7JS#[VW)Q]IG^Q2:[=KZ>
MSL\PGU\R+^:KB8C::\]KUQ1>ZQ:4A$ B I\49NZU0-;D_O^43([;6J+/I=$2
M)X,Y\D,7[;__B#^=K:9S7!U4GG_]GP]3B/\@00.5W+]>?@CS\P3[JZ+_;=7(
MFVMDOR[G[G.87?4#N 1ILDQC-@*"E^1&:Y[!1^Z@!&U\CKX$WL11'(3ZH[+]
M+I3SGO3Q$_WT'Y.@+(NE4"SK4J(=Q6>(5F0P-CH=7$9Q6Q8/Y.[=>?2X9UJG
M1\J-)+WC!/T4#,ZK6CQ8IW:\J)/T9L<:H#N/&]P@/4YP5P9*.250:0>.)46;
M$ZMQ?B&30CLK2R9&8YM4@XUJH"[]B_01\UD]<Z/-'FD1U'W_!7[!V6)SO_NL
M%JU^V+SS>>W(0Z]\OZ (L"R6GWY9+#>YKJOM0!'/HU(E\KJKT_+ESD*=?@3T
M4Y^1\Q!RFR8L@['P/1C1?=!\ITW3.&#HX.CV/%]\^E_U$F2U7KTNO\\_+Q=?
M,)]G/DQQ]?.?U>G%7 ^LK]<>_O3U(COB]9*^^S^8UIO18#&*(#%J<"+5&=XI
MUZ&5 4S,-NJL!5.Q37 T."\CM^L9"99W(J9Q,=+!,CDG_6*V>'$EU0[3/@9+
MIB8CF1IG ),4WDB;4#<I];]!Q;C0'!T3=R_5#E30B.C:%MJL:)5_FJ:WM0!Q
M^?R%5,]Q-GN/Z>-\,5M\^'K)DF72T_86G SDW<=:G$O?V5@'EG&#TOJ=(JC=
MWC<NNH[0YJ*M:#NP14?L!2\OQY/)(#A7PH NEM>>^0IJ:@/86J\E8T@L-FFM
M,P3Q(Y<V];$IGQP%'2#_;YL^0F\QX?3+1H E<>TB:DBI\-I0/T*T4H(71NHL
MM.*AR49\FY!QK>7IH; 84"_=GD*]._OT*2R_+LJ[Z8?YM$Q3S0#?UL!NVO?.
MIJFFBQQP(+7CDX<YFSJ$C8&.J>Z^YNK(D_9R20*!)*RO8WP-Q$PPH=TV^1!Y
M=&U2)Q\FZ>@#I<?$>W5 *X1CQ>5J\PW6 ]J:VE4B!)FDS8J5*)LT#]V-O)&;
MV0V#ESNG.\-KYHD;K?;&:Q0C-I8Q8XQ9U,Z3H"(AAU&4XKC+D+Q7WFB4:)O<
M]+4S9N0Q)*Q.0]75V^GJ'\\)X--U_6XBC<C6>@-6U,V=J]H/GUS7[+A2*3'!
MVS2@?82F;LW6/LBX<^PVD XZ<-SOS[1__?G\D/_7#:/3+UBK[+:K^&MMMN13
M21H*EZG6U]7.)0J!%5.82.AS:I)B<P"M(_?9; ._UCKK ):O\(]KPELNYO1M
MVEXK;1G:?KUR$3#X(*+BD- P4-ZRFAA'_ 46LQ;<J-C$:]V7T)$[9[8!9%-M
M=>O074YM+;>GMA[BO#WRM&$<M5W)'<HI>WBF[07D1+(LI% @E%H.'A-]AUH
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M]1\8EO=</C!OLD.9::\SAISJQ.K\" %6I8S:FFRP2>_N@?GH%>"#(_! [+>
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M L8")EBFC<F2!]7C>KG)QLA=:+Z_Q7($2GK85A[+3+I^BG!Q'YHG*23)4M&
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M^H.;QO>S:_?;% 7QO,@>9]!^3/]:3;OI\E[(:]$\DLO$)<M34A)8<A:#,2[
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M;C.6*CVW2^@;F$CKL'=QC-/-8#=:&:T@V"Z-N6/M"X@?N$/=-1"/UW;\C:T
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M:6G:MM\L=_^$94BX$FA&HT+B8015)SR&R664$KZ@>&98+IE21GC\-3UC/&!
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M&<NS*X6W5\H;=O9<V^RU:P<^0KT,-U$68^P)T*]BX_+K,"#IYXQ):LX ROC
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M<RTR,#(P,#8S,"YX<V102P$"% ,4    " !9@0U1,JJ;*%<8  !\\P  %0
M            @ %MIP$ 8VQB<RTR,#(P,#8S,%]C86PN>&UL4$L! A0#%
M  @ 68$-4;B.CV-%.@  IV<" !4              ( !][\! &-L8G,M,C R
M,# V,S!?9&5F+GAM;%!+ 0(4 Q0    ( %F!#5%KX $T:JT  '9C!P 5
M          "  6_Z 0!C;&)S+3(P,C P-C,P7VQA8BYX;6Q02P$"% ,4
M" !9@0U1D@L4RA->  #P100 %0              @ $,J ( 8VQB<RTR,#(P
M,#8S,%]P<F4N>&UL4$L! A0#%     @ 68$-4=XLYB)V!P  PBD  !D
M         ( !4@8# &-L8G,M97@S,3$R,#(P,#8S,'AQ,BYH=&U02P$"% ,4
M    " !9@0U1;X&QEH4'  "&*P  &0              @ '_#0, 8VQB<RUE
M>#,Q,C(P,C P-C,P>'$R+FAT;5!+ 0(4 Q0    ( %F!#5$L5J_ S@4  '8@
M   8              "  ;L5 P!C;&)S+65X,S(Q,C R,# V,S!Q,BYH=&U0
M2P$"% ,4    " !9@0U1'-MA<]X%  "Q(   &0              @ &_&P,
M8VQB<RUE>#,R,C(P,C P-C,P>'$R+FAT;5!+!08     "@ * *4"  #4(0,
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
